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Abstract
Iron is abundantly present on earth, essential for most microorganisms and crucial for 
human health. Human iron deficiency that is nevertheless highly prevalent in developing 
regions of the world, can be effectively treated by oral iron administration. Accumulating 
evidence indicates that excess of unabsorbed iron that enters the colonic lumen causes 
unwanted side effects at the intestinal host–microbiota interface. The chemical properties 
of iron, the luminal environment and host iron withdrawal mechanisms, especially during 
inflammation, can turn the intestine in a rather stressful milieu. Certain pathogenic enteric 
bacteria can however deal with this stress at the expense of other members of the gut 
microbiota, while their virulence also seems to be stimulated in an iron-rich intestinal 
environment. This review covers the multifaceted aspects of nutritional iron stress with 
respect to growth, composition, metabolism and pathogenicity of the gut microbiota in 
relation to human health. We aim to present an unpreceded view on the dynamic effects 
and impact of oral iron administration on intestinal host-microbiota interactions to provide 
leads for future research and other applications. 
1 Summary and scope of this review
Iron is a highly abundant metal on earth and is vital for virtually all organisms, including 
most bacterial species. Nonetheless, iron deficiency is the most prevalent human 
nutrition disorder worldwide and is generally treated by oral iron administration. Notably, 
accumulating evidence suggests that unabsorbed iron can stimulate growth and virulence of 
bacterial pathogens in the intestinal environment. Simultaneously, host iron status influences 
the local defence against pathogens. Salmonella enterica serovar Typhimurium, a highly 
prevalent intestinal pathogen around the world, is one example of a pathogenic bacterial 
species that can deal with the stress of iron limitation, iron abundance and host defence 
factors. It is able to adapt to these environmental triggers and exploit the environment to 
thrive at the expense of other bacterial species. In this review, we will thoroughly discuss 
the many different factors that are involved in iron-mediated host-pathogen interactions 
in the intestinal tract at the molecular level. We will first give a concise introduction in gut 
microbiology and nutritional stress. The central part of this review will present current 
knowledge about the effects of luminal iron on gut immunology and on the gut microbiota 
with respect to bacterial composition, pathogenicity and metabolism. These and other 
factors will also be related to pathogen stress in the gut lumen and are summarised in 
Figure 1. Furthermore, we will mostly focus on S. Typhimurium and its ways to deal with 
environmental stress and to turn the external situation in favour of its own growth and 
colonisation. Finally, we will place the topics we discussed in the context of serious threats 
that persist in tropical Africa, such as infectious diarrhoea and S. Typhimurium infection 
that is often associated with invasive disease in this region.
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Figure 1. Overview of stress factors towards pathogens in the colon lumen.
Schematic summary of the stress factors to which pathogens in the colon lumen are exposed. This is an 
incomplete list and only the main factors discussed in this review are depicted. 
Figure 2. The Fenton and Haber-Weiss reaction. 
Ferrous iron generates the hydroxyl radical and hydroxyl ion from hydrogen peroxide (1). The superoxide 
radical (to be formed from dioxygen) can then reduce ferric iron back to the ferrous form (2). The sum of both 
reactions is therefore described as the formation of molecular oxygen, hydroxyl radicals and hydroxyl anions 
from the superoxide radical and hydrogen peroxide (3) (Crichton, 2009). 
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2 General introduction
2.1 Gut microbiology & health
The human gut is the natural habitat for a unique large and dynamic bacterial community 
that greatly outnumbers human enterocytes. Major functions of the gut microbiota include 
important trophic effects on intestinal epithelia, on immune structure and function, and 
protection of the colonized host against invasion by pathogenic microbes via the production 
of trophic metabolites and immunostimulatory molecules (Abreu 2010, Flint et al 2007, 
Hooper et al 2012, Macfarlane and Macfarlane 2012, Stecher and Hardt 2008). The healthy 
gut microbiota is a balanced community that is shaped by host immunity & metabolism 
and environmental factors (Sekirov et al 2010). Perturbations (e.g. antibiotic treatment and 
/or overgrowth of enteric pathogens) of the balanced gut microbiota have been associated 
with gastrointestinal disorders such as diarrhoea, gastroenteritis and chronic inflammatory 
bowel disease (Sekirov et al 2010). The number of studies investigating the effect of diets on 
the mammalian gut microbiota composition and metabolism has increased greatly during 
the past years and revealed that the gut microbiota is clearly influenced by the host diet 
(Power et al 2014). It is currently not well defined whether the type of diet can significantly 
contribute to host health or disease via alteration of the gut microbiota composition.
2.2 Factors that shape the gut microbiota
Colonisation of the human gastrointestinal tract starts during birth and is known to be 
influenced by the place and mode of delivery (Penders et al 2006). Known factors that 
influence gut colonization after birth are among others hospitalisation, hygiene and the 
type of feeding (breast feeding or formula feeding) (Del Chierico et al 2012). In later life 
e.g. diet, hygiene, illness and aging will influence the gut microbial composition (Power et 
al 2014). Importantly, the gut microbiota composition is not only shaped by environmental 
factors, but also by genetic factors (e.g. genes related to host immunity (see also section 6) 
and is thus always a result of a combination of the two. This leads to highly variable inter-
individual gut microbiota profiles. The relative contribution of these factors to the shaping 
of the gut microbiota composition is not well known yet (Spor et al 2011). An interesting 
study of De Filippo et al. in which the gut microbiome of European children was compared 
with the gut microbiome of children living in African rural area, showed large differences 
between the groups. In this study ethnicity and many environmental factors were different, 
but it was suggested that diet played the dominant role over other variables (De Filippo et 
al 2010). 
2.3 Nutritional and metabolic stress in the gut lumen
The gut microbial community thrives on complex carbohydrates and proteins that are 
not digested and taken up by the upper intestine. The balanced community also depends 
on the provision of micronutrients for metabolism and replication. There is a continuous 
competition for these nutrients which is reflected in the different requirements and uptake 
mechanisms that certain species possess. Metabolic competition and interactions are also 
ways in which the gut microbiota restrains the growth of unwanted pathogens (Kamada et 
11
1
Nutritional iron turned inside out: intestinal stress from a gut microbial perspective
al 2013). One of the micronutrients that the vast majority of bacterial species require for 
their growth and metabolism is iron (Andrews et al 2003). However in the human body, 
iron availability to microbes is generally extremely limited, due to innate iron withholding 
mechanisms that aim to prevent growth of pathogenic invaders (Cassat and Skaar 2013). 
Such a tightly regulated system of nutritional immunity is not known for the lumen of 
human gut. However, also in the gut lumen with high amounts of dietary iron present, gut 
microbes have to deal with the stress of iron limitation as the presence of freely available 
“unbound” iron is probably limited due to the environmental conditions of the colon lumen. 
The balance of bound and unbound iron can be (re)disturbed by the oral administration of 
supplementary iron, a common strategy to treat iron deficiency, which is known to cause 
alterations of the gut microbiota composition and metabolism (see section 7&8). In Figure 
1 we summarised the (iron-related) stress factors that will be discussed throughout this 
review.
Although most knowledge on the effects of iron in the gut originates from studies on the 
colonic microbiota, we predict that the effects of iron availability on the small intestinal 
microbiota are likely to be different from the effects on the colonic microbiota. It is important 
to realize that the small intestinal microbiota has a much lower density of residing microbes, 
and that its composition and metabolism appears to fluctuate quickly in response to dietary 
input (Zoetendal et al 2012). Iron may play a large role within this environment where also 
pathogenic bacteria like Salmonella spp, Vibrio cholera and pathogenic E. coli may colonise. 
However, relatively little is known about the small intestinal microbiota, as it is much less 
accessible compared to the colonic (faecal) microbiota, which makes it difficult to study 
(Zoetendal et al 2012). Therefore, the focus of this review is on the colonic microbiota to 
which we refer to as ‘gut microbiota’.
3 Redox stress and microbes
3.1 The redox chemistry of iron 
Under physiological conditions iron is found mostly in the ferrous (Fe2+) or ferric (Fe3+) form 
and the easy redox cycling properties of this metal make it very well suited as a biocatalyst 
in proteins, or as an electron carrier (Andrews et al 2003, Crichton 2009). Under aerobic 
physiological conditions, iron is mostly present in its oxygenic ferric, virtually insoluble, 
form, with 10-9 M being the approximate concentration of ferric ion at pH 7 (Crichton 
2009). Fe3+ is practically only soluble in water when it is attained in a strong aqueous 
complex. Thus, despite the high abundance of iron on earth, its bioavailability can be very 
low. Fe3+ prefers oxygen ligands, while Fe2+ favours nitrogen and sulphur ligands (Crichton 
2009). Ferrous iron is much more soluble than ferric iron, but it is mainly found in anoxic 
or acidic environments. Importantly, free redox active iron can be very toxic under aerobic 
conditions via the formation of reactive oxygen species (ROS), generated through the 
Fenton and Haber-Weiss reaction (Figure 2). Of the ROS, one of the most reactive species 
known is the highly reactive hydroxyl ion OH-, which can induce severe damage to cells and 
biological molecules.
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3.2 Bacteria and redox stress
The vast majority of life on earth, including most microorganisms in the bacterial kingdom, 
depends on the presence of the transition metal iron for respiration and various metabolic 
processes. Only a very limited number of bacteria are known that do not depend on 
iron for their growth. The most well-known and notable group concerns the beneficial 
Lactobacillaceae, but also the pathogenic Borrelia burgdorferi does not use iron for its 
metabolism, both are dependent on manganese instead (Imbert and Blondeau 1998, Pandey 
et al 1994, Posey and Gherardini 2000). In addition, certain species of Streptococci that 
normally use iron can utilise manganese as an alternative transition metal (Jakubovics and 
Jenkinson 2001). Furthermore, bacteria that utilise iron have to avoid the toxicity of free 
redox active iron both intracellularly and extracellularly. To this purpose, bacteria possess 
several mechanisms to detoxify iron or oxidative stress directly, of which a selection is 
described below.
3.2.1 Detoxification of iron
Iron in its ferric form can be bound to three known types of bacterial high affinity storage 
proteins; ferritin (similar to what is found eukaryotes), bacterioferritin and DNA-binding 
protein from starved cells (DPS). DPS is an iron detoxification / iron storage protein that 
also binds to DNA and plays hereby a role in the protection of DNA from redox stress 
(Andrews et al 2003). These iron storage proteins lower the concentration of intracellular 
free iron by storing it in a soluble and non-toxic form. Iron can be released from these 
bacterial stores in times of iron scarcity, for example when residing inside mammalian host 
cells or in the blood stream (Andrews et al 2003).
Alternatively, bacteria can export a surplus of iron. E. coli can for example export iron via 
the exporter FieF and an iron-citrate efflux transporter (IceT) has been described for S. 
Typhimurium; these iron efflux systems have the supposed purpose to prevent stress from 
high levels of free intracellular iron (Frawley et al 2013, Grass et al 2005). Also a haem export 
mechanism (HrtAB or orthologous proteins) has been shown to alleviate the iron stress 
of haem in certain bacterial species (Cassat and Skaar 2013). Finally, Bifidobacteriaceae 
are able to bind iron to their surface, which subsequently reduces radical formation in the 
surrounding environment and may in the colonic lumen function as a mechanism of iron 
sequestration to prevent iron uptake by pathogenic species (Kot and Bezkorovainy 1999) 
(see also Figure 3).
3.2.2 Protective enzymes that neutralize oxidants
Several bacterial enzymes are known that directly counteract the formation of oxidative 
stress. One of these enzymes is Superoxide Dismutase (SOD), which catalyzes the 
dismutation of superoxide into the less toxic oxygen and hydrogen peroxide. Notably, the 
various members of the SOD family use different metals as a cofactor for functioning, 
among which are manganese and zinc. Host sequestration of manganese and zinc by 
calprotectin (excreted by immune cells) can therefore inhibit this bacterial defence 
mechanism and this way making bacteria more susceptible for oxidative stress (Damo et al 
2012) (See also section 9.1). Another well-known enzyme that neutralizes reactive oxygen 
13
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species (ROS) is catalase, which catalyzes the reaction of two hydrogen peroxide molecules 
to the non-toxic products water and oxygen. Finally, bacteria also possess peroxidases that 
can contribute to the oxidative stress defence. Peroxidases include glutathione peroxidase 
and alkylhydroperoxide reductase (Ahp) that can rapidly detoxify hydrogen peroxide, 
hydroperoxides, or peroxynitrite (Crichton 2009, Mishra and Imlay 2012). 
4 Iron, a precious and contested nutrient
4.1 Bacterial iron uptake
Although iron is present in sufficient amounts to sustain their replication in most habitats, 
bacteria still have to deal with the low solubility of this metal. Therefore, readily available 
iron is generally scarce and bacteria have evolved multiple iron uptake mechanisms to be 
able to fulfil their average need of 10-7 to 10-5 M for optimal growth. Several mechanisms 
of iron uptake were previously described for various bacterial species, and were most 
extensively studied in E. coli. In the latter bacterium, iron can be taken up in both its ferrous 
and ferric form. One of the mechanisms of ferrous iron uptake is via the Feo-uptake system 
(Andrews et al 2003). Moreover, ferric iron can be reduced to ferrous iron via an extracellular 
reductase, after which it can be taken up in the ferrous form (Cowart 2002). Alternatively, 
ferric iron can be taken up as ferric citrate, or bound to excreted bacterial siderophores, small 
iron chelators with a very high affinity for iron (Andrews et al 2003, Miethke and Marahiel 
2007). After excretion, bacteria re-internalise the ferric-siderophore complex via binding to 
specific receptors and transporters. For example the ferric-enterobactin complex binds to 
the outer membrane receptor FepA of gram-negative bacteria, after which it is transported 
to the periplasm, a process dependent on the TonB system that provides the energy for this 
transport. Next, the ferric-enterobactin-complex is further transported into the cytoplasm 
by ABC-transporters (Chu et al 2010). The role of siderophores in the colonic lumen is 
further described in section 5.3. Direct uptake of haem-bound iron and scavenging of haem 
with haemophores are other specialized ways of iron acquisition (Andrews et al 2003). It is 
important to mention that haem-iron is much more bioavailable for humans compared to 
non-haem iron (Zimmermann and Hurrell 2007), that haem causes oxidative and cytotoxic 
stress in the gut lumen and that haem can alter the (mouse) gut microbiota composition 
(IJssennagger et al 2012, IJssennagger et al 2013). In this review, we will however focus on 
the effects of non-haem iron on the growth, virulence and metabolism of gut microbes 
because dietary iron on average consist for 90% of non-haem iron (Hulten et al 1995), which 
percentage is likely even higher in the in the tropics. Furthermore, oral iron is always given 
as non-haem iron.
4.2 Iron & bacterial virulence
It has been known for a long time that the scarcity of iron generally limits bacterial 
growth whereas iron availability often enhances bacterial replication and the expression of 
virulence factors in pathogenic bacteria, thereby exaggerating infection (Bullen et al 2005, 
Litwin and Calderwood 1993, Payne and Finkelstein 1978, Weinberg 1978). Furthermore, 
knockout studies have shown that iron uptake mechanisms such as FeoB are required for 
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full virulence in vivo (Boyer et al 2002, Janakiraman and Slauch 2000, Naikare et al 2006, 
Tsolis et al 1996). Bacteria sense the availability of iron in the environment and a change in 
the amount of available iron (for example, from high to low) during invasion of the host is 
an important signal for the expression of virulence genes. On the one hand, under low iron 
conditions, the production of siderophores is derepressed, and also the production of toxins 
may be upregulated (Litwin and Calderwood 1993, Payne 1993). On the other hand, in vitro 
studies have shown that freely available iron can directly induce the expression of virulence 
genes in S. Typhimurium; especially bacterial adhesion to intestinal epithelial cells seems 
to be stimulated when iron is highly available (Bjarnason et al 2003, Kortman et al 2012) 
(Chapter 5). Thus both high and low iron conditions seem to be able to stimulate different 
aspects of bacterial virulence. 
4.3 Battle for iron in the human body
Both the host and the bacterial pathogen require iron for their cellular functions. As 
discussed above, free iron can be very toxic and that is one reason iron is bound to high-
affinity host proteins such as ferritin, transferrin, lactoferrin and haemoproteins, resulting 
in extremely low free iron concentrations of about 10-24 M (virtually zero) (Raymond et al 
2003). In the human body, tight binding of iron to proteins is also an effective form of innate 
defence against microorganisms, as they relatively require much higher free concentrations 
of 10-7 to 10-5 M for optimal growth, but which is still rather low. These host defence 
mechanisms are further enhanced upon infection. For instance on the systemic level, the 
inflammatory response evokes IL-6 production, which induces the production of the iron-
regulating peptide hormone hepcidin in the hepatocytes. Hepcidin in turn, binds to the 
iron exporter ferroportin at the membrane of host cells, e.g. macrophages and duodenal 
cells, hereby inducing its internalisation and degradation (Kroot et al 2011). The result 
of these events is a decrease of intestinal iron uptake, an increase of reticulo-endothelial 
system (RES) iron stores and consequently a decrease in iron availability to extracellular 
pathogens. Therefore, the ability to overcome iron withdrawal mechanisms of the human 
body in general is an important virulence trait of bacteria and there is no fight for iron 
without the armour of the pathogenic opponent. To acquire iron in the iron-limiting 
conditions created by the host, in particular during an inflammatory response, (invading) 
pathogens may express receptors for host transferrin and lactoferrin, but more well-known 
is the secretion of iron scavenging siderophores (Andrews et al 2003, Cairo et al 2006). 
These molecules mostly have a very high specificity and affinity for ferric iron and can 
therefore compete with iron bound to host proteins. To illustrate, transferrin has an affinity 
constant for ferric iron of about 1022, while the association constant of the siderophore 
enterobactin for ferric iron is approximately 1051 (Aisen and Listowsky 1980, Carrano and 
Raymond 1979). We note that (slightly) different association constants are circulating in 
literature for transferrin and enterobactin (Supplementary Table 1). Fortunately, the fight 
for iron does not end here as the mammalian host has evolved a mechanism to sequester 
some bacterial ferric-siderophore complexes with the innate defence peptide lipocalin-2 
(a.k.a. neutrophil gelatinase-associated lipocalin (NGAL), siderocalin, 24p3, uterocalin). 
By binding to the ferric-enterobactin-complex, lipocalin-2 prevents the uptake of ferric 
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enterobactin by bacteria, thereby enhancing nutritional immunity (Flo et al 2004). However, 
certain pathogenic bacteria can evade this sophisticated host defence mechanism by the 
production of ‘stealth siderophores’ (Allred et al 2013). For instance, S. Typhimurium and 
pathogenic E. coli can produce a C-glucosylated form of enterobactin, termed salmochelin, 
which escapes from the binding by lipocalin-2 (Hantke et al 2003, Raffatellu and Baumler 
2010). Another example is the production of aerobactin, which does not bind to lipocalin-2 
either, and is produced by for instance Klebsiella, Shigella, some Salmonella serovars and 
pathogenic E. coli strains (Flo et al 2004, Wooldridge and Williams 1993). If and to what 
extent the here discussed host and bacterial mechanisms are involved in a battle for iron at 
the intestinal host-microbiota interface will be discussed in the next sections.
5 Iron speciation and bacterial iron uptake mechanisms in the colon 
5.1 Iron speciation and availability for microbes in the colon
As far as we know, bacteria synthesize siderophores only when the availability of iron in their 
surround environment is limited. In the colonic lumen, large amounts of iron are regularly 
present, mostly constituted by excess dietary iron not absorbed in the duodenum (the major 
site of iron absorption). This is illustrated by the high concentration of iron found in faeces 
of British adults on a standard western diet and in weaning infants fed with complementary 
solid foods: approximately 100 µg Fe/g wet weight faeces, which is roughly equal to 1.8 mM, 
and which is much more than the minimal iron requirement of most bacterial species (Lund 
et al 1999, Pizarro et al 1987) (see also section 4.3). Moreover, the tight mechanisms of iron 
withholding for systemic sites as described above are not known to play a role in the gut 
lumen. Nevertheless, iron speciation and the potential presence of lactoferrin, lipocalin-2 
and maybe other yet unidentified defence proteins in the colon mucosa probably contribute 
to the limitation of iron at this site (Figure 3). Notably, lipocalin-2 is only expressed at a 
low level under healthy conditions (Cowland and Borregaard 1997) and would be more 
effective when readily available iron in the lumen is limited and thus when siderophores 
are produced. 
Due to the nature of foods and of the oxygenic and acidic environment of the stomach, most 
of the dietary non-haem iron that enters the intestine is in the ferric form (Jacobs and Miles 
1969). When the pH in the duodenum and small intestine rises, the solubility of ferric iron 
decreases (Figure 3). Simultaneously, the increase in pH favours the oxidation of ferrous 
iron in the presence of oxygen. Further downstream, the reduced environment in the colon 
may favour the reduction of iron into the ferrous form (Hedrich et al 2011). Also the colonic 
microbiota may influence the valence state of iron by the action of extracellular reductases 
(Cowart 2002, Takeuchi et al 2005) (Figure 3). The possible effect of colon luminal pH 
on iron solubility was discussed in a study from Romanowski et al., in which surgically 
injured mice with the oral provision of a phosphate buffer at pH 7.5 showed an increased 
colonic pH compared to mice provided with the same buffer at pH 6.0. The expression of 
bacterial siderophore systems was upregulated within the neutral pH-group, possibly due 
to a decreased solubility of iron in the intestinal lumen at a higher pH (Romanowski et al 
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2011). It should however be noted that phosphate also influences siderophore production 
and that iron is prone to form complexes with phosphate, which could have contributed to 
their findings. These in vivo results are nevertheless consistent with an in vitro study, which 
showed that lowering of the pH increased iron uptake (Salovaara et al 2003). 
Iron speciation and solubility in the colon is extremely difficult to predict as many factors 
can influence this process and the various iron species in the lumen are not easy to measure 
accurately. Consequently, the amount iron in the colon lumen that is readily available to 
bacteria is also difficult to estimate. Besides oxygen and pH, which are two main influencers 
of iron speciation, different food components can affect the valence state and solubility. The 
most famous food component in this matter is ascorbic acid (vitamin C), which chelates 
iron and also reduces ferric iron to its ferrous form (Figure 3). For this reason ascorbic 
acid is also known for its positive effect on iron absorption by the host (Miret et al 2003). 
Other organic acids such as citrate are known to form a soluble chelate with iron and may 
hereby prevent precipitation of ferric iron when the pH rises after passage through the 
stomach (van Dokkum 1992) (Figure 3). Nonetheless, the neutral to mildly acidic pH of 
the intestinal lumen favours precipitation with hydroxides and complex formation with 
mucins, certain amino acids, proteins, and other food components. Therefore, iron species 
such as iron oxides, iron hydroxides, iron phosphates and iron carbonates may be found 
in the intestinal lumen, but we do not know how accessible these insoluble forms of 
iron are for bacteria (Cremonesi et al 2002, Simpson et al 1992) (Figure 3). Bacteria may 
solubilise some of these forms by lowering the external pH, by reducing the iron to the 
more soluble ferrous form, or by binding to siderophores (Andrews et al 2003, Ratledge 
and Dover 2000). Ligands that potentially bind to iron and play a role in the colonic lumen 
are summarised in Supplementary Table 2. In Supplementary information 1 we envisage 
how orally administered iron will end up in the colon after ingestion. In conclusion, both 
ferrous and ferric forms of iron are likely to be present in the colon and there are reasons to 
believe that iron availability to the colonic microbiota is normally limited (see the following 
paragraphs). 
5.2 Quest for food-bound iron sources
Because iron speciation in the colon is difficult to predict and it is likely highly variable, not 
much is known about the accessibility of colonic luminal iron. Nonetheless, here we discuss 
a few iron sources that are normally not easy to access, but may become available to certain 
members of the gut microbiota through specialized mechanisms. It is likely that future 
research will reveal additional food-bound iron sources that can be utilised by bacteria. 
5.2.1 Polyphenol-iron
The human diet often contains polyphenols like tannins and catechols, which are highly 
present in e.g. tea and coffee. These compounds can bind iron very strongly and hereby 
prevent uptake of iron by the host, but also prevent the uptake of iron by bacteria. 
However, in an iron-limited environment, pathogenic bacteria that can produce and/or 
take up siderophores may benefit from the iron polyphenol withdrawal mechanism, most 
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Figure 3. Iron speciation, availability and the battle for iron in the colon lumen. 
Iron speciation in the gastrointestinal tract probably plays an important role in the accessibility of iron for the 
gut microbiota. In the stomach (on the left; very simplified), the low pH favours the solubility of both ferric and 
ferrous iron, not necessarily requiring a ligand (L) for solubility. When the pH increases in the small intestine, 
the solubility of mainly ferric iron decreases and more complexes with food components and host excretions 
will be formed. Within the colon, the pH slightly drops due to the production of e.g. lactate and SCFAs by the 
microbiota. The colonic part of the figure, where the microbiota depicted in orange represents both (beneficial) 
resident species and pathogenic species, shows the following aspects:
1)  On the left it is shown that iron bound to polyphenols (1a), e.g. tannins (1b) and phytate (1c), may be 
accessible via enzymatic degradation or via the removal of the iron by siderophores;
2)  The rather insoluble forms like iron in a complex with phosphate, carbonate or oxides are likely not readily 
accessible for the microbiota, but they may be solubilised by bacterial reduction or siderophoric chelation;
3)  Soluble forms of ferric iron may be reduced to ferrous iron after which it can be taken up by both the 
microbiota and the host (3a) and for instance, the soluble ferric citrate or ferrous ascorbate may be directly 
taken up by bacteria (3b). Notably, host iron uptake may be a mechanism to withdraw the iron from the 
colon lumen;
4)  On the right, several forms of iron are depicted from which we also do not know very well how accessible 
they are. We envisage that ferritin-iron (dietary or from sloughed enterocytes) (4a) is difficult to access, but 
iron bound to mucin, amino acids or lactate (4b) may be relatively easy to access and that may hypothetically 
be promoted by the low affinity siderophores α-hydroxyacids and α-keto-acids (4c);
5)  These low affinity siderophores (5a) may also play an important role in the phenomenon of iron cross-
feeding by heterologous siderophores within the microbiota (5b);
6)  The excretion of lipocalin-2 (LCN-2) in the colon lumen may scavenge iron bound to siderophores and 
hereby prevent uptake by (pathogenic) bacteria;
7)  Finally, at the lower right it is depicted that bacteria spp. may bind iron to their cell wall (as has been shown 
for Bifidobacterium), which likely prevents access to this iron by other (pathogenic) species. 
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probably by scavenging the iron bound to the polyphenols (Freestone et al 2007) (Figure 3). 
It is not known whether this mechanism plays a significant role in the gut lumen, but 
it might be relevant as both polyphenols and siderophores are likely to be present in 
the gut environment. In addition, certain bacteria, such as Streptococcus gallolyticus or 
Staphylococcus lugdunensis, can degrade the polyphenol tannate and this way provisionally 
liberate iron from this potent iron binder (Noguchi et al 2007, Smith et al 2005). 
5.2.2 Phytate-iron
Another compound with potent iron-binding activity is phytate, whose intestinal availability 
is high after consumption of a cereal-and-legume-based diet. Similar to tannate, certain gut 
microbes (e.g. coliforms and Bifidobacteriaceae) can degrade phytate, which might be a 
specialized way of liberating iron, the iron may become available for utilisation by either 
the degrading organisms or by other bacterial species (Markiewicz et al 2013) (Figure 3). 
Therefore, iron bound to phytate might be a relevant iron source for the colonic gut 
microbiota. It should however be noted that the iron complexed with phytate that reaches the 
colon is mostly in an insoluble form, thus being less susceptible to degradation (Schlemmer 
et al 2009). Nevertheless, degradation products of phytate that could be generated only 
through microbial action were previously found in the colon of conventional rats, but not 
in germ-free rats (Schlemmer et al 2009). These findings indicate that phytate degradation 
by microbes occurs in the colon. 
5.3 The evidence and need for siderophores in the colon
Even though some food compounds may be a source of iron, there are strong indications 
that readily available iron in the gut is generally limited, as studies have reported that the 
production of siderophores by enteric pathogens in the gut improves their survival and 
colonisation. The findings described herein suggest that siderophores are commonly 
produced by enteric pathogens in the colonic lumen, particularly if the intestine is 
inflamed. In the absence of intestinal inflammation, ferrous iron is likely available in the 
gut to some extent, due to the reducing environmental conditions of the colon, but it may 
also be formed through the action of microbial reductases. As such, enteric bacteria may 
utilise ferrous iron as an iron source via the Feo uptake system. A role for Feo in the gut 
was shown in both S. Typhimurium and E. coli, as isogenic mutant strains deficient in FeoB 
are outcompeted by their wild type strains during colonisation in the mouse intestine 
(Stojiljkovic et al 1993, Tsolis et al 1996). Similarly, a Campylobacter jejuni FeoB mutant 
is outcompeted during colonisation in rabbit ileal loops, in the chick caecum, and in the 
intestinal tract of piglets (Naikare et al 2006). Notably, a S. Typhimurium strain lacking both 
FeoB and TonB is further attenuated in the mouse intestine, indicating that both ferrous 
and ferric iron may be available in the mouse colon (Tsolis et al 1996). However, a single 
TonB mutant showed similar colonisation levels compared to the wild type strain (Tsolis et 
al 1996), suggesting that siderophore-mediated iron uptake is only required when the more 
standard mechanisms of iron uptake are somehow not possible, or when freely available iron 
is absent. In contrast, other studies reported a disadvantage in intestinal colonisation when 
siderophore-mediated iron uptake was affected. For instance, a S. Typhimurium mutant 
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in the ferrioxamine receptor FoxA was less able to colonise rabbit ileal loops and showed 
reduced virulence in a mouse typhoid model compared to the wild type strain, indicating 
that S. Typhimurium can utilise siderophores in favour of their virulence at the intestinal-
epithelial interface (Kingsley et al 1999). 
Other siderophores like aerobactin have been shown to play a role during colonization of the 
mouse caecum by a pathogenic E. coli strain (Torres et al 2012). In addition, E. coli mutants 
which were affected in the production or uptake of catechol-type siderophores showed 
impaired colonisation of the mouse intestine compared to the wild type strain (Pi et al 2012). 
Though all of these studies suggest that siderophores are secreted in the intestinal lumen, as 
far as we are aware, the study of Pi et al. is the only report that has also directly confirmed 
the presence of enterobactin in the mouse gut lumen (in the mucus) (Pi et al 2012). In future 
studies, it will be important to provide more information about the types and amounts of 
siderophores presents in the faeces, but it might be challenging to isolate and identify them 
from such a complex matrix. Taken together, the results discussed herein suggest that the 
production and utilisation of siderophores is a special-purpose iron uptake system in the gut 
lumen and they show that that these molecules are required for full bacterial virulence. The 
importance of siderophore-mediated iron acquisition appears to be even more important 
in the inflamed gut, where the iron-laden enterobactin is sequestered by the antimicrobial 
protein lipocalin-2. Non-pathogenic Enterobacteriaceae, such as certain E. coli strains, that 
solely rely on enterobactin for siderophore-mediated iron acquisition are susceptible to 
lipocalin-2, while pathogens like S. Typhimurium circumvent lipocalin-2-based defence via 
the production of alternative stealth siderophores like salmochelin, which is not recognized 
by lipocalin-2. Thus, salmochelin-dependent iron acquisition provides those species with 
a competitive advantage in the inflamed gut (Raffatellu et al 2009)(see also section 9.1). 
Overall, the aforementioned studies suggest that enteric pathogens constantly have to face 
the stress of limited iron availability in the normal gut and even more in the inflamed gut, 
and demonstrate that high affinity iron uptake systems are required for full virulence. 
5.4 Iron cross-feeding with heterologous siderophores 
An interesting phenomenon is the cross-feeding of heterologous siderophores, i.e. certain 
bacterial species can compete for and use each other’s siderophores, and sometimes they 
are even able to utilise a type of siderophore that cannot be produced by themselves. 
This is exemplified by Salmonella strains that can take up ferrioxamines (via the receptor 
FoxA) as mentioned above. They however cannot synthesize ferrioxamines themselves, 
but may be available from related species and other members of normal gut microbiota 
(Champomier-Verges et al 1996, Kingsley et al 1999). Examples of other genera that can 
utilize heterologous siderophores are Campylobacter and Pseudomonas (Baig et al 1986, 
Champomier-Verges et al 1996, Llamas et al 2006). A study with microbial isolates from 
marine sediments indicated that the growth of many bacteria depends on siderophore 
production by other bacteria within the same community (D’Onofrio et al 2010). Although 
there is not yet direct evidence, it may be anticipated that cross-feeding with siderophore-
iron plays a significant role in the colonic environment with its microbial community of 
>1000 different species (Figure 3).
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5.4.1 Low affinity siderophores
A distinct type of iron-binding siderophores, i.e. α-keto-acids and α-hydroxyacids (a reduced 
form of α-keto-acids), may be important players in the cross-feeding of siderophore-iron. 
α-Keto-acids and α-hydroxyacids are primary metabolites of both human cells and bacteria, 
but are also known to bind iron (Drechsel et al 1993). The ferric form of these siderophores 
can stimulate the growth of bacteria that reside in an iron-limited environment. To our 
knowledge, the association constant of these siderophores for iron has not been determined 
yet, but based on a study by Kingsley et al. it has been suggested by Reissbrodt et al. that these 
iron-binding acids have a lower affinity for iron compared to conventional siderophores 
(Kingsley et al 1996, Reissbrodt et al 1997). This is in agreement with the notion that 
conventional siderophores are synthesized for the purpose of iron scavenging, while α-keto-
acids are products of general metabolism (Reissbrodt et al 1997). Notably, it has been shown 
that the excretion of α-keto-acids by S. Typhimurium was increased upon iron limitation 
(Reissbrodt et al 1997). Although low affinity siderophores may not be very useful for 
pathogens invading the host with its high affinity iron-withholding proteins, they could 
significantly contribute to iron sequestration in the gut lumen where iron most probably 
can be scavenged more easily. Importantly, certain bacteria, among which are Salmonella 
spp. can benefit from the α-keto-acids type of siderophores by using them as iron sources 
(Kingsley et al 1996) (Figure 3). Consistent with these findings, we found two hydroxyacids 
with (tentative) siderophoric activity in an in vitro model of the human proximal colon 
containing a faecal microbiota (Kortman et al 2014b) (Chapter 3). 2-Hydroxyisovaleric acid 
was only detected in low iron conditions and not in moderate to high iron conditions, and 
2-hydroxyisocaproic acid was detected in higher amounts in low iron conditions compared 
to the moderate to high iron conditions (Kortman et al 2014b) (Chapter 3). These results 
suggest that the reduced iron availability might be a signal to increase the production of 
hydroxyacids for at least a subset of the gut microbiota. 
5.5 Summary of the quest for iron in the colonic lumen
To wrap up the preceding sections on iron speciation and availability in the colon lumen, we 
here outline the main points. First of all, the total luminal iron content is mainly dependent 
on dietary iron intake, but is generally considered high. However, the majority of this iron 
appears not to be readily available for the gut microbiota because much of the iron is bound to 
food or host derived compounds (ligands) that, together with the environmental conditions in 
the gastrointestinal tract, make the iron difficult to access. This is supported by the evidence 
that siderophore production by enteropathogens takes place in the (inflamed) colon, a process 
that is only required when readily available iron is low. These and other aspects that point at 
a gut bacterial quest for iron in the colon lumen are visualised in Figure 3. Finally, oral iron 
administration will change the iron speciation balance and it is likely that part of this extra 
iron becomes readily available for the gut microbiota (see sections 7 & 8). 
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6 Effect of host iron intake on gut physiology and immunology
To better understand the interplay between nutritional iron, the intestinal microbiota and 
the host, we review the basic aspect of the effects of luminal iron and host iron status on gut 
physiology and gut immunology in the following paragraphs. 
6.1 Colonic iron absorption
In humans, iron is mainly absorbed in the duodenum, but to a small extent also in the colon. 
Ferrous iron infused into the colon is much better absorbed than ferric iron, which is in 
line with findings in the duodenum where iron needs to be in the ferrous state for uptake 
by enterocytes (Ohkawara et al 1963). It can be envisaged that the effect of iron speciation 
on iron uptake is larger in the colon compared to the duodenum as the iron within the 
food matrix has travelled a longer route to the colon with many changes in environmental 
conditions, allowing the formation of many different iron complexes that possibly affect 
host iron uptake (see section 5.1 & 5.2). Colonic iron absorption may contribute to the iron 
needs of the body, but it may also be part of a defence mechanism as iron exclusion from 
the colonic lumen can contribute to nutritional immunity and restraining the gut microbial 
community, especially the growth and virulence of enteric pathogens (Figure 3). 
Interestingly, the microbiota itself also appears to play a role in host iron absorption. It 
is known that prebiotics can change the microbiota composition and metabolism as 
shown in humans, which in turn can influence iron absorption, as shown in pigs (Petry 
et al 2012, Tako et al 2008). A change in bacterial metabolism may for example involve an 
increase in lactate or SCFAs which can lower the pH and promote solubility and reduction 
of iron to the ferrous state (Salovaara et al 2003) (Figure 3). SCFA can also stimulate the 
proliferation of epithelial cells, hereby enhancing the absorptive surface, whereas prebiotics 
or their fermentation products may increase the expression of iron regulatory genes such 
as Divalent Metal Transporter 1 (DMT1) in both the duodenum and the colon (Tako et al 
2008, Yeung et al 2005). It has been shown that iron absorption genes in the colon of mice 
were higher expressed in iron-deficient mice compared to controls (Takeuchi et al 2005). 
This study also showed that the reductase Dcytb (highly expressed in the duodenum) was 
lowly expressed in mouse colon. Dcytb mediates conversion of ferric iron to ferrous iron, 
which is crucial for the uptake by enterocytes through the iron importer DMT1. Together 
this may suggest that it is not necessary for colonocytes to express this enzyme because 
the microbiota possesses reductase activity that already contributes to the conversion 
of ferric iron to ferrous iron (Takeuchi et al 2005). A role for the gut microbiota in iron 
absorption is also supported by the finding that germ-free raised rats showed decreased 
iron uptake compared to conventionally raised rats (Reddy et al 1972). Notably, also oral 
iron administration can modify the gut microbiota (see section 7) and this implies that the 
uptake of this administered iron might actually be influenced by the iron-induced changes 
in microbiota composition and metabolism. 
6.2 Effect of gut luminal iron on the host epithelial barrier function
Besides the effects of iron on the gut microbiota, which may cause a shift toward a more 
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pathogenic profile and an increase in virulence of enteric pathogens, iron may also directly 
exert unfavourable effects to the gut epithelium most likely via the promotion of redox 
stress. Importantly, a decrease in epithelial integrity has been reported in vitro with Caco-2 
cells exposed to iron (Ferruzza et al 2003, Natoli et al 2009). In contrast, an earlier study did 
not find a decrease in epithelial integrity when cells were incubated with iron, despite an 
increase in lipid peroxidation through iron (Courtois et al 2000). Also, in our hands we were 
not able to reproduce the decrease in epithelial integrity of Caco-2 cells observed by Ferruza 
et al. and Natoli et al. (Kortman, unpublished). However, a combined in vivo-ex vivo study 
with calf duodenum showed increased permeability after feeding the calves with a high iron 
diet, even though duodenal oxidative damage, as measured by malonyldialdehyde (MDA), 
was not different between diets (Hansen et al 2009). Furthermore, Nchito et al. showed 
that African schoolchildren had increased small intestinal permeability after being orally 
supplemented with iron, as indicated by an increased lactulose:mannitol ratio (Nchito et 
al 2006). This increased permeability may allow easier translocation of pathogenic bacteria 
across the gut wall. It has also been shown that oral iron tablets, due to iron deposition, 
can cause pathological changes in the mucosa of the upper gastrointestinal tract (Kaye et 
al 2008). Notably, the studies mentioned above were either focused on the small intestine, 
or their results were based on in vitro data. It is therefore less clear what the effects of iron 
on the colonic epithelium are in vivo. In the colonic lumen, oxygen is hardly available, but 
close to the epithelium and in the mucous layers there is an oxygen tension, resulting from 
diffusion from epithelial cells (Van den Abbeele et al 2011). This oxygen may contribute to 
iron generated radical formation. Indeed, it has been shown that oral iron supplementation 
can increase lipid peroxidation in the colon of rats, which may have affected epithelial 
integrity and which may contribute to the development of colorectal carcinoma via the 
induction of DNA damage (Lund et al 2001). These authors also reported that oral iron 
supplementation increased the free radical production in the faeces of human healthy 
volunteers (Lund et al 1999). Also, epidemiological and animal studies may point to a role 
of luminal iron in colorectal carcinogenesis (Chua et al 2010, Seril et al 2002). As elaborated 
on in section 8.1 of this review, nutritional iron may be related to the bacterial production 
of short chain fatty acids, which lower the pH of the intestinal environment. Remarkably, 
a lower pH is associated with a reduction in the conversion of bile acids to secondary bile 
acids, which are thought to exert harmful effects to the colonic wall (Boleij and Tjalsma 
2012, Macdonald et al 1978). This conversion may also be influenced by iron availability as 
bacteria use iron-dependent oxidoreductases for this process (Kang et al 2008). To finish 
this section, also the bacteria may suffer from iron-mediated oxidation stress in the colon 
lumen. However, oxygen tension is very low in the outer mucous layer and the lumen where 
the majority of the microbes reside, thus impeding the formation of oxidative stress (Van 
den Abbeele et al 2011). 
6.3 Effect of host iron status on gut immunology and defence
Iron plays an important role in host immunity and host iron status is therefore likely to 
influence host immunity (Figure 6). First of all, as discussed above, iron withholding is an 
important innate defence mechanism against microbial invaders. Iron is also required by 
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phagocytic cells to generate the oxidative burst with ROS and reactive nitrogen species to 
kill the invaders (Cairo et al 2006).
Both iron deficiency and iron overload are associated with impaired immune responses 
(Weiss 2005). Patients with iron overload (haemochromatosis) can experience oxidative 
damage to cells and organs, but they also have a higher risk of infection because of the 
increased availability of iron to pathogenic bacteria (Bullen et al 2005, Cassat and Skaar 
2013). Another reason for the increased risk of infection is the direct effect of iron on 
the immune system as it has been shown that hfe knockout mice (haemochromatosis 
mice) showed an attenuated intestinal inflammatory response, probably due to a reduced 
production of TNF-α and IL-6 by macrophages when they were stimulated with LPS or S. 
Typhimurium (Cherayil 2010, Wang et al 2008). The production of these pro-inflammatory 
molecules could be enhanced by pre-incubation of the isolated macrophages with hepcidin, 
which blocks the iron exporter ferroportin, suggesting that the impaired response is 
mediated by low hepcidin levels in haemochromatosis mice. It was also reviewed by Wang & 
Cherayil that alterations in intracellular and extracellular iron concentrations can influence 
the innate immune response by influencing host gene expression (Wang and Cherayil 
2009). Iron-loaded macrophages may fail to kill intracellular pathogens due to a reduced 
formation of nitric oxide, because iron inhibits Interferon-γ (IFN-γ) mediated pathways 
(Weiss 2005). In summary, iron levels need to be in good balance to maintain optimal 
immunity. Too much iron can provide an easy accessible source of iron for pathogenic 
bacteria and can reduce the immune response to infection, whereas iron deficiency can 
strengthen nutritional immunity against pathogenic invaders but which can also reduce the 
effectiveness of immune cells (Weiss 2005).
As host iron status can influence inflammatory pathways, also the intestinal innate mucosal 
defences are likely to be affected. One interesting aspect is the specific array of antimicrobial 
defences in the intestine. Enterocytes and Paneth cells secrete antimicrobial peptides (AMPs) 
such as defensins, cathelicidins, and other AMPs that confront the gut microbiota to another 
stress factor (Muniz et al 2012). Though little is known about the mechanism of regulation 
of their expression, AMPs show basal expression levels and they are increasingly expressed 
in response to inflammatory stimuli. The main site of expression is the small intestine, but 
to a less extent AMPs are also expressed in the colon, where they play a role in restraining 
the gut microbiota (Muniz et al 2012). As inflammation upregulates AMP expression, iron 
could provisionally influence expression levels of AMPs. Future research is needed to further 
elucidate AMP expression pathways and the putative effects of iron on colonic AMP pathways. 
One molecule with antimicrobial properties that plays a role in the gastrointestinal tract is 
indoleamine 2,3-dioxygenase 1 (IDO1), a molecule that starves tryptophan from microbes 
(Muller et al 2009). IDO1 is expressed in high amounts by macrophages and dendritic cells 
and its expression can be upregulated by IFNs (Cherayil 2009). Iron overload could therefore 
reduce IDO1 expression in the gut, as the expression of IFNs is reduced in iron-loaded 
macrophages (Weiss 2005). Another important molecule with antimicrobial activity concerns 
lipocalin-2, as discussed in section 9.1.1. We found that both mice on an iron-deficient diet 
and mice on a high-iron supplemented diet showed a decrease in faecal lipocalin-2 levels 
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during intestinal inflammation, which may have resulted in an impaired host defence against 
siderophilic pathogens in these mice (Chapter 4). The latter observation suggests that extreme 
(low and high) iron conditions result in an impaired intestinal host defence, but more research 
is needed to confirm this hypothesis.
6.4 Effect of host iron status on gut microbiota composition
As we will discuss in section 7, dietary iron can alter the gut microbiota composition. In 
addition, evidence accumulates that also host iron metabolism or iron status, possibly via 
effects on host immunity or altered luminal iron uptake, can influence the gut microbiota 
composition. Vice versa, the gut microbiota may influence host iron uptake, and thereby the 
host iron status. The former was exemplified by Buhnik-Rosenblau et al. who showed that 
deletions of genes involved in iron homeostasis altered the gut microbiota of the mutant mice. 
Interestingly, a hfe deletion did not alter faecal iron content or the content of other common 
minerals, but a Irp2 (Iron regulatory protein 2) deletion caused an increase in faecal iron 
levels and other minerals and electrolytes, due to an altered uptake by intestinal epithelial 
cells. Although they showed that the gut microbiome of the mutant mice was not significantly 
different from the wildtype, the hfe mutant mice showed a significantly different microbiome 
compared to the Irp2 mutant mice, possibly due to the greater genetic diversity between 
the mutant groups than between the single mutants and the wildtype (Buhnik-Rosenblau et 
al 2012). In a study with pregnant women, increased faecal Enterobacteriaceae and E. coli 
numbers, in combination with lower Bifidobacteriaceae numbers, correlated with an increase 
in serum ferritin and in transferrin saturation levels. Although, dietary intake was similar 
among the women of that study, an effect of dietary iron cannot completely be excluded as 
its intake was not assessed in this study (Santacruz et al 2010). In another study it has been 
shown that Indian women with iron deficiency anaemia had lower levels of Lactobacillaceae 
in their faeces, despite a similar dietary iron intake compared to non-anaemic individuals 
(Balamurugan et al 2010). One limitation of the latter study is that faecal iron levels were 
not determined and also a limited selection of Lactobacillaceae and other bacterial species 
were assessed. Besides potential differences in faecal iron due to differential duodenal uptake, 
another possible explanation for the lower abundance of Lactobacillaceae in the anaemic 
women is the potential role of colonic iron absorption (see section 6.1). Lactobacillaceae 
contribute to gut fermentation in a positive way and a decrease in their abundance could 
therefore be the reason for reduced colonic iron uptake, or it could even exert a more distant 
effect on duodenal absorption (Balamurugan et al 2010). Of note, modulation of the gut 
microbiota by prebiotics has been associated with increased iron uptake in rats and pigs and 
in the latter species also with an increase in colonic Lactobacillaceae (Freitas Kde et al 2012, 
Tako et al 2008). This supports a role of the microbiota in iron absorption, however as far as 
we are aware, in humans this effect has not been confirmed (yet) (Petry et al 2012). 
7 Effect of nutritional iron on the gut microbiota composition
The number of studies investigating the effect of diets on the mammalian gut microbiota has 
increased greatly during the past years. However, studies investigating the effect of nutritional 
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iron are relatively limited. So far, in vivo (humans and animal models) and in vitro studies have 
reported various outcomes regarding the influence of iron administration or iron deficiency 
on the composition of the gut microbiota, however some findings can be marked as consistent, 
as summarised in the following paragraphs and in Table 1 and Supplementary Table 3. 
7.1 Human studies 
It was recently shown that iron fortification resulted in a shift towards a potentially more 
pathogenic gut microbiota profile (i.e. increased relative abundance of potential pathogenic 
Enterobacteriaceae and a decrease of beneficial Lactobacillaceae) among school children 
in Ivory Coast (Zimmermann et al 2010). Notably, although not statistically significant, 
numbers of Salmonella spp. tended to be higher in the iron-fortification group. The 
increase in the abundance of faecal Enterobacteriaceae correlated with the increase in faecal 
calprotectin, which is a marker of gut inflammation. Very recently, similar effects were found 
in a study among Kenyan infants. Iron fortification increased the relative abundance of 
Enterobacteriaceae, among which were pathogenic E. coli species, and decreased the relative 
abundance of Bifidobacteriaceae, which also included a higher ratio of Enterobacteriaceae 
to Lactobacillaceae. Also in this study faecal calprotectin was elevated in infants receiving 
iron fortificant compared to the control group (Jaeggi et al 2014) (Chapter 2). Earlier studies 
showed by using culture techniques that an iron fortified cow’s milk preparation did not result 
in differential Enterobacteriaceae (other than E. coli) and Lactobacillaceae counts in neonatal 
(Dutch infants, first 3 months of life) gut microbiota, but isolation frequencies of Bacteroides 
spp. and E. coli were higher and isolation frequencies of Bifidobacteriaceae were lower under 
these conditions (Mevissen-Verhage et al 1985). Other bottle fed UK infants which received 
milk complemented with lactoferrin or lactoferrin plus iron, showed also increased numbers 
of E. coli in the iron group, but no effect on Bifidobacteriaceae, Lactobacillaceae, Bacteroides 
and Clostridia were found (Balmer et al 1989). 
In a later study with iron fortified formulas (without lactoferrin fortification) the same 
investigators found an increase in Clostridia and a decrease in Bacteroides, with no effect 
on E. coli, coliforms, Bifidobacteriaceae and Lactobacillaceae counts in faeces of UK infants 
(Balmer and Wharton 1991). This paragraph is finished with the interesting findings from 
a study with US infants in which an iron fortified diet was compared to a different meat 
diet that contained much less iron. Although the different types of diet may have influenced 
or contributed to differences in the gut microbiota composition, the iron-fortified diet was 
associated with a decrease in Bifidobacteriaceae and Lactobacillaceae and an increase in 
Bacteroidetes. Remarkably, when zinc was added to the iron fortified diet the microbiome 
responded similar to the meat diet, which contained similar amounts of zinc compared to 
the iron-zinc-fortified diet (Krebs et al 2013). Notably, zinc has been associated with reduced 
virulence of enteropathogens in the gut via the induction of bacterial envelope stress (Crane 
et al 2011, Mellies et al 2012). 
7.2 Animal studies
A study with weanling pigs receiving an iron-supplemented diet again reported higher counts 
of coliform bacteria, and found no effect on the populations of total anaerobic bacteria, 
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Bifidobacteriaceae, Lactobacillaceae, and Clostridia (Lee et al 2008). In two independent 
mice studies it was found that healthy mice receiving an iron-deficient diet had increased 
Lactobacillaceae numbers compared to the control group (Tompkins et al 2001, Werner et 
al 2011). Further, Tompkins et al. found higher numbers of total anaerobes and Enterococcus 
spp. in mice fed on the iron-deficient diet, while Werner et al. found increased numbers of 
Bifidobacteriaceae, Clostridium and unclassified Prevotellaceae, and decreased numbers of 
Bacteroides. Enterobacteriaceae counts were apparently not affected (not reported), but the 
parent taxon Proteobacteria appeared to be more abundant in the iron group (Werner et 
al 2011).
In rats, depending on iron dose and time point, several effects were found. There was an 
increase in Clostridium difficile enterotoxin (only after 24 hours) and at 2 weeks an increase 
in E. coli, Lactobacillaceae and Clostridium spp. was found, while Lactobacillaceae abundance 
was not different at 4 weeks and Clostridium spp. were again more abundant at 4 weeks 
(high iron dose only). The latter increase was accompanied by a decrease in enterococci 
and Bacteroides spp. (Benoni et al 1993). A recent study with young rats showed that an 
iron-deficient diet increased both Enterobacteriaceae and Lactobacillaceae numbers, while 
Bacteroides spp. and Roseburia spp./Eubacterium rectale numbers decreased. Subsequent 
iron repletion did not restore Roseburia spp./E. rectale numbers, but Lactobacillaceae and 
Enterobacteriaceae populations got back to their baseline levels (Dostal et al 2012a). In a 
very recent study of Dostal et al. various iron doses caused rather disperse effects on the 
abundance of the most dominant bacterial taxa in rats with a humanised gut microbiota 
(Dostal et al 2014b). In another recent study with rats and mice in which only Bacteroidetes, 
Enterobacteriaceae and Firmicutes were assessed, no effect of ferric iron on these tested gut 
microbes was found in non-colitis animals. These findings could indicate that ferric iron 
has less effect on the gut microbiota, but two important limitations of this study were the 
limited selection of tested taxa and the lack of testing the effects of the ferrous iron control 
on those taxa (Ettreiki et al 2012). 
7.3 In vitro studies
The in vivo studies described above illustrate that the effects of oral iron supplementation or 
an iron-deficient diet, leading to high and low amounts of colonic luminal iron respectively, 
can be various and contradictive. Host factors such as iron status, intestinal immune function, 
dietary habits and also environmental factors such as hygiene play probably an important 
role and result in a large variation in the effects of iron on the gut microbiota composition. 
The effect of such host factors can be better controlled in in vitro gut fermentation models, 
allowing to study the effect of sole iron on the gut microbiota. Obviously the lack of host 
immunity factors is also a drawback of in vitro models. Nevertheless, they are valuable tools 
for monitoring microbial metabolism during the passage of food. A recent in vitro study 
by Dostal et al. reported an increase in Lactobacillaceae, Enterobacteriaceae and Roseburia 
spp./E. rectale under low-iron conditions, which was consistent with the outcome of their 
study in young rats (Dostal et al 2012a, Dostal et al 2012b). Notably, when S. Typhimurium 
was added to this fermentation model, it grew unexpectedly less well under high-iron 
conditions compared to normal-iron conditions (Dostal et al 2012b). A possible explanation 
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for this is the absence of host-mediated inflammation on which S. Typhimurium can thrive 
(see section 9.1). In contrast to the rat study, Bacteroides spp. increased under low-iron 
conditions, except for extremely low-iron conditions were a decrease was found. Further, 
in a study were silage making was simulated it was found that extreme iron depletion by 
2,2-dipyridyl had no effect on growth and performance of Lactobacillaceae, but repressed 
the growth of Enterobacteriaceae effectively (Bruyneel et al 1990). Recently, we found, using 
an in vitro model that simulates the luminal conditions of the healthy adult proximal colon, 
that prominent changes were a relative decrease of Lactobacillaceae and Bifidobacteriaceae 
and an increase of Roseburia and Prevotellaceae in iron-rich conditions (Kortman et al 
2014b) (Chapter 3). 
7.4 Summary of the effects of nutritional iron on the gut microbiota composition
From the sections above it becomes clear that oral iron intake can influence the gut 
microbiota composition, but we note that the reported effects are markedly different from 
study to study. We also note that infants and young children belong to the population that 
most often requires oral iron therapy and that altering the gut microbiota composition may 
have a relative large impact on the developing microbiota of infants that do not yet have 
developed a stable core microbiota (Yatsunenko et al 2012). However, the potential long 
term effects of such iron therapy-induced changes are currently not known. The distinct 
outcomes of the studies described above can originate from many factors. In in vivo studies 
differential results may first of all very well be caused by the host, as the gut microbiota of 
mice, rats and humans are distinct and are likely to respond differently to iron intervention. 
The site of sampling of the gut microbiota also varied, as some animals were sampled in 
their gut (e.g. caecum) after sacrifice, while most studies used samples from excreted stools. 
Also, the iron source (formulation), dose of iron and length of iron intervention was not 
the same for all studies (Supplementary Table 3). Next, there were studies comparing iron-
deficient diets with diets containing normal amounts of iron on the one hand and studies 
comparing normal iron diets with iron-supplemented/fortified diets on the other hand. 
Obviously, in vitro studies may also result in different outcomes, compared to in vivo studies, 
but it has some advantages like the easy testing of various iron sources and concentrations 
in a highly controlled setting. It should also be mentioned that analysis techniques have 
changed tremendously during the last decades. Hence, we here compared older studies that 
used culture techniques, studies that used qPCR (consequently, the various studies did not 
assess the effect of iron on exact the same set of taxa) and recent studies that investigated 
the entire population, i.e. the most abundant genera, by using 16S rRNA pyrosequencing. 
Importantly, the studies differed in age of the human subjects and animals and they 
resided in dispersed geographic locations. Hence, the intrinsic gut microbiota might be 
very different at the start of the study and the environmental influence will be diverse. The 
geographic location might be of particular importance as the prevalence of iron deficiency 
and infections is generally higher, and hygiene standards are often lower in developing 
countries compared to industrialised countries. This is probably the reason why adverse 
effects of oral iron administration are more prevalent in developing countries. Importantly, 
two recent studies showed that both African children and infants receiving iron had higher 
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levels of potentially pathogenic Enterobacteriaceae and/or higher levels of pathogenic E. 
coli, which was paralleled lower levels of Lactobacillaceae and/or Bifidobacteriaceae (Jaeggi 
et al 2014, Zimmermann et al 2010) (Chapter 2). Notwithstanding the difference between 
studies and their outcomes, this also appears to be the most consistent and robust outcome 
of the other studies (comparing iron-sufficient or high-iron diets to low or iron-sufficient 
diets respectively) as mentioned above and as depicted in Table 1. E. coli was mostly 
increased and was never reported to decrease, lactobacilli were reported to increase only 
once and shows basically a net decrease, while bifidobacteria mostly decreased and never 
increased. In our view the most relevant outcomes are from the two studies among African 
children/infants (Jaeggi et al 2014, Zimmermann et al 2010) (Chapter 2), which are overall 
supported by studies among Western infants as well as animal or in vitro studies. It should 
also be noted that from a clinical point-of-view, it is most relevant to study the effects of 
oral iron administration among children in developing countries, but that those studies 
are not easy to set up and control. In contrast, studies among subjects in industrialised 
countries and especially studies with animal and in vitro models can be controlled much 
better, but are inferior with respect to clinical relevance. It is therefore a future challenge to 
design the experimental setup of the latter studies in such a way that they better resemble 
the clinically relevant environmental setting.
It is tempting to find explanations for the hitherto consensus outcome of iron on the gut 
microbiota composition as described above. The fact that Lactobacillaceae do not require iron 
(see section 3.2) could be an explanation for their decrease within a microbial community in 
response to iron, as they might be outcompeted by bacterial species that thrive on the extra 
iron, e.g. enteropathogens. We note that in older studies Enterobacteriaceae as a family were 
often not assessed, but an increase in coliforms and/or E. coli may consequently favour the 
growth and colonisation of closely related (pathogenic) Enterobacteriaceae, a phenomenon 
known as the like-will-to-like concept postulated by Stecher et al. (Stecher et al 2010). The 
common decrease in Bifidobacteriaceae through iron is more difficult to explain as they are 
known to be dependent on iron as their growth is generally impaired in response to iron 
limitation, created by the addition of the iron chelator dipyridyl (Bezkorovainy et al 1996, 
Cronin et al 2012). This growth impairment in response to dipyridyl indicates the absence 
of a high affinity siderophore mediated iron uptake system in most Bifidobacterium species, 
but it also indicates that they require iron for their growth. The common decrease of 
Bifidobacteriaceae in response to luminal iron could therefore be due to an altered balance 
in competition with other microbes or an effect in response to a changed environment such 
as the presence of stressful metabolites or oxidative stress. 
8 The effect of nutritional iron on bacterial metabolism in the gut
Next to microbiota composition, nutritional iron will affect metabolic pathways within 
the gut microbiota. In the following paragraphs we review the current knowledge on the 
bacterial fatty acid synthesis and the subsequent effect on virulence of pathogenic bacteria. 
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8.1 Effect of iron on the production of health promoting Short Chain Fatty Acids
Bacterial metabolism is important for our gut health because indigestible food components 
(mainly complex carbohydrates) are predominantly metabolized to the main Short Chain 
Fatty Acids (SCFAs) acetate, propionate and butyrate. These SCFAs are the principal 
metabolites in the colon, very beneficial for gut health and an energy source for enterocytes 
and more distant tissues (Macfarlane and Macfarlane 2011, Macfarlane and Macfarlane 
Figure 4. Potential effects of oral iron administration on the microbiota in the non-inflamed colon. 
Oral iron administration:
1)  Primarily increases the amount of iron in the colon, which may consist of both ferric and ferrous forms, 
available for uptake by the microbiota and the host (depicted on the left); 
2)  Can induce the formation of ROS close to the epithelium, which may elicit damage to the epithelium and 
stress to the local microbiota;
3)  May enhance the virulence of enteric pathogens, favouring colonisation and possibly the ability to adhere to 
and invade the epithelium; 
4)  Will alter the gut microbiota composition, which mostly involves a decrease in Bifidobacteriaceae, 
Lactobacillaceae and an increase in coliforms / E. coli; 
5)  Likely influences gut microbial metabolism (directly and/or via an altered microbial composition), which 
likely increases protein fermentation, resulting in the formation of toxic products (5a) and which may also 
affect beneficial carbohydrate (carb.) metabolism (5b) It is known that iron limitation may lower SCFA 
production and increase lactate production, which in turn can influence virulence of enteric pathogens 
either directly or via a change in luminal pH (5c). Notably, a changed microbial metabolism may influence 
the gut microbiota composition (5d).
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2012). The connection between iron and SCFA production was first described in two studies 
of Dostal et al. (Dostal et al 2012a, Dostal et al 2012b) (see also Figure 4). Specifically, the in 
vivo levels of butyrate and propionate were lower during luminal iron deficiency in rats, and 
were restored by iron repletion. Although it cannot be excluded that intestinal SCFA uptake 
was altered by the dietary interventions, these results suggested that iron supplementation 
could have a beneficial effect on gut health by increasing SCFA production. In contrast, 
however, in vitro SCFA production seemed not much stimulated by high iron conditions, 
and butyrate and propionate production was most clearly impaired during extremely low 
iron conditions. This decreased production was accompanied by a decrease in the SCFA-
producing species Roseburia spp./ E. rectale and Clostridium Cluster IV members (Dostal 
et al 2012b). Our in vitro fermentation studies showed that supplementary iron increased 
propionate levels slightly, but that total SCFA levels were not significantly changed 
(Kortman et al 2014b) (Chapter 3). A third (and very recent) study of Dostal et al. showed 
reduced caecal levels of acetate, propionate and butyrate in rats on an iron-deficient diet 
compared to rats on iron-supplemented diets. They additionally showed that propionate 
and butyrate levels were higher in rats on an iron-supplemented diet compared to rats 
on a control diet (and which were not first depleted from iron) (Dostal et al 2014b). It 
can thus be hypothesized that an iron-deficient diet (in combination with iron deficiency) 
may be unbeneficial for gut health because luminal SCFA levels can decrease under these 
conditions. Conversely, iron supplementation may increase health promoting luminal SCFA 
levels. Notably, enteric pathogens might benefit from a decrease in luminal SCFA levels, as 
SCFAs may influence their virulence (described in section 8.2). A decrease in butyrate may 
also decrease the intestinal expression of the AMP cathelicidin, and hereby weaken the host 
defence (Raqib et al 2006, Sekirov and Finlay 2009). 
A decrease in SCFA production under (extremely) low iron conditions can, besides changes 
in microbiota composition, possibly be explained by inhibition of iron-dependent enzymes 
involved in the pathways of butyrate and acetate synthesis. Approximately one third of 
acetate production can be assigned to the reductive acetyl-CoA-pathway (a.k.a. Wood-
Ljungdahl pathway) (Miller and Wolin 1996). This pathway contains several enzymes that 
depend on iron as a cofactor and acetate production may therefore decrease when iron 
availability is limited (Dostal et al 2012b, Ragsdale and Pierce 2008). Similarly, butyrate 
production also involves iron-dependent enzymes and may thus be lowered during iron 
limitation, which could also involve a reduction in acetate to butyrate conversion by certain 
species (De Vuyst and Leroy 2011). More (in vivo) research is needed to elucidate the effects 
of iron on the SCFA production by the gut microbiota, the metabolic pathways involved and 
the possible effects on gut health. One limitation may however be the rapid absorption of 
SCFAs and other bacterial metabolites by the host (Montagne et al 2003). Caecal, colonic, 
or faecal SCFA levels do therefore not necessarily reflect the actual production by the gut 
microbiota, and which also differs along the intestinal tract (Mortensen and Clausen 1996). 
This makes complementary in vitro studies very useful. Interestingly, African children had 
much higher faecal SCFA levels compared to European children, thus microbial production 
appeared to exceed absorption rates in these African children. This difference was likely 
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due to the plant-based diets of the African children, which may result in an enrichment 
of beneficial SCFA producing bacteria (De Filippo et al 2010) (see also section 2.2), but 
it should also be realized that the poorer health status of the African children may have 
compromised their capacity to absorb SCFA, which also would result in higher faecal SCFA 
levels.
8.2 Short Chain Fatty Acids and bacterial virulence
One of the health effects described to SCFAs relies in the lowering of the luminal pH, which 
is known to inhibit the growth of (pathogenic) E. coli (Duncan et al 2009), but also direct 
effects of SCFAs may cause growth inhibition of E. coli and Salmonella spp. (Ricke 2003, 
Topping and Clifton 2001). Notably, SCFAs and/or lowering of the pH may contribute to 
an increased solubility of luminal iron and other minerals (Freitas Kde et al 2012, Salovaara 
et al 2003). This in turn may enhance host mineral absorption, but also bacterial mineral 
uptake, from which both the host and bacteria could benefit. Another beneficial effect of 
SCFAs from the host’ perspective can be an increased host resistance against pathogenic E. 
coli infection through acetate production of for example Bifidobacteriaceae and decreased 
virulence of pathogens (Fukuda et al 2011). In addition, enteric pathogens have to deal with 
the stress of butyrate and propionate as they have been reported to down-regulate invasion 
genes (HilA, HilD, invF, SipC) of Salmonella pathogenicity island 1 (SPI-1) (Van Immerseel 
et al 2006). Notably, HilA, invF and SipC expression is also regulated by oxygen, pH and the 
iron metabolism regulator Fur (ferric-uptake regulator protein), resulting in upregulation 
of HilA under iron sufficiency (Teixido et al 2011, Troxell et al 2011). Low oxygen is also a 
signal for upregulation, but an acidic pH is associated with a down-regulation (Bajaj et al 
1996, Teixido et al 2011). In contrast to the downregulation of invasion genes by SCFAs, 
also upregulation of a virulence factor, i.e. the iha gene (involved in adhesion), in pathogenic 
E. coli has been reported. This SCFA-induced regulation appeared to be independent of 
iron (Herold et al 2009). It has also been shown that SCFAs can stimulate S. Typhimurium 
adhesion and invasion, via the induction of the acid tolerance system in response to the 
stress of a lower pH, however the lowering of virulence by SCFA appear to prevail (Ricke 
2003, Van Immerseel et al 2006)(see also Figure 4).
8.3 Effect of iron on the production of potentially toxic Branched Chain Fatty 
Acids
In contrast to carbohydrate fermentation, protein fermentation by gut bacteria can result in 
toxic or potentially toxic metabolites such as ammonia, H2S, Branched Chain Fatty Acids 
(BCFAs) (e.g. isobutyrate and isovalerate), indolic and phenolic compounds (Macfarlane 
and Macfarlane 2012).
Dostal et. al. showed that the production of BCFAs was decreased under low-iron conditions 
and increased under high-iron condition in vitro, indicating decreased and increased 
unbeneficial protein fermentation respectively (Dostal et al 2012b). This is in line with 
our in vitro findings that iron increased the production of BCFAs, and also toxic ammonia 
production, by an adult faecal microbiota (Kortman et al 2014b) (Chapter 3). Notably, 
BCFAs and ammonia are considered to be indicators of protein fermentation (Hoyles and 
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Wallace 2010) and these in vitro studies therefore indicate that iron stimulates protein 
fermentation, which may result in a more putrefactive and potentially toxic or carcinogenic 
environment (Macfarlane and Macfarlane 2012, Nyangale et al 2012)(Figure 4). In contrast, 
lactate (mostly derived from carbohydrate) levels have been found to decrease in response 
to iron in in vitro fermentation studies (Dostal et al 2012b, Kortman et al 2014b) (Chapter 
3). Notwithstanding the evidence for the toxicity of products originated from protein 
fermentation shown in multiple in vitro studies, we need to note that evidence for the in 
vivo toxicity is limited and a recent trial did not support a role of protein fermentation in 
human gut toxicity (Windey et al 2012a, Windey et al 2012b). On the other hand, protein 
fermentation is often associated with the growth of pathogenic bacteria (Rist et al 2013). 
Future in vivo research on the effect of iron on protein fermentation and toxicity is therefore 
warranted. Finally, it is important to realize that the effects of microbial metabolites are not 
limited to the gut as they are taken up and can have effects on distant sites and on systemic 
host metabolism (Mortensen and Clausen 1996, Nicholson et al 2012, Zheng et al 2011). 
We do not yet know how this affects human health and disease, but it implicates that iron-
induced changes of gut microbial activity may also have systemic effects.
9 How pathogens can thrive on the altered nutritional conditions 
during intestinal inflammation
9.1 Life in the inflamed intestine
It is currently well known that intestinal inflammation can cause dysbiosis of the gut 
microbiota and that this often results in an overgrowth of enteric pathogens (Stecher and 
Hardt 2008, Winter et al 2013a) (Figure 5). Pathogens can overcome the intestinal barrier 
and eventually cause intestinal inflammation when they get the opportunity to breach the 
colonisation resistance of beneficial resident strains (Kaiser and Hardt 2011, Lawley and 
Walker 2013). This may for example occur after antibiotic treatment that disrupts this 
resident microbiota (Stecher and Hardt 2008). Paradoxically, also host defence systems can 
contribute to dysbiosis at the site of infection. The secretion of AMPs and the production 
of reactive oxygen and nitrogen intermediates will also affect the non-pathogenic resident 
microbiota. Their susceptibility to radical species may even be enhanced by host-mediated 
sequestration of zinc and manganese that are required for members of the SOD family (that 
can neutralize these radicals); a process part of the nutritional immunity (Diaz-Ochoa et al 
2014, Kehl-Fie et al 2011). Once inflammation is established, enteric pathogens can exploit 
this inflammation and outgrow the resident microbiota (Barman et al 2008, Lawley et al 
2008, Lupp et al 2007, Stecher et al 2007, Winter et al 2010). First, some general mechanisms 
adopted by pathogens to achieve this will be discussed in the next paragraphs followed by 
paragraphs that describe the potential role of iron in such processes. 
9.1.1 Evasion of nutritional immunity
One example of a pathogen that benefits from an inflamed gut is S. Typhimurium. A first 
step of S. Typhimurium infection is the invasion of non-phagocytic intestinal cells by 
injecting effector proteins with the Type-three secretion system encoded by the Salmonella 
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pathogenicity island (SPI)-1 (T3SS-1) (Moest and Meresse 2013). Secondly, other effector 
proteins secreted by a second T3SS encoded on SPI-2 contribute to S. Typhimurium 
replication in macrophages (Figueira and Holden 2012). Both T3SS are important for 
the initiation of the inflammatory diarrhoea (Hapfelmeier et al 2005, Tsolis et al 1999), 
however, the amplification of the host response requires the activation of the resident T cells 
(mainly Th17 cells) to produce cytokines like IL-17 and IL-22, mediated by the macrophage 
cytokine IL-23 (Godinez et al 2008, Godinez et al 2009). In turn, IL-17 and IL-22 stimulate 
intestinal epithelial cells to secrete neutrophil chemoattractants (e.g. CXCL-1, CXCL-8) 
and antimicrobial proteins including lipocalin-2 (Behnsen et al 2014, Raffatellu et al 2009). 
Moreover, the neutrophils recruited to the gut also secrete large amounts of antimicrobial 
proteins, including lactoferrin, calprotectin and lipocalin-2 (Blaschitz and Raffatellu 2010)
(Figure 5). The goal of this host response is to limit micronutrient availability to pathogenic 
bacteria, however, also non-pathogenic resident strains have to face this armour of host 
defence. Pathogenic strains that express a lactoferrin receptor or can “steal” iron from 
lactoferrin by the use of siderophores have a growth advantage over strains unable to do 
this (Andrews et al 2003). Moreover, as lipocalin-2 sequesters the iron-laden siderophore 
enterobactin, bacterial pathogens that evade this response by secreting stealth siderophores 
such as salmochelin, have a competitive advantage for colonising the inflamed gut (Bachman 
et al 2011, Raffatellu et al 2009) (Figure 5). Furthermore, S. Typhimurium expresses a high 
affinity zinc transporter (ZnuABC) with which it can evade the sequestering of zinc by 
host calprotectin (Liu et al 2012). In addition to the evasion of nutritional immunity, other 
mechanisms that allow S. Typhimurium to thrive in the inflamed gut have been discovered 
and are highlighted below.
9.1.2 Utilisation of alternative respiration molecules by pathogens
In 2010, Winter et al. discovered that S. Typhimurium can thrive on tetrathionate, a 
molecule formed in the mouse gut during inflammation (Winter et al 2010). The formation 
of tetrathionate starts at the site of the gut microbiota, but involves an important host 
factor: protein fermentation by the gut microbiota produces H2S, which is converted to 
thiosulphate by the intestinal mucosa. It was postulated that thiosulphate can be converted 
to tetrathionate via the reaction of thiosulphate with reactive oxygen species, the latter being 
formed by the host in the inflammatory process. The newly formed tetrathionate can then 
be used as an electron acceptor by S. Typhimurium via the action of tetrathionate reductase 
(Figure 5). In addition to S. Typhimurium, several other pathogenic members of the phylum 
Proteobacteria possess this rather unique virulence trait, whereas most members of the gut 
microbiota are not likely to respire on tetrathionate (Winter and Baumler 2011). Therefore, 
tetrathionate respiration in the inflamed intestine appears to provide a luminal growth 
advantage for these Proteobacteria. 
One year later, work in the same laboratory showed that tetrathionate respiration by S. 
Typhimurium supported this pathogen’s utilization of luminal host-derived ethanolamine 
(Thiennimitr et al 2011). Ethanolamine is a substrate that is probably not ready fermentable 
by competing obligate anaerobic bacteria, thus providing a growth advantage for S. 
Typhimurium (Winter et al 2013a) (Figure 5). Next, it was discovered that E. coli can respire 
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on nitrate, a feature likely to be present in other members of the Enterobacteriaceae as well 
(Winter et al 2013b). Like tetrathionate, luminal nitrate levels also increase during intestinal 
inflammation (Figure 5). In summary, the release of reactive nitrogen and oxygen species 
leads to formation of nitrate, S-oxides and N-oxides on which certain pathogens can respire 
by the action of nitrate reductase, DMSO reductase and TMAO reductase respectively; this 
is in contrast to the many obligate anaerobe members of the gut microbiome that lack these 
oxidoreductases (Winter et al 2013a, Winter et al 2013b). Taken together, the alternative 
electron acceptors formed through the oxidative burst of inflammation can stimulate the 
growth and colonisation of enteric pathogens such as S. Typhimurium, which in turn can 
exaggerate inflammation. Freely available luminal iron may play a significant role in these 
processes, which is hypothesized below.
9.1.3 Motility of S. Typhimurium during inflammation
Another mechanism contributing to the exploitation of intestinal inflammation can be 
found in the motility and chemotaxis. Stecher et al., showed that S. Typhimurium defective 
in flagellar assembly and the ability to chemotax were only impaired in the inflamed intestine 
and not in the healthy intestine of mice. It was proposed that fully motile and chemotactic S. 
Typhimurium has better access to specific energy rich carbohydrates that are released from 
mucins during inflammation (Stecher et al 2008). We envisage that this may provisionally 
also apply for the access to certain iron sources in the inflamed colon, but this is subject 
of further investigations. Furthermore, it has been shown that S. Typhimurium uses 
chemotaxis to seek for niches in which tetrathionate and nitrate are present. The sensing of 
favourable energy containing sources and motility are thus important for the capability to 
thrive in the inflamed gut (Rivera-Chavez et al 2013).
9.1.4 The potential effect of iron on exploitation of inflammation by enteric 
pathogens
Iron administration programmes often take place in infection endemic regions, implicating 
an increased chance of iron ending up in an already inflamed gut. The mechanisms of 
pathogens to thrive in an inflamed gut described above inspired us to hypothesize about the 
possible effects of an increase in luminal iron on these pathogenic mechanisms. To the best 
of our knowledge this has not yet been investigated experimentally, therefore we here can 
only speculate on the potential effects of iron on exploitation of inflammation by enteric 
pathogens. These speculations add to the potential effects of iron on the gut microbiota as 
already discussed above, and which are summarised in Figure 4.
With regarding to nutritional immunity it can be envisaged that an excess of luminal 
iron decreases the need for the production of siderophores. Consequently, pathogens 
that can produce a stealth siderophore do not have an advantage over non-producers if 
iron is available, because siderophore production will be repressed (Figure 5). However, 
these pathogens are likely to benefit from the extra iron directly and enhance the 
expression of virulence proteins. Nevertheless, the resident microbiota would at least 
not be outcompeted via the stealth siderophore-mediated system. It should be noted, 
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Figure 5. Pathogen exploitation of intestinal inflammation leading to dysbiosis, and the potential effects of oral 
iron administration. 
The figure shows processes 1-5 contributing to dysbiosis, and process 6 that might be connected:
1)  The inflammatory response, triggered by intestinal pathogens, activates macrophages (1a), which in turn 
stimulates T-cells to secrete IL-22 and IL-17. This triggers secretion of chemokines by the epithelium, which 
attract neutrophils to the site of inflammation (1b). Importantly, the infiltrated neutrophils release ROS 
into the intestinal lumen (potentially strengthened by iron) as an innate defence mechanism, together with 
antimicrobial proteins (AMPs) such as lipocalin-2 (LCN-2), lactoferrin (Lf ) and calprotectin (CP) (1c).This 
process, and also the secretion of other AMPs by the epithelium, cause dysbiosis because pathogens like 
S. Typhimurium confer an advantage in this inflamed environment;
2)  The ROS generation by the neutrophils may be enhanced by luminal iron and which in turn favours the 
formation of tetrathionate (2a) on which S. Typhimurium can respire, and supports the utilisation of 
host-derived ethanolamine (2b). The formation of tetrathionate may potentially also be increased by iron-
stimulated microbial H2S production (2c). Furthermore, extra iron may directly interfere with alternative 
respiration by pathogens (2d) and favour the ubiquitous expression of tetrathionate reductase, which 
contains an iron-sulfur cluster (2e);
3)  Similarly, induction of ROS possibly favours formation of the alternative respiration molecule nitrate (3a) 
and also the nitrate reductase is dependent on an iron-sulfur cluster (3b);
4)  Extra iron (coming from the upper GI-tract) is likely to also enhance the dysbiosis process directly via its 
effects on gut microbiota composition;
5)  The production of alternative stealth siderophores such as salmochelin normally also promotes dysbiosis, 
but extra iron is likely to inhibit both siderophore and stealth siderophore production (5a). Lipocalin-2 
(LCN-2) based defence is likely not effective in the absence of siderophores (5b);
6)  Inflammation will increase the blood hepcidin levels, which in turns binds to the cellular iron exporter 
ferroportin at the basolateral side of the epithelial cell. This may cause an increase in intracellular epithelial 
iron, providing an iron source for invading pathogens (6a). This iron potentially influences inducible nitric 
oxide synthase (iNOS) production by the epithelium, as has been shown for macrophages (Weiss, 2005) (6b). 
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however, that intestinal inflammation would still suppress the growth of Bacteroidetes and 
Firmicutes, while enhancing the colonization of Proteobacteria. Thus, iron administration 
is unlikely to increase the colonization with beneficial microbes in this environment. An 
unfortunate paradox is that both iron withdrawal mechanisms and iron overload may 
enhance the colonization of pathogens during inflammation; nevertheless, the best way to 
limit pathogens’ growth is most likely by iron limitation because this best prevents access 
to the essential iron. One should also realize that a decrease or absence of siderophores 
would make lipocalin-2 based defence useless as it only prevents bacterial iron uptake via 
siderophores. It would therefore make sense that the host only expresses lipocalin-2 when 
siderophores are present and/or readily available iron is low. It is not yet known whether 
siderophores or luminal iron concentration can influence lipocalin-2 expression, but we 
know that this antimicrobial protein is only weakly expressed under normal conditions 
(Cowland and Borregaard 1997, Nielsen et al 1996, Raffatellu et al 2009). 
Another argument for the benefit of iron limitation in the inflamed gut is that iron excess 
could possibly enhance the alternative respiration pathway via the following mechanisms 
because: I) Increased luminal iron is associated with increased intestinal permeability 
and lipid peroxidation and the respiratory burst during inflammation may be enhanced 
by the redox properties of iron. In this way iron may increase the production of both 
tetrathionate ions and nitrate, thus promote tetrathionate and nitrate respiration by 
enteric pathogens (Figure 5); II) As described (see section 8.3), extra iron can increase 
microbial protein fermentation, which in turns leads to increased levels of H2S. As H2S is 
a precursor of tetrathionate, this may further support growth of enteric pathogens during 
inflammation (Figure 5); III) Crucial for the alternative respiration is the expression of the 
oxidoreductases, which require iron-sulfur clusters (Winter and Baumler 2011); if iron 
acquisition by the pathogen becomes easier through iron excess, the expression of the 
iron-containing oxidoreductases might be unhampered. It should be noted that it is not 
known whether the expression of these oxidoreductases is normally limited due to difficult 
accessible iron (Figure 5); IV) Finally, the reduction of ferric iron is considered an early 
form of microbial respiration, by which bacteria can generate energy (Pierre et al 2002). 
We therefore envisage that iron itself may function as an electron donor (Fe2+) or acceptor 
(Fe3+) for certain members of the gut microbiota, but also for pathogens that might use it 
for alternative respiration during inflammation (Figure 5). This is in-line with the view 
that reduction of ferric iron is considered an early form of microbial respiration and by 
which bacteria can generate energy (Pierre et al 2002). We want to emphasize that these 
hypothetical mechanisms and their potential contribution to exploitation of inflammation 
need to be examined experimentally in both in vitro and in vivo models. 
9.2 Iron and inflammatory bowel disease (IBD)
Compelling evidence that the provision of extra iron to an inflamed gut is contraindicated 
comes from patients with inflammatory bowel disease (IBD). These patients often get 
anaemia of the chronic disease (anaemia of inflammation), because iron uptake and iron 
homeostasis is unbalanced due to chronically increased systemic hepcidin levels (Cherayil 
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2010). These patients therefore require iron supplementation therapy, but caution has to be 
taken as oral iron has been shown to worsen the symptoms of IBD, while intravenous iron 
does not (Zhu et al 2010). In rats and mice where colitis was induced, it was shown that oral 
iron exaggerated the inflammation (Carrier et al 2006, Reifen et al 2000, Seril et al 2002). 
Moreover, mutant mice (TNFΔARE/WT) that develop distal ileitis remained healthy on an iron-
deficient diet, also in combination with intravenous iron administration (Werner et al 2011). 
These studies strongly suggested that oral iron can worsen gut inflammation, which might 
be (partly) caused by iron-induced radical formation, but also might be a consequence of 
the increased growth of pathogenic microbes that thrive on iron and inflammation, and 
hereby might contribute to the pathogenesis of IBD. It is known that the gut microbiota 
of patients with IBD differs from healthy controls, often showing that enteropathogenic 
strains are increased in IBD patients (Boleij and Tjalsma 2012). This difference might be 
enlarged by iron, as Werner et al. showed that ferrous sulphate caused marked alterations 
of the mouse caecal microbiota (Werner et al 2011). Amongst other differences, mice 
with ileitis on a diet supplemented with ferrous sulphate showed a reduction in beneficial 
Bifidobacteriaceae and Lactobacillaceae and an increase in Bacteroidaceae, but a similar 
abundance of Proteobacteria, when compared to mice with ileitis on a low-iron diet without 
ferrous sulphate (Werner et al 2011). Remarkably, Ettreiki et al., showed that juvenile 
treatment with ferric iron could prevent 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced 
colitis in mice and rats, whereas treatment with ferrous iron did not. Ferric iron could also 
prevent gut microbial dysbiosis, as it prevented the increase in Enterobacteriaceae during 
colitis (Ettreiki et al 2012). Results on the effects of ferrous iron on the microbiota were 
unfortunately not reported. 
Also in human IBD patients, administration of iron intravenously is preferred over oral iron 
administration. A recent systematic review concluded that intravenous iron is more efficient 
in restoring iron status, with less discontinuation of intervention due to adverse effects, 
compared to oral iron (Avni et al 2013). Another recent systematic review highlighted the 
gastrointestinal adverse effects due to oral iron administration, among which were nausea, 
diarrhoea and abdominal pain (Lee et al 2012). It is therefore concluded that intravenous 
iron therapy is preferred for IBD patients, which is in line with the conclusion of Zhu et al., 
a few years earlier (Zhu et al 2010). We however note that also intravenous iron therapy 
may not be without risk as this may induce iron overload (of reticulo-endothelial stores in 
patients with inflammation) (Rostoker et al 2012). Finally, a recent study concluded that 
iron fortification is well tolerated in patients with quiescent IBD (absence of inflammation), 
but is contra-indicated in patients with relapses (Tolkien et al 2013). A similar recent study 
confirmed the detrimental effect of oral iron administration in patients with forms of mildly 
active IBD (Powell et al 2013). To our knowledge, no one has investigated the effects of oral 
iron on the human gut microbiome during IBD yet, but it might very well be that alterations 
of the gut microbiota during oral iron therapy contribute to the exaggeration of intestinal 
inflammation. If not directly influenced by iron, certain bacterial species are likely to thrive 
on the inflammation, which is associated with elevated lipocalin-2 and calprotectin levels, 
also in IBD (Diaz-Ochoa et al 2014) (see section 9.1). Furthermore, at the site of intestinal 
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inflammation luminal iron may exaggerate this inflammation by catalysing the formation 
of toxic oxygen radicals. This scenario could promote alternative microbial respiration, but 
could also lead to cellular apoptosis, tissue damage and ER stress (Weiss 2011). It goes 
without saying that the adverse effects of oral iron in IBD patients are likely to apply for 
patients with acute forms of gastroenteritis as well. 
10 Iron challenges of enteric invasive pathogens during the infection 
route
This section will specifically discuss the aspects of iron in relation to virulence traits of 
invasive enteric pathogens that can also cause inflammatory diarrhoea, such as Salmonella, 
Shigella and Campylobacter (Navaneethan and Giannella 2008), from the colonic lumen 
to epithelial invasion, mainly using S. Typhimurium as a model organism. As mentioned 
in section 4.2, iron availability is an important signal for the expression of virulence genes 
by bacterial pathogens. Although readily available iron is not likely to be present in large 
amounts in the colon lumen, it is probably still high compared to readily available iron 
after entering the host tissues, with its excellent iron withdrawal mechanisms. Herein lies 
the iron challenge: for full virulence invasive enteric bacteria need mechanisms to deal 
with the changes in iron concentrations while they simultaneously have to be able to enter 
the host. To establish host invasion, epithelial adhesion is a first key step and requires 
different virulence mechanisms compared to the actual invasion, which is the next step to 
an infection. Moreover, evasion of the host defences is also indispensable to the success of 
the pathogen. 
10.1 Reaching the site of adhesion
The very first step that leads to infection may be the expression of flagella by the pathogen. 
Flagella enable microbes to swim in liquids and swarm over surfaces and have also been 
implicated in the adhesion to epithelial cells (Moens and Vanderleyden 1996). Motility is 
thus an important virulence factor and may be essential in the colon lumen to reach the 
epithelium and ultimately to invade the host. The expression of flagellum protein appears 
to be post-transcriptionally regulated by iron and oxidative stress, and it was proposed that 
iron inhibits flagellin synthesis of S. Typhimurium via the stabilisation of the aconitaseB 
(AcnB) clusters (Tang et al 2004, Tang et al 2005). In contrast, in Campylobacter jejuni, iron 
replete conditions were highly associated with the upregulation of flagellin biosynthesis 
genes (Butcher and Stintzi 2013). Results from our laboratory have also suggested that 
iron can increase the expression of flagellum protein in S. Typhimurium in vitro (Kortman, 
unpublished). It is thus difficult to predict how flagella synthesis responds to luminal iron, 
but the increased iron availability may increase the motility of pathogens in the relative 
iron-rich environment of the lumen in a non-inflamed environment (Figure 4), which 
would make sense in an evolutionary view from the pathogen’s perspective. Furthermore, 
it also fits with the finding that flagella synthesis is usually downregulated inside host cells, 




Nutritional iron turned inside out: intestinal stress from a gut microbial perspective
10.2 Epithelial adhesion
Once the motile (and invasive) pathogen has reached the epithelium, it should adhere to 
the cells to be able to invade the epithelium in a second step. We found that adhesion 
of several enteric pathogens to intestinal epithelial cells was markedly increased by iron 
in vitro (Kortman et al 2012). A recent study confirmed this effect, but also showed that 
iron-induced adhesion was minimized when S. Typhimurium was in an environment 
with bacterial metabolites, originating from an in vitro fermentation model (Dostal et al 
2014a). Other factors such as iron availability in the different media (cell culture medium 
vs. fermentation medium) or the deteriorating effect of fermentation medium on cultured 
intestinal epithelial cells, may however have contributed to those findings. In vitro data 
thus show that iron can increase bacterial adhesion (see also Figure 4), while in vivo studies 
point at an increased growth and colonisation of potentially pathogenic Enterobactericeae 
in vivo (Jaeggi et al 2014, Zimmermann et al 2010). There is however no direct evidence 
from in vivo studies that adhesion of enteric pathogens to the colon epithelium is increased 
by iron, thus further investigations on this issue, and on the effect of iron on molecular 
bacterial adhesion mechanisms, is necessary. Below we describe a few molecular bacterial 
adhesion mechanisms that are possibly involved.
The most commonly known adhesive molecules that many bacteria, among which is S. 
Typhimurium, express on their surface are the fimbriae, which can reversibly bind to the 
surface of eukaryotic cell surfaces (Wagner and Hensel 2011). Little is known about the 
expression of fimbriae in response to iron. A study with enterotoxigenic E. coli indicated that 
iron represses fimbriae, but it has also been shown that iron can upregulate the expression 
of the Fimbrial protein Z (FimZ) in S. Typhimurium (Bjarnason et al 2003, Karjalainen et 
al 1991). The large non-fimbrial protein SiiE, also expressed by S. Typhimurium, is another 
factor known to be involved in adhesion to the epithelial surface (Wagner and Hensel 2011). 
Not much is known about the expression of SiiE in response to iron, however its expression 
coincides with the expression of invasion genes and it is regulated by the same global regulator 
(sirA) as SiiE (Gerlach et al 2007). Remarkably, invasion genes are known to be upregulated 
in response to iron (discussed in section 10.3) and it is therefore likely that SiiE expression 
will also be increased by iron availability. Our in vitro experiments have indeed shown that 
iron can increase the expression of the SiiE-protein (Kortman GAM, unpublished). Finally, 
there is a potential link between iron availability and LPS-mediated adhesion. LPS is a 
known modulator of cellular adhesion and it has been described that iron limitation alters 
the LPS structure and it reduces the LPS expression in Helicobacter pylori (Jacques 1996, 
Keenan et al 2008). Furthermore, iron can up-regulate the expression of the rfaJ gene, which 
encodes UDP-D-glucose: (galactosyl) lipopolysaccharide glucosyltransferase, an enzyme 
involved in the LPS synthesis (Bjarnason et al 2003). These studies indicate that iron may 
stimulate both LPS biosynthesis and LPS-mediated adhesion.
10.3 Epithelial invasion
For invasive pathogens the next step for the establishment of an infection is the invasion 
of the intestinal epithelium. In Salmonella and Shigella, the largely studied type 3 secretion 
system (T3SS-1 and T3SS-2) is important in this step, as well as in the initial adhesion 
42
Chapter 1  
to the epithelium. Misselwitz et al. showed that T3SS-1 mediates irreversible docking of 
S. Typhimurium to HeLa cells (Misselwitz et al 2011). Notably, T3SS-1 is considered an 
essential virulence factor in causing host infections (Que et al 2013). The expression of 
T3SS-1, which includes invasion genes, is regulated by the action of multiple genes and 
regulators. This topic will not be discussed in great detail here, but can be found elsewhere 
in literature (Moest and Meresse 2013, Teixido et al 2011). Importantly, one of the regulators 
of T3SS is Fur (described in section 8b) and activation of Fur under iron sufficiency, together 
with a low oxygen tension, ultimately leads to increased T3SS-1 expression (Ellermeier and 
Slauch 2008, Teixido et al 2011, Troxell et al 2011). Vice versa, iron limitation will lead to 
decreased T3SS-1 expression. Notably, iron has shown to upregulate the expression of the 
invH gene in S. Typhimurium, which encodes an invasion protein (Bjarnason et al 2003).
When we translate these findings to the gut, it makes sense that the T3SS-1 will be switched 
on when pathogens transit in the lumen of the non-inflamed gut, where iron availability 
is probably limited, but relatively high compared to the environment inside the host. 
This scenario supports the pathogen’s expression of this important virulence mechanism 
for invading the host. After invasion, the availability of intracellular iron to pathogens is 
very limited, which, together with increased oxygen tension, may directly form a signal for 
the pathogen to switch off the T3SS-1 (Teixido et al 2011). Instead, the invaded pathogen 
may increase the expression of different virulence factors, such as the expression of high 
affinity iron uptake systems to acquire iron in the iron-limited environment of the host cell, 
and to switch on the T3SS-2 system to promote intracellular survival (Ibarra and Steele-
Mortimer 2009, Zaharik et al 2002). Interestingly, increased iron status of enterocytes 
promoted the invasion of Salmonella enteritidis into differentiated Caco-2 cells. Thus, the 
increased iron status of enterocytes may also further support the invasion process (Foster 
et al 2001). The iron content of enterocytes might increase during inflammation because 
of an increase in systemic hepcidin levels, which in turn prevents iron export from cells, 
presumably causing the trap of iron inside enterocytes (Figure 5). It can be envisaged that 
also oral supplementation can increase enterocyte iron status, although the relevance for 
the colon has to be investigated further. Notably, in vitro experiments show that moderate 
(extracellular) iron levels can increase invasion of S. Typhimurium into cultured intestinal 
epithelial cells, while high iron levels can conversely decrease invasion (Dostal et al 2014a, 
Kortman et al 2012). Finally, once the pathogen has breached the colonic epithelium it will 
highly trigger the host immune response. Survival of the pathogen may partly depend on 
the host iron status as this can affect the local immune response and the ability to quickly 
clear the infection (see section 7.2).
To conclude this section, it is clear that iron availability can have a large impact on the 
infection cycle (involving the flagellar, fimbrial and T3SS-1 system (Saini et al 2010)) of 
a pathogen and that increased luminal iron, but also increased intracellular iron levels of 
enterocytes may exaggerate the virulence of enteric pathogens. More research is however 
needed to investigate these aspects into more detail.
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11 Clinical relevance of nutritional iron stress
11.1 Iron deficiency in the tropics and oral iron administration programmes
As outlined above, iron is a highly abundant metal on earth and is vital for virtually all 
organisms (Cairo et al 2006). Despite its abundance, iron deficiency is the most prevalent 
nutrition disorder worldwide and especially infants and young children in the tropics are 
in a vulnerable age for developing iron deficiency anaemia. These children require oral 
iron therapy to prevent serious health consequences such as developmental impairment 
(De-Regil et al 2011, WHO and UNICEF 2004). It has been shown that iron deficiency 
can be effectively controlled by both iron supplementation and fortification programmes 
(Zimmermann and Hurrell 2007). Also iron-containing micronutrient powders (MNPs), 
which are added to food after cooking (in-home fortification), can be effective in reducing 
iron deficiency rates (Adu-Afarwuah et al 2008). Recent trials have, however, questioned 
the safety of untargeted iron supplementation and fortification in developing countries 
(Oppenheimer 2001, Sazawal et al 2006, Soofi et al 2013, WHO and UNICEF 2006, 
Zlotkin et al 2013). In 2007 the WHO advised against universal iron supplementation and 
fortification in malaria endemic regions with low standards of health care, considering 
the dramatic results of the Pemba trial of Sazawal et al. (Sazawal et al 2006, WHO 2007). 
Reported increases in infections during oral iron administration might be at least partly 
ascribed to bacteria that could originate from the gut and that thrive on extra iron. 
11.2 Oral iron administration and morbidity
Importantly, as discussed in section 7.1 it has recently been shown in two studies that 
oral iron administration can shift the gut microbiota towards a more pathogenic profile 
(Jaeggi et al 2014, Zimmermann et al 2010) (Chapter 2). Although morbidity rates were 
not significantly higher, the increase in enteric pathogens was associated with increased 
gut inflammation (Zimmermann et al 2010). Notably, a systematic review of oral iron 
supplementation trials reported a slight increase in the risk of developing diarrhoea upon 
oral iron administration (Gera and Sachdev 2002). Two recent trials with the administration 
of iron-containing MNPs to young children have also raised concerns with regarding to 
diarrhoea. In Pakistan a significant increase in severe and bloody diarrhoea and respiratory 
disease was reported and in Ghana there was an increased number of hospitalisations that 
was possibly partly due to diarrhoea (Soofi et al 2013, Zlotkin et al 2013). It should be noted 
that these MNPs contained multiple micronutrients and vitamins next to iron. 
It thus appears that oral iron increases the risk of getting diarrhoea in children. This is 
an important adverse effect, as diarrhoea contributed for 11% to the mortality of children 
< 5 years old in the WHO African region in 2010 (WHO 2013). Although iron-induced 
diarrhoea so far has not directly been linked to the stimulation of enteric pathogens, it 
is important to realize that diarrhoea is often a sign of gastrointestinal infection and that 
luminal iron might play a role in its aetiology (WHO and UNICEF 2009). Therefore, a prior 
recommendation of both the WHO and the U.S. National Institutes of Health Working 
group (NIH TWG) is to investigate the impact of iron preparations on the gut microbiota 
(WHO and UNICEF 2006).
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11.3 Effects of nutritional iron on Salmonella infection and other intestinal 
pathogens
S. Typhimurium is a common cause of diarrhoea and is a major cause of gastroenteritis 
and invasive disease in humans worldwide. Remarkably, in tropical Africa this pathogen is 
often associated with severe invasive disease rather than with gastroenteritis and diarrhoea 
(Feasey et al 2012, Graham 2010). Furthermore, invasive disease caused by Salmonella often 
co-occurs with malaria infection as malaria appears to predispose children for systemic 
Salmonella infection, while both infections clearly have a link with host iron homeostasis 
(van Santen et al 2013). As pointed out above, there is a concurrent high prevalence of 
iron deficiency among children in those countries. These children require oral iron 
therapy to prevent developmental impairment (WHO and UNICEF 2004). Precariously, S. 
Typhimurium appears to be stimulated by increased iron availability in several but not all 
published studies, as extensively discussed above. Moreover, S. Typhimurium has shown 
to possess mechanisms to exploit inflammation and outcompete the residing microbiota 
as discussed in section 9.1 (Winter et al 2013a). The effect of luminal iron content and 
host iron status in these exploitation mechanisms are largely unknown and needs therefore 
more attention. So far, relatively little is known about a potential link of nutritional iron 
with intestinal infection caused by other enteric pathogens, but which may be important 
to investigate for its clinical implications. For example Campylobacter requires iron for 
successful colonisation of the host intestine and it is known that iron can induce flagella 
biosynthesis (an important virulence trait) in Campylobacter jejuni, (Feldmann et al 
2007, Miller et al 2009). Moreover, certain pathogenic E. coli strains are known for their 
production and utilization of stealth siderophores, suggesting an important role of iron in 
their virulence (Feldmann et al 2007, Hantke et al 2003). Importantly, a recent study showed 
that Kenyan infants receiving iron-containing micronutrient powder had increased faecal 
pathogenic E. coli numbers compared to infants receiving micronutrient powder without 
iron (Jaeggi et al 2014) (Chapter 2).
11.4 Challenges in oral iron administration
A big challenge of oral iron administration in infection endemic regions is to increase 
the bioavailability of iron to the host, without enhancing the risk of (gut borne) bacterial 
infections. As known for years, the bioavailability (i.e. uptake) of non-haem iron including 
iron supplements, is low compared to haem iron in meat (Zimmermann and Hurrell 2007). 
Although much research has focused on finding a preparation and dose schedule with 
optimal absorption, the predicted uptake of (isotope-labeled) iron preparations from a 
standard diet in industrialized countries is only 2-18%, depending on host iron status as was 
recently reported by a systematic review (Collings et al 2013). Especially in geographic areas 
where infection pressure is high and diets are monotonously cereal- and legume-based, oral 
iron administration is very challenging. First of all, the cereal- and legume-based diets are 
commonly rich in polyphenols and phytate which bind iron (see sections 5.2.1 & 5.2.2) and 
therefore potent inhibitors of iron absorption and such diets can result in an absorption of 
iron from the diet of often less than 10%. This food matrix will also lower iron absorption 
from supplements of fortificants (Zimmermann and Hurrell 2007). Interestingly, although 
45
1
Nutritional iron turned inside out: intestinal stress from a gut microbial perspective
phytate reduces host iron uptake, it may also lower iron-induced colonic lipid peroxidation 
during moderate to high iron intake as has been shown for pigs, which is by itself a beneficial 
effect (Schlemmer et al 2009).
11.5 The iron administration paradox during infection
Chronic infection can cause anaemia. Ironically, uptake of dietary and supplemented iron 
will in these cases be impaired during inflammation due to malaria and other infections, 
which are highly prevalent in tropical Africa. As pointed out above, inflammation will 
generally increase circulating hepcidin, which is likely to lead to reduced intestinal iron 
absorption. Consequently, increased amounts of unabsorbed iron will enter the colon, 
where it may promote the growth and virulence of enteric pathogens and also alter gut 
Figure 6. Schematic overview of the main gut microbial factors that are influenced by oral iron administration 
and host iron status. 
This figure summarises the main two iron-related components that influence the gut microbiota composition, 
virulence and metabolism. 
1)  Orally administered iron can have direct impact on the gut microbiota composition (and the ratio of 
pathogenic bacteria to beneficial bacteria) and metabolism, and potentially on the virulence of enteric 
pathogens.
2)  Host iron status is influenced by dietary iron uptake and infection, this in turn influences host immunity 
factors which can affect the gut microbiota. Intestinal inflammation (not depicted in this figure) will have a 
large impact on the gut microbiota (Figure 5).
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microbial metabolism, especially during oral iron administration involving relative high 
amounts of iron (Figure 4). 
11.6 Targeted iron to those in need 
It would probably be best to screen infants and children in the tropics for iron deficiency 
before giving them extra iron, as it appeared that especially iron replete children suffered 
from adverse effects compared to iron deficient children (Sazawal et al 2006, WHO 2007). 
However, screening in rural areas of developing countries is complicated due to logistics, 
inflammation (making iron parameters less proper measures of body iron status) and its 
expensiveness. With regarding to the generally high rate of iron deficiency, untargeted oral 
iron administration is preferred above targeted treatment. Nonetheless, hepcidin has been 
proposed as a valuable biomarker in a point-of-care test to identify anaemic children as it can 
in theory discriminate between iron deficiency anaemia (IDA) (low hepcidin) and anaemia 
due to infection (ACD) (high hepcidin) (Jaeggi et al 2013, Prentice et al 2012). In the latter 
case it would be better to first treat the infection before starting with iron supplementation. 
However, recent data from a study in Kenya indicate that circulating hepcidin levels do not 
correlate with gut inflammation (during infancy), meaning that potential local injurious 
effects of iron supplements on infectious or inflammatory intestinal disease may not be 
properly predicted (Jaeggi et al 2013). In addition, a study in Malawian children showed that 
hepcidin was a poor predictor of bone marrow iron deficiency. Upregulation of hepcidin by 
inflammation and iron status was blunted by erythropoietin in this population, and therefore 
would have limitations as a biomarker to differentiate between IDA and ACD in this category 
of children (Jonker et al 2013). Thus, although promising, these recent studies underscore that 
the potential value of serum hepcidin to guide safe iron supplementation in infancy needs 
further clarification.
11.7 Approaches for safe oral iron administration without affecting the microbiota 
composition and metabolism
In the absence of robust and affordable biomarkers for targeted supplementation of iron, 
several strategies to increase bioavailability and safety of iron formulas for universal use have 
been investigated. Moreover, there are several additional approaches that can be thought of 
based on theoretical considerations. All these tested and hypothetical approaches will be 
discussed below.
11.7.1 Improving absorption of dietary iron
Usually, most diets contain sufficient amounts of endogenous iron, even plant-based diets, 
but the uptake is hampered by food components that bind and precipitate the iron. Improving 
the absorption of endogenous dietary iron is one strategy to prevent extra amounts of iron 
entering the colon. Nevertheless, when making dietary iron more bioavailable, also the 
availability for gut microbiota most likely increases. One approach, also mentioned above, is 
the addition of ascorbic acid as this compound supports the solubility of iron during passage 
in the stomach and intestine, even when polyphenols and phytate are present. A drawback is 
that ascorbic acid is susceptible to losses during storage and cooking (Hurrell 2002).
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Another approach which has already been successfully tested, is the reduction of dietary 
phytate by enzymatic degradation via the activation of endogenous phytase or the addition 
of a commercial phytase. It is important to greatly reduce the phytate content to achieve a 
significant increase in iron absorption (Hurrell 2002). Interestingly, it has been shown that 
the addition of a phytase, active at the pH within the stomach and intestine can significantly 
increase the iron absorption of a meal fortified with FeSO4 or NaFeEDTA (Nielsen et al 2013, 
Troesch et al 2009). The effects of dietary phytate digestion on the gut microbiota is however 
not known and needs further investigation. Above all, it is preferred to increase the diversity 
of monotonous diets, which also can enhance the absorption of iron and other essential 
micronutrients. Unfortunately, this can be very challenging in poorer countries (WHO and 
FAO 2006).
11.7.2 Low dose, highly bioavailable iron
As already mentioned in section 11.4, most oral iron administration studies have focused on 
the bioavailability of iron preparations. Other important classical aspects taken into account 
are the stability (e.g. as fortificant to those in flour), sensory experience, and cost. Hence, 
the majority of these studies did not evaluate the causes of the adverse gastrointestinal 
side effects that are frequently reported. Nevertheless, increasing the bioavailability of an 
iron preparation in the host is also a strategy to prevent large amounts of unabsorbed iron 
entering the colon. If iron bioavailability is high, then the dose might be lowered, while 
maintaining sufficient host iron absorption. The bioavailability might be improved by 
adding ascorbic acid as a well known enhancer of iron absorption; alternatively, the iron 
might be provided as NaFeEDTA to improve iron absorption from diets high in phytate, 
or soluble ionic iron can be encapsulated to increase stability and to prevent unwanted 
sensory effects (Hurrell 2002). A slightly different strategy could be the slow release of 
iron from a preparation, this way maximizing duodenal absorption. Providing a low dose, 
but highly bioavailable iron is a promising strategy for preventing large amounts of iron 
entering the colonic lumen, although it remains challenging to find the optimal dose and 
preparation. This is underscored by a very recent study which showed that micronutrient 
powder containing a low dose of 2.5 mg highly bioavailable iron as FeNaEDTA did not 
improve the body iron status of Kenyan infants, while their gut microbiota was still shifted 
towards a potentially more pathogenic profile (Jaeggi et al 2014).
11.7.3 Iron containing micronutrient powders (MNPs)
 A promising approach for the low dose strategy was the application of MNPs with highly 
bioavailable iron for untargeted in-home fortification plus the provision of other important 
minerals and vitamins. These MNPs are recommended by the WHO to treat iron deficiency, 
with the important remark that measures to prevent, diagnose and treat malaria in malaria-
endemic areas have to be established (WHO 2011). MNPs could avoid the need to screen 
infants for iron deficiency anaemia (IDA) and are expected to have less impact on the gut 
microbiota compared to iron supplementation doses, as the MNP iron dosage is generally 
lower and is always accompanied by a food matrix. However, MNPs with iron have recently 
been associated with increased hospital admission and bloody diarrhoea, but the effects of 
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MNPs on the gut microbiota have not been extensively studied yet (Soofi et al 2013, Zlotkin 
et al 2013).
11.7.4 Provision of probiotics and/or prebiotics together with iron
As oral iron administration tend to decrease numbers of the beneficial gut microbe families 
Lactobacillaceae and Bifidobacteriaceae (discussed in section 7.5), the simultaneous 
administration of probiotic bacteria may counteract this effect and contribute to the 
maintenance of these beneficial strains in the colonic lumen. To our knowledge, the 
combination of oral iron therapy and probiotic administration has not been studied yet 
and thus needs further investigation. Here we propose a few probiotic candidates to be 
provided during oral administration of iron based on the current knowledge. First of all, 
Bifidobacterium strains have a great potential as probiotics, because they can utilise and 
possibly bind iron to their surfaces, thereby making iron less available to pathogenic strains 
in the colon (discussed in section 3.2.1). Furthermore, some strains of Bifidobacterium have 
been reported to decrease the duration or incidence of diarrhoea in infants (Di Gioia et al 
2014). Bailey et al. discovered an iron-responsive probiotic strain of the species Streptococcus 
thermophilus. This strain showed enhanced growth in response to iron and might therefore 
be better able to compete with enteric pathogens during increased iron availability (Bailey 
et al 2011). Another very interesting probiotic strain is E. coli Nissle 1917, which can also 
thrive on iron (Deriu et al.) and has been shown to reduce S. Typhimurium adhesion to, and 
invasion into intestinal epithelial cells (Schierack et al 2011). Moreover, E. coli Nissle 1917 
is capable of reducing S. Typhimurium colonisation of the mouse inflamed gut because it 
can compete for iron with S. Typhimurium via several high affinity iron uptake mechanisms 
(Deriu et al 2013). It should however be noted that, the differential response to probiotics 
among individuals may limit the overall health benefit when a single strain is universally 
administrated to large populations (van Baarlen et al 2013). Future research will be needed 
to assess the potential benefit, and also to assess the safety of probiotic administration in 
infection endemic regions.
Finally, a slightly different approach may increase iron uptake by the host and improve gut 
health. Prebiotics such as inulin and fructo-oligosaccharides have been shown to increase the 
number of beneficial Bifidobacteriaceae and to decrease colonic pH (Vieira et al 2013). This 
study suggest that the simultaneous provision of prebiotics with iron might be a promising 
approach to both stimulate iron uptake and the colonisation of beneficial Bifidobacteriaceae 
(as discussed in section 6.1). It has indeed been shown that, whereas inulin can increase 
the Bifidobacteriaceae population and decrease colonic pH, it did not significantly increase 
iron uptake in women with low iron status (Petry et al 2012). Nevertheless, a trend towards 
increased iron absorption was reported, and future studies should reveal the benefit and 
safety of this approach.
11.7.5 Provision of antimicrobial agents
As iron appears to increase the number of enteric pathogens, one strategy is to suppress 
these “ironphilic” pathogens by antimicrobial agents). This way, the risk of getting infectious 
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diarrhoea may be lowered and the prevention of gut inflammation in general would lower 
the risk of pathogenic overgrowth. The provision of antibiotics is not advisable, as this 
treatment will have a (temporary) detrimental effect on the gut microbiota. One approach 
could be the provision of the natural antimicrobial compound carvacrol. We recently 
showed that carvacrol can reduce iron-induced virulence (i.e. adhesion) of S. Typhimurium 
and earlier it was shown that carvacrol improved gut health in piglets, thus carvacrol is a 
potential candidate for specifically reducing the iron-induced virulence of enteric pathogens 
(Kortman et al 2014a, Michiels et al 2010) (Chapter 6). Future studies should focus on the 
targeted delivery of carvacrol in the colon as well as on its effects on the gut microbiota. 
As mentioned in section 7.1, the provision of zinc may counteract the effects of iron, as 
zinc can reduce the virulence of enteropathogens (Crane et al 2011, Mellies et al 2012) but 
contradictory results have been obtained thus far. On the one hand, zinc appeared to reduce 
iron-induced gut microbial changes In US infants (Krebs et al 2013). On the other hand, 
MNP including iron and zinc (but also other micronutrients) did not reduce the incidence 
of bloody diarrhoea in Pakistani children compared to MNP including iron, but without 
zinc (Soofi et al 2013). Notably, zinc is also an pivotal metal for many bacteria and may 
therefore also support bacterial growth in general (Hood and Skaar 2012).
11.7.6 Limitation of accessibility of orally administered iron for enteric pathogens
The ideal oral iron preparation can be given in a low dose and is well absorbed by the 
host, resulting in only slightly increased amounts of iron entering the colon. However, host 
iron uptake will likely always comprise a rather low percentage of the dose given. An iron 
source highly bioavailable for the host, but hardly accessible for enteric pathogens, would 
therefore be most perfect. This may be very challenging with regarding to the effects of the 
environmental conditions of the stomach and intestine on iron speciation, but is may not 
be impossible. As already mentioned, it has been shown, with the limitations of the study, 
that ferric iron did not alter the gut microbiota of rodents and may therefore indicate that 
ferric iron ends up in less accessible form (e.g. insoluble) in the colon (Ettreiki et al 2012). 
Ferric iron is however generally not as bioavailable for the host as ferrous iron, although 
NaFe(III)EDTA has shown good bioavailability because of its solubility (Zimmermann and 
Hurrell 2007).
A rather new form of iron preparations is nanocompound iron. This nanostructured iron 
is poorly water-soluble but is surprisingly well absorbed by intestinal epithelial cells and 
rodents. It has been shown that nanocompound iron can be taken up via endocytosis by 
intestinal epithelial cells and it also showed good bioavailability in a mouse and rat study 
(Hilty et al 2010, Pereira et al 2013, Powell et al 2014). The effect of nanocompound iron 
on the gut microbiota remains to be investigated and will depend on the integrity of these 
nanocompounds in the intestinal tract and/or the capability of bacteria to utilise iron from 
these particles.
11.7.7 Natural iron complexes
Other more natural forms of iron such as lactoferrin and ferritin can also be good candidates, 
although the effect on the gut microbiota needs to be investigated for these iron sources as 
50
Chapter 1  
well. Plant ferritin as a whole can be absorbed by the human intestine via an endocytosis 
mediated pathway and has the potential to be used as a readily bioavailable iron supplement 
as reviewed by Theil et al. (San Martin et al 2008, Theil 2004). For example ferritin rich 
legume seeds such as soy beans can potentially be used as an iron source (Lönnerdal 2009). 
The stability of ferritin and availability of ferritin iron for gut bacteria in the colonic lumen 
is not yet known but it can be envisaged that this form is relatively difficult to access. 
Next, it has been shown that supplementation of lactoferrin can increase the iron status 
of infants and pregnant women (Lonnerdal 2009). This form of iron is generally not well 
available for bacteria, but certain pathogenic species have developed ways to sequester iron 
from lactoferrin via a lactoferrin receptor or siderophore-mediated uptake (as discussed 
in section 9.1.1) and may therefore provide these pathogenic species with a competitive 
advantage over other (beneficial) microbes.
To wrap up, many of the approaches mentioned in this section are already tested with regard 
to bioavailability to the host, but to assess their safety it would be required to study their 
effects on the gut microbiota. It remains difficult to predict in which form the originally 
administered iron will end up in the colon and to what extent it can be utilised by the 
microbes, which is especially important with regard to enteric pathogens. 
The perfect iron preparation shows good bioavailability for the host but not for (pathogenic) 
gut microbes, shows no adverse effects and is low cost for application in developing 
countries. When new iron preparations are tested in regions with high infection pressure 
it is advisable to also assess the effects on the gut microbiota. It goes without saying that 
preparations can first be tested in vitro gut models and animal models that closely resemble 
the relevant in vivo conditions.
12 Conclusion and future perspectives
Iron deficiency anaemia is widespread among the world and should generally be corrected to 
avoid serious health consequences. Although in industrialised countries oral iron therapy is 
commonly associated with gastrointestinal side effects, it is not known to increase the burden 
of infection in this setting. In contrast, in an African region with high infection pressure 
(e.g. malaria) and low hygiene standards oral iron supplementation has been associated 
with increased morbidity and mortality of children. Furthermore, oral administration can 
increase the incidence of diarrhoea, which may partly be caused by the outgrowth of enteric 
pathogens. In this review we extensively discussed the multifaceted effects of nutritional 
iron, oral iron administration, host iron status, intestinal inflammation and nutritional 
stress on the gut microbiota (summarised in Figure 6). From a gut microbial perspective it 
becomes clear that life in the colon lumen is not always easy and that many stress factors 
play a role, especially for enteric pathogens that are usually very well restrained in the 
healthy colon (Figure 1). Above all, it becomes clear that oral iron administration changes 
the gut microbiota profile on several fronts. Although the effects appear to be variable 
among studies, together they point at a shift towards a potentially pathogenic profile. 
The clinical relevance of these effects are not fully clear yet but it is highly recommended 
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that potentially pathogenic effects on the gut microbiota need to be avoided as much as 
possible. We therefore provide leads for the development of alternative iron preparations 
that provisionally have less impact on the gut microbiome. It goes without saying that 
more research on this matter will help us to increase the understanding of how the gut 
microbiome deals with iron and which way the iron can be administered best. 
13 Aim and outline of this thesis
Oral iron administration in infection endemic regions is associated with an increased 
susceptibility of children to infections. The aim of this thesis was to investigate the impact 
of oral iron administration at the intestinal epithelial interface on i) the pathogenicity of 
intestinal pathogens, ii) the gut microbiota composition, iii) gut microbial metabolism, and 
iv) host responses. Knowledge on the response of gut microbes to iron is pivotal for the 
design of oral iron supplementation strategies or alternative iron preparations with less 
adverse effects on the intestinal microbiota and the gastrointestinal tract.
Chapter 1 comprehensively reviews the current knowledge on many (clinical) aspects of oral 
iron administration with regard to effects on the gut microbiota and the host. Chapter 2 
shows the effects of oral iron fortification on the gut microbiota of African infants in a rural 
environment, a group of individuals highly vulnerable to iron deficiency and infections. 
Iron fortification caused a shift towards a more pathogenic gut microbiota profile and 
was associated with increased gut inflammation. Importantly, this outcome implies that 
oral administration programmes in similar areas need to be set up with adequate health 
measures, and stresses the importance of further research on the effects of iron on the 
gut microbiota as described in the following chapters of this thesis. In Chapter 3 we 
describe the effect of multiple iron preparations and doses on gut microbial composition 
and metabolism in a model for the human large intestine. The explorative and multi-omics 
approach gave valuable insights and showed that gut microbial metabolism shifted towards 
a more toxic profile. Next, in Chapter 4 the effects of oral iron administration on the host 
immune response in a mouse model for human intestinal bacterial infection are described. 
It shows that both the host immune response and innate defense can be attenuated by 
both iron deprivation and iron supplementation. This illustrates the complex interplay 
between bacterial pathogenicity, host iron status, host immunity and the gut microbiota, 
which can be further elucidated in future research. Chapter 5 describes that increased 
iron availability increases the virulence of intestinal pathogens, which was in particular 
evident by increased adhesion of pathogens to a monolayer of intestinal epithelial cells in 
vitro. In Chapter 6, the potential of the natural antimicrobial carvacrol to prevent iron-
induced virulence in vitro was investigated. The results indicate that supplementation of 
carvacrol can potentially prevent the stimulation of enteric pathogens during oral iron 
administration, but further research is required to assess this approach. Finally, Chapter 7 
summarizes the research in this thesis, highlights the gain in insights and provides directions 
for future research.
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Supplementary Tables
Supplementary Table 1. A selection of papers which illustrate that (slightly) different association constants (Ka) 
for transferrin and enterobactin circulate in literature. Also for estimated free iron concentration in normal 
human plasma different values can be found.
Supplementary Table 2. Dietary ligands or host secreted ligands for iron that may be found within the colonic 
lumen.1 
1 Note that association constants may have been determined at different conditions in the different studies
Study Transferrin (Ka)1 Enterobactin (Ka)1 Free [Fe] in plasma
(Bullen et al 2000) 1036 1052 10-18 M
(Miethke and Skerra 2010) 1022 1049 10-24 M
(Aisen and Listowsky 1980) 1022
(Aisen et al 1978) 1020
(Raymond et al 2003) 10-24 M
(Carrano and Raymond 1979) 1051
Ligand/iron species Reference
Organic acids
   Ascorbate (Cremonesi et al 2002, Hurrell and Egli 2010, Jacobs and Miles 1969, Miret et al 2003, van Dokkum 1992)
   Citrate (Cremonesi et al 2002, Jacobs and Miles 1969, Salovaara et al 2003, van Dokkum 1992)
   Lactate (Cremonesi et al 2002, Miret et al 2003)
   Oxalate (Conrad and Umbreit 2002, Salovaara et al 2003, van Dokkum 1992)
   Succinate (Cremonesi et al 2002, Salovaara et al 2003)
   Tartrate (Salovaara et al 2003)
Polyphenols
   Tannate (Conrad and Umbreit 2002, van Dokkum 1992)
   Catechols (Freestone et al 2007)
Phytate (Conrad and Umbreit 2002, Hurrell and Egli 2010)
Oxides / hydroxide (Simpson et al 1992)
Carbonate (Conrad and Umbreit 2002, Simpson et al 1992)
Phosphate (Conrad and Umbreit 2002, Simpson et al 1992)
Lactose2 (van Dokkum 1992)
Ferritin (Lönnerdal 2009, Vereecke et al 2011)
Lactoferrin (Lonnerdal 2009)
Mucins (Conrad and Umbreit 2002, Cremonesi et al 2002, Jacobs and Miles 1969, Miret et al 2003)
Amino acids (Conrad and Umbreit 2002, Cremonesi et al 2002, Hurrell and Egli 2010, Miret et al 2003, van Dokkum 1992)
Protein (animal) (Hurrell and Egli 2010, van Dokkum 1992)
Bile constituents (Cremonesi et al 2002, Jacobs and Miles 1970)
1Many of these ligands allow iron to bind in either the ferrous or the ferric state. Most likely, this list represents 
only a subset of the food or host derived ligands that can precipitate or solubilise luminal iron.
2In lactose tolerant people lactose is digested in the small intestine, so it is likely that lactose normally does not 
enter the colon in significant amounts.
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Supplementary Table 3: setting and set up of studies included in Table 1.
In vivo human (n=6) In vivo animal (n=7) In vitro (n=2)
Study Mevissen-Verhage et al. 1985 Benoni et al. 1993 Dostal et al. 2012b
Subjects Infants, newborns Rats (Sprague-Dawley) Children faecal samples 5
Setting European, The Netherlands Laboratory In vitro fermentation
Iron source & dose 5mg/L in cow-milk FeSO4, 10 or 30 mg Fe/kg water 
3 FeSO4, various
Duration First 3 months of life 2 2 and 4 weeks Long (70 days, with intervals)
Technique Culture techniques (faecal) Culture techniques (faecal) qPCR & pyrosequencing
Study Balmer et al. 1989 Tompkins et al. 2001  Kortman et al. 2014
Subjects Infants, newborns Mice Swiss-Webster, 5 weeks old  Dutch adult faecal samples
Setting European, United Kingdom Laboratory  In vitro fermentation
Iron source & dose 9 mg Fe/L (+ lactoferrin) FeCl3, 121 or 1590 mg/kg diet 
3  FeSO4 / Ferric citrate, medium-high
Duration 4 and 14 days 12 weeks  72 hours
Technique Culture techniques (faecal) Culture techniques (colonic)  Pyrosequencing & microarray
Study Balmer et al. 1991 Lee et al. 2008
Subjects Infants, newborns Weaning piglets, 3-d-old
Setting European, United Kingdom Controlled, concrete floors
Iron source & dose 6 mg Fe/L FeSO4; 50, 100 or 250 mg Fe/kg diet 
3
Duration 2-15 weeks 2 2 and 4 weeks 2
Technique Culture techniques (faecal) Culture techniques (faecal)
Study Zimmerman et al. 2010 Werner et al. 2011
Subjects School Children, 6-14-y-old Mice C57BL/6, 7 weeks old
Setting African, Ivory Coast, rural Laboratory
Iron source & dose Electrolytic iron, 20 mg/day FeSO4, 180 mg Fe/kg diet
Duration 6 months 11 weeks
Technique TGGE & qPCR (faecal) Pyrosequencing (caecal)
Study Krebs et al. 2013 Dostal et al. 2012a
Subjects Infants, 5-mo-old Rats (Sprague-Dawley), 21-d-old
Setting US Laboratory
Iron source & dose ~6 mg/serving 1 FeSO4; 10 or 20 mg/kg diet 
3
Duration 4 months 24 d depletion, then 13 d repletion
Technique Pyrosequencing (faecal) TGGE & qPCR (faecal)
Study  Jaeggi et al. 2014 Ettreiki et al. 2012
Subjects  Infants, 6-mo-old Mice (BalbC) and Rats (Wistar) 4
Setting  African, Kenya, rural Laboratory
Iron source & dose  2.5 or 12.5 mg/day 3,7 Ferric, 75 or 150 mg/kg water 3
Duration  4 months 6 weeks
Technique  Pyrosequencing & qPCR (faecal) qPCR, small selection of taxa (caecal)
Study Dostal et al. 2014b
Subjects Rats (Fischer 344), 5-wk-old 
Setting Laboratory, humanised microbiota
Iron source & dose FeSO4, 35 or 70 mg Fe/kg diet 
3,6
Duration 12 + 4 weeks
Technique Pyrosequencing & qPCR (caecal)
54
Chapter 1  
Supplementary information 1
Iron speciation of oral iron preparations
Iron speciation of dietary iron from the source to the colon is extensively discussed in 
the main article, but it is also intriguing to envisage in which form an oral supplement or 
fortificant will end up in the colon. Oral iron preparations are most commonly provided in a 
soluble and ferrous form (e.g. ferrous sulphate), but can also be given in a soluble and ferric 
form (e.g. FeNaEDTA). Although difficult to predict, we here envisage what happens with 
the iron preparation upon ingestion in the gastrointestinal tract.
Ferrous iron
Despite the presence of oxygen in stomach, the gastric acid will promote to keep the iron 
in the ferrous state. Probably not for 100% as it has been shown in mice that ferrous iron 
ends up mainly in the ferric form in the duodenum, resulting in a decreased solubility 
(Cremonesi et al 2002). When pH rises, oxidation of ferrous iron to the ferric form likely 
occurs, but oxygen levels in the small intestine lumen are low and very low in the colon. The 
environment of the colon lumen may therefore favour the ferrous state. Notably, host iron 
uptake mainly takes place in the duodenum, quickly after the rise in pH.
Ferric iron
The presence of oxygen and the low pH of the gastric acid will promote to keep the iron 
in its ferric form. When pH rises, its solubility rapidly decreases which in turn favours 
complexation with e.g. hydroxides. However, e.g. organic acids can keep the ferric iron in a 
soluble form (e.g. citrate), or reduce it to the ferrous form (e.g. ascorbate). If the ferric iron 
is provided in e.g. an EDTA complex, this also favours solubility (if the complex is stable in 
the stomach). Notably, for uptake via DMT1, the iron needs to be in the ferrous form, which 
requires action of the host reductase DcytB if iron is in the ferric (and soluble) state.
Conclusion
Bioavailability of ferrous iron to the host is generally better than that of ferric iron, which 
supports the above theories. Ferrous iron will largely be converted to the ferric form when 
pH rises after passage through the stomach, but is likely to remain partly in the ferrous 
form, which can explain the better host bioavailability compared to ferric iron. This is in 
line with the finding that orally administered ferrous iron can promote ROS formation in 
1 compared to a different low iron meat diet
2 consensus result over the whole period was deduced
3 consensus result for iron doses was deduced
4 consensus result for both species was deduced
5 faecal samples were used as starting microbiota for the in vitro fermentation
6 for the 70 mg/kg diets a mixture of ferrous sulphate and ferric citrate was used
7 the 2.5 mg dose was given as NaFeEDTA, the 12.5 mg dose was given as ferrous fumarate
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faecal water (Lund et al 1999) and it also fits with the idea that the less reactive ferric iron 
has less adverse effects on the gut wall as it probably will not be converted into ferrous iron 
to a large extent. Finally, we note that large amounts of food appear to decrease iron uptake, 
because of an increase in gastric acid pH which decreases solubility of iron (Simpson and 
Peters 1990). High food intake together with oral iron administration is therefore likely to 
promote early iron speciation, affecting host iron uptake and possibly also the accessibility 
for the gut microbiota. It goes without saying that specific food components not mentioned 
here will also affect iron speciation and solubility of the administered iron. This in turn 
affects accessibility of the iron for the gut microbiota. For more information on this matter, 
we refer back to section 5 (Iron speciation and bacterial iron uptake mechanisms in the
colon) of the main article and Supplementary Table 2. After all, concomitant food can thus 
decrease intestinal absorption of iron, but the simultaneous intake of food can also reduce 
gastrointestinal side effects and it is therefore advised to take iron preparations together 
with small amounts of food (Macdougall and Geisser 2013).
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Abstract
In-home iron fortification for infants in developing countries is recommended to control 
anaemia but low absorption typically results in >80% of the iron passing into the colon. Iron 
is essential for growth and virulence of many pathogenic enterobacteria. We determined 
the effect of high and low dose in-home iron fortification on the infant gut microbiome and 
intestinal inflammation. 
We performed two double-blind randomised controlled trials in 6 month old Kenyan 
infants (n=115) consuming home-fortified maize porridge daily for four months. In the 
first, infants received a micronutrient powder (MNP) containing 2.5 mg iron as NaFeEDTA 
or the MNP without iron. In the second, they received a different MNP containing 12.5 mg 
iron as ferrous fumarate or control. The primary outcome was gut microbiome composition 
analysed by 16S pyrosequencing and targeted real-time PCR (qPCR). Secondary outcomes 
included faecal calprotectin (marker of intestinal inflammation) and incidence of diarrhoea. 
We analysed the trials separately and combined. The study is registered with ClinicalTrials.
gov, number NCT01111864.
At baseline, 63% of the total microbial 16S rRNA could be assigned to Bifidobacteriaceae but 
there were high prevalences of pathogens, including Salmonella, C. difficile, C. perfringens, 
and pathogenic E. coli. Using pyrosequencing, +FeMNPs increased enterobacteria, 
particularly Escherichia/Shigella (p = 0.048), the enterobacteria/bifidobacteria ratio (p = 
0.020), and Clostridium (p = 0.030). Most of these effects were confirmed using qPCR; e.g., 
+FeMNPs increased pathogenic E. coli strains (p = 0.029). +FeMNPs also increased faecal 
calprotectin (p = 0.002). During the trial, 27.3% of infants in +12.5mgFeMNP required 
treatment for diarrhoea versus 8.3% in -12.5mgFeMNP (p = 0.092). There were no study-
related serious adverse events in either group.
In this setting, provision of iron-containing MNPs to weaning infants adversely affects the 
gut microbiome, increasing pathogen abundance and causing intestinal inflammation. 
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While infants have the highest rates of iron deficiency anaemia (IDA), they are also the group 
less well covered by universal fortification programmes. Micronutrient powders (MNPs), 
added directly to complementary foods after cooking (in-home fortification), can be an 
effective approach for providing additional dietary iron and reducing anaemia rates (Adu-
Afarwuah et al 2008). Currently, in-home fortification programmes are in place or planned in 
36 countries including 10 in Sub-Saharan Africa (UNICEF-CDC 2013).
However, the safety of iron-containing MNPs (+FeMNPs) is uncertain. A 2007 WHO 
Consultation, on the results of the Pemba trial where iron and folic acid supplementation 
increased child mortality (Sazawal et al 2006), did not recommend the use of +FeMNPs in 
malaria-endemic areas because of concerns about potential increases in infection (Fontaine 
2007). Two recent fortification trials in infants with an MNP containing 12.5 mg ferrous 
fumarate have raised safety concerns: in Ghana, there was an increased rate of hospitalisations 
possibly due to diarrhoea (Zlotkin et al 2013), and in Pakistan a small but significant increase 
in overall diarrhoea prevalence, bloody diarrhoea, and respiratory illness (Soofi et al 2013). 
An earlier systematic review concluded iron supplementation, but not fortification, may 
increase risk for diarrhoea (Gera and Sachdev 2002). If +FeMNPs increase risk for infection 
and diarrhoeal disease, this would be an important adverse effect, as diarrhoea contributes to 
the death of ≈1 in 9 under 5-year-old children in Sub-Saharan Africa (WHO 2013).
The food matrix of most cereal- and legume-based complementary foods is rich in phytic 
acid, a potent inhibitor of iron absorption; therefore usually less than 20% of iron added to 
these foods is absorbed (Tondeur et al 2004, Zimmermann and Hurrell 2007). In rural African 
populations with high levels of inflammation and infection, absorption is likely to be even 
lower, as inflammation increases circulating hepcidin the major iron regulator, which reduces 
dietary iron absorption through binding and degradation of the iron efflux protein ferroportin 
at the basolateral membrane of the enterocytes (Nemeth et al 2004). Thus, providing +FeMNPs 
to individuals with concurrent inflammation results in most of the iron passing unabsorbed 
into the colon. Once absorbed, iron in the body is bound to proteins limiting iron access to 
potential pathogens, and during infection iron supply is further reduced in the extracellular 
compartment and remains in macrophages and enterocytes (Cassat and Skaar 2013). There 
is no comparable system for sequestration of dietary iron known in the gut lumen, although 
neutral pH and the presence of defence molecules such as lipocalin-2 (Raffatellu et al 2009) 
may reduce iron solubility and availability to gut microbes.
Iron is an essential, growth-limiting nutrient for many gut bacteria, competing for unabsorbed 
dietary iron (Andrews et al 2003). For most enteric gram-negative bacteria (e.g. Salmonella, 
Shigella or pathogenic Escherichia coli), iron acquisition plays an essential role in virulence and 
colonization (Naikare et al 2006). In contrast, lactobacilli, a major group of beneficial ‘barrier’ 
bacteria improving gut integrity and reducing colonization by enteric pathogens (Anderson 
et al 2010), do not require iron, but instead rely on manganese (Weinberg 1997). Therefore, 
an increase in unabsorbed dietary iron through fortification or supplementation could 
modify the colonic microbiota equilibrium and favour growth of pathogenic strains over 
‘barrier’ strains. 
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Colonization of the human gastrointestinal tract begins at birth and depends on the mode of 
delivery, hygiene and prematurity (Penders et al 2006). The iron-binding protein lactoferrin 
in breast milk limits iron availability to the gut microbiota (Yen et al 2011), and may have 
a protective effect in breastfed infants. The relatively simple gut microbiota of breast-fed 
infants further diversifies with the introduction of complementary feeding (Vael and Desager 
2009). In a study comparing the gut microbiome among infants from the US, Venezuela 
and Malawi, there were significant differences between sites but a common pattern was 
the dominance of bifidobacteria throughout the first year of life, thereafter bifidobacteria 
diminish steadily leading to the establishment of an adult-like gut microbiome at about 3 
years of age (Yatsunenko 2012).
In a controlled trial of iron fortification in schoolchildren in Côte d’Ivoire, iron increased 
enterobacteria and intestinal inflammation, and decreased lactobacilli (Zimmermann et al 
2010). In older studies in European infants using culture methods, iron induced an increase 
in E. coli and a decrease in bifidobacteria (Balmer et al 1989), along with higher counts of 
Bacteroides (Mevissen-Verhage et al 1985). A recent small study in American infants (n=14) 
receiving complementary feeding regimens providing iron from fortified cereals or meat 
reported an increase in Bacteroidales and decreases in bifidobacteria, Lactobacillales and 
Rothia (Krebs et al 2013). In infants in Pakistan, +FeMNPs caused an increase in Aeromonas 
spp. compared to the non-supplemented control group (Soofi et al 2013).
Our study aim was to determine the effects of two widely used high and low dose +FeMNPs 
on the gut microbiome, using both barcoded 16S rRNA pyrosequencing and targeted real-
time PCR (quantitative polymerase chain reaction, qPCR), and intestinal inflammation in 
Kenyan infants prone to diarrhoeal disease. Our hypotheses were that iron fortification 
would: a) increase faecal enterobacteria and its ratio to bifidobacteria and/or lactobacilli; b) 
favour colonization by potential pathogens; and c) increase intestinal inflammation.
Materials and methods
Study site and participants 
The study was conducted in Msambweni County, in southern coastal Kenya. This is a 
malaria-endemic area, where 40% of the paediatric hospital admissions in 2006 were due to 
plasmodial infections (Okiro et al 2007). The region experiences a long rainy season from 
April to July and short rains from October to November. Farming is the main economic 
activity and maize the staple food crop, in this sparsely populated area. The typical local 
weaning food is the liquid maize porridge uji; a regular portion consists of about 8-10 g 
maize flour boiled in 100-150 mL water and sweetened with sugar.
In the catchment area of the Kikoneni health centre, we continuously recruited infants aged 
5.5 months. We recruited 80 infants from March 2010 until September 2011 and randomly 
assigned them to receive either an MNP with or without 2.5 mg iron as sodium iron 
ethylenediaminetetraacetic acid (NaFeEDTA, ±2.5mgFeMNP, MixMe®, DSM Nutritional 
Products Europe Ltd, Basel, Switzerland). We recruited 80 more infants from September 
2011 to May 2012 and randomly assigned them to receive either an MNP with or without 
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12.5 mg iron as ferrous fumarate (±12.5mgFeMNP, Sprinkles®, Hexagon Nutrition, Mumbai). 
The composition of the MNPs is shown in Table 1. Inclusion criteria were an infant age of 
5.5 months (± 3 weeks), mother at least ≥15 years of age, infant haemoglobin (Hb) ≥70 g/L, 
and no maternal or infant chronic diseases. The MNPs were packed in group-coded sachets 
(containing one daily dose). 
Study design
Prior intervention, we conducted triangle sensory tests (Meilgaard et al 2007) in local 
adults (n=25 per MNP). In these tests, the +FeMNPs were indistinguishable from the 
corresponding -FeMNPs and their acceptability was high (data not shown). 
Trained field workers instructed the mothers in cooking the uji and its fortification with the 
MNPs. Further, the participating mothers were trained on the home collection of the infant 
stool samples. Before starting the intervention with MNPs, we conducted a two week run-in 
period to familiarise the families with the stool collection method and the introduction of 
the maize porridge. 
Then, weekly for 4 months, we dispensed 7 MNP sachets and 2 kg of maize flour (Dola, 
Kitui Flour Mills Ltd, Mombasa, Kenya) directly to the participating mothers from six 
distribution points. We analysed triplicate samples of the maize flour for iron concentration 
by using atomic absorption spectroscopy, and for phytic acid (Makower 1970, Vanveldhoven 
and Mannaerts 1987) at the ETH Zurich. During the weekly distribution, field workers 
collected the previous week’s used and unused MNP sachets to assess compliance, recorded 
the infant feeding history and the health status by using a multiple choice questionnaire. If 
+2.5mgFeMNP -2.5mgFeMNP +12.5mgFeMNP -12.5mgFeMNP
Iron, mg 2.5 - 12.5 -
Zinc, mg 2.5 2.5 5 5
Vitamin A, µg 100 100 300 300
Vitamin D, µg 5 5 5 5
Vitamin C, mg 60 60 30 30
Copper, mg 0.34 0.34 - -
Tocopherol Equivalent, mg 5 5 - -
Iodine, µg 30 30 - -
Vitamin K1, µg 30 30 - -
Selenium, µg 17 17 - -
Thiamine, mg 0.5 0.5 - -
Riboflavin, mg 0.5 0.5 - -
Pyridoxine, mg 0.5 0.5 - -
Folic Acid Anhydrous, µg 90 90 - -
Niacinamide, mg 6 6 - -
Vitamin B12, µg 0.9 0.9 - -
Table 1: Composition of the two micronutrient powders, with and without iron*
*amounts per 1g powder 
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a mother reported any illness the dedicated study nurse examined the child and recorded 
treated episodes of malaria, diarrhoea and respiratory tract infections (RTI). The study 
nurse used a forced choice questionnaire to record treated cases of malaria, diarrhoea and 
respiratory tract infections at baseline (covering the last 3 months) and after 4 months 
(covering the entire intervention period).
Gut microbiome, short-chain fatty acids (SCFAs) and faecal calprotectin 
Stool samples were collected at baseline, 3 weeks and 4. The mothers were provided with 
plastic diapers, containers, spatulas, and Anaerocult sachets (Merck KGaA, Darmstadt, 
Germany) to generate an anaerobic environment, a falcon tube for the measurement of 8 mL 
water to wet the Anaerocult, along with an illustrated pamphlet to reinforce the sampling 
instructions. The stool samples were collected in the morning, kept anaerobic, and aliquots 
were frozen at -20°C the same day.
Faecal DNA was extracted with the Fast DNA Spin Kit for Soil, including a bead-beating 
step (MP Biomedicals, Illkirch, France) and concentration was quantified with a Nanodrop 
1000 spectrophotometer (Witec AG, Littau, Switzerland). For the preparation of the 
amplicon pool for pyrosequencing, the following universal primers were applied for 
amplification of the V3-V6 region of the 16S rRNAgene: a) forward primer, 
 5’-CCATCTCATCCCTGCGTGTCTCCGACTAGNNNNNNACTCCTACGGGAGGCAGCAG-3’ 
 (the italicised sequence is the 454 Life Sciences primer A, and the bold sequence 
is the broadly conserved bacterial primer 338F; NNNNNN designates the sample 
specific six-base barcode used to tag each PCR product); b) reverse primer 
5’-CCTATCCCCTGTGTGCCTTGGCAGTCTCAGCRRCACGAGCTGACGAC-3’ (the 
italicised sequence is the 454 Life Sciences primer B, and the bold sequence is the broadly 
conserved bacterial primer 1061R). PCR amplification mixture contained: 1 μL faecal DNA, 
1 µL bar-coded forward primer, 15 μL master mix (1 μL KOD Hot Start DNA Polymerase 
(1 U/μL; Novagen, Madison, WI, USA), 5 μL KOD-buffer (10×), 3 μL MgSO4 (25 mM), 5 
μL dNTP mix (2 mM each), 1 μL (10 μM) of reverse primer) and 33 μL sterile water (total 
volume 50 μL). PCR conditions were: 95°C for 2 minutes followed by 35 cycles of 95°C for 20 
s, 55°C for 10 s, and 70°C for 15 s. The approximately 750 bp PCR amplicon was subsequently 
purified using the MSB Spin PCRapace kit (Invitek) and the concentration was checked 
with a Nanodrop 1000 spectrophotometer (Thermo Scientific). A composite sample for 
pyrosequencing was prepared by pooling 200 ng of these purified PCR products of each 
sample. The pooled sample was purified using the Purelink PCR Purification kit (Invitrogen), 
with high-cutoff binding buffer B3, and submitted for pyrosequencing of the V3-V4 region 
of the 16S rRNA gene on the 454 Life Sciences GS-FLX platform using Titanium sequencing 
chemistry (GATC- Biotech, Germany). Targeted quantitative real-time polymerase chain 
reaction (qPCR) was performed using specific primers for bacterial subgroups most prevalent 
in the human gut and expected low-abundant pathogens (Supplementary Table 1). The 
enumeration of these bacterial groups was performed with a 7500 Fast Real-Time qPCR System 
(Applied Biosystems Europe BV, Zug, Switzerland) using SYBR Green PCR Master 
Mix (Applied Biosystems), and taxon-specific primers in a 25 µL volume. Duplicate 
sample analysis and standard curves were routinely performed in each run. Data were 
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analysed using the 7500 Fast System Sequence Detection Software (Version 1.4, Applied 
Biosystems). 
We measured faecal calprotectin using the Calprest ELISA assay for stools, following the 
manufacturer’s procedures (Eurospital, Trieste, Italy). For the measurement of the SCFAs 
(acetate, propionate, and butyrate), we homogenised 100-300 mg of stool in 1 mL 0.15 mM 
sulphuric acid and centrifuged at 9000 rpm and 2°C for 20 minutes (Underwood et al 2009). 
The supernatant was transferred into a microconcentrator and filtered by centrifugation 
at 4700 rpm and 2°C for 90 minutes (Chen and Lifschitz 1989). The HPLC analysis was 
performed using a Phenomenex column (Rezex ROA-Organic Acid H+ (8%), 300*7.8 mm). 
Biochemical indicators
At baseline, after 4 (±12.5mgFeMNP arms) and 6 months (±2.5mgFeMNP arms), venous 
blood samples (3 mL) were drawn using heparin vacutainers and butterfly needles. 
Haemoglobin was measured immediately after collection on site with a HemoCue 
(HemoCue AB, Ängelholm, Sweden) or a HemoControl device (EKF diagnostics Sales 
GmbH, Barleben/Magdeburg, Germany). Serum was separated by centrifugation and 
frozen on collection day. The remaining erythrocytes were washed thrice with normal 
saline, and zinc protoporphyrin to haem ratio (ZPP) was measured using a calibrated 
AVIV hematofluorometer (AVIV Biomedical, Lakewood, USA). Serum ferritin (SF), 
soluble transferrin receptor (sTfR) and C-reactive protein (CRP) were analysed at Lancet 
Laboratories in Nairobi using the Cobas Integra (Roche, Basel, Switzerland). We converted 
the Roche sTfR concentration to the Flowers assay (Flowers et al 1989) using the regression 
equation by Pfeiffer (Flowers=1.5*Roche +0.35) (Pfeiffer et al 2007). Serum hepcidin-25 was 
measured in Nijmegen (hepcidinanalysis.com, the Netherlands) by a combination of weak 
cation exchange chromatography and time-of-flight mass spectrometry (WCX-TOF MS) 
(Jaeggi et al 2013, Kroot et al 2010). Body iron stores (mg/kg body weight) were calculated 
from the ratio of sTfR to SF according to the equation by Cook et al. (body iron (mg/kg)=-
[log10 (sTfR*1000/SF) -2.8229)]/0.1207) (Cook et al 2003), and total body iron stores (mg) 
by multiplying with body weight. The following cut-offs were used: a) anaemia: Hb <110 g/L 
(WHO 2001), b) ID: body iron stores <0 mg/kg (Cook et al 2003); and c) inflammation: CRP 
≥4.1 mg/L (manufacturer’s reference range). 
Serum levels of human IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IFNγ, TNFα, and GM-
CSF were determined by using a human cytokine multiplex kit (Cytokine 10-plex panel, 
Invitrogen, Breda, Netherlands), and IL-12 (p40/p70) and IL-17 were determined by using 
Singleplex bead kits (Invitrogen) at Radboud University Medical Center, Nijmegen, the 
Netherlands.
Anthropometric indicators
At baseline and after 4 months, infant weight was recorded using a hanging scale (Salter 
235-6S, 25 kg x 100 g; Salter Brecknell, UK) and length using a measurement board (Shorr 
Production, LLC., Olney, MD). We calculated weight-for-age (WAZ), height-for-age (HAZ), 
weight-for-height (WHZ) and BMI-for-age (BAZ) Z-scores using the WHO Anthro software 
(Habil et al 2011).
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Statistical analysis
Data were analysed using IBM SPSS Statistics 20.0.0 (SPSS Inc., Chicago, IL) and Microsoft Office 
EXCEL 2010 (Microsoft, Redmond, WA). Data were double entered and distribution checked 
for normality; not normally distributed data were log transformed. Normally distributed data 
were expressed as means and standard deviations (SD) or standard errors of the mean (SEM). 
For log transformed data, we obtained geometric means (GM) and corresponding standard 
deviations (SD) for absolute concentrations by taking the antilog of these values. Correlations of 
gut microbial subgroups and intestinal inflammation were done using crude values and Kendall’s 
tau. Pyrosequencing data were analysed with a workflow based on QIIME v1.2,(Caporaso et al 
2010) and reads were filtered for chimeric sequences using Chimera Slayer.(Haas et al 2011) OTU 
clustering was performed with settings as recommended in the QIIME newsletter of December 
17th 2010 (http://qiime.wordpress.com/2010/12/17/new-default-parameters-for-uclust-otu-
pickers/) using an identity threshold of 97%. Diversity metrics were calculated as implemented 
in QIIME 1.2. Hierarchical clustering of samples was performed using UPGMA with weighted 
UniFrac as a distance measure as implemented in QIIME 1.2. The RDP classifier version 2.2 was 
performed for taxonomic classification (Cole et al 2009). Visualisation of differences in relative 
abundance of taxa between different study groups was done in Cytoscape (Shannon et al 2003). 
The baseline gut microbiome composition was illustrated using the approach presented by 
Sundquist et al. (Sundquist et al 2007). Statistical analysis of the pyrosequencing data was done 
with SciPy (www.scipy.org). Differences in relative abundance between groups at a single time 
point (cross-sectional) were compared by Mann-Whitney U (MWU) testing. Comparisons of 
targets of our primary interest (the phyla Firmicutes and Bacteroidetes, and the taxa lactobacilli, 
Roseburia spp., Clostridium spp., bifidobacteria, and enterobacteria) were not corrected for 
multiple testing. 
Longitudinal effects of intervention were statistically assessed by comparing change over time, 
which were calculated by dividing the relative abundance of a taxon at 4 months or 3 weeks by the 
relative abundance of a taxon at baseline. These changes over time for two groups were compared 
by MWU. Changes over time of ratios of enterobacteria to bifidobacteria or lactobacilli (ratio 
of relative abundances) were compared the same way. The development of specific taxa and 
phylogenetic diversity over time was assessed by paired testing using the Wilcoxon matched-
pairs signed-rank test. Multivariate redundancy analysis (RDA) was performed in R (http://
www.R-project.org) using the vegan package (Oksanen et al 2012).
For the qPCR analysis, a total of 22 bacterial targets were tested for a treatment effect 
in univariate general linear models (GLM) for the two MNPs, using baseline variables as 
covariates (Supplementary Table 1). Moreover, we assessed treatment effects of any iron 
fortification by pooling data from the two iron groups (+FeMNP) and control groups 
(-FeMNP) and using univariate GLM, including baseline values as covariates. A summary 
variable was created for the pathogenic E. coli community by summing copy numbers of 
the eaeA (E. coli attaching and effacing) gene detecting EPEC and EHEC strains, and of 
the heat-labile and heat-stable enterotoxin gene detecting ETEC LT and ETEC ST strains 
(Fukushima et al 2003).
Treatment effect on weight and height were assessed using GLM with baseline variables as 
covariates. Treatment effects on the incidence of diarrhoea, malaria, and RTI were assessed 
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using logistic regression. Baseline differences in iron status markers, inflammation markers, 
and hepcidin-25 were assessed using independent samples t-tests. Estimated intervention 
effects on iron status and hepcidin-25 were assessed with univariate GLM using baseline 
values as covariates. P values <0.1 were considered as a trend towards significance, and p 
values <0.05 as statistically significant.
Ethical aspects
This study was approved by the ethics and research committees of the Kenyatta National 
Hospital/ University of Nairobi (P167/6/2009 and P168/05/2011) and the Swiss Federal 
Institute of Technology Zurich (EK 2009-N-53). Caregivers of the infants gave written 
informed consent. A data safety monitoring board, including a paediatrician and a 
nutritionist, performed safety monitoring for the study. 
Results
Our estimated sample size was 100-120 infants, and we enrolled 115 infants into the study 
(Figure 1, trial profile). We originally recruited 160 infants, but during the two week run-
in period, 21 infants were excluded because they had received antibiotics in the previous 
two months and 24 infants did not provide an adequate baseline stool sample. During the 
study a further 11 infants were excluded because they received antibiotics or were unable 
to provide adequate stool samples. Use of antibiotics was unexpectedly high in this setting; 
this was the local standard of care. Due to a labelling error at the factory in a second batch 
of the ±2.5mgFeMNP sachets, 3 infants received mixed treatments and were excluded. 
Figure 1. Trial profile
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Figure 3 Differences in baseline gut microbiome composition in anaemic versus non-anaemic 6 month-old 
Kenyan infants. Nodes represent taxa; edges link the different taxonomic levels. The fold increase is calculated 
as the 2log of the ratio of the relative abundance in anaemic and non-anaemic (0= no difference between 
anaemia status, 1= twice as abundant in non-anaemic). The significance is expressed as the p value of a Mann-
Whitney U test of the anaemic and non-anaemic infant samples. The node-size corresponds to the relative 
abundance. Taxa (that is, nodes) were included in this visualization if they met the following criteria: all 
samples together have an average relative abundance of > 0.1% for the taxon and the study groups have a fold-
difference of at least 0.1 with a significance of p < 0.05 or the taxon has a child (that is, more specific taxonomic 
classification) meeting the criteria.
Figure 2. Baseline gut microbiome of the 6 month-old Kenyan infants enumerated by 16S rRNA pyrosequencing 
(n=101). The fraction of 16S rRNA reads (in %) attributed to specific taxonomic level is given below the taxon 
name.
83
Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in 
Kenyan infants
2
Therefore the final analysis was completed on 101 infants: 28 from +2.5mgFeMNP, 21 from 
-2.5mgFeMNP, 26 from +12.5mgFeMNP, and 26 from -12.5mgFeMNP. 
Baseline prevalence of anaemia, iron deficiency (negative body iron stores) and systemic 
inflammation were 67.3%, 25.5% and 29.7%, respectively. Nearly all infants were still 
being breastfed (99.0%), but 80.2% had already been introduced to complementary 
foods, predominantly uji starting on average at four months of age. Compliance with the 
sachets was 99.4% for ±2.5mgFeMNP and 96.2% for ±12.5mgFeMNP. The native iron and 
phytic acid concentrations in the maize flour were 1.15 ±0.06 mg and 310 ±20 mg per 
100 g, respectively. 
Figure 4. Differences in gut microbial composition after 4 months in Kenyan infants receiving iron containing 
micronutrient powders (+FeMNP) versus no-iron micronutrient powders (-FeMNP). A) +FeMNP vs. 
-FeMNP; B) +2.5mgFeMNP vs. -2.5mgFeMNP; C) +12.5mgFeMNP vs. -12.5mgFeMNP. Nodes represent taxa; 
edges link the different taxonomic levels. The fold increase is calculated as the 2log of the ratio of the relative 
abundance in +FeMNP and -FeMNP (0= no difference between group, 1= twice as abundant in +FeMNP, etc.). 
The significance is expressed as the p value of a Mann-Whitney U test. The node-size corresponds to the 
relative abundance (in %). Taxa displayed were selected based on the list of targets of our primary interest. 
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Baseline infant gut microbiome and its development over time
In total, 934,853 bacterial 16S rRNA sequences were analysed by pyrosequencing. At 
baseline, the infant gut microbiome consisted of the phyla Actinobacteria (64.3% of reads), 
Firmicutes (22.4%; including 4.7% Lactobacillus), Bacteroidetes (8.9%; including 3.6% 
Bacteroides and 4.3% Prevotella), and Proteobacteria (4.1%; including 3.3% Escherichia/ 
Shigella); and was highly dominated by the family of Bifidobacteriaceae, contributing 63.0% 
of the total 16S rRNA (Figure 2). There was no significant effect of baseline anaemia status 
on phylogenetic diversity among the infants (data not shown). However, an exploratory 
analysis revealed significant differences in taxa between anaemic and non-anaemic infants 
at baseline: non-anaemic infants harboured lower abundances of Prevotella (2.0% vs. 4.5%, 
p = 0.014), whereas they showed higher abundances of Actinomycetales (0.14 % vs. 0.09%, p 
= 0.004) and Streptococcus (6.3% vs. 3.9%, p = 0.023) (Figure 3).
The phylogenetic diversity in all stool samples increased after 3 weeks (p = 0.004) and 
further increased to 4 months (p = 0.005, Supplementary Figure 1). Redundancy analysis 
throughout the study found: a) a strong inter-individual variation of the gut microbial 
composition (p = 0.001); b) a significant difference in the gut microbiome of anaemic and 
non-anaemic infants (p = 0.031); and c) a significant difference in the gut microbiome of 
infants in the two MNP trials (±2.5mgFeMNP and ±12.5mgFeMNP, p = 0.015). Furthermore, 
strong time specific signatures were found (p = 0.001). Gender, season in which the 
intervention started, and the starting date of complementary feeding did not significantly 
affect the gut microbiome. Significant changes over time in the infants gut microbiome 
composition of the -FeMNP group from baseline (six months old) to endpoint (10 months 
old) are illustrated in Supplementary Figure 2. These changes involved an increase in 
Faecalibacterium and Prevotella, and a decrease in Enterobacteriaceae (p = 0.010, p = 0.006, 
p = 0.002 respectively).
Composition of the infant gut microbiome during iron fortification
The phylogenetic diversity of the gut microbiome was not significantly modified by +FeMNP 
versus -FeMNP (Supplementary Figure 1). Differences in the gut microbiome at endpoint 
for the combined ±FeMNP groups and the separate analysis of the ±2.5mgFeMNP and 
±12.5mgFeMNP are shown in Figure 4A-C. The changes over time in the relative abundance 
of a taxon between the ±FeMNP groups and the ±2.5mgFeMNP and ±12.5mgFeMNP are 
shown in Figure 5I-VI. Comparing +FeMNP versus -FeMNP, there were significantly 
higher abundances of the genera Clostridium, and Escherichia/ Shigella (p = 0.033, p = 
0.010, respectively), and a trend towards lower abundances of the genus Bifidobacterium (p 
= 0.085) in the +FeMNP group at endpoint (Figure 4A). In addition, the change over time 
in relative abundances (4 months vs. baseline) was significantly different in +FeMNP versus 
-FeMNP for Firmicutes, Escherichia/ Shigella, and Clostridium (p = 0.034, p = 0.030, p = 
0.048, respectively; Figure 5I-III). Comparing +2.5mgFeMNP to -2.5mgFeMNP, there were 
significantly higher abundances of the genera Escherichia/ Shigella (p = 0.044) and a trend 
towards higher in Roseburia (p = 0.083) in +2.5mgFeMNP versus -2.5mgFeMNP at endpoint 
(Figure 4B). In addition, the change over time in relative abundances (4 months vs. baseline) 
was significantly different in +2.5mgFeMNP compared to -2.5mgFeMNP for Escherichia/ 
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Shigella (p = 0.034; Figure 5IV). Comparing +12.5mgFeMNP to -12.5mgFeMNP, there were 
significantly higher abundances of Firmicutes (p = 0.018), Bacteroides (p = 0.045), a trend 
towards higher abundances of Clostridium spp. (p = 0.052) and Escherichia/ Shigella (p = 
0.067), and significantly lower abundance of Bifidobacterium (p = 0.047) in +12.5mgFeMNP 
versus -12.5mgFeMNP at endpoint (Figure 4C). In addition, the change over time in relative 
abundances (4 months vs. baseline) was significantly higher in +12.5mgFeMNP compared 
to -12.5mgFeMNP for Firmicutes (p = 0.046; Figure 5V) and showed a significantly larger 
decrease for Bifidobacterium (p = 0.049, Figure 5VI). 
Comparing +FeMNP versus -FeMNP by qPCR analysis, revealed a borderline significant 
effect of iron on enterobacteria (p = 0.061), with higher concentrations in +FeMNP (8.9 ±0.3 
log number of gene copies/g faeces) versus -FeMNP (8.0 ±0.4) at endpoint. Furthermore, 
there was a significant treatment effect on Roseburia spp./ Eubacterium rectale (p = 0.020), 
with lower concentrations in +FeMNP (4.4 ±0.4) versus -FeMNP (5.8 ±0.4). In the separate 
analyses of the two MNPs, a significant treatment effect was found on Roseburia spp./ E. 
rectale in ±12.5mgFeMNP (p<0.0001), with lower concentrations in +12.5mgFeMNP (3.2 
±0.4) versus -12.5mgFeMNP (6.2 ±0.5) at endpoint; while a significant treatment effect was 
seen for Eubacterium hallii in ±2.5mgFeMNP (p = 0.009), with higher concentrations in 
+2.5mgFeMNP (8.4 ± 0.6) versus -2.5mgFeMNP (7.1 ±0.5) at endpoint. 
Figure 5. Change from baseline to 4 months in taxa that differed significantly between +FeMNP and -FeMNP 
infants at 4 months. The boxplots (I-VI) report on significant changes over time from baseline to endpoint (I: p 
= 0.0.034, II: p = 0.030, III: p = 0.048, IV: p = 0.034, V: p = 0.046, VI: p = 0.049) of taxa being different in groups 
at endpoint (corresponding roman numerals and colours in Figure 4). Boxplots of 2log ratios (0= no difference 
for the two time points, 1= twice as abundant at 4 months, etc.) are displayed with the 10-90th percentiles.
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Examining the effect of iron on pathogenic gut microbiota, in all analysed stool samples, 
we detected Bacillus cereus in 39.5% (mean in detected samples: 4.6 log copies/g faeces 
(range: 3.3-7.2)), Staphylococcus aureus in 65.4% (6.6 (3.0-10.0)), Clostridium difficile in 
56.5% (7.2 (3.4-10.4)), members of the Clostridium perfringens group in 89.7% (7.7 (3.1-
10.4)), Salmonella in 22.4% (5.7 (4.4-7.9)) and Vibrio cholera in 0%. Further, we detected 
enteropathogenic E. coli (EPEC) in 65.0% (mean in detected samples: 6.0 log copies/g 
faeces (range: 3.2-9.3)), enterotoxigenic E. coli producing heat-labile toxin (ETEC LT) in 
49.2% (6.0 (3.0-10.5)), ETEC producing heat-stable toxin (ETEC ST) in 7.0% (5.7 (3.5-8.7)), 
enterohaemorrhagic E. coli producing shiga-like toxin 1 (EHEC stx1) in 9.6% (4.7 (3.4-7.4)), 
and EHEC stx2 in 8.5% (4.6 (3.6-6.3)). There was a significant treatment effect on the sum 
of the pathogenic E. coli at endpoint (p = 0.029), with higher concentration in the +FeMNP 
(6.0±0.5 log numbers of copies/g faeces) versus -FeMNP (4.5±0.5). In the separate analyses 
of the two MNPs, there was a significant treatment effect on the sum of the pathogenic E. coli 
in ±2.5mgFeMNP at midpoint (p = 0.012), and at endpoint (p = 0.043), with transient lower 
concentrations in the +2.5mgFeMNP (4.9±0.7) versus -2.5mgFeMNP (7.0±0.5) at midpoint 
and higher concentrations in +2.5mgFeMNP (6.5±0.6) versus -2.5mgFeMNP (4.1±0.8) at 
endpoint. No effect of iron on pathogenic E. coli could be detected in the ±12.5mgFeMNP. 
The increase in the sum of pathogenic E. coli through iron fortification was significant in 
infants with baseline iron deficiency (p = 0.012) but not in infants who were iron sufficient 
(p = 0.327).
Figure 6A-D shows the ratio of abundances of enterobacteria to bifidobacteria and 
lactobacilli analysed by pyrosequencing and qPCR. Using pyrosequencing, the ratio of 
the relative abundances of enterobacteria to bifidobacteria changed significantly over 
time from baseline to endpoint in the +FeMNP versus -FeMNP (p = 0.020; Figure 6A). 
At endpoint, the enterobacteria to bifidobacteria ratio was significantly higher in the 
+FeMNP versus -FeMNP (p = 0.004); similarly in the separate analysis of the MNPs, the 
enterobacteria to bifidobacteria ratio was significantly higher in +2.5mgFeMNP (p = 
0.030) and in +12.5mgFeMNP (p = 0.049), compared to the respective control groups at 
endpoint. The qPCR analysis confirmed this, showing a significant effect on the ratio of 
enterobacteria to bifidobacteria in +FeMNP compared to -FeMNP group at endpoint (p 
= 0.008, Figure 6B); with a trend towards a significant effect in the separate analysis of 
±2.5mgFeMNP (p = 0.053) and ±12.5mgFeMNP (p = 0.098). Using pyrosequencing, the 
ratio of the relative abundance of enterobacteria to lactobacilli in +FeMNP did not change 
over time from baseline to endpoint, after a temporary decrease at 3 weeks (p = 0.018) 
in +FeMNP versus -FeMNP; however, at endpoint, the ratio enterobacteria to lactobacilli 
was significantly higher in +FeMNP (p = 0.023; Figure 6C). Using qPCR, a similar trend 
towards a higher ratio of enterobacteria to lactobacilli was detected at endpoint in +FeMNP 
compared to -FeMNP (p = 0.062, Figure 6D). Furthermore, pyrosequencing analysis of 
±2.5mgFeMNP and ±12.5mgFeMNP separately showed a borderline significantly higher 
ratio of enterobacteria to lactobacilli in +12.5mgFeMNP versus -12.5mgFeMNP (p = 0.055) 
at endpoint, with a temporary decrease after 3 weeks (p = 0.021); but did not differ at any 
time point in +2.5mgFeMNP versus -2.5mgFeMNP. 
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Figure 6. Ratio of infant enterobacteria to bifidobacteria at baseline, 3 weeks and 4 months comparing +FeMNP 
and -FeMNP assessed by: A) pyrosequencing (log2 ratio of the relative abundance); and B) qPCR (ratio of log 
numbers of copies/g faeces). Ratio of infant enterobacteria to lactobacilli assessed by: C) pyrosequencing; and 
D) qPCR. Boxplots are displayed with the 10-90th percentiles. Values differed significantly between groups 
(+FeMNP and -FeMNP): A) the change over time from baseline to endpoint in ratios was significant different 
between groups (p = 0.020); at endpoint the ratios were significantly higher in +FeMNP versus -FeMNP (p 
= 0.004). B) the ratios were significantly different between groups at 4 months using GLM and adjusted for 
baseline differences (p = 0.008). C) the change over time from baseline to 3 weeks in ratios was significantly 
different (p = 0.018), but the change over time from baseline to endpoint was not different between +FeMNP 
versus -FeMNP; at endpoint the ratios were significantly higher in +FeMNP versus -FeMNP at endpoint (p 
= 0.023). D) the ratios were borderline significantly different between groups at 4 months using GLM and 
adjusted for baseline differences (p = 0.062). 
Figure 7. Infant faecal calprotectin 
concentrations at baseline and 4 
months in the pooled data from the –
FeMNP versus +FeMNP groups, in the 
-2.5mgFeMNP versus +2.5mgFeMNP, 
and in the -12.5mgFeMNP versus 
+12.5mgFeMNP. Values differed 
significantly over the trial between the 
±12.5mgFeMNP groups (p = 0.008) and 
the pooled MNP groups (±FeMNP, p = 
0.002), using GLM and baseline variables 
as covariates. Boxplots are displayed with 
the 10-90th percentiles.
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Faecal calprotectin, SCFAs, iron status, and systemic inflammation
Intestinal inflammation, assessed by faecal calprotectin, was significantly higher in infants 
receiving +FeMNP (229.2 ±1.9 µg/g) versus -FeMNP (123.3 ±2.1 µg/g, p = 0.002). In the 
separate analyses of the MNPs, faecal calprotectin values were significantly elevated in 
+12.5mgFeMNP (248.9 ±2.2 µg/g) versus -12.5mgFeMNP (102.5 ±2.2 µg/g, p = 0.008), but 
were not significantly higher in +2.5mgFeMNP (215.6±1.6 µg/g) versus -2.5mgFeMNP 
(165.6±1.8 µg/g, p = 0.164, Figure 7). The increase in faecal calprotectin through iron 
fortification was significant in infants who were iron sufficient at baseline (p = 0.0002) but 
not in infants with iron deficiency (p = 0.912). There were no significant correlations of faecal 
calprotectin with the overall gut microbiome composition assessed by pyrosequencing. 
The qPCR data revealed intra-sample correlations of faecal calprotectin with none of 
the commensal bacteria but with the sum of pathogenic E. coli (p = 0.011, t=.177), and 
enterobacteria (p = 0.008, t=.201), and members of the C. perfringens group (p = 0.007, 
t=-.206) at 3 weeks, and EPEC (p = 0.024, t=.190) at 4 months. There were no significant 
differences in faecal acetate, propionate, or butyrate concentrations between +FeMNPs and 
-FeMNPs during the intervention (Supplementary Table 2).
There was a significant treatment effect of +12.5mgFeMNP versus -12.5mgFeMNP on body 
iron (p = 0.001), SF (p = 0.004), sTfR (p = 0.008), ZPP (p = 0.039) and a trend towards 
an effect on hepcidin-25 (p = 0.052, Supplementary Table 3). In contrast, there was no 
significant treatment effect of +2.5mgFeMNP versus -2.5mgFeMNP on any iron status 
indicator or hepcidin-25. There was no treatment effect of either +FeMNP on serum 
CRP (Supplementary Table 3) or serum IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-17, 
IFNγ, TNFα or GM-CSF (data not shown). There was a significant treatment effect of 
+2.5mgFeMNP versus -2.5mgFeMNP on IL-12, which was higher in +2.5mgFeMNP (523.6 
±1.5 µg/g vs. 431.9 ±1.4 µg/g, p = 0.028). 
Growth
There was no significant treatment effect of iron on weight gain. However, we identified 
a significant increase of linear growth in +FeMNPs (70.2 ±1.1 cm vs. 68.5 ±1.1 cm at 
endpoint, p = 0.017, Supplementary Table 3). This effect was significant in the infants 
of ±12.5mgFeMNP (70.2 ±1.1 cm vs. 68.1 ±1.1 cm at endpoint, p = 0.011), but not in 
±2.5mgFeMNP. Linear growth was not correlated to gut microbiota or faecal calprotectin.
Morbidity
On enrolment, 19.2% of mothers reported a treated episode of diarrhoea in their infant 
during the previous 3 months, 29.7% a treated RTI, and 3.8% a treated malaria episode. 
During the intervention, incidence of treated RTI and malaria did not significantly differ 
between +FeMNP versus -FeMNP. However, there was a trend towards a greater incidence 
of treated episodes of diarrhoea in +12.5mgFeMNP versus -12.5mgFeMNP: 27.3% (n=6/22) 
versus 8.3% (n=2/24, p = 0.092).
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This study shows that in breastfed, 6 months old infants from rural Africa, the gut 
microbiome is dominated by Bifidobacteriaceae, but harbours many gram negative and 
gram positive pathogens. Our findings indicate that the iron in MNPs favours growth 
of several of these potentially pathogenic subgroups. At the same time, iron decreases 
abundances of bifidobacteria, shifting gut microbial balance away from beneficial ‘barrier’ 
strains towards a potentially more pathogenic profile. This is accompanied by an increase in 
intestinal inflammation. Our findings in Kenyan infants are comparable to those of a recent 
controlled trial in school-aged children in Côte d’Ivoire receiving iron-fortified biscuits 
containing 20 mg iron/day as electrolytic iron for 6 months (Zimmermann et al 2010). 
The expected absorption of electrolytic iron in that setting was <5%, and there was no 
decrease in anaemia or iron deficiency in the iron fortified group. Although the study was a 
secondary analysis, only qPCR methods were used, and the authors did not report increases 
in specific pathogens; it did demonstrate that iron fortification can extensively modify the 
gut microbiota, increasing enterobacteria and decreasing lactobacilli, along with increased 
intestinal inflammation measured by faecal calprotectin. The differences between these 
two studies are likely due to age-related differences in the gut microbiota between infants 
and older children, but may also reflect differences in methods used to characterise the 
gut microbiome, differences in geographic setting, and possibly, differences in the iron 
compound and/or dose given. A recent high dose iron supplementation trial in low-to-
middle income South African schoolchildren residing in an area with an improved water 
supply and a lower risk of contaminated food (Dostal et al 2014), supports the suggestion 
that environmental variables modulate the effects of iron on intestinal inflammation and 
gut microbiota. Despite the high iron dose, there were no measurable effects on intestinal 
inflammation measured by faecal calprotectin, nor on gut microbiota evaluated by qPCR. 
Overall, these data suggest that the effects of supplemental or fortification iron on the gut 
microbiota and intestinal inflammation in children are more pronounced in settings where 
hygiene standards are low and the microbiome is likely to be populated by opportunistic 
enteropathogens. 
Iron fortification in both the present study and in the Ivorian study (Zimmermann et al 
2010) favoured growth of enterobacteria over bifidobacteria and/or lactobacilli, and this 
could be due to their different iron requirements and metabolism. Many pathogenic 
enterobacteria require iron acquisition for bacterial virulence (Boyer et al 2002, Bullen et 
al 2000) and/or gastrointestinal tract colonization (Tsolis et al 1996). Only few bacteria 
do not require iron, of which lactobacilli is the major group (Weinberg 1997). Lactobacilli 
do not produce siderophores and their growth is similar in media with and without iron 
(Pandey et al 1994). Bifidobacterium breve, an important bifidobacteria species in breast-
fed infants, can sequester luminal iron using a divalent metal permease (Bezkorovainy and 
Solberg 1989, Bezkorovainy et al 1996), but the majority of bifidobacteria do not produce 
siderophores or other active iron carriers. Abundant bifidobacteria, lactobacilli and other 
beneficial bacteria in the colon provide an important ‘barrier effect’ against colonization and 
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invasion by pathogens (Coconnier et al 1997, Lievin et al 2000, Weinberg 1997). Our findings 
suggest that +FeMNPs weaken this protective effect. If +FeMNPs promote expansion of 
enterobacteria, this may be important because abundances of closely related species can 
predict susceptibility to intestinal colonization by pathogenic bacteria (Nakamura et al 
2009). In our study, this effect may have encouraged colonization by potentially pathogenic 
members of the genus Escherichia/ Shigella spp., evidenced by the higher abundances of this 
genus in the +FeMNP groups at endpoint, and in particular of the five pathogenic E. coli 
subgroups (EPEC, ETEC LT, ETEC ST, EHEC stx1, and stx2). 
Calprotectin is a calcium- and zinc-binding protein found in the cytosol of neutrophils, 
monocytes and activated macrophages (Gisbert and McNicholl 2009). Faecal calprotectin 
levels mainly reflect migration of neutrophils into the gut mucosa and is a non-specific 
marker of intestinal inflammation elevated in children with gastroenteritis (Berni Canani 
et al 2004). Faecal calprotectin is markedly higher during infancy than in later childhood 
(Konikoff and Denson 2006). In healthy Ugandan children, median faecal calprotectin were 
278 µg/g at 3-6 months, 183 µg/g at 6-12 months of age and fell to 28 µg/g at school-age 
(Hestvik et al 2011). We used a different assay than the Ugandan study, but found comparable 
levels of faecal calprotectin at baseline. In -FeMNP groups, faecal calprotectin decreased 
as expected over the 4 month intervention while in +FeMNP groups, and particularly in 
+12.5mgFeMNP, levels remained significantly elevated. In the Ivorian fortification study, 
where school-age children received ≈9 mg of iron per day, faecal calprotectin increased 
sharply and was correlated with the increase in gut enterobacteria (Zimmermann et al 
2010). Although we found no significant difference in systemic concentrations of most 
cytokines, circulating IL-12 concentrations were significantly higher in +2.5mgFeMNP 
versus -2.5mgFeMNP at endpoint. Gut microbial antigens can stimulate secretion of IL-
12 by gut macrophages and induce development of Th1 cells (Maynard et al 2012). Thus, 
in our study, IL-12 secretion may have been triggered by invasive pathogens or dysbiosis 
resulting from increased luminal iron; notably, in +2.5mgFeMNP versus -2.5mgFeMNP, 
the Escherichia/ Shigella taxon was significantly higher at endpoint, an effect not seen in 
+12.5mgFeMNP. Furthermore, dietary iron has shown to increase intestinal inflammation 
in this study and others (Carrier et al 2006, Zimmermann et al 2010); through different 
potential pathways such as neutrophil infiltration, lipid peroxidation, NF-ĸB activation 
and proinflammatory cytokines (Carrier et al 2006). Electron acceptors generated as by-
products of host inflammatory response have been proposed to favour facultative anaerobes, 
in particular enterobacteria (Winter et al 2013).
The +FeMNPs we used in this study contained iron as two different forms, ferrous and 
ferric, and the ferric iron was bound to a chelator (EDTA). Our data does not clarify 
whether the form of dietary iron is a potential determinant of the changes induced in the 
gut microbiota, as the relative concentration of ferrous versus ferric iron in the human 
colon resulting from dietary iron ingestion is unknown. However, even if different forms 
of iron are ingested, it is likely that most of the unabsorbed dietary iron that enters the 
colon is in the oxidised, ferric (Fe3+) form, mainly as ferric oxides or hydroxides (Simpson 
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et al 1992). In the colon, low-oxygen tension would favour the reduction of ferric to ferrous 
(Fe2+) iron. Systems for acquisition of both ferrous and ferric iron have been identified in 
many gastrointestinal pathogens. Although ferric ion has a solubility of only 10−17 M at pH 
7 and bacteria generally require iron at around 10−7 to 10−5 M to achieve optimal growth 
(Andrews et al 2003), bacteria can reduce ferric iron to the more soluble ferrous form and/
or use extracellular ferric iron chelators, such as siderophores, as solubilizing agents prior to 
uptake (Koster 2001). Many enteric pathogens, including Salmonella spp. and Escherichia/ 
Shigella spp. (Naikare et al 2006), take up iron-siderophore complexes via specific outer 
membrane receptors. Most enteric gram-negative bacteria also have active transport 
systems for ferrous iron (Andrews et al 2003), and iron transporter FeoB-mediated ferrous 
iron acquisition may increase virulence (Boyer et al 2002).
In our study, the ferrous fumarate-containing +12.5mgFeMNP tended to cause greater 
modifications of the gut microbiome and more intestinal inflammation; this was likely due 
to the fact that its iron dose was 5-fold that of the chelated ferric iron in the +2.5mgFeMNP. 
However, it is not clear from our findings if the higher iron dose was more detrimental: 
although +12.5mgFeMNP resulted in lower abundances of Bifidobacterium, and higher 
levels of faecal calprotectin, as well as a trend towards higher rates of treated diarrhoea, 
the effect on Escherichia/ Shigella, the ratio of enterobacteria to bifidobacteria, and on the 
increase of pathogenic E. coli was stronger with +2.5mgFeMNP. Therefore, our data do not 
clarify whether the lower iron dose MNP would have a better safety profile. 
In accordance with previous studies on human gut microbiota (Backhed et al 2005, De 
Filippo et al 2010, Fallani et al 2011, Qin et al 2010), the four dominant phyla in our 
infants at baseline were Actinobacteria (63%, mainly Bifidobacteriaceae), Firmicutes (22%), 
Bacteroidetes (9%), and Proteobacteria (4%). We found more distinct treatment effects after 
4 months than after 3 weeks, likely due to the rapid fluctuations in the gut microbiome 
at 3 weeks caused by the introduction of the complementary feeding (Vael and Desager 
2009). This finding underscores the importance of allowing the gut microbiome time to 
adapt to changes in diet when evaluating an intervention and comparing different trials. 
Our data from the gut microbiome of African infants are comparable to those reported 
in Dutch infants using qPCR methods that found similar abundances of bifidobacteria, 
E. coli, and lactobacilli (Penders et al 2006). However, in contrast, many of our infants 
carried enteropathogens, with over half of the faecal samples containing C. difficile, 
S. aureus, members of the C. perfringens group, enteropathogenic and/or enterotoxigenic 
E. coli, and nearly one in four harbouring B. cereus and/or Salmonella. Our data also suggest 
the baseline gut microbiome of anaemic versus non-anaemic infants may differ, as may their 
response to +FeMNPs. Anaemic infants showed higher Prevotella (Bacteroidetes) and lower 
Actinomycetales (Actinobacteria) and Streptococcus (Firmicutes) abundances than non-
anaemic infants. A previous study comparing the gut microbiome of older children from 
Burkina Faso and Italy found higher concentrations of Bacteroidetes (especially Prevotella 
and Xylanibacter) and lower concentrations of Firmicutes and Escherichia/ Shigella in 
the Burkinabe than Italian children (De Filippo et al 2010). Thus, our findings suggest 
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higher rates of anaemia in African children may contribute to differences observed in gut 
microbiota in African versus European children.
In rats, the availability of colonic iron may modulate gut microbiota metabolites, and in 
particular, production of caecal SCFAs (Dostal et al 2012). This could have important gut 
modulatory effects, as SCFAs have been reported to inhibit growth or reduce concentrations 
of Salmonella enteritidis, Salmonella enterica serovar Typhimurium, E. coli, Shigella flexneri 
and Campylobacter jejuni (Ricke 2003, Topping and Clifton 2001), and butyrate can down-
regulate expression of genes involved in Salmonella invasion at low doses (Van Immerseel 
et al 2006). In in vitro fermentations, low iron concentrations decreased numbers of SCFA-
producers, including Roseburia spp./ E. rectale, Clostridium Cluster IV members and 
Bacteroides spp., and decreased butyrate and propionate concentrations in the effluent 
(Dostal et al 2013). In the present study, we found no effect of iron-containing MNPs on 
faecal SCFA concentrations. This difference may be due to the fact that 95-99% of SCFAs 
produced by bacterial fermentation are absorbed in the colon, so concentrations measured 
in faeces likely do not reflect levels in the colonic lumen (Scheppach 1994). In Swedish 
infants, faecal butyrate and propionate concentrations steadily increased over the first two 
years of life, while faecal acetate increased rapidly in the first few weeks after birth and then 
plateaued (Midtvedt and Midtvedt 1992). A similar pattern from 6 to 10 months of age was 
visible in the Kenyan infants in this study.
Data on the effect of iron interventions on diarrhoeal incidence in children disagree. In a 
systematic review of controlled trials of oral iron supplementation or fortification, provision 
of iron was associated with a 11% higher risk of developing diarrhoea (p = 0.04) (Gera and 
Sachdev 2002). Four food fortification studies reported diarrhoeal outcomes, three provided 
iron-fortified infant formula (Brunser et al 1993, Power et al 1991, Singhal et al 2000), and 
one provided an iron-fortified infant food (Javaid et al 1991). Since that review, two small 
iron fortification trials done in school-age children have not reported an increased risk for 
diarrhoea (Manger et al 2008, Moretti et al 2006). However, a controlled trial in Swedish 
and Honduran infants providing iron supplements from 6 to 9 months, among infants 
with Hb ≥110 g/L, iron treatment increased risk for diarrhoea (Dewey et al 2002). Recent 
controlled iron supplementation trials (12.5-15 mg Fe/day) in Peru (Richard et al 2006) 
and Bangladesh (Chang et al 2010) reported a significant increase in diarrhoea. Two large 
trials of iron and folic acid supplementation in infants and children (subjects aged 12-35 
months received 12.5 mg Fe/day, younger children received half the dose) in Nepal (Tielsch 
et al 2006) and Tanzania (Sazawal et al 2006) reported no difference in diarrhoea incidence. 
However, in a controlled study in Ghanaian children that used the same +12.5mgFeMNP as 
in our study, there were significantly more hospital admissions in the iron group [RR (95% 
CI) 1.23 (1.02-1.49)], and based on data from the outpatient register, 83% of the additional 
cases in the iron group were due to diarrhoea, but this was not significant [RR (95% CI) 1.12 
(0.86−1.46)] (Zlotkin et al 2013). A recent study in Pakistan found an increase in diarrhoea 
in infants receiving +12.5mgFeMNP, with or without zinc, compared to untreated controls 
[without zinc: OR (95%CI) 1.15 (1.00-1.3); with zinc: 1.31 (1.13-1.51)] (Soofi et al 2013). In 
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the present study, there was a trend towards a higher rate of diarrhoea requiring treatment 
in the infants receiving the +12.5mgFeMNP. Therefore, the available data suggest oral iron 
supplements and +FeMNPs may modestly increase in risk for diarrhoea in infants. Our 
findings of a shift in the gut microbiome towards a potentially more pathogenic profile 
along with the increase in intestinal inflammation could provide a potential mechanism for 
this adverse effect. 
This is the first controlled intervention trial to examine the effect of +FeMNPs on the 
African infant gut microbiome and our findings need confirmation in other settings and 
populations. Both IDA and diarrhoea are major causes of morbidity and mortality in infants 
in developing countries. In-home fortification with +FeMNPs has repeatedly been shown 
to reduce IDA rates in infants and children, but whether they increase risk for diarrhoeal 
disease remains uncertain. The limited available clinical evidence and our findings of their 
effects on the gut microbiome and inflammation, suggest +FeMNPs may not be entirely 
safe in settings with high infectious disease burdens. Currently, WHO recommends 
fortification using MNPs containing iron, vitamin A, and zinc for children aged 6 to 23 
months irrespective of their iron status in settings with an anaemia prevalence of >20% and 
in conjunction with measures to treat malaria, promote improved sanitation, and improve 
overall management of diarrhoea (WHO 2011). At the same time, WHO recommends iron 
supplementation only be targeted to infants with IDA, while providing adequate protection 
from malaria.4 Our findings, together with others (Soofi et al 2013, Zlotkin et al 2013), 
suggest that, until safer formulations are available, +FeMNPs should be targeted to infants 
with IDA, while providing adequate protection from malaria and diarrhoea. 
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Supplementary Tables
Supplementary Table 1. Species, target gene, and primers used for the quantitative real-time polymerase chain 
reaction.
Species Target gene 
(description)
Primer and sequence (5'-3') Reference




(Fierer et al 2005)




(Bartosch et al 2004, Liu et 
al 2003)




(Fierer et al 2005)




(Bartosch et al 2004)




(Cleusix et al 2009)
Lactobacillus/ Leuconostoc/ Pediococcus 
spp.




(Furet et al 2009)




(Ramirez-Farias et al 2008, 
Walker et al 2005)




(Ramirez-Farias et al 2008)




(Hold et al 2003, Ramirez-
Farias et al 2008)




(Bartosch et al 2004, Wang 
et al 1996)







(Pereyra et al 2010)




(Fukushima et al 2003, 
Rahn et al 1992)




(Brakstad et al 1992, 
Fukushima et al 2003)




(Fukushima et al 2003, 
Wang et al 1996)




(Rinttila et al 2004)




(Rinttila et al 2004)




(Fukushima et al 2003, 
Walker et al 2005







(Fukushima et al 2003)








(Fukushima et al 2003)








(Fukushima et al 2003)






(Fukushima et al 2003)






Liu et al 2013)
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Supplementary Table 2. Faecal short-chain fatty acid (SCFA) composition over the time of the iron-fortification 
trial.
•  Data are geometric means ±SD. There were no differences between +FeMNP and -FeMNP using GLM with 
baseline as covariate and p <0.05. 
• In all infants, propionate (p = 0.004) and butyrate (p = 0.0001) increased significantly from baseline to endpoint 
using paired t-test; 
•  this was also seen in +FeMNP (propionate (p = 0.029) and butyrate (p = 0.022) and to some extent in -FeMNP 
(propionate (p = 0.070) and butyrate (p = 0.002)).
Supplementary Figure 1. Alpha diversity of the 
infant gut microbiome over the time course of the 
trial in the pooled groups (+FeMNP and -FeMNP). 
Phylogenetic diversity was not influenced by 
+FeMNP intervention, but increased significantly 
over time (p = 0.004 for baseline to 3 weeks and 
p = 0.005 for 3 weeks to 4 months). Boxplots are 
displayed with the 10-90th percentiles.
Intervention Time point SCFA (µmol/g) Acetate (µmol/g) Propionate 
(µmol/g)
Butyrate (µmol/g)
+FeMNP baseline 96.1 ± 1.6 76.9 ± 1.4 12.4 ± 1.8 6.9 ± 1.7
3 weeks 107.6 ± 1.6 83.3 ± 1.4 15.0 ± 1.7 8.8 ± 1.6
4 months 106.2 ± 1.5 75.0 ± 1.3 19.4 ± 1.6 11.8 ± 1.7
-FeMNP baseline 104.2 ± 1.5 83.0 ± 1.3 14.0 ± 1.5 7.2 ± 1.5
3 weeks 110.3 ± 1.5 85.7 ± 1.3 14.4 ± 1.5 10.1 ± 1.6
4 months 105.3 ± 1.6 74.5 ± 1.4 17.8 ± 1.8 13.0 ± 1.7
ALL baseline 99.7 ± 1.6 79.6 ± 1.4 13.1± 1.7 7.0 ± 1.6
3 weeks 108.8 ± 1.5 84.6 ± 1.4 14.8 ± 1.6 9.4 ± 1.6
4 months 105.7 ± 1.6 74.8 ± 1.4 18.6 ± 1.7 12.4 ± 1.7
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Abstract
Oral iron administration in African children has been associated with an increased burden 
of infectious diseases. However, it remains unclear to what extent oral iron administration 
affects the intestinal microbiome. We here investigated the impact of multiple iron 
preparations and doses on growth and metabolism of the human gut microbiota in a well-
controlled in vitro model of the large intestine. TNO’s in vitro model of the large intestine 
(TIM-2) was inoculated with a human microbiota, without supplementary iron, or with 
50 or 250 µmol/L ferrous sulfate, 50 or 250 µmol/L ferric citrate, or 50 µmol/L hemin. 
High resolution responses of the gut microbiota composition and functions were examined 
by 16S rRNA pyrosequencing, microarray analysis, and metagenomic sequencing. 
The metabolome was assessed by fatty acid quantification, gas chromatography-mass 
spectrometry (GC-MS) and 1H-NMR spectroscopy. Cultured intestinal epithelial Caco-2 
cells were used to assess fecal water toxicity. Microbiome analysis showed a clear iron-
induced decrease of Bifidobacteriaceae and Lactobacillaceae under iron-rich conditions, 
paralleled by an increase of Roseburia and Prevotella. Metagenomic analyses showed an 
enrichment of microbial motility-chemotaxis systems, while the metabolome markedly 
changed from a saccharolytic to a proteolytic profile in response to iron. Branched chain 
fatty acids and ammonia levels increased significantly, in particular with ferrous sulfate, and 
we also identified siderophoric microbial metabolites that were specifically produced under 
low-iron conditions. Importantly, we confirmed that the metabolite-containing effluent 
from iron-rich conditions showed increased cytotoxicity to intestinal epithelial cells. Our 
data indicate that in the absence of host influences, iron induces a more hostile intestinal 
environment characterized by i) a reduction of beneficial microbes, ii) increased levels of 
bacterial metabolites that can impair the barrier function of the gut wall, and iii) an increase 
of virulence-associated pathways of enteric pathogens. It can be envisaged that these in 
vitro phenomena also contribute to an increased risk for enteric infections in vivo. 
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Iron deficiency is the most prevalent nutritional disorder worldwide, mostly affecting 
infants, young children, and women in developing countries. This deficiency has major 
health consequences such as poor pregnancy outcome, and impaired physical and cognitive 
development of children (Muthayya et al 2013, WHO and UNICEF 2004). Several trials have 
shown that iron deficiency can be effectively controlled by both iron supplementation and 
fortification programmes (Zimmermann and Hurrell 2007). However, the uptake of iron 
from the intestines is influenced by many factors and is usually limited (Hurrell and Egli 
2010). Iron supplementation or fortification therefore generally results in a large fraction 
of unabsorbed iron entering the colon, being potentially available for the gut microbiota. 
Importantly, oral iron administration is known to increase the incidence of diarrhea and 
has been associated with increased gut inflammation (Gera and Sachdev 2002, Jaeggi 
et al 2014, Zimmermann et al 2010). It is therefore highly warranted to investigate the 
effects of nutritional iron on the gut microbiota composition and metabolic activity. 
It was recently shown that iron fortification caused a potentially more pathogenic gut 
microbiota profile (i.e. increased relative abundance of Enterobacteriaceae and a decrease 
of beneficial Lactobacillaceae and/or Bifidobacteriaceae) in African children and infants 
(Jaeggi et al 2014, Zimmermann et al 2010) (Chapter 2). This increase in the abundance 
of fecal Enterobacteriaceae correlated with an increase of fecal calprotectin (Zimmermann 
et al 2010), which is a marker of gut inflammation. Notably, the reported effect of oral 
iron administration on the gut microbiota composition varies between studies. The most 
consistent outcome of iron supplementation appears to be a decrease in Lactobacillaceae 
and Bifidobacteriaceae, and an increase in Escherichia coli (Balmer et al 1989, Balmer and 
Wharton 1991, Benoni et al 1993, Dostal et al 2012a, Dostal et al 2012b, Dostal et al 2014b, 
Jaeggi et al 2014, Kortman et al 2014a, Krebs et al 2013, Lee et al 2008, Mevissen-Verhage 
et al 1985, Tompkins et al 2001, Werner et al 2011, Zimmermann et al 2010) (Chapter 1). 
The large variation in the effects of iron on the gut microbiota composition in humans and 
animals may be explained by differences in host factors such as iron status, intestinal immune 
function, dietary habits and the environmental setting. Importantly, in vitro models for the 
colon are valuable tools for monitoring microbial composition and metabolism during the 
passage of food and allow the reproducible testing of the effects of iron on the microbiota 
in isolation, by eliminating any influence of the host. 
Besides the intestinal microbiota composition, the bacterial metabolic activity is also 
important for gut health. For example, indigestible food components can be metabolized 
into the main Short Chain Fatty Acids (SCFAs) acetate, propionate and butyrate, which are 
beneficial for gut health (Macfarlane and Macfarlane 2011). In contrast, protein fermentation 
can result in toxic or potentially toxic metabolites such as ammonia, Branched Chain Fatty 
Acids (BCFAs) (e.g. isobutyrate and isovalerate), and phenolic compounds (Macfarlane and 
Macfarlane 2012, Nyangale et al 2012). It has recently been shown that iron can influence 
the bacterial metabolic activity (Dostal et al 2012a, Dostal et al 2012b, Dostal et al 2014b). 
The in vivo levels of butyrate and propionate were lower during luminal iron deficiency in 
rats, which could be restored by iron repletion (Dostal et al 2012a). In vitro, butyrate and 
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propionate production were most clearly impaired during very low iron conditions, while 
conversely, the production of these SCFAs was not stimulated by high iron conditions. The 
production of BCFAs as a result of protein fermentation was decreased under low iron 
conditions, but in contrast to the production of SCFAs, this putrefactive metabolic activity 
did increase under high iron conditions (Dostal et al 2012b). Interestingly, a recent study in 
rats showed that supplementary iron increased cecal SCFA levels not only when compared 
to an iron-deficient diet, but also when compared to a control diet (Dostal et al 2014b). 
However, the latter rat study did not specifically report on the production of BCFAs. 
Together, these studies suggest that iron supplementation may have health-promoting 
effects via an increase in microbial SCFA production, but potentially also deleterious 
effects by increasing toxic protein fermentation. Thus, the net effects of iron preparations 
on gut microbial metabolism remain inconclusive and need further exploration with both 
a targeted and metabolomic approach. In the present study, we investigate the effect of 
multiple iron sources and doses on the human gut microbiota composition and metabolic 
activity, for which we use the well suited and highly controlled TNO Intestinal Model 2 
(TIM-2) for the human large intestine (Maathuis et al 2009, Minekus et al 1999). 
Materials and methods
Origin of the microbiota
The microbiota for the TIM-2 experiments consisted of an active fecal microbiota of 6 
Dutch Adult volunteers (male: n= 3, age=32.7 (21-39); female: n=3, age=33.3 (28-41)). Fecal 
samples were collected, kept in an anaerobic environment and were proceeded quickly to 
mixing and homogenization in an anaerobic cabinet. Mixed stools were used in a fed batch 
fermentor simulating the ‘cecum’ conditions as described by Maathuis et al. (Maathuis et 
al 2012). Briefly, 670 ml medium without the addition of iron and hemin was inoculated 
with 80 g of mixed stools and incubated for 44h at 37˚C and under anaerobic conditions 
by a gaseous nitrogen flux, with fed-batch addition of 1250 ml medium over time. The 
resulting fed-batch culture was aliquoted and snap-frozen in liquid nitrogen and stored at 
-80˚C before inoculation in TIM-2. It has been shown that these standardized samples are 
similar in composition and activity of a fresh fecal sample (Kovatcheva-Datchary et al 2009, 
Minekus et al 1999, Venema et al 2000).
Dynamic in vitro model of the large intestine (TIM-2)
TNO’s in vitro model of the proximal large intestine (TIM-2) accurately simulates 
the average physical and dynamic conditions in the human proximal colon and has 
been described in detail before (Maathuis et al 2009, Minekus et al 1999, Rehman et al 
2012). TIM-2 is characterized by a physiological water content and constant removal of 
metabolites via a dialysis system, simulating host uptake, maintaining physiological levels 
of these metabolites, and allowing metabolite production kinetics to be recorded. This 
makes the model well suited to study both microbial composition and metabolic activity 
(Minekus et al 1999, Venema et al 2000). In short, the tightly computer controlled model 
consisted of glass units with a flexible wall inside through which peristaltic movements were 
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achieved regularly. This way the lumen was mixed and transported through the system. 
Temperature was set at 37˚C and the pH at 5.8 (simulating the pH in the proximal colon), 
controlled with a pH sensor in combination with secretion of sodium hydroxide. A dialysis 
system consisting of semipermeable hollow fibers was running through the lumen. A flow 
of dialysis liquid through the dialysis system constantly removed water and fermentation 
products. Therefore, physiological concentrations of small molecules, such as electrolytes, 
were retained and accumulation of microbial metabolites was prevented. A constant volume 
of the luminal content was maintained by water absorption controlled by a level sensor. The 
system was kept anaerobic by flushing with gaseous nitrogen. This resulted in the growth of 
a highly active and dense microbiota comparable to that found in the human proximal colon 
(Kovatcheva-Datchary et al 2009, Minekus et al 1999, Venema et al 2000). 
Standard ileal efflux medium (SIEM) and dialysis liquid composition
Standard ileal efflux medium (SIEM) was slightly modified for experiments in TIM-2 
compared to the medium which was described by Gibson et al. 1988, mainly concerning a 
higher concentration of carbohydrates, pepton, casein and Tween 80 (Minekus et al 1999, 
van Nuenen et al 2003). For the purpose of our experiments we removed the standard 
iron sources (0.009 g/L FeSO4.7H2O and 0.02 g hemin g/L) from the SIEM formulation to 
produce a non-iron supplemented lowFe control. Notably, it still contained low amounts 
of endogenous iron sources that come with the other ingredients. SIEM contained the 
following components (g/L): 9.0 pectin, 9.0 xylan, 9.0 arabinogalactan, 9.0 amylopectin, 
43.7 casein, 74.6 starch, 31.5 Tween-80, 43.7 bactopepton, 0.7 ox-bile, 4.7 g K2HPO4.3H2O, 
8.4 g NaCl, 0.7 g MgSO4.7H2O, 0.8 g CaCl2.2H2O and 0.3 g cysteine.HCl, plus 1.5 ml of a 
vitamin mixture containing (per litre): 1 mg menadione, 2 mg D-biotin, 0.5 mg vitamin B12, 
10 mg pantothenate, 5 mg nicotinamide, 5 mg p-aminobenzoic acid and 4 mg thiamine. The 
pH was adjusted to 5.8. Low iron dialysis liquid contained (per litre): 2.5 g K2HPO4.3H2O, 
4.5 g NaCl, 0.5 g MgSO4.7H2O, 0.45 g CaCl2.2H2O, 0.05 g bile and 0.4 g cysteine.HCl, plus 
1 ml of a vitamin mixture as mentioned above. The pH was adjusted to 5.8. All medium 
components were provided by Tritium Microbiology (Eindhoven, The Netherlands). SIEM 
did not require pre-digestion. For the experiments the iron sources as described below were 
added to the SIEM and dialysis liquid.
TIM-2 experiments and test conditions 
Experiments were carried out as described before (Maathuis et al 2012). All experiments 
were performed in duplicate. At the start of each experiment, the model was inoculated with 
approximately 30 mL of the standardized microbiota (that was used for each experiment) 
and 80 mL of dialysate. The microbiota was allowed to adapt to the model conditions for 
16h. After this adaptation period there was a 2-hour starvation period to allow the micro-
organisms to ferment all available carbohydrates in the system. Then a 3-day experimental 
period was started. Interventions with iron were as follows:
i) no additional iron (lowFe), ii) 50 µmol/L ferrous sulfate (50FeS), iii) 250 µmol/L 
ferrous sulfate (250FeS), iv) 50 µmol/L ferric citrate (50FeC), v) 250 µmol/L ferric citrate 
(250FeC) and vi) 50 µmol/L hemin (FeH). Although hemin will not be used as an oral 
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iron supplement, we included this iron source as an additional condition to investigate 
how the gut microbiota responds to a complex iron source that is more difficult to access. 
Iron was added to the lumen at t=0, 24 and 48h and was also provided in the constant 
flow of dialysis liquid to prevent loss of iron from the lumen. Samples were taken from 
the lumen and from the dialysate starting after the adaptation period (set as time point 0) 
and at 8, 24, 32, 48, 56 and 72h after starting the iron intervention. Samples were used to 
determine microbiota composition, levels of iron, SCFA, BCFA, ammonia, and to profile 
the metabolome by 1H-NMR spectroscopy and GC-MS organic acid analysis. After 24h and 
48h, a total lumen sample of 25 mL was removed from the system to simulate passage of 
material from the proximal to the distal colon. This way a physiological colonic transit time 
of 48h was mimicked. In each experiment, SIEM was fed during the 3-day experimental 
period with 60 mL/day and contained the iron source and concentration corresponding to 
the applied conditions. 
Iron quantification in the TIM-2 lumen
Iron content of luminal samples was determined by a ferrozine based assay (Iron Reagent, 
Liquid FerroZine® Method Kit, ThermoScientific). To determine total iron in the lumen, 
luminal samples were first treated with acid-potassium permanganate to free the iron. 
Lumen samples were 2x diluted with MilliQ water (MQ) and were 1:1 mixed with freshly 
prepared iron releasing reagent (1.2 Mol/L HCl:4.5% KMnO4 (1:1)), within a fume hood. 
Samples were mixed and incubated for 1h at 60˚C, then 1/8 part ascorbic acid (20% w/v) was 
added to convert all iron to the Fe2+ state. After another incubation for 1h at 60˚C samples 
were cooled to RT and spun for 5 min at 16,100g to pellet stool particles. 32 µl sample was 
applied to a microplate (in duplicate) and 160 µl reagent A (kit) was added. After a 2 min 
incubation the absorbance (A) at 560 nm was recorded with a microplate reader. Next 6.4 
µl reagent B (kit) was added and samples were incubated for 10 min at 37˚C. Absorbance 
(B) was recorded at 560 nm and was corrected for absorbance A. The iron content was 
calculated by comparing the absorbance with a series of ferrous sulfate standards.
DNA extraction from luminal samples for microarray analysis and high throughput 
sequencing
Total fecal DNA from collected samples was isolated as described previously (Crielaard et 
al 2011), with some minor adjustments: 200mg of material was initially mixed with 250 μL 
lysis buffer (Agowa, Berlin,Germany), 250 μL zirconiumbeads (0.1 mm), and 200 μL phenol, 
before being introduced to a BeadBeater (BioSpec Products, Bartlesville, OK, USA) for two 
times 2 min. DNA yield was quantified using a NanoDrop ND-1000 spectrophotometer 
(NanoDrop Technologies). 
Real-time PCR to determine the total number of bacteria in the TIM-2 lumen
DNA extracted from the lumen at 0h and 72h was subjected to quantitative PCR to 
investigate the variation in the total amount of bacteria after different iron exposures and 
was performed as described previously (Ladirat et al 2013). 
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16S rRNA pyrosequencing of the gut microbiome
16S rRNA pyrosequencing was the main method for studying the gut microbiome composition 
at the 24h and 72h time points. For the preparation of the amplicon pool for pyrosequencing, 
the following universal primers were applied for amplification of the V3-V6 region of the 
16S rRNA gene: a) forward primer , 5’-CCATCTCATCCCTGCGTGTCTCCGACTAGNNNN 
NNACTCCTACGGGAGGCAGCAG-3’ (the italicized sequence is 454 Life Sciences primer 
A, and the bold sequence is the broadly conserved bacterial primer 338F; NNNNNN 
designates the sample-specific six-base barcode used to tag each PCR product); b) reverse 
primer 5’-CCTATCCCCTGTGTGCCTTGGCAGTCTCAGCRRCACGAGCTGACGAC-3’ 
(the italicized sequence is 454 Life Sciences primer B, and the bold sequence is the broadly 
conserved bacterial primer 1061R). PCR amplification mixture contained : 1 μL fecal DNA, 
1 µL bar-coded forward primer, 15 μL master mix (1 μL KOD Hot Start DNA Polymerase (1 
U/μL; Novagen, Madison, WI, USA), 5 μL KOD-buffer (10×), 3 μL MgSO4 (25 mM), 5 μL 
dNTP mix (2 mM each), 1 μL (10 μM) reverse primer) and 33 μL sterile water (total volume 
50 μL). PCR conditions were: 95°C for 2 minutes followed by 35 cycles of 95°C for 20 s, 55°C 
for 10 s, and 70°C for 15 s. The approximately 750 bp PCR amplicon was purified using the 
MSB Spin PCRapace kit (Invitek) and subsequently by using the Purelink PCR Purification 
kit (Invitrogen), with high-cutoff binding buffer B3. DNA concentration of the purified 
products was checked with a Nanodrop 1000 spectrophotometer (Thermo Scientific). A 
composite sample for pyrosequencing was prepared by pooling 200 ng of each purified 
sample and submitted for pyrosequencing of the V3-V4 region of the 16S rRNA gene on 
the 454 Life Sciences GS-FLX+ platform using Titanium sequencing chemistry (GATC-
Biotech, Germany). 
Microarray analysis of the microbiota by I-Chip
Analysis of the microbiota with the Intestinal (I)-Chip was executed as described by Maathuis 
et al. (Maathuis et al 2012). Briefly, the ‘intestinal chip’ (I-Chip) has been developed as a 
fast method to determine the composition of the microbiota. 16S rDNA based sequences 
of roughly 400 microorganisms have been placed on a DNA micro-array as previously 
described (Crielaard et al 2011). The DNA was labeled and hybridized to the microarray. 
After washing the arrays were scanned and analyzed. Analysis of the composition of the 
microbiota (using I-Chip) indicated the bacterial genera which were selectively stimulated 
or suppressed by the iron interventions. Changes in the composition of the microbiota in 
the experiments were analyzed for the 0, 24, 48 and 72h time points as described below. 
This analysis was included to validate pyrosequencing results, to study additional time 
points and to study the effect of iron on low-abundant taxa that were below the limit of 
detection of 16S rRNA pyrosequencing.
Metagenomic sequencing
DNA of the lowFe and 50FeS conditions at the 72h time point was barcoded, the samples 
pooled, and sequenced using paired 251 bp sequencing on two lanes of an Illumina 
HiSeq2500 instrument. The pooled samples were applied to both lanes to minimize 
potential lane-specific biases. 
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SCFA/BCFA quantification in lumen and dialysate samples
Samples (t = 0, 24, 48 and 72h) were centrifuged as described earlier and a mixture of formic 
acid (20%), methanol and 2-ethyl butyric acid (internal standard, 2 mg/ml in methanol) was 
added to the clear supernatant. A 0.5 μl sample was injected on a GC-column (Stabilwax-
DA, length 15 m, ID 0.53 mm, film thickness 0.1 mm; Varian Chrompack, Bergen op Zoom, 
The Netherlands) in a Chrompack CP9001 gas chromatograph using an automatic sampler 
(Chrompack liquid sampler CP9050; Varian Chrompack). Specifically, concentrations 
of acetate, propionate, butyrate, valerate, isovalerate and isobutyrate were determined 
(Maathuis et al 2009). 
Ammonia quantification in lumen and dialysate samples
Samples (t = 0, 24, 48 and 72h) were centrifuged for 5 min at 12,000g. Ammonia in the 
supernatant was determined based on the Berthelot reaction, in which ammonia first 
reacts with alkaline phenol and then with sodium hypochlorite to form indophenol blue. 
The absorbance of the indophenol blue is directly proportional to the original ammonia 
concentration and is measured at 660 nm. The measurement was automated on a Cobas 
Mira Plus autoanalyzer (Roche, Almere, The Netherlands) and was performed by Bio-
aNAlytiX (Mook, the Netherlands). Concentrations in the samples were determined via 
comparison with a series of standard solutions with known concentrations (Maathuis et al 
2009). 
1H-NMR spectroscopy of dialysate samples
Dialysate samples of lowFe, 50FeS, 250FeS, FeH and 50FeC at 72h were measured with 1D and 
2D COSY NMR spectroscopy. 250FeC was not analyzed because of expected interference of 
large amounts of H in the citrate. A small volume (20 µl) of 20.2 mM trimethylsilyl-2,2,3,3-
tetradeutero-propionic acid (TSP, sodium salt; Aldrich) in D2O was added to 700 µl of the 
sample, providing a chemical shift reference (0.00 ppm) and a deuterium lock signal. The 
pH was adjusted to 2.50 and 7.00 using concentrated HCl. Finally, 650 µl of the sample was 
placed in a 5 mm NMR tube (Wilmad Royal Imperial; Wilmad LabGlass, USA). 1H-NMR 
spectra were obtained on a Bruker Avance I 500 spectrometer, operating at 11.7 T, with 
a Broad Band Inverse (BBI) probehead equipped with a actively shielded z-gradient coil. 
1D 1H spectra were acquired as 256 transients in 64K data points with a spectral width 
of 10080 Hz. The sample temperature was 298K; the H2O resonance was presaturated 
by single-frequency irradiation during a relaxation delay of 4 s; a pulse width of 7 µs was 
used (corresponded to a 90° excitation pulse). Shimming of the sample was performed 
automatically using the Topshim shim program (Bruker). The resonance line widths for TSP 
and all metabolites were <1 Hz. Phase and baseline were corrected manually. All spectra 
were scaled to TSP and metabolite and TSP resonances were fitted semi-automatically with 
a Lorentzian line shape. Metabolite concentrations in the sample were calculated to the 
known concentration of the TSP standard (singlet, 9 protons) and expressed as mmol/l. In 
the 2D COSY spectra, the spectral widths in the F1 and F2 domains were 6002 Hz. A total 
of 4K data points were collected in t2, 128 t1 increments with 16 transients per increment 
were used, and the relaxation delay was set to 2 s. Before the Fourier transformation, a 
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sine-bell function was applied in both time domains. During the relaxation delay, the water 
resonance was pre-saturated.
Organic acid analysis of dialysate by GC-MS
Organic acids were analyzed using standard techniques. Briefly, to 0.5 mL of dialysate 
sample (72h) 2.5 mL SETH buffer (0.25 mol/L sucrose; 2 mmol/L (K)EDTA; 10 mmol/L Tris; 
5x104 U heparin (pH 7.4)) was added. The mixture was acidified to pH2 with concentrated 
HCl (10%), after which the organic acids were extracted by ethylacetate twice, derivatized 
with trimethylsilyl (TMS), and analyzed on an Agilent 7890A gas chromatograph (GC), 
coupled to a flame ionisation detector (FID) and an Agilent 5975C inert XL MSD mass 
spectrometer. Quantification of organic acids was done by calculation of peak areas and 
comparison with an internal standard (4-phenylbutyric acid). Relative concentrations were 
expressed relative to the lowFe condition which was set at 100%. 
Cell line, media and growth conditions
The colon adenocarcinoma cell line Caco-2 (obtained from the American Type Culture
Collection) was cultured under standard conditions (37°C and 5% CO2) in DMEM (Lonza) 
supplemented with 10% fetal calf serum (Invitrogen), 20 mmol/L HEPES, 100 nmol/L 
nonessential amino acids (Invitrogen), 2 mmol/L L-glutamine (Lonza) and Penicillin/
Streptomycin (100 U/mL and 100 µg/mL, respectively) (Pen Strep, Invitrogen). The cells 
were subcultured every 6 days and used between passage numbers 3-16.
Fecal water (dialysate) cytotoxicity to Caco-2 monolayer assays
Caco-2 cells were allowed to grow and differentiate in 22 days to a polarized tight monolayer 
on the membrane of a Transwell® Permeable Support (24 wells, 6.5 mm insert) with 0.4 µm 
polycarbonate membrane (Corning) under standard culture conditions. 
Dialysis liquid samples (not containing bacterial metabolites) and dialysate samples of the 
72h time point were spun for 10 min at 36,000g and 4˚C. Concentrated tannic acid (Riedel-
de Haën) was added to the supernatants in a final concentration of 10 µmol/L to precipitate 
the excess iron. After a 10 min incubation at RT the samples were spun again and the 
supernatants were filter sterilized by the use of a 0.2 µm filter. Iron removal was confirmed 
by the ferrozine based assay as described as above (without acid-potassium permanganate 
treatment). Pre-treated dialysates were warmed to 37˚C and 200 µl was applied in triplicate 
to the apical side of the Caco-2 monolayers after a wash in Hank’s Balanced Salt Solution 
(HBSS; Invitrogen, Cat. 14025-09). As a control, standard maintaining buffer HBSS with 
10 µmol/L tannic acid was used. Basolateral compartments were filled with 0.6 ml HBSS. 
To check for the monolayer integrity, the Trans Epithelial Electrical Resistance (TEER) was 
periodically measured with the use of the Millicell®-ERS (Millipore). After incubation the 
basolateral compartments were sampled for lactate dehydrogenase (LDH) quantification 
and were replaced with 0.5 ml fresh HBSS. Apical compartments were washed once with 
HBSS and replaced with 0.2 ml filter sterilized 1 mmol/L phenol red in HBSS. The cells 
were incubated for 1 h at standard conditions, the TEER was determined and the lower 
compartment was sampled to quantify phenol red permeability. Next, the cells were washed 
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twice with PBS and the basolateral compartment once. To quantify cell death 50 µl 0.4% 
Trypan blue in PBS was applied to the cells and incubated for 2 min at RT. Then, cells 
(twice) and basolateral chamber (once) were washed with PBS. We want to emphasize 
that we removed the iron from the dialysate prior to Caco-2 exposure and this way we 
only examined the effects of the microbial metabolome and excluded potential additional 
effects towards the cells due to redox activity of iron. We note that the presence of iron may 
augment the toxic effects of the metabolome as it has previously been shown that iron can 
have detrimental effects on the intestinal epithelium (Ferruzza et al 2003, Natoli et al 2009).
  
Phenol red permeability:
Samples from the basolateral compartments were split in technical duplicates of 180 µl and 
20 µl 0.1 mol/L NaOH was added. Absorbance was recorded in a microplate reader at 540 
nm. The amount of phenol red that was diffused through the monolayers was compared 
relatively to the control. 
LDH quantification:
To investigate the detrimental effect of the dialysates to the Caco-2 monolayers, the LDH 
release into the basolateral medium was determined. Samples were collected as described 
and were used in the Cytotox 96® Non-Radioactive Cytotoxicity Assay (Promega) according 
to the manufacturer’s protocol. The LDH concentrations were compared relatively to the 
control.
Trypan blue-exclusion test:
Washed filters were excised from the insert by scalpel and transferred to a microtube. 200 
µl acetone-0.5% (w/v) Na2SO4 (7:3) was added and tubes were sonicated in a water bath 
to extract the trypan blue from the filters. Tubes were spun for 5 min at 16,100g and the 
supernatant was transferred to a microplate. Absorbance was recorded at 560 nm with 450 
nm as reference wavelength. Trypan blue intensity was compared relatively to the control. 
Adapted from Sakai et al. (Sakai et al 1998).
Statistics and data presentation
Statistical analysis of total bacteria qPCR data, metabolic data and cell cytotoxicity 
data
TIM-2 experiments were performed in duplicate (n=2) which is a small sample size, but we 
have previously shown that the variations in the system are small because of the fact that a 
standardized microbiota is used and because the system is computer controlled (Venema et 
al 2000). Total bacteria were compared between time points by a paired t-test and among 
the single iron conditions by a 2-way-ANOVA with repeated measures and Bonferroni’s 
post-hoc test. The effects of iron on the metabolome were compared among the single 
conditions, but also as pooled data (when appropriate); mediumFe (50 µmol/L ferrous 
sulfate and 50 µmol/L ferric citrate; n=4) and highFe (250 µmol/L ferrous sulfate and 250 
µmol/L ferric citrate; n=4). Data from the hemin condition, a more complex iron source, was 
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never pooled with another condition. When two doses of the same iron source were pooled 
this is indicated as FeS (both ferrous sulfate conditions; n=4) and FeC (both ferric citrate 
conditions; n=4). Metabolite levels, presented as mean+range, were compared by Tukey’s 
multiple comparison post-hoc test. Cytotoxicity of dialysates to Caco-2 monolayers was 
tested at least in triplicate and results were expressed as mean + SD. The course of TEER was 
compared by linear regression analysis of the slope and comparison of the mean area under 
the curve (AUC) by an unpaired t-test. Means of phenol red permeability, LDH-release and 
trypan blue staining data were compared by an unpaired t-test. In case of unequal variances 
(as assessed by F-test) an unpaired t-test with Welch’s correction was carried out. Analysis 
was performed using GraphPad Prism version 5.03 for Windows, GraphPad Software, San 
Diego California USA. P-values < 0.05 were considered statistically significant and P-values 
< 0.10 were considered as an important trend throughout the paper. 
Analysis of 16S rRNA sequencing data
Pyrosequencing data were analyzed with a workflow based on QIIME v1.2 (Caporaso 
et al 2010) using settings as recommended in the QIIME 1.2 tutorial, with the following 
exceptions: reads were filtered for chimeric sequences using Chimera Slayer (Haas et al 2011). 
OTU clustering was performed with settings as recommended in the QIIME newsletter of 
December 17th 2010 (http://qiime.wordpress.com/2010/12/17/new-default-parameters-
for-uclust-otu-pickers/) using an identity threshold of 97%. Diversity metrics were 
calculated as implemented in QIIME 1.2. Hierarchical clustering of samples was performed 
using UPGMA with weighted UniFrac as a distance measure as implemented in QIIME 
1.2. The RDP classifier version 2.2 was performed for taxonomic classification (Cole et al 
2009). Multivariate redundancy analysis (RDA) was done using Canoco 5.0 (Ter Braak and 
Smilauer 2012), using default settings of the analysis type “Constrained-supplementary”. For 
the permutation tests, 500 randomizations were done, keeping duplicate samples as blocks. 
Details on the underlying mathematics can be found in (Ter Braak and Smilauer 2012). 
Visualization of differences in relative abundance of taxa between different study groups 
was done in Cytoscape (Shannon et al 2003). Statistical analysis of the pyrosequencing data 
was done with SciPy (www.scipy.org). Differences in relative abundance between groups 
at a single time point (cross-sectional) were compared by Mann-Whitney U (MWU) 
testing. Correlations of taxa with metabolite levels in 24h and 72h samples were assessed 
by Spearman’s correlation rank test. Linear regression (GraphPad Prism version 5.03) was 
used to plot the best-fit line with 95% confidence interval and to determine whether the 
deviation of the slope was significantly different from zero (when the deviation was not 
different from zero the correlation was considered not relevant). Medians of phylogenetic 
diversity and distances were compared by Kruskal-Wallis test with Dunn’s post test, or 
MWU test (GraphPad Prism version 5.03). The effects of iron on the microbiome were 
compared among the single conditions, but also as pools as described above. P-values for 
the microbiome data were not corrected for multiple testing as they were analyzed in an 
explorative manner. 
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Analysis of microarray (I-Chip) data
Duplicate measurements at four time points (t=0, 24h, 48h, and 72h) from all incubation 
conditions were analyzed. Intensity measurements of the I-Chip were normalized 
(normalized - log2 (x+1)) and scaled between 0 and 1 across all measurements. Next, we 
calculated Spearman correlations per probe across the time series between all measurements, 
and calculated permutation p-values by randomizing the measurements for each probe.
Analysis of metagenomic sequencing data
After demultiplexing the metagenomic sequencing reads, stringent Q30 quality trimming 
was applied using Trimgalore v0.2.4 (www.bioinformatics.babraham.ac.uk/projects/trim_
galore/), resulting in 69.9 and 59.8 million quality trimmed read pairs for the lowFe and 50FeS 
conditions respectively, at an average single ended read length of 207 ± 47 nt. Metagenomic 
sequencing reads were annotated by aligning them to the human gut gene catalog (Qin et 
al 2010) with Bowtie using default parameters (Langmead et al 2009). This resulted in an 
alignment rate of 29.0% and 36.8% for the lowFe and 50FeS conditions respectively. The 
abundances of KEGG orthologs (Kanehisa et al 2014) and SEED subsystem annotations 
(level-1 subsystems and the more detailed level-2 subsystems annotation) (Overbeek et 
al 2005) were normalized by sample size. Enrichment was calculated as the log2 ratio of 
the average abundance of the function in the iron datasets over the lowFe datasets, plus a 
small pseudocount of 10-9. Significance was calculated using a two-sided t-test with unequal 
variance across all the sequenced datasets. P-values for the metagenome data were not 
corrected for multiple testing as they were analyzed in an explorative manner.  
Results
Total iron concentration in the TIM-2 lumen
The total iron content of the TIM-2 lumen was determined over time to study the effect 
of the different iron sources, iron dose and our dosing schedule on the actual luminal iron 
content. This also allowed us to compare TIM-2 luminal iron content with the in situ iron 
content of human fecal samples. The iron content of the non-supplemented lowFe condition 
(see materials and methods) on average (range 8 – 72h) was 1.0 (0.7 – 1.3) mg/L and did not 
increase over time. Conversely, the iron concentration markedly increased over time in all 
conditions with supplementary iron (Supplementary Figure 1). For the 50FeS and 250FeS 
conditions (50 and 250 µmol/L ferrous sulfate) the average concentrations were 10.4 (3.7 – 
15.4) and 24.3 (9.6 – 34.8) mg/L respectively. In the 50FeC and 250FeC conditions (50 and 
250 µmol/L ferric citrate) it was 8.4 (2.8 – 12.7) and 21.0 (10.3 – 32.4) mg/L respectively. 
In FeH (50 µmol/L hemin; a more complex and less available iron source) the average 
concentration was 4.2 (1.8 – 6.9) mg/L. The iron concentration in feces of Dutch adult 
volunteers, extrapolated to the higher water content of the standard ileal efflux medium 
(SIEM; the water content of SIEM is approximately three times higher than in human feces), 
was estimated to be 19.5±3.5 µmol/L (Supplementary Figure 1). Thus, compared to the 
total iron concentration in feces, the iron content of the lowFe condition can be described 
as iron-deficient. 
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Figure 1. Multivariate redundancy analysis (RDA) of the microbiota composition. 
A&B) The conditions were grouped at iron level: low, medium (pooled 50FeS and 50FeC conditions), high 
(pooled 250FeS and 250FeC conditions) and hemin (50 µmol/L hemin). RDA was performed using Canoco 5.0. 
Taxonomic composition at the genus level was used as response data, iron level as explanatory variable, time 
point and experiment as supplementary variables. The variation explained by the ordination axis is significantly 
higher than random (p = 0.04; permutation test). 
C&D) To study differences between iron sources, conditions were grouped at iron source: low (endogenous Fe), 
sulfate (pooled 50FeS and 250FeS), citrate (pooled 50FeC and 250FeC) and hemin. Taxonomic composition at 
the genus level was used as response data, iron source as explanatory variable, time point and experiment as 
supplementary variables. The variation explained by the ordination axis is significantly higher than random (p 
= 0.032; permutation test). Red symbols represent iron level or iron source classes, light green samples the two 
replicate experiments and dark green symbols the two time points. Open symbols are the individual samples. 
The colored lines are envelopes connecting samples of the same iron level or iron source. Length of arrows 
reflects significance. Classified sample diagrams in A&C, Taxa – metadata biplots in B&D. 
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Figure 2. Differences in gut microbial 
composition between the lowFe 
control and the medium and high Fe 
and conditions at 72h.
Nodes represent taxa; edges link the 
different taxonomic levels. The fold 
difference is calculated as the 2log of 
the ratio of the relative abundance in 
the lowFe and mediumFe conditions 
(A) or in the lowFe and highFe 
conditions (B) (0 = no difference 
between groups, 1 = twice as 
abundant in mediumFe/highFe, 
etc.). In this explorative analysis, 
the significance is expressed as the p 
value of a Mann-Whitney U test. The 
node-size corresponds to the relative 
abundance. Taxa (that is, nodes) 
were included in this visualization 
when the fold difference met a 
significance level of p < 0.1, or when 
the taxon had a child (that is, more 
specific taxonomic classification) 
meeting this criterion.
1  Phascolarctobacterium was not 
detected within the lowFe condition 
and has therefore an estimated 2log 
fold difference of 10.
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Figure 3. Effect of iron on the gut microbial production of SCFAs, valerate, BCFAs and ammonia.
Cumulative levels at 72h (mean+range) of the main SCFAs acetate, butyrate and propionate are displayed for 
the pooled mediumFe and highFe conditions in panel A. Cumulative levels (mean+range) of the main SCFAs 
in the pooled FeS and FeC conditions are shown in panel B. Valerate levels (mean+range) are displayed for 
each condition and were not pooled because a pool of iron level or iron source would not very well reflect the 
differences observed between the individual iron conditions (E). Cumulative levels at 72h (mean+range) of the 
BCFAs isobutyrate and isovalerate are displayed for pooled iron level in panel C and for the pooled iron sources 
in D. Cumulative ammonia levels (mean+range) are displayed for the pooled mediumFe and highFe conditions 
(F) and pooled iron sources (G). Means of the same metabolite without a common letter differ significantly 
(p < 0.05). Analyses of the single (non-pooled) conditions are shown in Supplementary Figure 7.
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The influence of iron on the gut microbiota composition
Total bacteria content of the lumen
To study the effect of the various iron sources and concentrations on the total number of 
bacteria in the lumen of TIM-2, the number of bacteria was determined at t = 0h and 72h 
by qPCR. Overall, the number of bacteria was higher at 72h compared to 0h (p = 0.045), 
but iron source or concentration had no significant effect on the outcome (p = 0.14). 
Comparisons within the single conditions showed that the total number of bacteria was 
significantly increased from 0 to 72h in 50FeC only (p < 0.01) (Supplementary Figure 2).
Microbiome analysis by 16S rRNA sequencing
Next, we determined the microbiome composition by analyzing a total of 82,681 bacterial 
16S rRNA sequences obtained by pyrosequencing. Overall, the microbiome (samples taken 
at 24h and 72h combined) consisted of the phyla Firmicutes (58.4% of the 16S rRNA reads), 
Bacteroidetes (33.8%), Actinobacteria (6.9%) and Proteobacteria (0.8%) (Supplementary 
Figure 3). At 24h, the phylogenetic diversity index (a measure of α-diversity) was similar 
among all conditions and was not yet affected by iron. However, at 72h the diversity 
was different among groups (p = 0.046), where the diversity of the lowFe condition was 
lower compared to the highFe (250FeS and 250FeC combined) conditions (p < 0.1) 
(Supplementary Figure 4A). Supplementation of iron as ferrous sulfate (FeS) or ferric citrate 
(FeC) did not have a significant differential effect on diversity (Supplementary Figure 4B).
Multivariate redundancy analysis (RDA) showed that the different iron levels had 
a distinct non-overlapping microbiota composition (p = 0.040) (Figure 1A), while 
iron supplementation as FeS or FeC resulted in a similar microbiota profile, but that was 
distinct from that of the lowFe and FeH conditions (p = 0.032) (Figure 1C). The outcome 
of the RDA was supported by analysis of the phylogenetic distance (Unifrac weighted 
and unweighted measures for β-diversity) between the samples taken at 72h (Supplementary 
Figure 4C-E). The main differences between the microbiome of the lowFe controls 
and the conditions with mediumFe and highFe at 72h are summarized in Figure 2A and B, 
respectively. These analyses revealed that the families Lactobacillaceae, Bifidobacteriaceae 
and Streptococcaceae were less abundant in the mediumFe and highFe conditions 
compared to the lowFe controls and that the Lachnospiraceae, and to a lesser extent, 
Prevotellaceae families were more abundant in the mediumFe and highFe conditions. 
This is consistent with the outcome of the RDA, where these same taxa (on the genus 
level) separated the lowFe from the mediumFe and highFe conditions (Figure 1B and 
D). Differences between the mediumFe and highFe conditions and differences between 
the lowFe and FeH conditions are shown in Supplementary Figure 5A and 5B, 
respectively.
Microbiome analysis by I-Chip and metagenomic sequencing 
To support and validate the data from 16S rRNA sequencing, we investigated the 
changes of taxa over time and the effects of iron on certain species by using an 
I-Chip microarray platform for the analysis of the microbial community in the TIM-
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2 lumen at every time point (0h, 24h, 48h and 72h). Moreover, shotgun metagenomic 
sequencing allowed taxonomic analysis of the duplicate samples of lowFe and 50FeS at 72h, 
this was also used to support the 16S rRNA sequencing data.
In both the I-Chip and metagenomic datasets, Prevotella was markedly higher in all 
conditions with supplementary iron at 72h. I-Chip data furthermore showed that Prevotella 
generally increased in the conditions with iron with a small decrease after 48h, while its 
levels remained relatively low and stable in the lowFe condition (Supplementary Table 1 
and Supplementary Figure 6A). Metagenomic analysis also showed that Prevotella levels 
were higher in 50FeS compared to lowFe at 72h (2log ratio: 7.07; p = 0.006) (Supplementary 
Figure 6B). Next, I-Chip analysis showed a gradual increase of Roseburia in the50FeS, 250FeS 
and 50FeC conditions, and metagenomic analysis confirmed that specifically Roseburia 
intestinalis was more abundant at 72h in 50FeS compared to lowFe (2log ratio: 2.01; p = 0.073) 
(Supplementary Tables 1 and 2). 16S rRNA sequencing showed that the sulfate-reducing 
bacteria (SRB) member Desulfovibrionales (order) was more abundant in the conditions 
with iron at 72h (Figure 2A, B). This is consistent with the metagenomic analysis, where the 
genus Desulfovibrio (2log ratio: 3.08; p = 0.042) and specifically the species D. desulfuricans 
(2log ratio: 3.66; p = 0.043) and D. piger (2log ratio: 1.33; p = 0.030) were more abundant 
in the 50FeS condition compared to lowFe (Supplementary Table 2). Interestingly, although 
genus Bacteroides as a group was not significantly more abundant in the iron groups, several 
Bacteroides spp. were significantly more abundant in 50FeS compared to lowFe, including 
the opportunistic pathogen Bacteroides fragilis (2log ratio: 1.79; p = 0.029), which was 
also apparent from the I-Chip analysis, mainly for the FeS conditions (Supplementary Tables 
1 and 2).
The metagenomic shotgun sequencing also detected sequences from outside the bacterial 
domain, including Archaea, Eukaryota, and a small minority of viral sequences. On average, 
Archaea comprised only 0.3% of the metagenomic reads that were annotated to cellular 
organisms, but Archaea as a group were relatively more abundant in the 50FeS group than 
in the lowFe group at 72h (2log ratio: 4.90; p = 0.095). Specific Archaea members that were 
more abundant included Methanosphaera (2log ratio: 6.49; p = 0.001), Methanobrevibacter 
(2log ratio: 7.27; p = 0.091) and Methanobacteria (2log ratio: 7.24; p = 0.093) (Supplementary 
Table 2).
The influence of iron on the gut microbial metabolome
Iron is involved in many metabolic processes and is indeed known to influence gut bacterial 
metabolism, as described above. Iron-induced changes in the gut microbial composition may 
also affect gut microbial metabolic activity. Therefore, it is important to investigate the effects 
of supplementary iron on the gut microbial metabolome. 
Short Chain Fatty Acid and Branched Chain Fatty Acid levels
To study the effect of iron on the production of the main SCFA and BCFA, the cumulative 
amounts of these metabolites were determined in the lumen and dialysate. Analysis of the 
individual SFCAs showed no significant effect of iron supplementation on acetate production. 
However, propionate production was doubled in highFe compared to lowFe (p < 0.05) and 
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Figure 4. Effect of iron on metabolite levels associated with saccharolytic activity. 
Lactate levels (mean+range) at 72h are shown relative to the lowFe control which was set at 100%; the average 
concentration of lactate in the lowFe condition was 3.3 mmol/L as quantified by 1H-NMR spectroscopy (A). 
Iron source and level had marked effects on relative succinate levels (mean+range) at 72h (lowFe set at 100%) 
and are therefore shown for every single condition. The average concentration of succinate in the lowFe 
condition was 0.29 mmol/L as quantified by 1H-NMR spectroscopy (B). Formate levels (C) and ethanol levels 
(D) (mean+range) at 72h as determined by 1H-NMR spectroscopy are not shown for pooled conditions because 
the 250 µmol/L ferric citrate condition was not analyzed by 1H-NMR spectroscopy. Means without a common 
letter differ significantly (p < 0.05).
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Figure 5. 500 MHz 1H-NMR spectra (regions 2.7-0.5 ppm and 8.5-8.0 ppm) of dialysate samples.
1H-NMR spectroscopy at pH 2.50 of the lowFe condition (upper panel) and 250FeS condition (lower panel) 
at 72h showed that the SCFAs butyrate and acetate were similar in both conditions, while propionate content 
was slightly higher in 250FeS. Lactate and ethanol disappeared in the iron condition, while valerate content 
showed the opposite effect (see also Figure 4 and 5). Peak assignments: butyrate (1, 6 and 8), propionate (2 
and 9), ethanol (3), lactate (4), alanine (5), acetate (7), formate (10), valerate (11, 13 and 15) isobutyrate (12) 
and isovalerate (14). # increased in the condition with iron; * decreased in the condition with iron. Of both 
conditions 1 replicate is shown, which were representative for their duplicate.
Figure 6. Effect of iron on organic acid levels associated with proteolytic or polyphenol metabolism and on 
organic acids with siderophoric activity.
Concentrations (mean+range) of phenylpropionate, 4-hydroxy-phenylpropionate and phenylacetate at 72h are 
displayed relative to the lowFe condition which was set at 100%. §We note that phenylacetate levels included 
traces of glycerol in 1 biological replicate of 50FeS, 250FeS and FeH, but which were negligible amounts relative to 
the phenylacetate levels (A). Concentrations (mean+range) of metabolites with siderophoric activity; 2-hydroxy-
isovalerate, 2-hydroxy-isocaproate and phenyllactate at 72h are displayed relative to the lowFe condition which 
was set at 100%. §We note that phenyllactate levels included negligible traces of a unknown metabolite in 1 
biological replicate of 50FeC and FeH. Means of the same metabolite without a common letter differ significantly 
(p < 0.05) (B).
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propionate levels were also significantly higher in highFe compared to mediumFe (p < 0.05). 
Butyrate production was similar in all conditions, but was lowest in FeH, which was different 
from mediumFe (p < 0.05) (Figure 3A). Iron source had no significant impact on SCFA levels, 
except for a lower butyrate level in FeH compared to FeC (Figure 3B). Although the absolute 
valerate content was low compared to the other SCFAs, it showed a significant increase under 
250FeS compared to lowFe (p < 0.05). The valerate level in 250FeS was also significantly higher 
than in FeH and 50FeC (p < 0.05 for both) (Figure 3E). Total BCFA production was markedly 
increased in both ferrous sulfate conditions compared to lowFe, being significantly different 
for 250FeS (p < 0.05). Also the FeS pool showed significantly higher BCFA levels compared to 
lowFe, FeH, and to the FeC conditions (all p < 0.05), which implies that ferrous sulfate stronger 
stimulated protein fermentation compared to ferric citrate. (Figure 3D). Interestingly, iron 
level (medium vs high) had no significant impact on BCFA levels (Figure 3C). Analyses of the 
single (non-pooled) conditions are shown in Supplementary Figure 7.
Ammonia levels
Ammonia, a toxic metabolite that originates from protein breakdown, was determined in 
the lumen and dialysate of TIM-2. Similar to BCFAs, the cumulative ammonia level was 
increased in all iron conditions and most prominently in the ferrous sulfate conditions. 
When iron levels were pooled, the ammonia level was higher in both mediumFe and highFe 
than in lowFe (p < 0.05) (Figure 3F). Interestingly, when the iron sources were pooled, 
only the ferrous sulfate pool showed a significantly higher ammonia level than lowFe (p < 
0.05), but the ferrous sulfate pool was not significantly different from the ferric citrate pool 
(Figure 3G).
1H-NMR-spectroscopy and organic acid analysis
1H-NMR spectroscopy and GC-MS organic acid analysis were used to explore the gut 
microbial metabolome in the dialysate. 1H-NMR spectroscopy detected a total of 26 
metabolites, of which 20 could be identified and quantified (Supplementary Table 3). 
Moreover, 9 organic acid metabolites could be identified and relatively quantified by GC-
MS organic acid analysis. A main effect of iron supplementation was the sharp decrease 
of lactate compared to the lowFe control (p < 0.05), which was detected with both GC-MS 
and 1H-NMR techniques (Figure 4A). Another abundant metabolite that mainly derives 
from carbohydrate fermentation, was succinate. Compared to lowFe, succinate content was 
higher in FeH and 50FeC (p < 0.05 for both). Remarkably, the succinate level was higher in 
50FeC compared to 50FeS (p < 0.05), but was almost absent in both high-iron conditions, 
with a large difference between 50FeC and 250FeC (p < 0.01) (Figure 4B). 
Part of a 1H-NMR spectrum is depicted in Figure 5 where lowFe and 250FeS are compared. 
1H-NMR spectroscopy thus confirms the increase in valerate as mentioned above. This 
technique also revealed an almost equal decrease of approximately four fold in formate 
content for all iron-supplemented conditions (250FeC not assessed) compared to lowFe (p 
< 0.001) (Figure 4C). Further, metabolite profiling showed a decrease in ethanol content in 
both ferrous sulfate conditions compared to lowFe (both p < 0.01) and also when compared 
to FeH and 50FeC (both p < 0.05) (Figure 4D).
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Among the organic acids identified, most were amino acid or polyphenol-derived and they 
generally showed an increase upon iron supplementation. Phenylpropionate content tended 
to be higher in both ferrous sulfate conditions, and also in the ferric citrate conditions 
(not significant) (Figure 6A). Phenylacetate levels appeared to be higher 50FeS and 250FeS 
compared to lowFe, but it was not detected in 50FeC and 250FeC (Figure 6A). 4-Hydroxy-
phenylpropionate content was mainly increased in both ferrous sulfate conditions (not 
significant) (Figure 6A). Although only in small amounts, 3-hydroxy-phenylpropionate was 
exclusively detected in 250FeS and was considered to be absent in all other conditions (data 
not shown). Although none of these effects were statistically significant, they support our 
findings that proteolytic activity is stimulated by iron supplementation. 
Siderophoric metabolites detected by organic acid analysis
Other amino acid-derived metabolites were categorized as compounds with siderophore 
activity. 2-Hydroxy-isovalerate was only detected in substantial amounts in the dialysate of 
lowFe and FeH (Figure 6B). 2-Hydroxy-isocaproate content showed a similar pattern and 
was significantly lower in the pooled ferrous sulfate, the pooled ferric citrate, the pooled 
mediumFe and the pooled highFe conditions compared to lowFe and FeH (all p < 0.05). 
Phenyllactate content was relatively variable within the biological duplicates, nevertheless it 
was exclusively below the detection limit in all ferrous sulfate replicates and also in 250FeC 
(Figure 6B). These data support a potential siderophore function of these metabolite in 
a low-iron environment or in an environment with a complex iron source that is poorly 
available for microbes. 
Correlations of metabolite levels with the gut microbiome
It is conceivable that the changes in gut microbial metabolism can result from an altered gut 
microbiome composition. However, gut microbial metabolism may, in theory, also respond 
to iron without a change in abundances of certain taxa. As a first attempt to link changes in 
the gut microbiome composition to the marked changes in microbial metabolism we aimed 
to correlate SCFA, butyrate, propionate, acetate, BCFA and ammonia levels with the relative 
abundance of bacterial taxa of the microbiome as analyzed by 16S rRNA pyrosequencing.
Short Chain Fatty Acids
The sum of luminal butyrate, propionate and acetate levels in the lumen at 24h and 72h 
correlated positively with Roseburia, and was inversely correlated with Bifidobacteriaceae 
(Supplementary Figure 8A-B). Butyrate levels were positively correlated with Roseburia and 
Coprococcus, which both are known for the production of butyrate, and with Clostridiales, 
while Bifidobacterium correlated negatively (Figure 7A-D). Propionate correlated with 
Prevotella and Dialister, and was inversely correlated with Pediococcus and Lactobacillaceae 
(Figure 7E-H). Acetate levels could be correlated to Bacteroidales and were inversely 
correlated to Desulfovibrionales, Clostridiales and Enterobacteriaceae (Figure 7I-L). Other 
correlations of SCFA levels with the microbiome are displayed in Supplementary Figure 8C-
L. Spearman r and p-value of a Spearman rank test are depicted within the figures.
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Branched Chain Fatty Acids and ammonia
The level of the proteolytic metabolites ammonia and BCFA could be correlated to the 
following taxa. Lachnospiraceae (among which were Roseburia and Coprococcus) were 
strongly correlated with BCFA levels, and also Oscillibacter, Clostridiales, Desulfovibrionales 
and Enterobacteriaceae correlated positively with BCFA levels. Conversely, Pediococcus, 
Lactobacillaceae and Enterococcaceae were inversely correlated (Figure 8). Similar results 
were found for cumulative ammonia levels as they strongly correlated with Lachnospiraceae 
(among which were Roseburia and Coprococcus) , and also with Clostridiales, 
Desulfovibrionales, Oscillibacter, Enterobacteriaceae and Dialister. Furthermore, cumulative 
ammonia levels were inversely correlated with Pediococcus, Bacteroides and Lactobacillaceae 
(Supplementary Figure 9A-K). Other correlations of BCFA and ammonia with the 
microbiome are displayed in Supplementary Figure 9L-T.
Metagenomic analysis: mapping the metabolome to the metagenome
To deduce where the changes in microbial metabolism may originate from, we correlated 
the relative abundance of bacterial taxa to metabolite levels, and moreover, we linked 
the metabolite levels to metabolic pathways identified in the metagenome. Furthermore, 
metagenomic analysis allowed us to explore what other functions and hallmarks were over- 
or underrepresented in the lowFe and 50FeS microbial communities.
General metagenomic annotations
To investigate the effect of iron on the functional potential of the gut microbial community, 
we analyzed a total of 69.9 and 59.8 million quality trimmed metagenomic sequencing read 
pairs (average single end read length: 207 base pairs) for the lowFe and 50FeS replicates at 
72h, respectively. A total of 43.2 million sequences (32.5%) were aligned to the human gut 
microbial gene catalogue (Qin et al 2010) allowing them to be functionally characterized 
in terms of the SEED subsystems and KEGG orthology annotations An overview of the 
functional composition (SEED subsystems) of the lowFe and 50FeS conditions is shown in 
Supplementary Figure 10.
The functions that were most strongly affected by the iron treatment were related 
to the ‘Motility & Chemotaxis’ level-1 subsystem (Supplementary Table 4), that was 
overrepresented in 50FeS compared to lowFe (2log ratio: 0.40; p = 0.044). The more detailed 
annotations provided by the SEED level-2 subsystems showed that this could be attributed 
to the categories ‘Flagellar Motility’ (2log ratio: 0.80; p = 0.053), ‘Flagellum’ (2log ratio: 
0.67; p = 0.054) and ‘Bacterial Chemotaxis’ (2log ratio: 0.19; p = 0.091) (Supplementary 
Table 4). Moreover, this was also supported by the many flagellar and chemotaxis related 
KEGG orthologs that were significantly enriched in 50FeS (Supplementary Table 5). 
One subsystem of special interest in the context of this study was ‘Iron Acquisition & 
Metabolism’. Although there was no net difference found of the level-1 subsystem, we found 
that the level-2 subsystem ‘Transport of Iron’ was enriched in the 50FeS condition (2log 
ratio: 0.34; p = 0.001) (Supplementary Table 4), as may be expected for the condition with 
supplementary iron.
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Saccharolytic and proteolytic related subsystems
With metagenome analysis we aimed to link the marked metabolic changes described 
above to the enrichment or depletion of SEED subsystems and KEGG orthologs to find 
out which mechanisms were possibly responsible for the metabolic changes. This is rather 
complex as many enzymatic systems can work in two directions and because the balance 
in microbial production and utilization of metabolites is often difficult to predict. This 
analysis nevertheless provided some clues which might explain part of the metabolic 
pattern as we observed in the lumen/dialysate. Metabolite analysis pointed at a shift from 
carbohydrate fermentation towards protein fermentation upon iron supplementation. 
Subsystem data showed that the level-2 subsystem ‘Protein Degradation’ was enriched 
in 50FeS (2log ratio: 0.39; p = 0.008). This involved enrichment of aminopeptidases (EC 
3.4.11.x) (KEGG orthologs; Supplementary Table 5), which may be involved in exogenous 
protein fermentation. Carbohydrate related subsystems that may support a decreased 
carbohydrate fermentation include level-2 subsystems ‘Fructooligosaccharides (FOS) & 
Raffinose Utilization’ (2log ratio: -0.20; p = 0.071) and ‘Beta-glucoside Metabolism’ (2log 
ratio: -0.64; p = 0.022), both of which were reduced in 50FeS (Supplementary Table 4). The 
apparent shift towards a proteolytic profile was characterized by an increase in ammonia, 
BCFA and aromatic metabolites. We attempted to link these specific changes to the 
subsystems and KEGG orthologs as specified below. 
Ammonia related subsystems
Level-1 subsystem ‘Amino Acids and Derivatives’ showed that its level-2 subsystems 
‘Lysine Degradation’ (2log ratio: -0.25; p = 0.045) was underrepresented in 50FeS, while 
‘Tryptophan Synthesis’ and ‘Cysteine Biosynthesis’ were enriched (2log ratio: 0.41; p = 
0.005 and 0.36; p = 0.012 respectively). This would typically lead to decreased amounts 
of ammonia, but in contrast, ‘Glutamate Dehydrogenase’ (2log ratio: -0.28; p = 0.061) and 
‘Glutamine Synthetases’ (2log ratio: -0.36; p = 0.106), which may assimilate ammonia, 
were underrepresented in 50FeS. Additionally, subsystem ‘Ammonia Assimilation’ was 
underrepresented in 50FeS (2log ratio: -0.24; p = 0.037) which could fit with the increase 
of ammonia in this condition (Supplementary Table 4). Annotation of the metagenomic 
sequencing reads to KEGG orthologs showed that nitrogen fixation genes NifA and NifB 
were enriched in 50Fe, which also fits with increased levels of ammonia (Supplementary 
Table 5).
Branched Chain Fatty Acid-related subsystems
Level-1 subsystem ‘Amino Acids and Derivatives’ showed that its level-2 subsystem 
‘Ketoisovalerate Oxidoreductase’ was enriched in 50FeS (2log ratio: 0.45; p = 0.050) 
(Supplementary Table 4). This ferredoxin-type enzyme is involved in the degradation of 
valine, leucine and isoleucine degradation which can result in the production of BCFAs. 
Annotation of the sequences to KEGG orthologs also showed that ketoisovalerate 
oxidoreductase (EC 1.2.7.7) was enriched in the 50FeS condition compared to lowFe 
(Supplementary Table 5). 
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Figure 9. Toxicity of the microbial metabolome for an intestinal monolayer.
Effect of dialysis liquids (before exchange in TIM-2; not containing microbial metabolites) and dialysates (after 
exchange in TIM-2; at 72h) of the lowFe condition and 50FeS condition on the integrity and permeability 
of a Caco-2 monolayer. Epithelial integrity is displayed as relative transepithelial electrical resistance (TEER) 
which was regularly recorded during 7h incubation. HBSS was used as a standard maintaining buffer which 
should keep the TEER at a constant high level. The decrease in epithelial integrity of the 50FeS dialysate was 
significantly faster compared to the lowFe dialysate as analyzed by linear regression. We note that iron was 
removed from the dialysis liquids and dialysates prior to applying them to the epithelial monolayers (A). 
Epithelial permeability as determined by the flux of phenol red from the apical side to the basolateral side (B). 
** p < 0.01. n=3 for the dialysis liquids before exchange in TIM-2 and n=6 for the dialysates after exchange; at 
72h in TIM-2.
Figure 8. Bacterial taxa that correlate with BCFA levels.
The relative abundance (fraction of the total 16S rRNA; e.g. 0.01 = 1%) of bacterial taxa in all samples at 24h and 
72h (as determined by 16S rRNA pyrosequencing) was correlated with the sum of isobutyrate and isovalerate 
(collectively called BCFAs) levels in the same samples. Panels A-E show positive correlations while panels F-H 
show inverse correlations. Best fit lines with 95% confidence bands were generated by linear regression analysis. 
Spearman r and p-value are displayed for each graph. This figure shows the taxa that correlated best, additional 
taxa are shown in Supplementary Figure 9.
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Aromatic compounds related subsystems
Level-1 subsystem ‘Amino Acids and Derivatives’ showed that its level-2 subsystem 
‘Aromatic Amino Acid Interconversions with Aryl Acids’ was enriched in 50FeS (2log 
ratio: 0.76; p = 0.040). This ferredoxin-type system converts aromatic amino acids to aryl 
acids, among which is phenylacetate and possibly also other phenylalanine derivatives 
like phenyllactate and phenylpropionic acid. Similarly, level-1 subsystem ‘Metabolism of 
Aromatic Compounds’ showed an enrichment of the level-2 subsystem ‘Aromatic Amin 
Catabolism’ (2log ratio: 0.55; p = 0.088) which may have contributed to the higher levels of 
phenyl derivatives in the 50FeS condition. In contrast, subsystem ‘Homogentisate Pathway 
of Aromatic Compound Degradation’ was mildly underrepresented in 50FeS (2log ratio: 
-0.27; p = 0.014) (Supplementary Table 4).
Cytotoxicity of the fecal water
Based on the metabolome data, the toxicity of the fecal water was increased with iron, 
especially in the ferrous sulfate conditions. To confirm this, the cytotoxicity of the 50FeS 
dialysate towards a tight monolayer of intestinal epithelial Caco-2 cells was assessed. These 
cytotoxicity tests comprised multiple readouts, i.e. monitoring of the trans epithelial 
electrical resistance (TEER) (cellular monolayer integrity), phenol red permeability (cellular 
monolayer permeability), lactate dehydrogenase (LDH) release (cell cytotoxicity) and 
trypan blue staining (cell death). To exclude the effect of iron itself on the cells, iron was 
removed from all dialysates prior to the cytotoxicity analyses. Monitoring of TEER showed 
a deteriorating effect of the dialysis liquids (before exchange in TIM-2) and dialysates (after 
exchange; sampled at 72h) in the TIM-2 system when compared to a standard maintaining 
buffer. Remarkably, the 50FeS dialysate at 72h showed a larger relative TEER decrease 
compared to the lowFe dialysate at 72h (Figure 9A). The slopes were significantly different 
(p = 0.002), and also the area under the curve (AUC) of 50FeS was smaller compared to 
lowFe (p = 0.021). Phenol red permeability confirmed these findings as the permeability of 
the Caco-2 monolayer was shown to be increased after exposure to 50FeS dialysate at 72h 
compared to lowFe dialysate at 72h (p = 0.008) (Figure 9B). LDH release and trypan blue 
staining showed the same trend, as 50FeS dialysate evoked increased cell cytotoxicity and 
cell death (p = 0.081 and p = 0.067 respectively) (Supplementary Figure 11A and B).  
Discussion
To find solutions for the unwanted side effects of oral iron administration, such as 
diarrhea and increased gut inflammation, it is important to investigate the effects of iron 
on the gut microbiota composition and metabolic activity. Although several studies have 
reported on the effects of iron on the gut microbiota composition, the effects of iron on 
gut microbial metabolism and its functional potential has remained largely unexplored. 
The present study is the first to report on the effect of multiple iron sources and doses on 
the gut microbiome composition, metagenome, and that included profiling of the effects of 
these iron interventions on the gut microbial metabolome in both an explorative and 
targeted manner. 
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As expected, iron had a marked effect on the gut microbiome composition. Our data 
indicate that the high iron doses had an additional effect on the gut microbiome composition 
compared to the medium iron doses. Interestingly, the ferrous sulfate and ferric citrate 
conditions had a very similar effect on the gut microbiota composition. Comparison of the 
relative abundance of single bacterial taxa between groups showed that the most apparent 
differences were the lower abundance of Streptococcus, Lactobacillus and Bifidobacterium 
with supplementary iron, which is roughly in line with previous studies for at least the latter 
two taxa (Kortman et al 2014a) (Chapter 1). We did however not observe an increase in 
Enterobacteriaceae or closely related taxa, which was frequently observed in former in vivo 
studies (Balmer et al 1989, Benoni et al 1993, Jaeggi et al 2014, Lee et al 2008, Mevissen-
Verhage et al 1985, Zimmermann et al 2010). This could suggest that an increase in 
Enterobacteriaceae depends on host inflammatory responses which they can exploit to their 
own benefit (Winter et al 2013). Another explanation that we cannot exclude, is that the 
specific composition of the here used adult gut microbiota of Dutch volunteers, which is 
different from the above mentioned infant or animal microbiota in previous studies, might 
inhibit overgrowth of this taxon. Instead, we found increased levels of the genera Roseburia, 
Coprococcus, Oscillibacter, Prevotella and Desulfovibrio. So far, reported effects of iron on 
Roseburia abundance have been disperse (Dostal et al 2012a, Dostal et al 2012b, Dostal et al 
2014b). We here report an increase in Roseburia intestinalis in response to iron in both the 
mediumFe and highFe conditions compared to lowFe. Consistent with our findings, Dostal 
et al. showed an increase of Coprococcus during iron supplementation (Dostal et al 2014b). 
In contrast to our findings on Prevotella, one study that reported on the effect of iron on 
Prevotella abundance showed a lower abundance in mice fed with an iron-supplemented diet 
compared to an iron-deficient diet (Werner et al 2011). Similar to our findings, Desulfovibrio 
has previously been found to increase in mice on an iron-supplemented diet, but it was also 
shown that iron did not change Desulfovibrio abundance in rats despite an increase in the 
sulfate reducing bacteria (SRB) group (Dostal et al 2014b, Werner et al 2011), of which 
Desulfovibrio is the most dominant genus. Desulfovibrio are known for the production of 
toxic H2S from sulfate and sulfur containing amino acids (Blaut and Clavel 2007, Davila et 
al 2013, Nyangale et al 2012). Interestingly, iron appears to induce the activity of certain 
SRB, while increases in both SRB and in H2S have been associated with inflammatory bowel 
disease (IBD) (Carbonero et al 2012, Dinh et al 2004). An increase in Desulfovibrio might thus 
be undesirable. Moreover, we show that several bacteria of the lactic acid bacteria group, 
including Lactobacillus (as mentioned above), Streptococcus, Pediococcus and Enterococcus 
showed a decreased relative abundance in response to iron. Enterococci have been described 
in relation to iron supplementation before. Previous studies showed inconsistent outcomes, 
but like in our study, most studies also showed a lower abundance of Enterococci with 
iron (Balmer and Wharton 1991, Benoni et al 1993, Dostal et al 2012b, Dostal et al 2014b, 
Tompkins et al 2001, Werner et al 2011). Next, previous studies differ in the reported effects 
of iron on the abundance of Bacteroides (Balmer et al 1989, Balmer and Wharton 1991, 
Benoni et al 1993, Dostal et al 2012a, Krebs et al 2013, Mevissen-Verhage et al 1985, Werner 
et al 2011). We here report that the relative abundance of certain Bacteroides species, among 
which is the opportunistic and potent pathogen B. fragilis (Wexler 2007), was increased 
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with 50FeS. Finally, it appeared from our study that Archaea tend to increase with ferrous 
sulfate, with Methanosphaera being the most significant taxon. The role of Archaea in the 
human gut microbiota is rather unexplored. They could be involved in the pathogenesis 
of intestinal diseases, but it was also proposed that their presence is a sign of a healthy 
gut, because they can thrive on health promoting bacterial metabolites such as SCFAs and 
formate (Jarrell et al 2011, Matarazzo et al 2012). The relative increase in Archaea may thus 
have contributed to the changed metabolite levels as we observed, either in the utilization 
of bacterial metabolites and/or the production of other metabolites (discussed below).
The gut microbiome composition moved thus slightly towards a less favorable profile, but 
the most prominent effect under iron-rich conditions was the change of the gut microbial 
metabolome from a saccharolytic to a proteolytic profile. Lactate and formate levels were 
much lower in all conditions with supplementary iron compared to lowFe, also ethanol 
levels were decreased and succinate levels were decreased in the highFe conditions. These 
metabolites are primarily derived from carbohydrate, and levels of lactate and formate 
being the highest in the lowFe condition are consistent with previous findings of an in vitro 
study of Dostal et al. under extremely low iron conditions (Dostal et al 2012b). Despite 
the apparent decrease in saccharolytic activity with iron in our model, the production of 
the mainly carbohydrate derived SCFAs was not decreased, probably due to the fact that 
the main SCFAs can also be produced from protein (Macfarlane and Macfarlane 2012). 
More specifically, acetate and butyrate levels did not differ significantly compared to lowFe, 
but propionate levels were higher in the highFe conditions. This is partially in line with 
previous in vivo and in vitro findings of Dostal et al., although their data from different 
models were not always consistent at this point (Dostal et al 2012a, Dostal et al 2012b, 
Dostal et al 2014b). 
In our model, the increased proteolytic activity of the gut microbiota under iron-rich 
conditions was evident by the increased levels of ammonia (a toxic metabolite), BCFAs 
and valerate, which are all protein fermentation-related metabolites (Hoyles and Wallace 
2010, Hughes et al 2008, Macfarlane and Macfarlane 2012, Nery et al 2012, Nyangale et al 
2012, Smith and Macfarlane 1997). The iron-induced switch towards a more proteolytic 
profile is further supported by the tendency that aromatic metabolites were increased. 
These metabolites are degradation products of aromatic amino acids and polyphenols and 
it is known that phenylacetate levels can increase upon a high protein diet (Beloborodova 
et al 2012, Davila et al 2013, Smith and Macfarlane 1997). Little is known about the toxicity 
of these specific compounds, but phenolic compounds are generally considered to be 
unbeneficial for human health (Nyangale et al 2012, Smith and Macfarlane 1997, Windey 
et al 2012b). Importantly, it is well known that protein fermentation in general results in 
the formation of a putrefactive and toxic environment (Macfarlane and Macfarlane 2012, 
Nyangale et al 2012). 
Our present study shows for the first time that the gut bacterial metabolites that are 
produced under iron-supplemented (50FeS) conditions are indeed harmful to a human 
intestinal epithelial monolayer. This was not evident from previously described in vitro 
studies, but which may be explained by a different design and the use of different gut-model 
and cell-systems (Dostal et al 2012b, Dostal et al 2014a). In addition, we want to emphasize 
133
Gut microbial metabolism shifts towards a more toxic profile with supplementary iron in a kinetic model of the human large 
intestine
3
that our in vitro toxicity findings cannot directly be translated to in vivo situations (Dostal 
et al 2012a, Dostal et al 2014b, Windey et al 2012a), but our data nevertheless indicate 
that similar effects on gut bacterial metabolism in vivo could have significant implications 
in infection endemic regions as an impaired barrier function of the gut wall could play a 
pivotal role in the initiation of infections by (opportunistic) enteric pathogens. 
Increased iron availability has been associated with an increase in virulence of bacterial 
pathogens (Bullen et al 2005, Kortman et al 2012). This inspired us to look into the abundance 
of virulence associated subsystems in our metagenome data. Flagella enable microbes to 
swim and swarm over surfaces and can be involved in adhesion to epithelial cells, which 
make them an important virulence factor (Moens and Vanderleyden 1996). Intriguingly, 
our results show that the level-1 subsystem ‘Motility and Chemotaxis’ was enriched in the 
50FeS condition. Level-2 subsystems not only showed that flagella related subsystems were 
enriched in 50FeS, but also bacterial chemotaxis. This could suggest that ferrous sulfate 
selected for bacterial groups that use flagella and chemotaxis to seek for nutrient-rich 
niches (Rivera-Chavez et al 2013, Stecher et al 2008). Thus, iron could provide motile and 
chemotactic enteric pathogens with a competitive advantage over other members of the 
microbiota under iron-rich conditions. Overall, our data provide indications that in the 
absence of host influences, iron creates a more hostile intestinal environment which can be 
characterized by i) a reduction in beneficial microbes and an increase of certain bacterial 
species with pathogenic potential, ii) increased levels of metabolites that can impair the 
barrier function of the gut wall, and iii) an increase of virulence-associated pathways of 
enteric pathogens. The combination of these three effects could very well contribute to the 
increased risk for enteric infections. In vivo, the host immune status and the composition of 
the gut microbiota will largely determine whether or not an intestinal infection will become 
apparent.
Our metabolome data represent a steady state situation that is the result of both metabolite 
production and consumption. Cross-feeding of microbial metabolites is anticipated to have 
a large influence on the metabolome composition (Nyangale et al 2012, Rajilic-Stojanovic 
2013). Based on our 16S rRNA pyrosequencing and metagenomic data and literature we 
can however provide specific leads for the explanation of the iron-induced changes in gut 
microbial metabolic activity. First of all, many metabolic pathways rely on the action of 
iron-dependent enzymes (ferredoxin-type enzymes with iron-sulfur clusters), for instance 
in the Wood-Ljungdahl pathway, and may thus be influenced by iron supplementation 
(Hood and Skaar 2012, Ragsdale and Pierce 2008). Secondly, redox balance needs to be 
maintained and microbial fermentation is regulated by this balance (Macfarlane and 
Macfarlane 2003). It can be envisaged that supplementary iron has a large impact on the 
redox balance as this transition metal is able to function as an electron donor and electron 
acceptor. Importantly, also the availability of carbohydrates has a large impact on the type 
of metabolites that will ultimately be produced. Interestingly, when sufficient carbohydrate 
is present there is a decreased need to decarboxylate succinate to produce propionate, as 
has been observed for certain Bacteroides spp. (Macfarlane and Macfarlane 2003). This fits 
with our findings that levels of succinate decreased while propionate levels increased in 
the high-iron conditions, indicating that carbohydrate sources were depleted early in the 
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iron-rich conditions. Early depletion of carbohydrate sources by the gut microbiota in the 
conditions with supplementary iron may also clarify the increase in proteolytic activity. 
Furthermore, it may explain the low levels of lactate in the iron-supplemented conditions, 
but this might also be attributed to the lower abundance of lactic acid bacteria in the same 
conditions.
Correlations of metabolite levels with the relative abundance of bacterial taxa do not provide 
a causal relationship but may provide some indication which taxa are responsible for the 
differences observed. It is interesting to see that Prevotella, whose growth was stimulated with 
iron, was positively correlated with propionate levels. Prevotella may drive the conversion of 
succinate to propionate (Nyangale et al 2012), especially when carbon sources are limiting 
(as discussed above), which fits with the finding that propionate levels were increased in 
the highFe conditions while succinate was decreased in those conditions. From literature it 
is well-known that Roseburia and Coprococcus (both belong to the Lachnospiraceae family) 
and Faecalibacterium are producers of butyrate (Louis and Flint 2009). Indeed we found 
a strong positive correlation of Roseburia and Coprococcus with butyrate levels, but not 
with Faecalibacterium. So far, very little is known about gut microbiota members that 
convert amino acids to BCFA. Suspected members are Clostridium spp. and Atopobium, but 
only Clostridium coccoides has previously been correlated with fecal BCFA levels (Rajilic-
Stojanovic 2013, Thompson-Chagoyan et al 2011). Two groups of bacteria that are generally 
associated with proteolytic activity are Bacteroides and Clostridium (Cummings and Englyst 
1987, Nyangale et al 2012), and although iron may theoretically have induced their metabolic 
activity, their abundance did not significantly change in our system. Candidates that were 
identified in this study and that may be involved in BCFA and ammonia production are 
Lachnospiraceae, Oscillibacter, Clostridiales and Desulfovibrionales as they all positively 
correlated with BCFA and ammonia levels. Thus, Lachnospiraceae not only correlated with 
(beneficial) butyrate levels, but also strongly correlated with the (unbeneficial) BCFA and 
ammonia levels in our study, which has not been described before. Enrichment or depletion 
of certain genetic characteristics in the metagenomic data also provided clues about the 
microbial pathways involved in the iron-induced changes in gut microbial metabolism. 
The most obvious findings involved the protein- and amino acid related subsystems, 
such as ‘Protein Degradation’, ‘Ketoisovalerate Oxidoreductase’, ‘Aromatic Amino Acid 
Interconversions with Aryl Acids’ and ‘Aromatic Amin Catabolism’ which were enriched 
in the 50FeS condition compared to the lowFe condition. It is interesting to note that the 
enzyme ketoisovalerate oxidoreductase needs iron as a cofactor, and is not only present in 
bacteria, but also in Archaea (Heider et al 1996). This may implicate that not only bacteria, 
but also Archaea contributed to the iron-induced production of BCFAs.
Another fascinating aspect of our findings concerned the identification of the bacterial 
metabolites 2-hydroxy-isovalerate, 2-hydroxy-isocaproate and phenyllactate that have 
siderophoric activity (Drechsel et al 1993). Indeed, levels of these iron-binding acids were 
relatively high in the lowFe condition and the hemin (a more complex and less available 
iron source, and which in TIM-2 resulted in a lower total iron content compared to the 
mediumFe and highFe conditions) condition, while they were low or absent in the medium 
and high-iron conditions. This confirms the idea that bacteria only produce siderophores 
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when readily available iron is scarce. We cannot be sure that these siderophoric metabolites 
indeed acted as siderophores, but as the levels of these amino acid derived siderophores 
oppose the trend of the other amino acid derived metabolites levels, our results strongly 
suggest that limitation of iron has been the trigger to produce these acids for at least a subset 
of the gut microbiota. This also implies that iron availability was limited in both the lowFe 
and hemin conditions. Notably, the production of siderophoric α-ketoacids has previously 
been shown to be upregulated in Salmonella enterica serovar Typhimurium in response to 
iron-limiting conditions, underlining that the production of such acids responds to iron 
deprivation (Reissbrodt et al 1997). Despite the relatively low affinity for iron compared to 
conventional siderophores (Kingsley et al 1996, Reissbrodt et al 1997) these acids may play 
an important role in iron scavenging and iron cross-feeding in the colon lumen under iron 
limiting conditions. 
Although the iron sources ferrous sulfate and ferric citrate differed in their counter-anion 
and initial valence state of the iron, they appeared not to cause marked differences in 
microbiome composition. However, differential results were observed on gut microbial 
activity and it appeared that the metabolic profile of the ferric citrate conditions was less 
proteolytic compared to the ferrous sulfate conditions. This indicates that ferric citrate 
may be preferred as an iron source to be used in human food supplements, we however did 
not compare the in vitro cytotoxicity of the ferric citrate conditions with the ferrous sulfate 
conditions. More research is needed to reveal whether ferric citrate is indeed preferred over 
ferrous sulfate as a more beneficial source of dietary iron, from both a gut microbial and host 
perspective. In a previous study we observed good bioavailability of ferric citrate in a Caco-
2 model (Kortman et al 2014b), but it is also required to study the effects of gastrointestinal 
passage on iron preparations as this will affect iron speciation and possibly also the effects 
on the gut microbiota. We note that inorganic anions such as sulfate can affect microbial 
fermentation as these anions can function as an electron sink (Macfarlane and Macfarlane 
2003). Although the contribution of sulfate in the condition with ferrous sulfate was 
relatively small compared to the amount of sulfate already present in the SIEM and dialysis 
liquid (2.5-12.3% of the amount of sulfate present as magnesium sulfate), the additional 
sulfate may have influenced microbial metabolism. The citrate in the ferric citrate condition 
might have formed an alternative carbon source and could have contributed to differential 
microbial activity compared to the ferrous sulfate conditions, but the contribution of citrate 
to the amount of carbon sources already present is also relatively small. Notwithstanding 
their biochemical differences, both ferrous sulfate and ferric citrate caused a shift towards 
an unbeneficial proteolytic profile, which appeared not to be sufficiently compensated by 
the increase in beneficial propionate levels.
In conclusion, this study shows that the provision of iron (provided as ferrous sulfate or 
as ferric citrate) to a human gut microbiota resulted in a lower abundance of beneficial 
bacteria, an increase in toxic metabolites and an increase in bacterial virulence-associated 
pathways. Thus, supplementation of these forms of iron creates a more hostile intestinal 
environment which is likely to increase the risk of enteric infection. Our data also show 
that iron limitation increases the production of bacterial metabolites with iron-binding 
features. If and how these metabolites act as siderophores and mediate bacterial iron uptake 
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under these conditions remains to be determined. One future challenge that remains, is 
to pinpoint metabolic changes to particular microbes, for which we provide novel leads. 
A metatranscriptomic approach is needed to provide better insight in the effects of iron 
on the actual microbial metabolism and can help to pinpoint these metabolic properties 
to certain taxa. This may be complemented with e.g. a LC-MS, HPLC, and/or NMR 
spectroscopy metabolomics approach to identify and quantify additional microbial volatile 
and non-volatile metabolites (Nyangale et al 2012). This will aid in the development of an 
iron preparation that is highly available to humans, but has little to no impact on the gut 
microbiota composition and metabolism. To reduce the risk for unwanted side effects this 
is an important challenge that remains in combating anemia in underdeveloped infection 
endemic regions. 
Data access
The sequencing datasets accompanying this study are available in the European Nucleotide 
Archive with the study accession number [ENA: PRJEB6542]. Supplementary Tables 1, 2, 4 
and 5 will provisionally be available as online supplementary information, upon publication 
of the manuscript.
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Supplementary Figures and Legends
Supplementary Figure 1. Iron content of the TIM-2 lumen in the various iron conditions.
Average total iron concentration in the TIM-2 lumen over time (mean±range; n = 2 for each time point). 
Supplementary iron accumulated in the lumen during the 72h incubation. As a reference, the total iron content 
measured in feces of Dutch adult volunteers (n=3) is indicated by the dashed line (mean±SD). The feces was 
diluted three times to obtain a similar consistency as the TIM-2 lumen which has a higher water content as 
compared to human feces.
It should be noted that the majority of the supplemented iron was bound to solid matter of the SIEM, or was 
precipitated in the TIM-2 lumen, and that iron concentration in the ‘fecal water’ (lumen supernatant) was 
much lower and relatively stable over time compared to the total lumen sample (data not shown). Iron could 
accumulate via influx of iron from the dialysis liquid and feeding the system with fresh SIEM. The measured 
fecal iron concentration of 59 mg Fe/kg wet weight feces (undiluted) reflected the fecal iron content of healthy 
Dutch human adults. This is somewhat lower compared to the approximate 100 mg Fe/kg wet weight feces 
that was found in British adults in a study of Lund et al. (Lund et al 1999). Remarkably, Chile infants fed with 
unfortified cow’s milk formula had an average fecal iron content of 60 mg Fe/kg, which is higher than expected 
for such a diet and a group with an iron deficiency prevalence of 25.7%. The iron content even increased to 100 
mg Fe/kg feces when solid foods were introduced at the age of 7 months (Pizarro et al 1987). Based on these 
studies our highFe condition would reflect a rather normal iron content, even when compared to the fecal iron 
content of infants. However, iron supplemented as ferrous sulfate or ferric citrate is very different from less 
readily available endogenous iron sources such as present in grains and vegetables. Therefore our mediumFe 
and highFe conditions can be best described as iron-supplemented conditions. Readily (freely) available iron 
concentrations and iron speciation in the colon lumen remain however very difficult to predict and to measure.
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Supplementary Figure 2. Total bacterial cells in the TIM-
2 lumen at baseline and at 72h.
Total number of bacteria (mean+range; n = 2) as 
determined by qPCR in the TIM-2 lumen was similar 
at 0h (baseline) and was generally increased at 72h (p 
= 0.045). This increase was significant for the 50FeC 
condition only when the single conditions were analyzed. 
Overall, iron source or concentration had no effect on 
the outcome on the change in total bacteria from baseline 
to 72h. ** p < 0.01. 
Supplementary Figure 3. Overall gut microbiome as determined by 16S rRNA pyrosequencing.
This visualization shows the average abundance (in %) of 16S rRNA reads attributed to the specific taxonomic 
level and represents all samples in the 16S rRNA pyrosequencing analysis (all conditions at 24h and at 72h).
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Supplementary Figure 4. Effect of iron on the phylogenetic diversity and phylogenetic distance.
The phylogenetic diversity (PD) index of the lowFe, mediumFe (pooled 50FeS and 50FeC conditions), highFe 
(pooled 250FeS and 250FeC conditions), FeH (50 µmol/L hemin) is given at 24h and 72h (median + range; n 
= 2-4). At 24h medians were similar, but at 72h medians differed significantly (P = 0.046) and the diversity of 
lowFe was lower compared to highFe (A).The phylogenetic diversity (PD) index of the lowFe, FeS (pooled 50FeS 
and 250FeS conditions), FeC (pooled 50FeC and 250FeC conditions), and FeH at 24h and 72h (median + range; 
n = 2) is given in panel B. At 72h, medians tended to differ significantly (P = 0.023), and the diversity of lowFe 
was lower compared to FeC (B). 
The phylogenetic distance (min-max whiskers with median) between the various (pooled) conditions at 72h 
for the unweighted (C) and weighted index (D) are given. Both showed that the phylogenetic distance between 
the lowFe and highFe conditions was significantly larger compared to the distance between the lowFe and 
mediumFe conditions (p = 0.003 and p = 0.005 for weighted and unweighted respectively). This analysis further 
showed that the phylogenetic distance between the ferrous sulfate conditions and the lowFe condition was not 
different compared to the distance between the ferric citrate conditions and the lowFe condition, for both the 
weighted and unweighted measures (C and D). The phylogenetic distance (min-max whiskers with median) 
at 72h between the lowFe and FeH was significantly higher compared to the distance between lowFe and 
mediumFe for the weighted Unifrac index only, suggesting that the high abundance of Prevotella in the hemin 
condition accounts for this difference in phylogenetics (E). All indices were calculated from the 16S rRNA 
sequencing data. # p< 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Supplementary Figure 5. Differences in gut microbial composition between the mediumFe and the highFe 
conditions and differences between the lowFe and FeH condition at 72h.
Nodes represent taxa; edges link the different taxonomic levels. The fold difference is calculated as the 2log of 
the ratio of the relative abundance in the mediumFe and highFe conditions (A) or as the 2log ratio of the relative 
abundance in the lowFe and FeH conditions (B) (0 = no difference between groups, 1 = twice as abundant in 
mediumFe/highFe, etc.). In this explorative analysis, the significance is expressed as the p value of a Mann-
Whitney U test. The node-size corresponds to the relative abundance. Taxa (that is, nodes) were included in 
this visualization when the fold difference met a significance level of p < 0.1, or when the taxon had a child (that 
is, more specific taxonomic classification) meeting this criterion.
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I-Chip analysis showed that the Prevotella level (all Prevotella probes on the chip taken together; n=9) was 
fairly constant in the lowFe condition, while there was a visible increase over time in the conditions with iron 
(pool of all iron conditions; +Fe) (A). Metagenomic analysis showed a large fold difference in genus Prevotella at 
72h between the lowFe (set to 1) and 50FeS condition (2log ratio: 7.07; p = 0.006). For the majority this appeared 
to be attributable to the species Prevotella copri (p = 0.006), but which was also the only Prevotella species that 
was found in the metagenomic database that we used for annotation (Qin et al 2010) (B).
Interestingly, we here show that supplementary iron increased the abundance of Prevotella, while a relatively 
high Prevotella abundance has been associated with carbohydrate rich plant based diets and has been found 
to be more abundant in African children compared to European children (De Filippo et al 2010, Wu et al 2011, 
Yatsunenko et al 2012). It is however difficult to speculate how these finding may relate to the iron-induced 
increase in Prevotella in TIM-2.
Supplementary Figure 7. Effect of supplementary iron on SCFA, BCFA, and ammonia levels.
Cumulative levels at 72h (mean + range) of the main SCFAs acetate, butyrate and propionate are displayed 
for the single conditions in panel A. Cumulative levels at 72h (mean + range) of the BCFAs isovalerate and 
isobutyrate are displayed for the single conditions in panel B. Means of the total BCFA without a common letter 
differ significantly (p < 0.05). Cumulative levels at 72h (mean + range) of ammonia are displayed for the single 
conditions in panel C. 
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Supplementary Figure 8. Overview of additional bacterial taxa that correlate with luminal SCFA, acetate, 
butyrate and propionate levels.
The relative abundance (fraction of the total 16S rRNA) of bacterial taxa in all samples at 24h and 72h (as 
determined by 16S rRNA pyrosequencing) was correlated with luminal SCFA (A-B), butyrate (C-H) propionate 
(I) and acetate (J-L) levels in the same samples. Best fit lines with 95% confidence bands were generated by 
linear regression analysis. Spearman r and p-value are displayed for each graph.
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Supplementary Figure 9. Overview of bacterial taxa that correlate with cumulative ammonia levels and 
additional taxa that correlate with luminal BCFA levels.
The relative abundance (fraction of the total 16S rRNA) of bacterial taxa in all samples at 24h and 72h 
(as determined by 16S rRNA pyrosequencing) was correlated with luminal ammonia levels in the same 
samples at 24h and cumulative ammonia levels at 72h (A-Q). Panels R-T show additional (to the main article) 
correlations of the relative abundance of bacterial taxa at 24h and 72h with luminal BCFA levels in the same 
samples. Best fit lines with 95% confidence bands were generated by linear regression analysis. Spearman r and 
p-value are displayed for each graph.
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Supplementary Figure 10. Functional analysis of metagenomic sequencing data.
Overview of the functions that were present in the lowFe and 50FeS conditions (Level-1 SEED subsystems) and 
the proportion of reads that were annotated to these functions.
Supplementary Figure 11. Effect of iron on the microbial metabolome toxicity towards a Caco-2 intestinal 
monolayer.
Effect of dialysis liquids (before exchange in TIM-2; not containing microbial metabolites) and dialysates (after 
exchange in TIM-2; at 72h) of the lowFe condition and 50FeS condition on cell cytotoxicity and cell death 
of a Caco-2 monolayer. Cell cytotoxicity as determined by LDH-release (whiskers min to max) tended to be 
higher in the 50FeS dialysate compared to the lowFe dialysate (n=6) (A). Cell death as determined by trypan 
blue staining (whiskers min to max) tended to be higher in the 50FeS dialysate compared to the lowFe dialysate 
(n=6) (B). # p < 0.1.
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Supplementary Table 3. 1H-NMR resonances from metabolites observed in dialysate samples at 72h 
(measured at pH=2.50)
Metabolite CS [splitting] (ppm)
Acetate 2.08 [si]
Alanine 1.50 [do] 3.87 [qu]
Butyrate 0.91 [tr] 1.60 [sx] 2.35 [tr]
Cholate† 0.71 [si]
Ethanol 1.17 [tr] 3.65 [qu]
Formate 8.24 [si]
Isobutyrate 1.14 [do] 2.60 [mu]
Isoleucine 0.94 [tr] 1.02 [do]
Isovalerate 0.94 [do] 2.02 [mu] 2.26 [do]
Lactate 1.41 [do] 4.36 [qu]
Leucine 0.95 [tr] 0.97 [do]
Methanol 3.35 [si]
Phenylalanine 7.35 [mu]
Phenylpropionate 2.71 [tr] 2.94 [tr] 7.32 [mu]
Propionate 1.06 [tr] 2.20 [qu]
Succinate 2.66 [si]
Trimethylamine 2.89 [do]
Tyrosine 6.89 [do] 7.19 [do]
Valerate 0.88[tr] 1.32 [mu] 1.56 [mu] 2.32 [tr]
Valine 0.99 [do] 1.05 [do] 2.28 [mu] 3.62 [do]
X1 2.66 [tr] 2.86 [tr]
X2 1.74 [mu] 3.28 [mu]
X3 3.55 [tr]
X4 3.60 [tr]
X5 6.84 [do] 7.17 [do]
X6 2.44 [tr]
† Tentative assignment based on Jacobs et al. (Jacobs et al 2008)
X1-X6 could not with certainty or tentatively be assigned to a known metabolite
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Orally administrated iron is suspected to increase susceptibility to enteric infections 
among children in infection endemic regions. Here we investigated the effect of dietary 
iron depletion and supplementation on the pathology and local immune responses in 
intestinal infection models. Mice were held on iron-deficient, normal-iron, or high-iron 
diets and after two weeks they were orally challenged with the mouse pathogen Citrobacter 
rodentium. Dietary intervention significantly altered iron stores in liver and spleen. 
Microbiome analysis by pyrosequencing revealed profound iron- and infection-induced 
shifts in microbiota composition. Two weeks after infection, animals on the iron-deficient 
diet had a gut microbiota that was dominated by Parabacteroides, while animals on the 
medium/high-iron containing diets had an Allobaculum dominated microbiota profile. 
Remarkably, fecal levels of the innate defensive molecules and markers of inflammation 
lipocalin-2 and calprotectin were not influenced by dietary iron intervention alone, but 
were markedly lower in mice on the iron-deficient diet after infection. Furthermore, mice 
on the iron-deficient diet tended to have a lower grade of colon pathology and to gain 
more weight. Complementary experiments showed that iron-deprivation was associated 
with prolonged survival of the nematode Caenorhabditis elegans after infection with 
Salmonella enterica serovar Typhimurium and, importantly, that iron increased the 
pathogenicity of this pathogen. Together, these data show that iron limitation restricts 
disease pathology upon bacterial infection in two different animal models. However, our 
data also showed decreased intestinal inflammatory responses of mice fed on high-iron 
diets. Thus additionally, our study indicates that iron influences several processes at the 
intestinal host-pathogen interface and that the clinical outcome of oral iron administration 
is difficult to predict as this may highly depend on host iron status, immune status and the 
gut microbiota composition. 
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Iron deficiency is highly prevalent among the world and has major health consequences 
(Muthayya et al 2013, WHO and UNICEF 2004). Oral iron administration programmes 
can effectively correct iron deficiency (Zimmermann and Hurrell 2007), but concerns 
have been raised regarding the safety of iron supplementation as there is evidence 
suggesting that untargeted oral iron supplementation in regions with high prevalence of 
malaria transmission and infectious diseases can cause an increase in infections, hospital 
admission and mortality in young children (Oppenheimer 2001, Sazawal et al 2006, WHO 
and UNICEF 2006). This might be at least partly ascribed to iron also being an essential 
requirement for the growth of most bacterial species (Andrews et al 2003). Importantly, 
iron uptake by the upper intestine is generally limited (Hurrell and Egli 2010), which results 
in a large fraction of unabsorbed iron entering the colon, being potentially available for 
the gut microbiota. It is therefore not surprising that iron has been shown to influence the 
gut microbiota composition in a number of studies, among which were two studies among 
African children and infants which showed that iron fortification caused a potentially more 
pathogenic gut microbiota profile (Jaeggi et al 2014, Kortman et al 2014, Zimmermann et 
al 2010) (Chapters 1 & 2). 
In the past few years it thus became apparent that supplementary iron can have a large 
impact on the gut microbiota composition, but the potential effects on host immune 
responses remained largely unexplored. Given the importance of the gut microbiota in 
shaping the host intestinal immune system (Hooper et al 2012) this issue however deserves 
further investigation as dietary iron could have an indirect effect on the responsiveness of 
the immune system via alteration of the gut microbiota (Cherayil et al 2011). Furthermore, 
host iron metabolism is largely intertwined with host immunity and it is known that host 
iron status affects the inflammatory response to pathogenic invaders (Cherayil 2010). 
We previously showed that the dysregulated iron metabolism in a mouse model of type 
I hemochromatosis resulted in an attenuated host immune response against Salmonella 
enterica serovar Typhimurium in the gastrointestinal tract (Wang et al 2008). Importantly, 
also iron deficiency is associated with an impaired immune response, but may remarkably 
increase the resistance against intracellular pathogens, probably due to increased nutritional 
immunity (Oppenheimer 2001, Puschmann and Ganzoni 1977, Weiss 2005). 
As iron status can affect the immune response it is likely that also the array of antimicrobial 
defenses that is secreted from the intestinal mucosa gets affected. Enterocytes and Paneth 
cells secrete antimicrobial peptides (AMPs) such as defensins, cathelicidins and lipocalin-2 
(a.k.a. neutrophil gelatinase-associated lipocalin (NGAL) or siderocalin). Lipocalin-2 is a 
molecule of our special interest as it is involved in host iron homeostasis and because it can 
prevent bacterial iron uptake via iron-scavenging siderophores, which they produce under 
iron-limiting conditions (Philpott 2010). The importance of lipocalin-2 based defense 
is demonstrated by a study showing that lipocalin-2 knockout mice had an increased 
susceptibility to bacterial infection (Liu et al 2013). In the intestine, lipocalin-2 is only weakly 
expressed under normal conditions, but increases markedly during intestinal inflammation 
mainly due to the influx of neutrophils which secrete large amounts of lipocalin-2 (Blaschitz 
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and Raffatellu 2010, Cowland and Borregaard 1997, Nielsen et al 1996, Raffatellu et al 2009). 
The effects of supplementary iron have not yet been investigated during gastroenteritis 
caused by a bacterial pathogen in an animal model. This is now warranted as the last few 
years it became apparent that intestinal inflammation can be exploited by specific enteric 
pathogens, such as Salmonella spp. and Citrobacter spp., a process leading to dysbiosis 
(Winter and Baumler 2011) and which may be influenced by supplementary iron (Kortman 
et al 2014) (Chapter 1). To get more insight in the effects of iron during gastroenteritis we 
here for the first time examined the effects of dietary iron depletion and supplementation 
on the mouse gut microbiome and on intestinal immunity and pathology. We focused on the 
expression of intestinal lipocalin-2, which may be affected either through direct effects of 
iron on mammalian cells or indirectly through an altered gut microbiota. To investigate the 
effects of these iron-related modulations on the outcome during gastroenteritis we orally 
challenged mice with the mouse pathogen Citrobacter rodentium. This well-established 
model for infectious gastroenteritis closely mimics the pathology caused by human food-
borne bacterial pathogens (Borenshtein et al 2008, Mundy et al 2005, Mundy et al 2006). 
We show that mice on an iron-deficient diet as well as mice on a high-iron supplemented 
diet showed a decrease in fecal lipocalin-2 levels during intestinal inflammation, which 
may have result in impaired host defense against siderophilic pathogens in these mice. We 




Animals, iron diets and Citrobacter rodentium challenge 
The mouse trials were performed in four separate experiments, allowing the analysis of 
an increased number of different parameters. For all experiments, female, 4-6 weeks old 
C57BL/6 mice from Jackson Laboratories were group-housed and placed on diets with 
different concentrations of iron (iron-deficient, normal-iron, and high-iron). The iron-
deficient diet (Harlan laboratories) contained 2-6 mg of iron per kg chow. The normal-
iron diet (control diet; 45 mg/kg iron) was either obtained pre-prepared from Harlan 
(experiments 1-3), or was prepared by adding ferrous sulfate to the iron-deficient diet to give 
a total of 45 mg/kg iron (experiment 4). To obtain the high-iron diet, enough ferrous sulfate 
was added to either the pre-prepared normal-iron diet (experiments 1-3) or iron-deficient 
diet (experiment 4) to provide a total of 225 mg iron per kg chow. Mice in experiments 1 
(n=3 per group) and 2 (n=3-4 per group) were placed on the iron diets for 2 weeks after 
which they were euthanized to investigate the local and systemic effects of dietary iron 
intervention alone. For animals in experiment 3 (n=5 per group) and experiment 4 (n=5 
per group) these two weeks were followed by a challenge with C. rodentium (strain DBS100; 
from the American Type Culture Collection) through oral gavage. To this purpose, bacteria 
were grown overnight in Luria broth (LB) and resuspended in PBS before administration 
to the mice (0.2 mL/mouse; ~5*108 CFUs). Diets were continued during infection. Body 
weights were monitored during the course of infection and stool samples were sampled at 
appropriate time points. Animals were euthanized 2 weeks after starting the C. rodentium 
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challenge after which colon, liver, spleen, serum/plasma and fecal samples were collected 
for several analyses. The design of these experiments is depicted in Figure 1.
Colon histopathology
At necropsy, the entire colon was removed and flushed gently with PBS. An approximately 
0.5 cm long piece was excised from the junction of the middle and distal thirds of the 
colon, placed in a tissue mould containing Tissue-Tek Cryo-OCT compound (Thermo 
Fisher Scientific, Waltham, MA) and quick frozen in liquid nitrogen. Five µm sections were 
cut on a Leica CM1850 cryostat (Leica Biosystems, Buffalo Grove, IL) and stained with 
hemotoxylin and eosin following standard protocols. The severity of C. rodentium-induced 
colitis was examined in a blinded fashion by two independent investigators, and graded 
using a histopathological scoring system (more severe colitis is indicated by a higher score) 
as published previously (Chen et al 2005). 
Iron measurements
Description available in the Supplementary materials and methods.
Figure 1. Trial profile.
Mouse trials which were performed in four separate experiments. 4-6 weeks old , female, C57BL6 mice in 
experiment 1 (n = 3 per group) and 2 (n = 3-4) were sacrificed after 14 days of dietary iron intervention and 
were analyzed for serum / stool / tissue iron content, or lipocalin-2. Mice in experiment 3 (n = 5) and 4 (n 
= 5) were orally infected with C. rodentium, while the diets were continued for another 14 days. Samples 
were analyzed for stool / tissue iron content, hepcidin, lipocalin-2, calprotectin, or colon histopathology. Gut 




Fecal and plasma/serum lipocalin-2
Lipocalin-2 levels were quantified in stool and plasma/serum samples using the Duoset 
murine Lcn-2 ELISA kit (R&D Systems) with the following adaptations. The capture 
antibody and detection antibody were used at a concentration of 2 µg/mL and 250 ng/
mL respectively. Serum and plasma were 2000 times diluted in reagent diluent (1.0% BSA 
in PBS). Fecal samples were reconstituted in 250 µL PBS containing 0.1% Tween 20 (100 
mg/mL) and protease inhibitors (Complete Mini cocktail tablets, Roche). Samples were 
vortexed for 20 min at 4°C to obtain a homogenous suspension. Debris was pelleted and 
the supernatant was stored at -80°C until use. Samples were measured in a 50-2000 times 
dilution. Protein concentrations in the fecal samples were estimated by using the PierceTM 
BCA Protein Assay Kit (Thermo Scientific) and lipocalin-2 levels were normalized for total 
protein content. Lipocalin-2 levels in plasma/serum samples were expressed as ng/mL.
Fecal calprotectin
Protein from mouse fecal samples was extracted as described for Lipocalin-2 ELISA and a 2 
times diluted extract was applied to the S100A8/S100A9 ELISA Kit (Immundiagnostik AG) 
according to the manufacturer’s instructions. Calprotectin levels were normalized for total 
protein content.
Colon cytokine secretion
At necropsy, the entire colon was removed and flushed gently with PBS. An approximately 
0.5 cm long piece was excised from the junction of the middle and distal thirds of the colon, 
placed in 1 mL of complete Dulbecco’s Modified Eagle Medium with 10% heat-inactivated 
fetal bovine serum, and incubated overnight at 37°C in a tissue culture incubator. The 
supernatants were collected and used to estimate IL-6, IL-17 and TNFα concentrations by 
ELISA using the relevant Duo-set capture and detection antibodies (R&D Systems). The 
colon tissue was homogenized in lysis buffer containing 1% Triton X-100 in 10 mM Tris-
HCl, pH 8.0; 150 mM NaCl and the protein concentrations of the homogenates used to 
normalize the cytokine concentrations. 
Hepcidin quantification
Hepcidin-1 (Hep-1) levels in mouse serum/plasma samples from C. rodentium-infected 
mice that were held on different iron diets and reference Hep-1 values from an independent 
group of (uninfected) C57BL/6 mice fed on a standard diet were determined as described 
previously by a combination of hydrophobic extraction and time-of-flight mass spectrometry 
(TOF MS) using a synthetic internal standard (rabbit Hep-25; Peptides International) 
for normalization (Tjalsma et al 2011). Peptide spectra were generated on a Microflex 
LT matrix-enhanced laser desorption/ionisation TOF MS platform (Bruker Daltonics). 
Mouse Hep-1 levels were expressed in nM relative to the known concentration of the 
internal standard. 
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Fecal DNA was extracted by using the FastDNA® SPIN Kit for Feces (Mpbio) according to 
the manufacturer’s instruction but with the following adaptations. The fecal pellets were 
resuspended in 500 µL of sodium phosphate buffer, after which the sample was transferred 
to the lysing matrix. Lysis by bead-beating was performed in a MagNa Lyser instrument 
(Roche) for 2 times 20 sec at 6500 rpm.
Mouse gut microbiome 16S rRNA pyrosequencing
Mouse fecal microbiomes were determined at baseline, at 13 days (before infection) and at 
27 days (after infection; end point). Pyrosequencing was performed as described previously 
(Jaeggi et al 2014), (Chapter 2) with the exception that all barcoded amplicons were 
separately purified by using the Purelink Purification kit (Invitrogen), before pooling them. 
The amplicon pool was submitted for pyrosequencing of the V3-V4 region of the 16S rRNA 
gene on the 454 Life Sciences GS-FLX+ platform using Titanium sequencing chemistry 
(GATC-Biotech, Germany).
Quantitative real-time PCR to determine fecal C. rodentium abundance
qPCR of C. rodentium was performed as follows. The PCR amplification mixture contained 
1 µL fecal DNA, 1 µL forward primer, 1µL reverse primer, 10 µL of Power SYBR® green 
PCR Master Mix (Applied Biosystems) and 7 µL of sterile water (total volume 20 µL). PCR 
conditions were: 95°C for 10 min followed by 40 cycles of 95°C for 15 sec and 60°C for 60 
sec. The quantification of C. rodentium was normalized for total bacteria in the sample. 
qPCR for total bacteria was performed according to the same protocol with the exception 
that a 100-fold dilution of the fecal DNA was used. Primers for the detection of C. rodentium 
were Sig70S: TCCAGCGTAGAGTCCGAAATC and Sig70A: TGCCCATTTCGCGCATAT 
(Cordone et al 2005) and for total bacteria P891F: TGGAGCATGTGGTTTAATTCGA and 
P1033R: TGCGGGACTTAACCCAACA (Yang et al 2002).
Nematode viability assay
For nematode infection assays, Caenorhabditis elegans glp-4(bn2) sek-1(km4), a pathogen-
sensitive strain with temperature-sensitive sterility (ref Moy et al., 2006) was maintained 
at 15°C on nematode growth medium, using E. coli DH5α (Life Technologies Inc.) as a 
source of food. Nematodes were age-synchronised by isolating eggs through treatment with 
hypochlorite/NaOH, and L1 hatchlings were deposited on lawns of E. coli DH5a grown on 
NGM agar. Plates were incubated at 25°C (at this temperature adult nematodes of the strain 
used do not produce any progeny), and when the nematodes reached the L4 stage they were 
collected from the plates and washed at least three times using M9 buffer (3 g/L KH2PO4, 
6 g/L Na2HPO4, 5 g/L NaCl and 0.25 g/L MgSO4·7H2O). Agar plates of Iscove’s Modified 
Dulbecco’s Medium (does not contain iron in its formulation) (IMDM, Invitrogen) were 
prepared as follows. Firstly, IMDM medium was briefly warmed to 45°C and mixed with 
5% (in water) melted ultra pure agar (Difco Noble Agar) that was cooled to 45°C, to give 
a final concentration of 1.2% agar. Ferric ammonium citrate to final concentrations of 0, 
1, 10 or 100 µmol/L were added and plates (55 mm) were poured immediately. Cultures 
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of S. Typhimurium NTB6 (Kortman et al 2012) or E. coli DH5α were grown in IMDM 
medium with 0.5 µmol/L ferric ammonium citrate until the end of the exponential growth 
phase. 10 µl of these cultures was used to seed the IMDM-agar plates, which were then 
incubated for 18 hours at 37°C. 30-40 L4 stage nematodes were deposited on the lawns of 
S. Typhimurium or E. coli DH5α. 5 plates were used for each iron concentration. Survival 
of nematodes during co-incubation was scored regularly during 13 days and was expressed 
as the LT50 (defined as the time to kill 50% of the population) and the area under the curve 
(AUC) was determined as another measure for survival time. Observations were carried 
out using a standard dissecting microscope; nematodes were scored as dead when they 
lost their normal sigmoidal shape and failed to move in response to gentle touch with a 
platinum wire. Viability of the bacterial lawns was not affected by iron concentration (data 
not shown).
Statistics and data representation
Analysis of mouse responses and nematode survival
To compare means, one-way ANOVA with Tukey’s post-hoc test (to compare all means) 
or with Bonferroni’s post-hoc test (for comparison of selected means) was performed. To 
analyze the effect of dietary iron intervention and intestinal infection on body weights, 
the area under the curve (AUC) for each mouse was determined, after which groups were 
compared as described above. The correlation between fecal lipocalin-2 and calprotectin 
levels was assessed by Pearson correlation test and linear regression was used to plot the 
best-fit line (with 95% confidence interval). Statistical tests were performed using GraphPad 
Prism version 5.03 for Windows, GraphPad Software, San Diego California USA. P-values 
< 0.05 were considered statistically significant and P-values < 0.10 were considered as an 
important significance level. 
Analysis of 16S rRNA pyrosequencing data
Pyrosequencing data were analyzed with a workflow based on QIIME v1.2 (Caporaso 
et al 2010) using settings as recommended in the QIIME 1.2 tutorial, with the following 
exceptions: reads were filtered for chimeric sequences using Chimera Slayer (Haas et 
al 2011). OTU clustering was performed with settings as recommended in the QIIME 
newsletter of December 17th 2010 (http://qiime.wordpress.com/2010/12/17/new-default-
parameters-for-uclust-otu-pickers/) using an identity threshold of 97%. Diversity metrics 
were calculated as implemented in QIIME 1.2. Hierarchical clustering of samples was 
performed using UPGMA with weighted UniFrac as a distance measure as implemented in 
QIIME 1.2. The RDP classifier version 2.2 was performed for taxonomic classification (Cole 
et al 2009). Multivariate redundancy analysis (RDA) was done using Canoco 5.0 (Ter Braak 
and Smilauer 2012), using default settings of the analysis type “Constrained-supplementary”. 
Visualization of differences in relative abundance of taxa between different study groups 
was done in Cytoscape (Shannon et al 2003). Statistical analysis of the pyrosequencing data 
was done with SciPy (www.scipy.org). Differences in relative abundance between groups at 
a single time point (cross-sectional) were compared by Mann-Whitney U (MWU) testing. 
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Medians of phylogenetic diversity were compared by Kruskal-Wallis test with Dunn’s 
post test (GraphPad Prism version 5.03). The effects of iron on the microbiome were 
compared among the single conditions, but also as pools as described above. P-values for 
the microbiome data were not corrected for multiple testing as they were analyzed in an 
explorative manner.
Ethics Statement 
All mouse studies were carried out in accordance with the recommendations in the Guide 
for the Care and Use of Laboratory Animals of the National Institutes of Health. The 
protocol was reviewed and approved by the Institutional Animal Care and Use Committee of 
Massachusetts General Hospital (protocol number 2008N000061, animal welfare assurance 
number A3596-01). 
Results
Systemic and local responses to dietary iron intervention
Effects of dietary iron intervention on systemic and intestinal parameters
Previous studies have shown that the intestinal infection after ingestion of C. rodentium 
by mice closely mimics human colitis caused by food-borne bacterial pathogens, such as 
enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC respectively) 
(Borenshtein et al 2008, Mundy et al 2005, Mundy et al 2006). Here we used this mouse 
model to investigate the effect of dietary iron levels on disease pathology by first placing 
mice for 14 days on diets with three different iron levels (deficient, normal, high) (Figure 
1). During this period, body weight as a measure for general health was similar for all 
three groups (Figure 2). Also serum iron (Supplementary Figure 1A) and serum lipocalin-2 
levels (Figure 3A) were not different among groups. Furthermore, fecal lipocalin-2 and 
calprotectin levels were not different in the three groups (Figure 3B-D). In contrast, fecal 
iron concentrations and liver/spleen iron levels were significantly different among the 
three groups at day 14 (Supplementary Figure 1B-C), showing that the iron diets were, as 
expected, effective in changing luminal iron concentrations as well as body iron stores. 
Together, these data show that the iron-deficient and the high-iron dietary interventions 
for 2 weeks changed luminal iron content and body iron stores, but also indicate that there 
was no clear effect on intestinal and general health at this point.
Effects of dietary iron intervention on the gut microbiome composition
In total, 214,520 bacterial 16S rRNA sequences were analyzed by pyrosequencing. At 
baseline, the mouse gut microbiome consisted of the phyla Bacteroidetes (71.2% of the 16S 
rRNA reads), Firmicutes (27.3%), Tenericutes (0.8%) and Actinobacteria (0.6%). After 2 
weeks of dietary intervention the phylogenetic diversity index (a measure of α-diversity) 
was decreased in the iron-deficient group compared to baseline (p < 0.05). The same effect 
was observed in the high-iron group, although not significantly different from baseline, the 
diversity was lower in the high-iron group compared to the normal-iron group at day 13 (p 
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Figure 3. Lipocalin-2 and calprotectin levels in uninfected and infected mice.
Systemic lipocalin-2 levels in uninfected mice of experiment 1 (serum), or in infected mice of experiments 3 
(serum) and 4 (plasma) are depicted in panel A. Fecal lipocalin-2 levels in uninfected mice of experiment 3 (day 
13), or in infected mice of experiment 3 and 4 (day 27) are depicted in panel B and C respectively. Note, the 
different scale of the y-axis in these panels. Panel D shows fecal calprotectin levels in uninfected (day 13) and 
infected (day 27) mice of experiment 4. The (Pearson) correlation between fecal calprotectin and lipocalin-2 
levels in mice of experiment 4 (day 13 and day 27), plotted by linear regression (best-fit line with 95% confidence 
interval), is shown in panel E. # p < 0.1; * p < 0.05; ** p < 0.01; *** p < 0.001. Solid lines indicate comparisons with 
significant outcome between dietary groups at one time point. Dashed lines indicate significant comparisons 
between uninfected and infected mice (only mice of the same dietary intervention group were compared).
Figure 2. Body weight of the mice during the time 
course of the experiment.
Body weights (mean ±SE) of mice in experiment 4 (n 
= 5) were monitored during 28 days. Until infection 
at day 14 (indicated by the arrow) body weights were 
similar, but tended to differ among the dietary groups 
after infection.
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< 0.05) (Supplementary Figure 2). Multivariate Redundancy Analysis (RDA) shows that the 
gut microbiome of mice at baseline was similar for all dietary iron groups (p = 0.422), as 
expected. Clearly, after two weeks of dietary iron intervention, the mice had a distinct non-
overlapping gut microbiome composition (p = 0.002)(Figure 4A). Hierarchical clustering 
analysis clearly clustered the baseline microbiomes together and separated them from the 
later time points (Figure 5). It also showed that the microbiome of the mice on the high-iron 
diet had most extensively changed. The most prominent change appeared to be the shift 
from a Barnesiella dominated profile to an Allobaculum dominated profile.
Next the relative abundances of all detected bacterial taxa among groups at day 13 were 
compared in an explorative manner. The overall main differences between diets with a 
higher iron level compared to diets with a lower iron level were an increased abundance of 
Clostridium and a lower abundance of Dorea (Figure 6). Although the normal-iron group 
did not show a lower abundance of Lactobacillus and Bifidobacterium compared to the iron-
deficient group, in the high-iron group there was a consistent relative lower abundance 
of these taxa compared to the iron-deficient and normal-iron groups. Furthermore, 
Peptococcus, Bacteroides and Allobaculum were consistently more abundant in the high-iron 
group (Figure 6), which is also indicated by multivariate RDA (Figure 4B).
Figure 4. Multivariate redundancy analysis (RDA) of the microbiota composition. 
RDA was performed using Canoco 5.0. Taxonomic composition at the genus level was used as response data 
and dietary iron groups over time as explanatory variable. Triangles represent dietary iron intervention groups 
at day 1, 13 and 27 (experiment 4). Other symbols are the individual samples, which are connected with lines 
to form envelopes of the same group. Length of arrows reflects significance. A: Classified sample diagram. B: 
Taxa – metadata biplot. To test the significance of the links between dietary intervention and sample clustering, 
separate RDAs were done for each individual time point. Clustering by treatment was not significant at baseline 
(p = 0.422), while they significantly differed at day 13 (p = 0.002) and at day 27 (p = 0.002). 
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Responses to intestinal bacterial infection during dietary iron intervention
Effects of dietary iron intervention and colitis on the gut microbiome composition
As mentioned above, the phylogenetic diversity index decreased over time in all groups. 
This was strongest for the high-iron group, which ended up significantly lower at day 27 
compared to the iron-deficient group (p < 0.05) (Supplementary Figure 2). This analysis 
shows that during infection mice that were held on the iron-deficient diet were able to 
maintain part of their gut microbial diversity. Hierarchical clustering analysis roughly 
grouped the normal-iron and the high-iron group together at day 27, while it separated these 
groups from the iron-deficient group at day 27, which clustered more close to the baseline 
situation (Figure 5). It also indicates that the microbiomes of the mice on the normal-iron 
and high-iron diets had most extensively changed. Again, the most prominent change was 
a shift from a Barnesiella dominated profile to an Allobaculum dominated profile. The 
microbiome of the mice on the iron-deficient diet also changed and was dominated by 
Parabacteroides at day 27. The difference in gut microbiome composition among groups at 
day 27 is strongly supported by the RDA, which shows that the dietary iron intervention 
caused a distinct non-overlapping gut microbiome profile (p = 0.002). Additionally, the 
gut microbiome profile of each group at day 27 appeared not to overlap with the groups at 
day 13 (Figure 4A). Together, these analyses show that dietary iron had a large impact on 
the mouse gut microbiome, especially during intestinal inflammation. In the subsequent 
paragraph the differences among groups in both the dominant and subdominant taxa are 
shown.
To reveal differences, the relative abundances of all detected bacterial taxa were compared 
among groups at day 27 in an explorative manner. After infection, main differences were 
a higher abundance of Allobaculum and Enterorhabdus in the normal/high-iron groups 
compared to the iron-deficient group (p = 0.005 and p = 0.004 respectively for both the 
normal-iron and high-iron groups vs the iron-deficient group). In addition, in the high-
iron group a higher abundance of Bacteroides was found compared to both the iron-
deficient and the normal-iron groups (p = 0.004 for both). For the taxa Bifidobacterium, 
Lactobacillales/Lactobacillus and Parabacteroides we consistently found a lower abundance 
in all comparisons, meaning that that their abundance was lower in the normal/high-iron 
groups compared to the iron-deficient group, as well as in the high-iron group compared 
to the normal-iron group (Figure 7). Multivariate RDA also generally associates the taxa 
mentioned in this paragraph with the respective dietary iron groups (Figure 4B).
The course of C. rodentium infection during dietary iron intervention
Citrobacter was lowly abundant relative to all 16S rRNA reads at day 27, but was not detected 
at all in samples from baseline and day 13 by pyrosequencing. We therefore performed a 
qPCR specific for C. rodentium to be able to quantify this low-abundant pathogen which 
initiated the intestinal inflammation. As expected, this analysis showed that there was much 
more C. rodentium present in the stools at day 27 compared to baseline and day 13 (approx. 
1*105 fold difference), but there were no differences observed among the dietary groups 
(data not shown). This suggests that in vivo C. rodentium colonization was not influenced 
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by the iron diets at this point, although differences may have existed at an earlier time point 
after infection, which was not assessed in this study. 
The body weights of mice tended to differ rapidly after initiation of infection at day 14 
among groups (p = 0.085) (Figure 2). Interestingly, mice on the iron-deficient diet seemed to 
recover most quickly as only this group had at day 28 an average body weight that was above 
that of the day of infection, while mice on a diet with normal iron content tended to suffer 
most from the colitis. Like uninfected mice fed on the iron diets for 2 weeks, also infected 
mice fed on the diets for 4 weeks had altered tissue iron stores (Supplementary Figure 1D).
Histological examination of colon sections at day 28, showed a non-significant tendency 
towards a lower average histopathology score for mice on the iron-deficient diet compared 
to the normal and high-iron diets, with a large within-group variation (Figure 8A). Notably, 
this observation could fit with the observation that mice on the iron-deficient diet appeared 
to suffer less from the colitis as indicated by the outcome on body weights. However, based 
Figure 5. Hierarchical microbiome clustering of the dietary groups over time.
The microbiomes of fecal samples at day 1, day 13 and day 27 (experiment 4) were clustered using UPGMA 
with weighted UniFrac as a distance measure. The figure was generated using iTOL (Letunic and Bork 2011). 
Sample names with the same color are within the same dietary group at the same time point. Colored bars 
represent the relative abundance of a bacterial genus (the number of reads assigned to a genus divided by the 
total number of reads assigned up to the phylum level) in the sample. Mice within a group had no individual 
ID (indicated as `x`).
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Figure 6. Effect of 2 weeks dietary iron 
intervention on the microbiome of uninfected 
mice.
Nodes represent taxa; edges link the different 
taxonomic levels. The fold difference after 13 
days of dietary intervention is calculated as the 
2log of the ratio of the relative abundance in 
the iron-deficient and normal-iron conditions 
(A) or in the iron-deficient and high-iron 
conditions (B) or in the normal-iron and 
high-iron conditions (C) (0 = no difference 
between groups, 1 = twice as abundant, etc.). 
In this explorative analysis, the significance is 
expressed as the p value of a Mann-Whitney U 
test. The node-size corresponds to the relative 
abundance. Taxa (that is, nodes) were included 
in this visualization when the fold difference 
met a significance level of p < 0.1 and when 
the relative abundance was > 0.05%, or when 
the taxon had a child (that is, more specific 
taxonomic classification) meeting this criterion. 
1 These taxa were not detected in one of the 
dietary groups and have therefore an estimated 
2log fold difference of 10.
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Figure 7. Combined effect of dietary iron and 
intestinal inflammation on the mouse gut 
microbiome.
Nodes represent taxa; edges link the different 
taxonomic levels. The fold difference between 
groups at day 27 is calculated as the 2log of 
the ratio of the relative abundance in the 
iron-deficient and normal-iron conditions 
(A) or in the iron-deficient and high-iron 
conditions (B) or in the normal-iron and 
high-iron conditions (C) (0 = no difference 
between groups, 1 = twice as abundant, etc.). 
In this explorative analysis, the significance is 
expressed as the p value of a Mann-Whitney 
U test. The node-size corresponds to the 
relative abundance. Taxa (that is, nodes) 
were included in this visualization when the 
fold difference met a significance level of p 
< 0.1 and when the relative abundance was 
> 0.05%, or when the taxon had a child (that 
is, more specific taxonomic classification) 
meeting this criterion. 
1 These taxa were not detected in one of 
the dietary groups and have therefore an 
estimated 2log fold difference of 10.
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on the body weights, mice on a normal-iron diet seemed to suffer more from colitis than 
mice on the high-iron diet, something which is not evident from the histopathological 
examination.
Intestinal responses to C. rodentium challenge during dietary iron intervention
Colon pro-inflammatory cytokine production ex vivo
To evaluate the effects of intestinal infection during dietary iron intervention on the 
intestinal cytokine response, colon sections were sampled at day 28 (14 days after C. 
rodentium challenge) and ex vivo secreted levels of IL-6, TNF-α and IL-17 were measured 
by ELISA. Figure 8B shows that secreted levels from animals on the iron-deficient diet were 
lowest for all three pro-inflammatory cytokines. For IL-17 this was significantly different 
from the normal-iron diet (p < 0.01), but secreted IL-17 was also significantly lower in the 
high-iron group (p < 0.05). Secreted IL-6 levels showed a similar tendency. TNF-α tended 
to increase with increasing amounts of iron in the diet (not significantly), but the sum 
of the three pro-inflammatory cytokines per mouse showed the same trend as for IL-6 
and IL-17. The sum of secreted levels was different among groups (p = 0.040) and was 
significantly lower for the iron-deficient diet compared to the normal-iron diet (p < 0.05) 
(Supplementary Figure 3). Together, these findings suggest that the intestinal cytokine 
response is about maximum at normal dietary iron levels, and which generally appears 
diminished at both low and high dietary iron levels. 
Fecal lipocalin-2 and calprotectin levels upon intestinal inflammation
ELISA measurements of lipocalin-2 in feces showed that lipocalin-2 levels were low at day 
13, prior to infection. Lipocalin-2 levels were however markedly increased after infection at 
day 27, most prominently in the feces of mice on the normal-iron diet. After infection, fecal 
lipocalin-2 levels were significantly higher in the normal-iron group compared to both the 
iron-deficient and high-iron group (p < 0.01 and p < 0.05 respectively) (Figure 3C). 
Fecal calprotectin is a common and validated marker for intestinal inflammation (Kopylov 
et al 2014). We therefore measured fecal calprotectin next to fecal lipocalin-2, to examine 
whether the effect of dietary iron on lipocalin-2 levels were also found on calprotectin 
levels and to examine the grade of inflammation. Interestingly, like lipocalin-2 levels, fecal 
calprotectin levels were increased at day 27 compared to day 13 and most prominently in 
the normal-iron diet group, which was significantly different from the high-iron group (p 
< 0.05) (Figure 3D). Notably, although levels of lipocalin-2 were generally still higher in 
inflamed mice compared to non-inflamed mice, fecal calprotectin levels in inflamed mice 
on the high-iron diet were mostly not elevated compared to levels in non-inflamed mice. 
The similar response of lipocalin-2 and calprotectin is underscored by the finding that their 
fecal levels had a strong correlation (Pearson r = 0.50; p = 0.007) (Figure 3E). Together, these 
findings suggest that the intestinal inflammatory response was blunted in both the iron-
deficient and high-iron diets. 
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Figure 8. Colon histopathology and Ex vivo secretion of pro-inflammatory cytokines by mouse colon explants.
A) Histopathological score of colon sections of infected mice in experiment 3 (n = 3) and experiment 4 
(n = 4 - 5) at day 28.
B) Colon explants of infected mice (day 28) in experiment 4 (n = 3 - 5) that were on the different iron-diets and 
were challenged with C. rodentium, were incubated overnight in culture medium, after which secreted pro-
inflammatory cytokines IL-6, TNF-α and IL-17 were measured by ELISA. Cytokine levels were normalized for 
total colon protein. Levels (mean + SE) of IL-6 and TNF-α are on the left y-axis, and IL-17 levels on the right 
y-axis. Means without a common letter of the same cytokine differ significantly, p < 0.05.
Figure 9. Systemic hepcidin (Hep-1) levels in 
infected mice and uninfected reference mice.
Hepcidin levels in infected mice (day 28) in serum 
of mice in experiment 3 (n = 4 - 5) and in plasma 
of mice in experiment 4 (n = 5). Hepcidin levels in 
plasma of an independent group of (uninfected) 
control mice (C57BL/6 mice on a standard diet) 
were included to show reference Hep-1 levels in 
healthy mice (n = 7). * p < 0.05.
Figure 10. Survival of C. elegans decreases upon 
bacterial infection with increasing iron levels.
Survival of the nematode C. elegans, which was 
used as a simple in vivo gut model, was monitored 
during 13 days and the LT50 (defined as the time 
to kill 50% of the population) was determined. 
Whiskers are displayed with median and min 
to max. Whiskers without a common letter and 
representing nematode survival on S. Typhimurium 
differ significantly, p < 0.01.
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Systemic responses to C. rodentium challenges during dietary iron intervention
Analogous to the findings in feces, systemic lipocalin-2 levels were markedly higher in 
the infected mice at day 28 compared to uninfected mice at day 14 (Figure 3A). Intestinal 
inflammation thus induces production of lipocalin-2 which can be detected systemically. In 
addition, systemic lipocalin-2 levels were different among groups (p = 0.002) and highest in 
the mice on the normal-iron diet, which was significantly different from mice on the iron-
deficient diet (p < 0.05) (Figure 3A).
As mentioned above, the iron diets did not affect systemic iron levels. Systemic iron levels 
are mediated by the key iron-regulatory peptide hormone hepcidin (Hep-1 in mice), which 
blocks the ferroportin transporter in macrophages and the duodenum. Among others, 
hepcidin expression is regulated by host iron status and inflammation (Kroot et al 2011). 
We here aimed to assess the effect of dietary iron on Hep-1 induction by colitis. As shown 
in Figure 9, nearly all mice on the normal and high-iron diets had plasma Hep-1 levels that 
were clearly above those found in an independent group of uninfected reference control 
mice (Tjalsma et al 2011) on a standard diet (p < 0.05 for both comparisons), but were not 
markedly different from each other. In contrast, a subset of mice on the iron-deficient diet 
had very low Hep-1 levels that were just below the hepcidin levels found in uninfected 
control mice.
Iron limitation prolongs survival of Salmonella-infected nematodes
To confirm the potential protective effect of iron limitation on the pathology of enteric 
infection as observed in our mouse model, we investigated the effect of iron on the 
pathogenicity of the human gut pathogen S. Typhimurium in a live nematode gut model. 
This has previously been shown to be a suitable model host for S. Typhimurium infection 
(Labrousse et al 2000). Survival of C. elegans that forages on S. Typhimurium decreased 
in the presence of increasing concentrations of iron. This was reflected in the nematode 
survival time (LT50), which was on average decreased by 1.3 and 2 days in the 10 and 100 
µmol/L ferric ammonium citrate conditions respectively, compared to the no-iron condition 
(p < 0.01 and p < 0.001, respectively) (Figure 10). Furthermore, the AUCs of the survival 
curves of the conditions with 10 and 100 µmol/L ferric ammonium citrate were significantly 
lower compared to the no-iron condition over the course of the experiment (p < 0.05 and 
p < 0.001 respectively) (Supplementary Figure 4). At the same time this iron-dependency 
was absent when C. elegans foraged on a E. coli control strain. These data confirm a subtle, 
but reproducible, protective effect of low dietary iron intake on the pathology of enteric 
infection. Importantly, these data also confirm that iron can increase the virulence of an 
enteric pathogen as we previously showed in vitro (Kortman et al 2012) (Chapter 5). 
Discussion
It is well known that both oral iron administration and intestinal inflammation can alter the 
gut microbiota composition and that host iron status influences the inflammatory response 
(Kortman et al 2014) (Chapter 1). Furthermore, oral iron administration has been associated 
with increased levels of fecal calprotectin (indicating increased gut inflammation) and with 
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an increased incidence of diarrhea (Gera and Sachdev 2002, Jaeggi et al 2014, Zimmermann 
et al 2010). Nonetheless, little is known about the effects of nutritional iron on the gut 
microbiota composition and the host immunological response during periods of intestinal 
inflammation. We therefore investigated the effects of iron on pathology, gut microbiota 
composition and host intestinal immune responses in the non-inflamed and inflamed 
colon and we here for the first time show that dietary iron has profound effects on the gut 
microbiome composition and on the host immune response during colonic infection by 
common food-borne bacterial pathogens in a mouse model.
Although iron diets by themselves had clearly effect on luminal iron content and tissue 
iron stores as expected, we found no effects on general health as reflected by body weights 
and the immunological parameters lipocalin-2 and calprotectin that we measured at this 
point. Remarkably, there were profound effects on the gut microbiome composition. 
Compared to the composition at baseline, all dietary groups had a changed microbiota 
after 2 weeks, which can probably be explained by the change in diet at the start of the 
intervention. The gut microbiomes shifted towards an Allobaculum dominated profile, 
which was most apparent for the high-iron diet group. This group also showed a lower 
relative abundance of the beneficial Bifidobacteriaceae and Lactobacillaceae families 
compared to the normal-iron and iron-deficient diets, which is one of the most consistent 
findings of dietary iron intervention studies so far (Kortman et al 2014) (Chapter 1). As 
expected, C. rodentium challenge clearly resulted in colonic inflammation as observed by 
colon histopathology and determination of the inflammatory parameters lipocalin-2 and 
calprotectin. Dietary iron intervention had limited effect on the grade of inflammation as 
determined by histopathological examination. However, there appeared to be a minor trend 
towards a higher grade of inflammation with supplementary iron. This fits with previous 
studies showing that supplementary iron during IBD exaggerates colitis in animals and 
gastrointestinal complaints in IBD patients (Carrier et al 2006, Lee et al 2012, Reifen et 
al 2000, Seril et al 2002, Zhu et al 2010). Our experiments also indicate that mice on the 
iron-deficient diet suffered slightly less from the colitis compared to the other groups as 
reflected by mouse body weights. Interestingly, previous studies showed that non-infected 
rats on an iron-deficient diet for 5 weeks gained less weight and ate less, while also mice on 
an iron-deficient diet had a lower body weight compared to control mice after 12 weeks of 
intervention (Dostal et al 2012, Tompkins et al 2001). This suggests that an iron-deficient 
diet in a non-inflamed situation tends to decrease weight gain on the longer term, while it 
may prevent weight loss during intestinal inflammation.
Another systemic effect of the colonic inflammation was an increase in hepcidin levels. 
Importantly, several infected mice on the iron-deficient diet had lower hepcidin levels 
compared to uninfected reference mice. These findings are in-line with previous human 
studies showing that severely anemic infants and children in Africa with elevated 
inflammatory markers did not always have concurrent elevated hepcidin levels (Jaeggi et 
al 2013, Jonker et al 2013). This suggests that also in mice, a threshold body iron level 
is required for a physiological Hep-1 upregulation upon intestinal infection. If body iron 
levels are below this threshold, the iron demand, which asks for low hepcidin, renders these 
animal non-responsive to the infection stimulus. Analogous to hepcidin, lipocalin-2 has 
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a role in iron homeostasis and is involved in innate immunity by withholding iron from 
bacterial pathogens (Malyszko et al 2010). Iron withholding by lipocalin-2 is established 
by the direct sequestering of iron-containing bacterial siderophores, for example in the 
gut lumen (Kortman et al 2014) (Chapter 1). It is known that systemic lipocalin-2 levels 
are elevated in patients with IBD, but the origin of circulating lipocalin-2 is not clear and 
could be attributed to the activation of both local and distant immune cells (Cayatte et al 
2012, Janas et al 2014, Oikonomou et al 2012). Notably, levels of lipocalin-2 (secreted by 
intestinal epithelial cells and infiltrating immune cells) have also been shown to increase 
in the inflamed gut (Chassaing et al 2012, Nielsen et al 1999, Vijay-Kumar et al 2007). It 
has therefore been suggested that fecal lipocalin-2 can be used as a non-invasive marker 
for gut inflammation (Chassaing et al 2012). Remarkably, our study shows that both the 
iron-deficient diet and the high-iron diet lowered lipocalin-2 production compared to the 
normal-iron diet and that the effects were very similar on the local and systemic level. 
Fecal calprotectin has been known as a marker for gut inflammation for a long time (Berni 
Canani et al 2004, Kopylov et al 2014) and contributes to innate immunity by binding of zinc 
and manganese, hereby preventing uptake of these micronutrients by bacteria (Hood and 
Skaar 2012). We here show that the calprotectin response of infected mice on the high-iron 
diet was blunted, which was in line with fecal lipocalin-2 levels. As the histopathological 
score of these mice appeared not to be lower, these findings suggest that calprotectin and 
lipocalin-2 as a marker for gut inflammation may be less reliable during the provision 
of a high-iron-supplemented diet. The lower levels of these inflammatory markers may 
also indicate a reduced innate immune defense. From a functional point-of-view, the 
consequences of lower lipocalin-2 levels during high-iron conditions might be limited as 
it is likely that no or less siderophores are produced by intestinal pathogens in that case. 
In contrast, during iron-limiting conditions, when there likely is siderophore production, 
it may be advantageous to intestinal pathogens that lipocalin-2 levels are lower. Notably, 
certain intestinal pathogens can exploit the host lipocalin-2 and calprotectin based defense 
to their own benefit (Liu et al 2012, Raffatellu et al 2009). It may be envisaged that lower 
levels of lipocalin-2 and calprotectin abate these exploitation mechanisms. This is however 
subject for further investigations.
It is difficult to explain why both the iron-deficient diet and the high-iron diet lowered 
lipocalin-2 production compared to the normal-iron diet. We hypothesized that local 
lipocalin-2 production could be influenced by a combination of luminal iron concentration 
and bacterial siderophore production as it would make sense that expression of lipocalin-2 
is highest when readily available iron is low and when siderophores are being produced. 
This does however not fit with the lower levels of lipocalin-2 in the iron-deficient group 
compared to the normal-iron group. In addition, pro-inflammatory cytokine secretion 
and fecal calprotectin levels generally showed the same trend, pointing at a more general 
mechanism. As already mentioned, both host iron deficiency and iron overload have been 
associated with an attenuated immune response (Oppenheimer 2001, Puschmann and 
Ganzoni 1977, Wang et al 2008, Weiss 2005) and it might thus very well be that the iron 
status of mice contributed to a decrease in levels of pro-inflammatory cytokines, lipocalin-2 
and calprotectin. Other explanations could lie in the effects of dietary iron and host iron 
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status on the gut microbiome and whether C. rodentium and other intestinal pathogens were 
able to thrive in the intestinal lumen and trigger the host immune response. Interestingly, it 
has recently been described that the gut microbiota composition is an important factor in 
the susceptibility to C. rodentium infection and the subsequent immune response (Collins 
et al 2014).
After 2 weeks of infection, C. rodentium abundance in the feces was not different among 
groups, but we cannot exclude that earlier during infection C. rodentium thrived best in the 
colonic lumen of mice on the normal-iron diet. We nevertheless found profound effects of 
dietary iron and colitis on the gut microbiome composition, which may have contributed 
to the effects on the host inflammatory response. Of note, Enterorhabdus virtually only 
appeared after infection and its relative abundance was highest in the normal-iron group, in 
which also fecal lipocalin-2 and calprotectin levels were highest. Although further research 
to a potential causal relationship is needed, it could imply that Enterorhabdus spp., of which 
little is known, contributed to the effects on the host inflammatory response. It may be 
hypothesized that the gut microbiome profile of the mice on the iron-deficient diet was 
potentially less pathogenic compared to the diets with iron as the relative abundance of the 
beneficial Bifidobacteriaceae and Lactobacillaceae was highest in the iron-deficient group. 
It has previously been shown that C. rodentium infection in mice caused a temporal increase 
in the relative abundance of Enterobacteriaceae (of which C. rodentium itself is a member) 
1 week after initiation of infection, with a decrease to 2 weeks after infection (Lupp et 
al 2007). However, a later study could not confirm this temporary generalized bloom of 
Enterobacteriaceae in the intestinal lumen, possibly due to a different microbiota profile 
prior to infection and the provision of different diets (Hoffmann et al 2009). In the present 
study, we only analyzed the fecal gut microbiome 2 weeks after initiation of infection and 
found a very low relative abundance of Enterobacteriaceae. These were however exclusively 
detected after infection and tended to be relatively more abundant in the gut microbiome 
of mice on the high-iron diet. 
Figure 11. Complex interplay of iron, host immunity and the gut microbiome.
Schematic overview of the interactions between dietary iron, inflammation, host iron status, gut immune 
function and the gut microbiome.
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Although our experiments provide leads for the mechanisms behind, the design did not allow 
to dissect the complex interplay of dietary iron, host iron status and the gut microbiome on 
the host intestinal immune response (Figure 11). Future studies are needed to dissect the 
underlying mechanisms further. A similar mouse study, but with a larger number of mice 
to increase power, could be complemented with non-infected control mice and with mice 
that receive oral iron treatment during infection only, to allow exclusion of host iron status 
effects. Our analyses can be extended with measurements of other immune factors such as 
expression of AMPs, a larger panel of cytokines, and analysis of host gene expression by 
e.g. microarray. It remains however difficult to investigate the interplay between the gut 
microbiome and host iron status as both host iron status and dietary iron content have 
been reported to affect the gut microbiome composition, making it very hard to unravel the 
effects of host iron status on the gut microbiome composition and vice versa (Kortman et 
al 2014) (Chapter 1). 
In summary, our data suggest the existence of a maximum in the inflammatory response 
with regard to dietary iron content, with the peak lying around the normal daily intake of 
iron, something which has not previously been described in literature. Mainly the iron-
deficient diet dampened the intestinal inflammatory response, and which also seemed to 
lower intestinal pathology. The latter was however more evident in our simple nematode 
gut model, in which iron-limitation restrained pathology as reflected by a prolonged 
survival of C. elegans that foraged on the intestinal pathogen S. Typhimurium under iron-
limitation. Furthermore, it confirms that supplementary iron can enhance the virulence 
of S. Typhimurium as we previously have shown in vitro (Kortman et al 2012) (Chapter 5). 
These findings underscore the paradox that oral administration may increase the virulence 
of intestinal pathogens, while decreasing the host intestinal defense at the same time. This 
undesired combination may provide intestinal pathogens with increased opportunities to 
evade the host immune response during oral iron therapy and strengthens the idea that oral 
iron administration programs in developing countries need to be set up with the highest 
amount of care, with close monitoring until the remaining questions about the actual effect 
of iron at the intestinal host-microbiota interface have been unraveled. Future research 
should also be directed at finding iron formulations that do not affect the gut microbiome 
to a large extent. Together, our data support the hypothesis that low iron intake is predictive 
against intestinal infection and inflammation, but also suggest that the clinical outcomes of 
oral iron administration may highly depend on the iron status, immune status and the gut 
microbiota composition of children that receive oral iron treatment.
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Supplementary Figures and legends
Supplementary Figure 2. Effect of dietary iron 
and intestinal inflammation on the mouse gut 
microbiome.
The phylogenetic diversity (PD) index of the 
microbiomes of the dietary groups over time 
are given (min-max whiskers with median). 
Differences between groups at the same time 
point are indicated with solid lines (comparisons 
between groups were made at the same time point 
only). Differences within groups over time are 
indicated with dashed lines (A).
Supplementary Figure 1. Iron content of serum, stools and tissues during the intervention.
Serum iron (A) and stool iron (B) in uninfected mice of experiment 1 and 2 after 14 days of 
dietary iron intervention. Tissue iron stores (mean + SE) of uninfected mice of experiment 
2 after 14 days of dietary iron intervention (C) and of infected mice of experiment 4 after 
28 days of dietary intervention (D). Means without a common letter differ significantly, 
p < 0.05 
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Supplementary Figure 3. Colon secreted pro-
inflammatory cytokines.
Colon explants of infected mice (day 28) in 
experiment 4 (n = 3 - 5) that were on the 
different iron-diets and were challenged with C. 
rodentium, were incubated overnight in culture 
medium, after which secreted pro-inflammatory 
cytokines IL-6, TNF-α and IL-17 were measured 
by ELISA. Cytokine levels were normalized for 
total colon protein. Displayed is the sum of IL-
6, TNF-α and IL-17 secretion. Means without 
a common letter of the same cytokine differ 
significantly, p < 0.05.
Supplementary Figure 4. Nematode survival on pathogenic S. Typhimurium and non-pathogenic E. coli.
Survival of the nematode C. elegans, which was used as a simple in vivo gut model, was monitored during 
13 days (mean±SE). The AUC of both the 100 µmol/L and 10 µmol/L ferric ammonium citrate (FAC) was 
significantly lower (p < 0.05) compared to the iron-limited (no FAC) condition when the nematode foraged on 
S. Typhimurium.
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Supplementary materials and methods
Iron measurements
Serum iron concentration was determined by the use of the Trace DMA Kit (Thermo 
Scientific) according to the manufacturer’s instruction. Spleen, liver, and stool iron 
concentrations were measured by the tissue non-heme iron assay protocol as described 
by Torrance and Bothwell (Torrance and Bothwell 1968). Briefly, 500 µL of acid reagent (3 
mol/L HCl containing 10% trichloroacetic acid) was added to approximately 75 mg tissue 
and incubated at 65˚C for 20 h. After incubation, samples were centrifuged to obtain the 
supernatant and 20 µL was applied to a microplate. Then, 200 µL chromogenic reagent 
containing 127 mg/L bathophenanthroline sulphonate disodium salt (Fluka), 936 mg/L 
thioglycolic acid sodium salt (Sigma-Aldrich) and sodium acetate (2.2 times diluted from a 
saturated solution) was added to the samples. After 10 min incubation at room temperature 
(RT) color formation was measured at 560 nm. Iron concentration was determined by 
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Recent trials have questioned the safety of untargeted oral iron supplementation in 
developing regions. Excess of luminal iron could select for enteric pathogens at the expense 
of beneficial commensals in the human gut microbiota, thereby increasing the incidence 
of infectious diseases. The objective of the current study was to determine the effect of 
high iron availability on virulence traits of prevalent enteric pathogens at the host-microbe 
interface.  
A panel of enteric bacteria was cultured under iron-limiting conditions and in the presence of 
increasing concentrations of ferric citrate to assess the effect on bacterial growth, epithelial 
adhesion, invasion, translocation and epithelial damage in vitro. Translocation and epithelial 
integrity experiments were performed using a transwell system in which Caco-2 cells were 
allowed to differentiate to a tight epithelial monolayer mimicking the intestinal epithelial 
barrier. Growth of Salmonella Typhimurium and other enteric pathogens was increased in 
response to iron. Adhesion of S. Typhimurium to epithelial cells markedly increased when 
these bacteria were pre-incubated with increasing iron concentration (p = 0.0001), whereas 
this was not the case for the non-pathogenic Lactobacillus plantarum (p = 0.42). Cellular 
invasion and epithelial translocation of S. Typhimurium followed the trend of increased 
adhesion. Epithelial damage was increased upon incubation with S. Typhimurium or 
Citrobacter freundii that were pre-incubated under iron-rich conditions. In conclusion, our 
data fit with the consensus that oral iron supplementation is not without risk as iron could, 
in addition to inducing pathogenic overgrowth, also increase the virulence of prevalent 
enteric pathogens. 
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Iron is a highly abundant metal on earth and is vital for virtually all organisms. Despite its 
abundance, iron deficiency is the most prevalent nutrition disorder worldwide. It mostly 
affects infants, young children and women in developing countries. Iron deficiency has 
major health consequences such as infection, poor pregnancy outcome, and impaired 
physical and cognitive development (WHO and UNICEF 2004). Several trials have 
shown that iron deficiency can be effectively controlled by both iron supplementation 
and fortification programmes (Zimmermann and Hurrell 2007). However, safety of iron 
supplementation has been questioned and there is evidence suggesting that untargeted 
oral iron supplementation in regions with high prevalence of malaria transmission and 
infectious diseases can cause an increase in infections, hospital admission and mortality in 
young children (Oppenheimer 2001, Sazawal et al 2006, WHO 2007). This might be at least 
partly ascribed to iron also being an essential requirement for the growth of most bacterial 
species. Importantly, iron availability is frequently involved in the expression of virulence-
associated properties in pathogenic bacteria (Andrews et al 2003, Bullen et al 2005). 
The human gut is the natural habitat for a large and dynamic bacterial community. Major 
functions of the gut microbiota include important trophic effects on intestinal epithelia, on 
immune structure and function, and protection of the colonized host against invasion by 
pathogenic microbes (Flint et al 2007). It has been described that dietary ferric iron and iron 
deprivation can influence the microbiota composition of the mouse intestine (Tompkins et 
al 2001, Werner et al 2011). Very recently, Zimmermann et al. showed in a study among 
African children that iron fortification caused a potentially more pathogenic gut microbiota 
profile (i.e. increased relative abundance of pathogenic species) (Zimmermann et al 2010). 
This was predominantly the case for Salmonella spp., which are capable of invading human 
epithelial cells, translocate across the colonic wall, and subsequently can cause systemic 
disease (Gordon et al 2008, Ibarra and Steele-Mortimer 2009, Zimmermann et al 2010). 
The increase in infections upon oral iron supplementation that was reported by Sazawal 
et al. (Sazawal et al 2006) might partly originate from such pathogenic shifts in the colon 
microbiota due to high concentrations of unabsorbed iron during treatment. Abundance 
of pathogenic enterobacteria after oral iron supplementation might cause diarrhea and 
a systematic review of Gera and Sachdev indeed reported a slight increase in the risk of 
developing diarrhea upon oral iron administration (Gera and Sachdev 2002). Importantly, 
diarrhea is most often a sign of gastrointestinal infection and is a major cause of morbidity 
and mortality among young children worldwide (WHO and UNICEF 2009). Therefore, 
a prior recommendation of both the WHO and the U.S. National Institutes of Health 
Technical Working Group (NIH TWG) is to investigate the impact of iron preparations on 
the gut microbiota (WHO 2006). 
Roughly, there are two factors - directly driven by luminal iron - which may act together in 
gut borne infections: i) decrease in epithelial integrity and ii) increase in pathogen growth 
and virulence. Decrease in epithelial integrity has been reported in vitro and ex vivo and 
the corresponding increased permeability of the intestine may provide a portal of entry for 
opportunistic enteric pathogens (Ferruzza et al 2003, Hansen et al 2009, Nchito et al 2006). 
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However, little is known about the direct effects of luminal iron on the growth and virulence 
of enteric pathogens. Therefore, the aim of this study was to investigate how the pathogenic 
potential of gut bacteria is modulated by iron in vitro. To this purpose, bacterial adhesion, 
invasion and translocation characteristics of a panel of enteric pathogens was investigated 
using differentiated monolayers of the intestinal epithelial cell lines Caco-2 and E12 as a 
model for the gut epithelium. 
Materials and methods
Bacterial strains, media and growth conditions
The strains used in this study were: Salmonella Typhimurium NTB6, Escherichia coli NTB5, 
Enterococcus faecalis ATCC 19433, Lactobacillus plantarum WCFS1 (Boleij et al 2011) 
and Citrobacter freundii NTBK1. These bacteria were cultured at 37˚C/5%CO2 in Iscove’s 
Modified Dulbecco’s Medium (IMDM, Invitrogen). This chemically defined medium does 
not contain iron in its formulation. For L. plantarum the medium was supplemented with 
30 mg/L MnCl2·4H2O, 1 g/L sodium acetate and 10 mmol/L HCl. To determine the effect 
of iron on bacterial growth, fresh IMDM medium with increasing ferric citrate (Sigma-
Aldrich) concentrations (0-1000 µmol/L) was inoculated with a fresh overnight culture. To 
monitor bacterial growth, the optical density was periodically measured at 620 nm (OD620).
Cell line, media and growth conditions
The colon adenocarcinoma cell line Caco-2 (obtained from the American Type Culture
Collection) was cultured under standard conditions in DMEM (Lonza) supplemented with 
10% heat-inactivated FBS (Invitrogen), 20 mmol/L HEPES, 100 nmol/L nonessential amino 
acids (Invitrogen), and 2 mmol/L L-glutamine (Lonza). The cells were subcultured every 
6 days and used between passage numbers 2-25. A description of the culturing of mucus 
producing E12 cells is available from the Online Supporting Material and methods.
Bacterial adhesion and invasion assay
The influence of iron on adhesion and invasion of the mentioned bacterial strains was 
studied by the use of the following adhesion assay.
Pre-incubation of bacteria with ferric citrate: IMDM with increasing ferric citrate 
concentrations (0-50 µmol/L) was inoculated with overnight cultures and grown to 
exponential phase. The bacterial cells were pelleted, resuspended and concentrated in 
IMDM with 10% glycerol for storage at -80˚C until use. Serial dilutions of thawed stocks 
were transferred to blood agar plates and incubated overnight to determine the colony 
forming units (CFU). 
Culturing of Caco-2 cells: Caco-2 cells were subcultured in a 24-well plate and maintained 
until use in adhesion and invasion assays. The assays were performed on confluent 
monolayers between 13-21 days after seeding the cells. 
Bacterial adhesion and invasion assay: The Caco-2 monolayers were washed once with PBS. 
The stocks of bacterial strains that were grown in IMDM with or without ferric citrate 
were pelleted and resuspended in IMDM. Next, bacteria were added to the monolayers at a 
187
Iron availability increases the pathogenic potential of Salmonella Typhimurium and other enteric pathogens at the intestinal 
epithelial interface
5
multiplicity of infection (MOI) of 10:1 in IMDM followed by incubation for 2 h at standard 
conditions. To determine the number of adherent bacteria, monolayers were washed three 
times with PBS, cells were trypsinized and lysed with ice-cold PBS containing 0.025% 
Triton X-100. Serial dilutions of cell lysates were transferred to blood-agar plates for CFU 
counting. To determine the number of invaded bacteria, monolayers were washed three 
times with PBS, incubated for another 1.5 h and subsequently incubated with 200 mg/L 
gentamycin (Invitrogen) + 50 mg/L ampicillin (Calbiochem) for 1 h at standard conditions 
to kill extracellular bacteria. Subsequently, the monolayers were washed twice with PBS, 
trypsinized and lysed for CFU counting as described above. 
Bacterial translocation assay
Caco-2 cells were allowed to grow and differentiate in 21 days to a polarized tight monolayer 
on the membrane of a Transwell® Permeable Support (12 wells, 12 mm insert) with 3.0 µm 
polycarbonate membrane (Corning) under standard culture conditions. At day 21, the wells 
and inserts were washed once with PBS and IMDM was added. To check for the monolayer 
integrity, the trans epithelial electrical resistance (TEER) was measured with the use of the 
Millicell®-ERS (Millipore). Bacteria that were or were not pre-loaded with iron (as described 
above) were apically added to the monolayers at a MOI of 10:1 in IMDM. Infected cells were 
incubated at standard conditions and monolayer integrity was monitored by periodical 
TEER measurements. After 2 h both compartments were washed three times with PBS and 
fresh IMDM was added. The incubation of infected cells was continued for 2 h after which 
a sample of the lower compartment was taken to determine the amount of translocated 
bacteria by CFU counting. 
Determination of LDH-release of epithelial cells upon bacterial infection. 
To investigate the detrimental effect of enteric bacteria to Caco-2 monolayers, the lactate 
dehydrogenase (LDH) release into the growth medium was determined. Media from 
adhesion experiments were collected after 2 h of incubation. Samples were spun for 15 
min at 16,100 × g at 4˚C. Supernatants were used in the Cytotox 96® Non-Radioactive 
Cytotoxicity Assay (Promega) according to the manufacturer’s protocol.
Statistical analysis
Each adhesion/invasion and translocation experiment was performed with 2-3 biological 
replicates, repeated up to 3 times on separate days and results were expressed as mean + 
SD. To compare the means, one-way ANOVA with Tukey’s post-hoc test (for comparison of 
> 2 means with equal variances, as assessed by Bartlett’s test or F-test) or an unpaired t-test 
(2-tailed) (for comparison of 2 means) was used. In case of unequal variances (as assessed 
by F-test), unpaired t-test with Welch’s correction was carried out. Analysis was performed 
using GraphPad Prism version 4.00 for Windows, GraphPad Software, San Diego California 
USA. P-values < 0.05 were considered statistically significant and P-values < 0.10 were 




In vitro growth of enteric bacteria
To investigate whether pathogenic bacteria have a potential growth advantage over non-
pathogenic bacteria in an iron-rich environment, the effect of ferric citrate on growth of a 
selection of enteric bacteria was tested in vitro (Figure 1). These experiments revealed a clear 
concentration-dependent growth stimulatory effect in iron-supplemented growth medium 
for the pathogen S. Typhimurium and the opportunistic pathogens C. freundii and E. coli 
(Figure 1A-C). Only a small beneficial effect was noted for the opportunistic pathogen 
E. faecalis, while iron did not influence growth of the non-pathogenic commensal 
L. plantarum (Figure 1D and E). 
Adhesion of enteric bacteria to an epithelial monolayer 
Adhesion to host epithelial cells is an important virulence characteristic for pathogenic 
bacteria. To test the contribution of iron availability to bacterial adhesion, bacteria were 
pre-incubated with ferric citrate and added to epithelial monolayers under iron-limiting 
conditions, after which the percentage adhesion of the inoculum was determined. As 
shown in Figure 2A, adhesion of S. Typhimurium significantly increased with increasing 
iron concentration (one-way ANOVA: p = 0.0001, 0 µmol/L vs. 10 µmol/L: p < 0.05). This 
increase was not due to differential growth since the CFU did not differ among the 1-50 
µmol/L ferric citrate conditions during the time course of this experiment. The opportunistic 
pathogen C. freundii tended to adhere more (p = 0.097) and E. coli adhered more (p = 0.014) 
after pre-incubation with 10 µmol/L ferric citrate compared to bacteria pre-incubated 
under iron-limiting conditions (Figure 2B and C). Adhesion of the opportunistic pathogen 
E. faecalis was not influenced by pre-incubation with iron (Figure 2D). Interestingly, the 
non pathogenic commensal L. plantarum (Figure 2E) displayed a slight, but non-significant 
decrease in adhesion characteristics in response to an increase in iron availability.
Mucus, covering the human intestinal epithelium, could influence bacterial adhesion. 
Therefore, we investigated whether iron availability could also increase the adhesion of 
S. Typhimurium to mucus producing E12 cells. The latter cell line is derived from HT29-
MTX and capable of forming tight monolayers covered with an adherent mucus layer 
(Behrens et al 2001). For all conditions the adhesion of S. Typhimurium to E12 cells was 
much higher compared to Caco-2 cells (data not shown). Importantly, also in this case the 
tendency towards increased adhesion of bacteria that were pre-incubated with increased 
iron concentrations was found to be statistically significant (p < 0.05; Supplementary Figure 
1A). The latter observation indicates that a protective mucus layer does not prevent the 
increased adhesion of iron-loaded bacteria to intestinal epithelial cells. 
Invasion of enteric bacteria into epithelial cells
During the infectious process, bacterial adhesion can be followed by invasion into intestinal 
epithelial cells. Therefore, the effect of pre-incubation with ferric citrate on cell invasion 
was assessed for S. Typhimurium, E. faecalis and L. plantarum. Of these strains, only S. 
Typhimurium was able to substantially invade a differentiated monolayer of epithelial 
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Figure 1. Effect of iron on growth of enteric bacteria. 
Effect of various concentrations of ferric citrate on in vitro growth of (A) S. Typhimurium, (B) C. freundii, (C) 
E. coli, (D) E. faecalis and (E) L. plantarum. 
Figure 2. Effect of iron on bacterial 
adhesion to an epithelial monolayer. 
Adhesion (mean + SD) of enteric 
bacteria to a monolayer of Caco-2 cells 
is given as percentage of the inoculum. 
A: S. Typhimurium, n=8. B: C. freundii, 
n=4. C: E. coli, n=6. D: E. faecalis, n=6. 
E: L. plantarum, n=5. Means without a 
common letter differ, p < 0.05. Notably, 
adhesion data of S. Typhimurium were 
derived from 4 separate experiments 
performed at 13, 15, 18 and 21 days 
post-seeding of Caco-2 cells. The fact 
that each experiment revealed the 
same trend is indicative for similar 
physiochemical properties of the 
monolayer at these time points. 
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cells. Similar to adhesion, invasion of S. Typhimurium tended to increase with increasing 
iron concentration up to 10 µmol/L ferric citrate (One-way ANOVA, p = 0.09; Figure 3). 
However, this trend disappeared when the percentage bacterial invasion was calculated 
as a function of the adherent bacteria (Supplementary Figure 2). This indicates that the 
increase in invasion is merely a consequence of increased adhesion of S. Typhimurium, 
and that invasion itself is not largely influenced by iron availability. Notably, the invasion of 
bacteria pre-incubated with 50 µmol/L ferric citrate was unexpectedly low in relation to the 
increased adhesion under these conditions. 
Translocation of enteric bacteria across an epithelial monolayer
To cause a systemic infection, enteric bacteria first need to breach the intestinal epithelial 
barrier. Therefore, the ability of S. Typhimurium to translocate across an epithelial 
monolayer was investigated as a function of iron availability. As shown in Figure 4A, 
translocation of S. Typhimurium clearly increased with increasing iron availability up 
to 10 µmol/L ferric citrate (10 µmol/L vs. iron deplete control p = 0.06). Interestingly, 
translocation sharply decreased when bacteria were pre-incubated with 50 µmol/L ferric 
citrate (Figure 4A). As a control experiment, the translocation of L. plantarum was assessed. 
Translocation of this bacterium was neglectably low and not stimulated by increased iron 
availability (data not shown). 
The ability of S. Typhimurium to translocate across a mucus covered epithelial layer 
of E12 cells was also investigated. These experiments showed that also in this case, the 
translocation of S. Typhimurium across E12 cells increased (p < 0.05) when the bacteria 
were pre-incubated with increasing concentrations of ferric citrate (Supplementary Figure 
1B). These data indicate that a protective mucus layer does not abolish the iron-dependent 
increase in translocation efficiency of S. Typhimurium across an epithelial monolayer 
(Figure 4A). 
Effect of iron-loaded bacteria on epithelial integrity and cell cytotoxicity
To monitor epithelial integrity during the translocation experiments, the electrical 
resistance of the monolayer was monitored by TEER measurements at regular intervals. 
These experiments showed that incubation with S. Typhimurium resulted in decreased 
TEER values in time (Figure 4B). As expected, the deterioration rate of the epithelial 
integrity increased when S. Typhimurium was pre-incubated with iron as depicted for the 
10 µmol/L ferric citrate condition. In contrast, the integrity of the monolayer remained 
unaffected upon incubation with other tested bacteria, irrespective of a pre-incubation 
step with ferric citrate, as illustrated for L. plantarum (Figure 4B). As a second indicator 
of epithelial damage, the cellular LDH release was determined after enteric bacteria were 
allowed to adhere to the monolayer for 2 hours. As shown in Figure 5, epithelial cells 
tended to release more LDH in response to S. Typhimurium that was pre-incubated with 10 
µmol/L ferric citrate compared to the 0 µmol/L condition (p = 0.09). This is in line with the 
increased deterioration rate under these conditions as monitored by TEER measurements. 
Interestingly, the LDH release in response to C. freundii pre-incubated with 10 µmol/L 
ferric citrate was also greater compared to C. freundii grown in iron deplete medium 
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Figure 3. Effect of iron on invasion of S. Typhimurium 
into epithelial cells.
Invasion (mean + SD) of S. Typhimurium into Caco-2 
cells, n=2. Invasion after 3.5 h is given as percentage of 
the inoculum. The inoculum was removed after 2 hours of 
adhesion time. Means of 0 – 10 µmol/L ferric citrate were 
compared by one-way ANOVA. 
Figure 4. Effect of iron on the ability of S. Typhimurium to 
cross and deteriorate an epithelial monolayer.
Effect of iron on the ability of S. Typhimurium to cross 
an epithelial monolayer of Caco-2 cells and the integrity 
of this monolayer. A: The translocation is given as 
percentage of the inoculum (mean + SD), n=2. Means 
without a common letter differ, p < 0.07. B: The integrity 
of the Caco-2 monolayer during S. Typhimurium (St) 
and L. plantarum (Lp) translocation, monitored by TEER 
measurements. 
Figure 5. Effect of iron on the ability of enteric bacteria to 
induce cell damage. 
LDH-release (mean + SD) as a measure of cell damage of 
Caco-2 cells upon co-incubation with S. Typhimurium 
(St, n=5), C. freundii (Cf, n=4), E. coli (Ec, n=4), E. faecalis 
(Ef, n=4), and L. plantarum (Lp, n=2) pre-incubated with 
or without ferric citrate. The percentage LDH release 
compared to the control (no bacteria) was corrected for 
the number of bacteria in the medium (average between 
t=0 and t=2 h). Means within a group and without a 
common letter differ significantly, p < 0.05.
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(p = 0.018), despite the fact that the TEER did not drop under these conditions (data not 
shown). The latter observation implies that LDH release is an early marker for epithelial 
damage, which may correlate with adhesion of pathogenic bacteria (see Figure 2B). In this 
respect, the E. coli strain used in this study seems not very hostile since the TEER did not 
drop and LDH release did not increase despite an increased adhesion after pre-incubation 
with 10 µmol/L ferric citrate. Contrarily, the LDH release in response to E. faecalis and L. 
plantarum was low compared to the release in response to the other bacteria, and unaffected 
by pre-incubation of these bacteria with ferric citrate. The latter observation is consistent 
with the fact that adhesion of these bacteria remained unaffected under iron rich conditions 
(Figure 2D and E). 
Discussion
The safety of iron supplementation and fortification programmes in developing countries 
has been questioned (WHO 2007). Very recently it has been shown that biscuits fortified with 
low bioavailable electrolytic iron caused an increase in fecal enterobacteria (predominately 
Salmonella spp.) in African children (Zimmermann et al 2010). This shift towards a more 
unfavorable number of enteric pathogens might be one of the origins of the increase in 
infections, hospital admissions and mortality which was found by Sazawal et al. (Sazawal et 
al 2006). Here we investigated the relative effects of iron on growth and virulence traits of 
enteric pathogens and commensals. 
Our in vitro experiments showed that the switch from iron-limiting to iron rich conditions 
resulted in an enhanced growth of S. Typhimurium and other enteric pathogens. On the 
other hand, growth of L. plantarum that is not strictly dependent on iron (Pandey et al 
1994), was not enhanced by iron. These results fit with the finding that enteric pathogens 
have the potential to outgrow the commensal population when large amounts of unabsorbed 
dietary iron enter the colon in vivo (Zimmermann et al 2010).
The ability to replicate is important for all bacteria, but to establish an infection, pathogens 
first need to adhere to the colonic wall. Our current study clearly showed that iron availability 
increased adhesion of enteric pathogens to intestinal epithelial cells in vitro, which was 
most prominently observed for S. Typhimurium. Importantly, the increased adhesion of S. 
Typhimurium as a function of iron was not only observed with Caco-2 cells, but also in case 
of mucus producing intestinal epithelial E12 cells that may more closely resemble the in vivo 
situation. In contrast, iron did not affect adhesion of E. faecalis and even seemed to slightly 
reduce the adhesion of L. plantarum to epithelial cells. Importantly, these results indicate that 
in addition to a growth advantage of enteric pathogens, iron also has the potential to contribute 
to increased colonization of these enteric pathogens to the colonic wall. In vivo, colonization 
of enteric pathogens depends on many factors, among which the colonization resistance of the 
resident commensal population. In this respect, Stecher et al. postulated the interesting “like 
will to like” concept, based on the observation that mice with relatively high E. coli densities in 
their intrinsic intestinal population were more susceptible to Salmonella infections (Stecher et 
al 2010). It may therefore be envisaged that iron can also indirectly enhance S. Typhimurium 
infections in vivo by increasing intestinal colonization with related commensals. 
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Translocation across the colonic wall is the third step in establishing a gut-borne infection. 
Our current in vitro data show that iron availability increases the cell invasion and epithelial 
translocation potential of S. Typhimurium. However, the increase in invasion seems to be 
a direct consequence of the increased adhesion, which implies that there is no stimulatory 
effect of iron on invasion itself. This could indicate that the type III secretion system (T3SS) 
of S. Typhimurium, which is directly involved in the invasion of epithelial cells, was not 
further induced by ferric citrate under the applied experimental conditions. Nevertheless, 
other studies have shown that T3SS is induced by iron through the ferric uptake regulator 
(Fur) (Ellermeier and Slauch 2008, Janakiraman and Slauch 2000, Teixido et al 2011). 
Interestingly, invasion even appeared slightly less efficient when S. Typhimurium was 
pre-incubated in 50 µmol/L ferric citrate, suggesting that certain invasion-specific factors 
become affected under excessive iron conditions. S. Typhimurium initially invades directly 
into host cells and can hereby affect tight junction complex proteins (Ibarra and Steele-
Mortimer 2009, Jepson et al 1995, Kohler et al 2007). This affects epithelial integrity and 
subsequently provides the opportunity for S. Typhimurium to cross the epithelium via the 
paracellular route (Kohler et al 2007). The reduced translocation efficacy at excessive iron 
conditions could therefore fit with impaired cell invasion of S. Typhimurium during the 
initial phases of infection. Besides enteroinvasive strains like S. Typhimurium, there are 
many other enteric pathogens that do not translocate across the bowel wall, but can cause 
severe intestinal inflammation. The virulence of such pathogens is also likely to be positively 
influenced by increased iron availability.
Our experiments showed that pre-incubation of the enterobacteria S. Typhimurium and 
C. freundii with iron increased damage to epithelial cells as measured by LDH release. 
This may very well be associated with the increased adhesion of these bacteria under these 
conditions. However, the release of bacterial products such as toxins, which was not assessed 
in this study, could differ between high and low iron conditions and can also play a role in 
the increased epithelial cell damage. Furthermore, iron-loading of S. Typhimurium resulted 
in faster deterioration the epithelial integrity of a monolayer (TEER measurement), which 
was associated with increased bacterial translocation up to 10 µmol/L ferric citrate. Since 
high TEER values mainly represent the existence of tight junctions (Kohler et al 2007), this 
is in line with a hypothetical model in which S. Typhimurium actively affects tight-junction 
complexes, which is stimulated upon increased invasion of epithelial cells under iron-rich 
conditions. We want to emphasize that all adhesion, invasion and translocation assays 
were performed with bacteria that were pre-loaded with iron, but that the experiments 
themselves were performed under iron-limiting conditions. This was important to prevent 
bias in our data, as it has been reported that iron itself has the potential to damage the gut 
wall directly via generation of oxygen radicals (Ferruzza et al 2003, Natoli et al 2009). In our 
current study, Caco-2 cells and E12 cells were maintained under standard condition without 
any additional iron, which is different from the study design of Foster et al. who showed 
that elevated iron status of enterocytes increased bacterial invasion (Foster et al 2001). 
Clearly, our study adds that enteric pathogens themselves have the potential to benefit from 
increased luminal iron availability, already during the initial phases of infection (i.e. cell 
adhesion and cell damage). 
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In summary, our in vitro data support the hypothesis that luminal iron from oral iron 
supplementation or fortification can increase growth and virulence of enteric pathogens. 
It goes without saying that an animal infection model is required for future validation 
of our data in a more complex situation. Nevertheless, our study clearly supports the 
current idea that nutritionist should be aware of the potential harmful effects of oral iron 
supplementation in areas with high infection pressure, as present in developing countries. 
The ideal safe iron preparation should be low dose and highly bioavailable for humans, 
while it is difficult to access for enteric pathogens. Research to the latter part is currently 
underexposed, but certainly deserves more attention in the light of the recent awareness 
of the risk of general iron supplementation programmes. In addition, it is important to 
develop point-of-care diagnostic tools to discriminate between individuals with iron 
deficiency anemia (IDA) who will directly benefit from iron supplementation and those 
with anemia due to chronic infection (ACD). In the latter case, anemia is (also) a result 
from the human iron-withdrawal strategy mediated by increased circulating levels of the 
iron-regulatory hormone hepcidin upon (malarial) infection (de Mast et al 2009, Kemna et 
al 2008). Subsequently, hepcidin not only blocks iron release from the reticulo-endothelial 
macrophages but it also inhibits absorption from the intestine (Cercamondi et al 2010, 
Kemna et al 2008), meaning that luminal pathogens will benefit more from dietary iron 
supplementation than the host itself. Reliable on-site discrimination between ACD and 
IDA may contribute to the safe supplementation of iron. From a mechanistic point of view, 
several questions remain to be answered, such as the identification of the enterobacterial 
factors that are responsible for the increased adhesion under iron-rich conditions. This and 
other questions will be subject of our ongoing investigations.
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Supplementary Figures and legends
Supplementary Figure 1. Effect of iron on the ability of S. Typhimurium to adhere to, and translocate across, 
an epithelial monolayer of E12 cells covered with mucus. In vitro adhesion (mean + SD) to E12 cells, and 
translocation (mean + SD) of S. Typhimurium across a monolayer of E12 cells. A: Because adhesion to E12 cells 
was much higher than adhesion to Caco-2 cells, the number of adherent bacteria to E12 cells was expressed 
as percentage of the average CFU (CFU at start – CFU after 2h) in the culture medium, n=2. B: Translocation 
is given as percentage of the average CFU (CFU at start – CFU after 2.5h) in the culture medium, n=3. Means 
without a common letter differ p < 0.05.
Supplementary Figure 2. Effect of iron on invasion of S. Typhimurium into Caco-2 epithelial cells. 
Invasion (mean + SD) of S. Typhimurium into Caco-2 epithelial cells. Invasion after 3.5 hours is given as 
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Oral iron therapy can increase the abundance of bacterial pathogens, e.g. Salmonella 
spp. in the large intestine of African children. Carvacrol is a natural compound with 
antimicrobial activity against various intestinal bacterial pathogens, among which is the 
highly prevalent Salmonella enterica serovar Typhimurium. This study aimed to explore 
a presumed interaction between carvacrol and bacterial iron handling and to assess the 
potential of carvacrol in preventing the increase of bacterial pathogenicity during high 
iron availability. S. Typhimurium was cultured with increasing concentrations of iron and 
carvacrol to study the effects of these combined interventions on growth, adhesion to 
intestinal epithelial cells and iron uptake/influx in both bacterial and epithelial cells. In 
addition, the ability of carvacrol to remove iron from the high-affinity ligand transferrin 
and a Fe-dye complex was examined. Carvacrol retarded growth of S. Typhimurium at all 
iron conditions. Furthermore, iron-induced epithelial adhesion was effectively reduced by 
carvacrol at high iron concentrations. The reduction of growth and virulence by carvacrol 
was not paralleled by a change in iron uptake or influx into S. Typhimurium. In contrast, 
bioavailability of iron for epithelial cells was moderately decreased under these conditions. 
Further, carvacrol was shown to lack the properties of an iron-binding molecule, however, it 
was able to weaken iron-ligand interactions by which it may possibly interfere with bacterial 
virulence. In conclusion, our in vitro data suggest that carvacrol has the potential to serve as 
a novel dietary supplement to prevent pathogenic overgrowth and colonization in the large 
intestine during oral iron therapy.  
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Introduction
Salmonella enterica serovar Typhimurium is a major cause of gastroenteritis and invasive 
disease in humans, particularly in susceptible children in tropical Africa (Graham 2010). 
Concurrently, there is a high prevalence of iron deficiency among children in developing 
countries. These children require oral iron therapy to prevent developmental impairment 
(WHO and UNICEF 2004). Precariously, growth and colonization of S. Typhimurium 
appears to be stimulated by increased luminal iron availability in vitro, as well as in vivo, in 
several but not all published studies (Dostal et al 2012a, Dostal et al 2012b, Kortman et al 
2012, Zimmermann et al 2010). Thus, there is an unfulfilled need to suppress this common 
intestinal pathogen. 
Carvacrol is a monoterpenoid phenol present in essential oils, it has antimicrobial activity 
and is one of the main components in oregano and thyme oil (Burt 2004). It has been shown 
to be active against various intestinal pathogens, including S. Typhimurium (Burt 2004). 
Carvacrol appears to target the outer membrane of gram-negative bacteria and increases 
membrane permeability, hereby causing depletion of the cellular ATP pool, leakage of other 
cytoplasmic constituents and outer membrane-associated material (Burt 2004, Helander 
et al 1998). However, this process is currently not fully understood and additional modes 
of action might exist. It has previously been shown that subinhibitory concentrations of 
carvacrol can affect virulence traits as it slightly reduced adhesion of S. Typhimurium to 
intestinal epithelial cells and significantly reduced invasion into these cells (Inamuco et al 
2012). In contrast, it was shown that increased iron availability promoted S. Typhimurium 
adhesion to, and invasion into, intestinal epithelial cells (Kortman et al 2012) (Chapter 5). 
Further, carvacrol was shown to increase expression of the heat shock protein GroEL and 
inhibit the synthesis of flagellin in Escherichia coli O157:H7 when grown in a standard rich 
medium (Burt et al 2007). On the other hand, moderate to high iron availability reduced 
GroEL expression and increased flagellin synthesis in S. Typhimurium compared to low iron 
availability (Kortman et al, unpublished data). The above findings inspired us to speculate 
that carvacrol may exert (in part) its antimicrobial mode of action through interference with 
pathways for bacterial iron handling. The present study aimed to investigate this hypothesis 
and to explore the potential of carvacrol to serve as a food additive to prevent pathogenic 




Bacterial strain, media and growth conditions
The strain used in this study was Salmonella Typhimurium NTB6 (Kortman et al 2012). This 
bacterium was cultured at 37˚C and 5% CO2 (standard conditions ) in Iscove’s Modified 
Dulbecco’s Medium (IMDM, Invitrogen). This chemically defined medium does not contain 
iron in its formulation. 
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Growth curves and determination of the Minimal Inhibitory Concentration (MIC)
To determine the effects of iron and carvacrol on growth of S. Typhimurium, IMDM 
medium with increasing ferric citrate (Sigma-Aldrich) and carvacrol (Sigma-Aldrich) 
concentrations was inoculated with a fresh bacterial culture after overnight growth. A stock 
solution of ferric citrate was made in MilliQ water (MQ) and a 0.1 mol/L stock of carvacrol 
was made in absolute ethanol. Final concentrations of ethanol were kept constant at 2.5% 
(v/v) for each condition. Portions of 200 µL culture medium were inoculated in a microplate 
(in duplicate) and incubated statically at 37˚C within a plate reader. To monitor bacterial 
growth, the optical density was automatically measured at 620 nm (OD620) every 20 min.
To determine the lowest concentration of carvacrol that inhibits the visible growth of S. 
Typhimurium NTB6 in IMDM, a serial dilution of carvacrol (0, 0.75, 1.0, 1.25, 1.5, 1.75, 
2.0 and 2.5 mmol/L) in IMDM in the presence of 0, 1, 10, or 100 µmol/L ferric citrate was 
tested. 2 ml media in sterile 75x12 mm capped tubes was inoculated with a fresh bacterial 
culture and the OD620 was assessed after overnight incubation at 37˚C. A negative control 
containing no bacteria was included. The MIC value, for the specific incubation conditions 
applied in the present study, was defined as the lowest concentration where no increase in 
optical density was observed and concentrations of carvacrol below the MIC (and above 
0 mmol/L) that still supported growth were defined as subinhibitory. It should be noted 
that we chose to determine the MIC values for the growth medium that was used in this 
study to sustain consistent growth conditions. If desired in future studies, the MIC should 
be determined in a more standard reference growth medium (see e.g. CLSI or EUCAST 
recommendations) (CLSI , EUCAST). 
Cell line, media and growth conditions
The human colorectal adenocarcinoma cell line Caco-2 (obtained from the American Type 
Culture Collection) was cultured at standard conditions in DMEM (Lonza) supplemented 
with 10% heat-inactivated FBS (Invitrogen), 20 mmol/L HEPES, 100 nmol/L nonessential 
amino acids (Invitrogen), and 2 mmol/L L-glutamine (Lonza). Cells were subcultured every 
6 days and used between passage numbers 3-6.
Bacterial adhesion assay
The influence of iron and carvacrol on adhesion of S. Typhimurium to Caco-2 cells was 
studied by the use of the following adhesion assay.
Pre-incubation of bacteria with ferric citrate and carvacrol: IMDM with increasing ferric 
citrate concentrations (0-50 µmol/L) and carvacrol concentrations (0-0.5 mmol/L) was 
inoculated with S. Typhimurium (overnight culture) and grown to exponential phase. The 
bacterial cells were pelleted, resuspended and concentrated in IMDM with 10% glycerol for 
storage at -80˚C until use. Serial dilutions of thawed stocks were transferred to blood agar 
plates and incubated overnight to determine the colony forming units (CFU). 
Culturing of Caco-2 cells: Caco-2 cells were subcultured in a 24-well plate and maintained 
until use in adhesion assays. The assays were performed on confluent monolayers between 
14-16 days after seeding the cells. 
Bacterial adhesion assay: The Caco-2 monolayers were washed once with PBS. The pre-
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incubated stocks of S. Typhimurium were pelleted and resuspended in IMDM. Next, bacteria 
were added to the monolayers at a multiplicity of infection (MOI) of 10:1 in IMDM followed 
by incubation for 2 h at standard conditions. To determine the number of adherent bacteria, 
monolayers were washed three times with PBS, cells were trypsinized and lysed with ice-cold 
PBS containing 0.025% Triton X-100. Serial dilutions of cell lysates were transferred to blood-
agar plates for CFU counting. 
Determination of iron uptake by S. Typhimurium under influence of carvacrol
To determine the effect of carvacrol on iron uptake by S. Typhimurium, bacterial cells 
were grown with iron and carvacrol after which total iron content of the bacteria was 
determined. 10 mL cultures of S. Typhimurium were incubated with ferric citrate (0-50 
µmol/L) and carvacrol (0-0.5 mmol/L) under standard conditions. Bacteria were harvested 
by centrifugation for 5 min at 3220 x g and pellets were resuspended in 5 mL PBS containing 
1 mmol/L deferoxamine (DFO; Sigma-Aldrich) to sequester iron that is loosely bound to the 
outer membrane of the bacteria. After another centrifugation step, pellets were resuspended 
in 1.5 mL PBS and transferred to fresh 2-mL tubes. Tubes were centrifuged for 5 min at 
10,000 x g and the supernatant was removed. Pellets were snap frozen in liquid nitrogen 
(3x), wet pellet weight was noted and iron content was determined by acid digestion of 
the bacteria and use of the chromogen bathophenanthroline as described by Torrance and 
Bothwell (Torrance and Bothwell 1968). To this purpose, bacterial pellets were resupended 
in 80 µL of acid reagent (3 mol/L HCl containing 10% trichloroacetic acid) and incubated 
at 65˚C for 20 h with continuous mixing. After incubation, samples were centrifuged to 
obtain the supernatant and 20 µL was applied to a microplate. Then, 200 µL chromogenic 
reagent containing 127 mg/L bathophenanthroline sulphonate disodium salt (Fluka), 936 
mg/l thioglycolic acid sodium salt (Sigma-Aldrich) and sodium acetate (2.2 times diluted 
from a saturated solution) was added to the samples. After 10 min incubation at room 
temperature (RT) color formation was measured at 540-560 nm. Iron concentration was 
determined by comparison to a standard curve made of ferrous sulfate and was corrected 
for wet pellet weight.
Determination of iron bioavailability to Caco-2 cells
To examine the effect of carvacrol on the uptake of iron by enterocytes, Caco-2 cells were 
exposed to iron and carvacrol. Iron uptake was quantified by measurement of intracellular 
ferritin levels. 
Culturing of Caco-2 cells: As described above, with the exception that the assays were 
performed between 13-14 days after seeding the cells. 
Exposure of Caco-2 cells to iron and carvacrol: 2 days before incubation of the cells with iron 
and carvacrol the standard culture medium was replaced by IMDM. Both ferric citrate and 
ferrous sulfate (20 µmol/L Fe) in combination with carvacrol (0-0.3 mmol/L) or ascorbic 
acid (200 µmol/L) and tannic acid (2 µmol/L) as positive and negative control respectively, 
were applied to the cells in fresh IMDM. Higher concentrations of carvacrol could not be 
tested because of cytotoxic effects to the cells. The cells were incubated for 20 h at standard 
conditions. At harvesting cells were washed once with 1 mL PBS containing 1 mmol/L DFO 
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and washed once with 1 mL PBS. Cells were frozen on dry ice and after thawing 100 µL of 
5 mmol/L NaOH was added. Cells were then lysed by sonication for 15 min in a sonication 
bath containing ice water. To neutralize, 50 µL of 10 mmol/L HCl was added and cells were 
loosened by scraping. Suspensions were sonicated 5 min and then transferred to fresh tubes. 
Debris was pelleted by centrifugation and the supernatant was used for quantification of 
total protein and ferritin. 
Quantification of ferritin levels: Samples were applied to the ferritin ELISA (Spectro 
Ferritin, Ramco) and the assay was performed according to the manufacturer’s instructions. 
Ferritin levels were normalized for total protein content. Total protein was measured by 
the use of a Bradford protein assay (Biorad) according to the manufacturer’s instructions. 
Iron removal from transferrin assay
To examine the potential of carvacrol to sequester iron, the ability of carvacrol to remove 
iron from transferrin was investigated. Incubation buffer containing 100 mmol/L Tris-HCl 
(pH 7.5) and 10% glycerol (v/v) was depleted of trace iron by pre-treatment with Chelex-100 
resin (Sigma-Aldrich). Then, 50 µg of holo-transferrin (hTf ) from human (Sigma-Aldrich) 
was dissolved in 50 µL incubation buffer and hTf was incubated with carvacrol (0-250 
µmol/L) and positive controls DFO (500 µmol/L ) and tannic acid (Sigma-Aldrich; 100 
µmol/L) for 18 h at 37˚C. The iron binding status of transferrin (Tf ) was investigated by 
polyacrylamide gel electrophoresis according to the method described by Makey and Seal, 
1976 (Makey and Seal 1976) with a few adaptations. Briefly, a freshly prepared solution 
containing 6% acrylamide (37.5:1 with bis-acrylamide), 6 mol/L urea and TBE buffer (0.1 
mol/L Tris; 0.01 mol/L boric acid; 0.05 mol/L EDTA, pH 8.4) was pre-treated with chelex-100 
resin and then polymerized in a BioRad Protean II vertical minigel system. The gel was pre-
run at 70V for 20 min, and 20 µg of the Tf samples was loaded. Partially saturated human 
transferrin (Sigma-Aldrich) was used as a marker standard (20 µg). The gel tray was placed 
in ice water and electrophoresis was performed at 100 V for 7 h. After electrophoresis the 
gel was fixed for 15 min in fixative containing 10% (v/v) acetic acid, 50% (v/v) methanol and 
40% demineralized water (v/v). To visualize forms of Tf, it was stained with Coommassie 
Brilliant Blue. 
Iron removal from CAS assay
A universal chemical assay for the detection of iron acquisition siderophores was used to 
examine the capability of carvacrol to remove iron from a dye-Fe complex. Chrome Azurol 
S (CAS) in complex with ferric iron and hexadecyltrimethylammonium bromide (HDTMA) 
has a blue color, which turns orange when iron is removed from the dye by a stronger ligand. 
The method used was originally described by Schwyn & Neilands (1986) (Schwyn and 
Neilands 1987). Briefly, a 2 mmol/L CAS (Tokyo Chemical Industry) solution was prepared 
and 1875 µL was mixed with 375 µL ferric iron solution (1 mmol/L FeCl3 (Merck) in 10 
mmol/L HCl). Separately, 1.5 mL of 10 mmol/L HDTMA (Sigma-Aldrich) was placed in an 
acid cleaned volumetric flask of 25 mL and the CAS-iron mixture was slowly added with 
simultaneous mixing. Then 1.077 g of anhydrous piperazine (Fluka) was dissolved in 7 mL 
MQ and 1560 µL of 12 mol/L HCl was added. This buffer was rinsed into the volumetric 
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Figure 1. Effect of iron and subinhibitory concentrations of carvacrol on growth of S. Typhimurium.
(A) Effect of 0.6 mmol/L carvacrol (CV) on S. Typhimurium growth (mean ± range) during 8 h in medium with 
1 µmol/L (open circles) or 100 µmol/L ferric citrate (FeC) (open squares) compared to the same conditions 
without carvacrol (filled circles and squares, respectively) (n = 2; duplicate wells). (B) Effect of 1mmol/L 
carvacrol on growth of S. Typhimurium during 13.3 h with 100 (open squares), 50 (open circles), 10 (filled 
squares), or 1 µmol/L ferric citrate (filled circles), n = 2. Without addition of any iron growth is more hampered 
as the trace amount of iron in the IMDM limits growth of S. Typhimurium (Kortman et al 2012). 
Figure 2. Effect of carvacrol on iron-induced 
adhesion of S. Typhimurium to an epithelial 
monolayer.
Adhesion (mean + SD) of S. Typhimurium to a 
monolayer of Caco-2 cells is given as percentage 
of the inoculum and expressed relative to the 
conditions without iron during pre-incubation. 
Data consists of 3 separate experiments in which 
adherent colony forming units were determined 
on different days with duplicate wells, n = 6. 
* p < 0.05; *** p < 0.001.
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flask and MQ was added to 25 mL to complete the assay solution. The solution was stored in 
a plastic tube in the dark. To establish increased speed in iron exchange, a shuttle solution 
was prepared which involved the addition of 25.42 mg 5-sulfosycilic acid dihydrate (Sigma-
Aldrich) to the assay solution before adding the final MQ to a total of 25 mL.
Iron removal capacity and speed of iron removal was tested in a microplate. 100 µL carvacrol 
(0-1 mmol/L in IMDM or MQ), DFO (0-20 µmol/L in IMDM or MQ), or tannic acid (0-5.9 
µmol/L in IMDM or MQ) was mixed with 100 µL CAS assay (shuttle) solution. Absorption 
was periodically monitored at 620 nm.
Statistical analysis
To compare means, an unpaired t-test (2-tailed) was used. In case of unequal variances (as 
assessed by F-test), an unpaired t-test with Welch’s correction was carried out. To assess the 
slope of iron dependent adhesion, linear regression analysis was applied. For comparison 
of iron uptake by S. Typhimurium under influence of carvacrol, two-way ANOVA was 
performed. All analyses were performed using GraphPad Prism version 5.00 for Windows, 




Growth of S. Typhimurium in response to iron and carvacrol
To evaluate the possibility that the antimicrobial effect of carvacrol can be explained 
by its interference with bacterial iron handling, the effect of carvacrol on growth of S. 
Typhimurium was tested under moderate iron and iron rich conditions. In general, these 
experiments showed that carvacrol can delay the onset of growth of this bacterium. Growth 
delay was established under both moderate iron concentrations and high iron conditions 
(Figure 1A and supplementary Figure 1). In the absence of carvacrol the high iron conditions 
were not influencing growth as compared to the moderate iron concentrations. However, in 
the presence of carvacrol a shorter lag phase is observed with culture medium containing 
high iron concentrations as compared to growth with moderate iron concentrations. 
This suggests that high iron availability partly compensates the postponement effect of 
carvacrol. Notably, increased carvacrol concentration of 1 mmol/L strongly retarded 
growth, but growth was strikingly less retarded in 50-100 µmol/L ferric citrate as compared 
to 1-10 µmol/L ferric citrate (Figure 1B). Levels of carvacrol ≤ 1 mmol/L were found to 
be the subinhibitory range under these conditions as 1 mmol/L carvacrol was the highest 
concentration tested that still supported growth under all iron conditions. A slightly higher 
concentration of 1.25 mmol/L effectively prevented an increase in optical density after 
overnight growth (MIC).
Adhesion of S. Typhimurium to an epithelial monolayer 
Adhesion to host epithelial cells is an important virulence characteristic for pathogenic 
bacteria. To test whether iron-induced adhesion, as observed previously (Kortman et al 
2012), can be counteracted by carvacrol, S. Typhimurium was first pre-incubated with 
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Figure 3. Total iron content of S. Typhimurium 
after growth with iron and carvacrol.
S. Typhimurium was grown to mid-log phase 
with increasing concentrations of iron and 
carvacrol. Iron content (mean + range) is 
given as ng per mg wet biomass, n = 2. Means 
without a common letter differ significantly, 
p < 0.05. 
Figure 4. Influence of carvacrol on the 
bioavailability of iron to an epithelial 
monolayer.
Caco-2 cells were exposed to equimolar 
concentrations of iron and increasing 
concentrations of carvacrol. Bioavailability of 
iron is expressed as total intracellular ferritin 
content, corrected for total protein (mean + 
SD). Data consists of 2 separate experiments 
with measurements performed in triplicate, 
n = 6. Means without a common letter differ 
significantly, p < 0.05.
Figure 5. Iron from transferrin removal assay
hTf was incubated with increasing 
concentrations of carvacrol and the positive 
controls DFO and tannic acid (TA) to assess 
iron removal from hTf. Lane 1: partially 
saturated Tf, lane 2: hTf control, lane 3: 500 
µmol/L DFO, lane 4: 0 µmol/L carvacrol 
(CV) solvent control, lane 5: 1 µmol/L CV, 
lane 6: 10 µmol/L CV, lane 7: 100 µmol/L CV, 
lane 8: 250 µmol/L CV, lane 9: 100 µmol/L 
TA. Upper arrow indicates Tf without iron 
bound to it, middle arrow indicates Tf with 
1 Fe-atom bound, lower arrow indicates hTf 
with 2 Fe-atoms bound to the protein.
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increasing concentrations of ferric citrate and carvacrol. To determine the adhesion, pre-
incubated bacteria were added to intestinal epithelial monolayers (Caco-2) under iron 
limiting conditions and without carvacrol. Adhesion was expressed as the percentage 
of the bacterial inoculum and relative to the conditions without iron addition during 
pre-incubation. As shown in Figure 2, iron stimulated the adhesion of S. Typhimurium, 
however this effect was significantly reduced by carvacrol, especially at the highest iron 
concentration tested. It should be noted that carvacrol did not significantly affect adhesion 
in the condition without iron (Supplementary Figure 2). Linear regression analysis revealed 
that the slope of the control conditions without carvacrol (2.79 ± 0.50) was significantly 
steeper than the slope of the 0.2 mmol/L carvacrol conditions (0.51 ± 0.20) (p = 0.013). 
Slope of the conditions with 0.5 mmol/L carvacrol (1.47 ± 0.48) was lower compared to the 
controls, although not significantly (p = 0.129). Taken together, these experiments show 
that subinhibitory levels of carvacrol can reduce iron-induced adhesion of S. Typhimurium 
to an epithelial monolayer.
Iron uptake by S. Typhimurium under influence of carvacrol
One of the mechanisms by which carvacrol could influence bacterial adhesion is the inhibition 
of iron uptake by S. Typhimurium, which consequently would affect adhesion traits. To 
investigate this, we measured total iron content of S. Typhimurium cells which were grown in 
the presence of increasing concentrations of ferric citrate and carvacrol. The iron content of 
the bacteria grown without carvacrol was significantly increased in the 10 µmol/L ferric citrate 
condition compared to the 1 µmol/L ferric citrate condition (p = 0.012) and further increased 
with 50 µmol/L ferric citrate (p = 0.034 compared to 1 µmol/L ferric citrate), indicating 
increased iron uptake at increasing iron concentration as expected (Figure 3). Carvacrol 
appeared not to influence iron uptake or influx significantly at all iron concentrations tested 
(two-way ANOVA). As carvacrol did not reduce the uptake of iron by S. Typhimurium, the 
inhibiting effect on adhesion can probably not be explained by altered iron uptake. 
Bioavailability of iron to intestinal epithelial cells under influence of carvacrol
To examine the effect of carvacrol on intestinal iron uptake in vitro, iron together with 
nontoxic concentrations of carvacrol were applied to Caco-2 monolayers. Next to ferric 
citrate, ferrous sulfate was tested as this form of iron is widely used in iron supplementation 
studies. Cytoplasmic levels of ferritin were used as a measure for cellular iron uptake. 
As shown in Figure 4, in the absence of carvacrol bioavailability of ferric citrate was 
higher compared to ferrous sulfate (p = 0.004). Bioavailability of both iron sources 
was considerably reduced by carvacrol; ferritin formation was about 2.5 times less 
with 0.3 mmol/L carvacrol compared to the no carvacrol controls (p < 0.0002 for both 
iron sources). Notably, carvacrol did not abolish iron uptake, while the addition of the 
food derived and strong iron binding tannic acid at 2 µmol/L resulted in a near complete 
block of iron uptake (Supplementary Figure 3A). We note that higher concentrations 
of carvacrol could not be tested due to toxic effects to the cells, as determined by a 
LDH-release assay (Supplementary Figure 4). In contrast, 200 µmol/L ascorbic acid as a 
known promoter of iron uptake enhanced iron uptake of both iron sources, especially of 
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ferric citrate (p = 0.003 and p < 0.0001 for ferrous sulfate and ferric citrate respectively) 
(Supplementary Figure 3B). 
Iron binding capacity of carvacrol
The potential iron binding capacity of carvacrol, or its ability to dissociate iron from iron 
binding ligands, was investigated in an iron from transferrin removal assay and a universal 
siderophore CAS assay. The iron from transferrin removal assay revealed that carvacrol up 
to 0.25 mmol/L could not take away iron from transferrin, indicating that carvacrol is not 
a high-affinity iron binding molecule and cannot dissociate the transferrin-iron complex 
(Figure 5). In contrast, use of the strong iron-binding molecules DFO and tannic acid that 
served as positive controls in this assay, clearly showed their ability to remove of 1 or 2 iron 
atoms from the transferrin molecule. 
Figure 6. Effect of carvacrol on the stability of the CAS-Fe complex.
Removal of iron from the colored complex is displayed as a decrease in optical density. Carvacrol or DFO was 
incubated with the CAS-Fe complex without and with shuttle solution (filled and open symbols respectively). 
(A) Dissociation of the Fe-dye complex in time was monitored without addition of carvacrol (filled circles) 
and with addition of 0.2 mmol/L (filled and open squares) or 0.6 mmol/L carvacrol (filled and open triangles). 
(B) As control conditions, the CAS-Fe complex was incubated without DFO (filled and open circles) and with 
addition of 20 µmol/L DFO (filled and open triangles).
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As shown in Figure 6A, the siderophore-CAS assay revealed that carvacrol can dissociate 
the Fe-dye complex partly (0.2 mmol/L) or completely (0.6 mmol/L), however this was only 
observed after a long incubation of 15 hours, while dissociation of the Fe-dye complex was 
already evident after only 3 hours for the positive controls DFO (Figure 6B) and tannic acid 
(not shown) at low concentrations. CAS-shuttle solution increased the transfer speed of Fe 
from the dye to DFO, but this was not true for carvacrol (Figure 6 A&B). Together, these 
results indicate that carvacrol does not bind iron strongly, but it may be able to disturb iron-
ligand complexes under certain conditions. 
S. Typhimurium global LPS composition during growth with iron and carvacrol
As LPS is an important factor in bacterial adhesion (Bravo et al 2011, Kong et al 2011) 
and carvacrol is known to induce the release of LPS from E. coli O157:H7 (Helander et al 
1998), carvacrol could affect adhesion characteristics of S. Typhimurium by removing LPS 
from the cell surface. We therefore examined the effect of carvacrol on LPS content and 
global LPS composition during growth under moderate to high iron conditions. As shown 
in Supplementary Figure 5, carvacrol up to 0.5 mmol/L did not detectably influence LPS 
quantity or global LPS composition. It should be noted that this general analysis cannot 
visualize LPS in great detail and only indicates that carvacrol did not alter global LPS status 
of S. Typhimurium during growth, which makes it less likely that iron-induced adhesion was 
reduced by modulating LPS integrity at the bacterial surface.
Discussion
Oral iron supplementation has potential harmful side effects on gastrointestinal health 
as a consequence of increased colonization and growth of bacterial pathogens (Kortman 
et al 2012, Zimmermann et al 2010) (Chapter 5). As a result there is a demand for safer 
iron supplementation programmes. Therefore, we here assessed by an in vitro approach 
whether the simultaneous addition of carvacrol as an antimicrobial agent could counteract 
the potential adverse effect of iron on the prevalent intestinal pathogen S. Typhimurium. 
In the present study, we showed that subinhibitory concentrations of carvacrol retarded 
bacterial growth under all tested conditions. Notwithstanding the presence of sufficient 
amount of iron in all conditions, the growth-retardation effect of carvacrol was most 
pronounced under conditions of moderate iron availability. This suggested that its 
antimicrobial activity is partly related to an iron scavenging effect that is less effectual under 
high iron conditions. Nevertheless, we want to emphasize that subinhibitory concentrations 
of carvacrol delayed growth of S. Typhimurium under all conditions. Hence, the previously 
described antimicrobial activity of carvacrol also applies for conditions with high iron 
availability (Burt 2004). Although the ability to replicate is important for bacterial pathogens, 
the adhesion to host tissues or epithelium is pivotal to establish an infection. Our current 
data confirm previous findings that iron induces adhesion of S. Typhimurium to intestinal 
epithelial cells in vitro (Kortman et al 2012) (Chapter 5). Importantly, pre-incubation of 
S. Typhimurium with subinhibitory concentrations of carvacrol clearly reduced adhesion 
induced by moderate to high iron concentrations. Together, these observations support 
211
Iron induced virulence of Salmonella Typhimurium at the intestinal epithelial interface can be suppressed by carvacrol
6
the use of carvacrol as a potential additive in oral iron preparations to prevent pathogenic 
overgrowth and colonization during iron supplementation. 
An antimicrobial additive in an iron preparation should not decrease iron uptake from 
the intestinal lumen or, ideally, should increase it. We therefore investigated the effect of 
carvacrol on the uptake of iron from different sources by intestinal epithelial Caco-2 cells. 
Expression of ferritin was used as a read-out, which is commonly used as a gold standard 
to study bioavailability of iron preparations (Glahn et al 1998). Although carvacrol clearly 
restricted iron uptake of both ferrous sulfate and ferric citrate, it did not block iron uptake 
completely like tannic acid did, a well-known iron binder (South and Miller 1998). In general, 
the bioavailability of ferrous iron is better than ferric iron (Hernandez et al 2003, Santiago 
2012, Yokoi et al 2009), but with ferric citrate higher amounts of ferritin were measured as 
compared to ferrous sulfate, indicating that in this system the bioavailability of ferric citrate 
is better. The higher solubility and stability of ferric citrate compared to ferrous sulfate is 
probably the explanation for this observation. Thus, carvacrol seems not to meet the ideal 
criteria of an iron additive as it impairs iron uptake by intestinal cells in vitro. Nevertheless, 
this decreased level of iron bioavailability could still suffice for adequate iron uptake and 
healthy iron homeostasis in vivo, whereas it may be accompanied by a desirable decrease in 
virulence of pathogenic gut bacteria. 
Iron scavenging by carvacrol could have explained the growth delay and decreased adhesion 
of S. Typhimurium under moderate iron conditions and the decreased bioavailability of iron 
to Caco-2 cells in the presence of carvacrol. However, based on the molecular structure of 
carvacrol it seems unlikely that it can bind iron ions. Additionally, in the present study we 
showed that carvacrol could not remove iron from the high affinity protein transferrin, 
but was able to dissociate a dye-Fe complex during prolonged incubations. Together, this 
indicates that carvacrol seems not to bind iron directly, but is able to disturb iron-ligand 
complexes with lower affinity. It can therefore be envisaged that carvacrol may interfere 
with iron uptake pathways of intestinal epithelial cells rather than making it less bioavailable 
by scavenging of iron ions. However, it remains to be elucidated by which molecular 
mechanisms carvacrol could affect cellular iron uptake systems. In contrast to the reduced 
iron uptake by intestinal epithelial cells, we were not able to show a significant effect of 
carvacrol on iron uptake or influx into S. Typhimurium. Consequently, the observed effects 
of subinhibitory concentrations of carvacrol on iron-induced growth and adhesion can 
probably not be explained by interference with bacterial iron uptake or increased influx, but 
instead seems predominantly caused by other (iron-independent) activities of carvacrol. 
Although total iron content of S. Typhimurium was not altered by carvacrol, the free 
intracellular iron pool balance could be distorted. A potential elevation of the intracellular 
“free” iron pool may enhance cell stress via generation of oxygen radicals (Fenton chemistry). 
This increased iron toxicity may contribute to an overall reduced fitness of the bacteria, 
which could very well result in the observed adhesion defects under iron-replete conditions 
in the presence of carvacrol. If true it remains difficult to explain why S. Typhimurium 
grows slightly better in medium with carvacrol and high iron concentrations, but adheres 
less well under these conditions when compared to bacteria grown under intermediate 
iron conditions with carvacrol. Another possible explanation for the carvacrol-induced 
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delay in growth and decreased adhesion of S. Typhimurium involves a decrease in outer 
membrane integrity/stability or an altered surface structure. Carvacrol is known to induce 
release of LPS from E. coli O157:H7 (Helander et al 1998). Similarly, iron depletion is 
associated with reduced LPS content in Helicobacter pylori (Keenan et al 2008). As LPS is a 
known modulator of bacterial adhesion, both iron concentration and addition of carvacrol 
could therefore theoretically affect S. Typhimurium adhesion. However, the outcome of 
our first LPS characterization experiments did not show a clear alteration of LPS content 
or structure when S. Typhimurium was grown in the presence of iron and carvacrol. 
Nevertheless, carvacrol and high concentrations of iron could still destabilize the bacterial 
outer membrane through interference with divalent cations such as Mg2+ and Ca2+ that bind 
to the anionic LPS and hereby stabilize the outer membrane (Nikaido 2003). Carvacrol 
and iron could somehow distort this delicate balance and thereby indirectly influence LPS-
mediated adhesion. To asses this hypothesis, the potential interaction of iron and carvacrol 
with LPS needs to be investigated further in greater detail. This could involve the detection 
and characterization of LPS shed into the medium using additional LPS characterization 
techniques.
In summary, the natural antimicrobial carvacrol can potentially be used as an additive 
during oral iron therapy to prevent pathogenic overgrowth and colonization in the large 
intestine. Future in vivo research should reveal whether carvacrol can indeed improve 
safety of oral iron therapy. The success of this approach will depend on defining an optimal 
dose of carvacrol which exerts its antimicrobial effect in the host’s intestines, but does 
not inhibit improvement of host iron status. One challenge in dosing is the absorption 
of carvacrol by the host upper GI-tract which likely results in low concentrations in the 
colon and reduced effectiveness in this target organ. This is probably the reason that oral 
carvacrol administration was previously shown to have little effect on colonic microbiota 
composition in piglets (Michiels et al 2010). Nevertheless, gastrointestinal health in these 
piglets was improved which could for instance relate to a reduction in virulence of low 
abundant gut pathogens, whereas other modes of carvacrol delivery, e.g.in encapsulated 
form, still need to be examined (Michiels et al 2010). Importantly, the latter approach could 
be used for the targeted delivery of antimicrobial activity in the human colon during oral iron 
administration with minimal effect on iron uptake in the ileum of the host. Subinhibitory 
concentrations of carvacrol are nevertheless likely to occur in the colon. Nonetheless, 
subinhibitory concentrations are effective in reducing bacterial virulence as we show in 
the present study and which is supported by previous findings (Inamuco et al 2012, van 
Alphen et al 2012). Under the experimental culture conditions of our study a concentration 
of carvacrol ≥ 0.2 mmol/L was already effective in reducing iron induced adhesion, while 
concentrations ≤ 0.3 mmol/L were well tolerated by the differentiated intestinal epithelial cell 
line Caco-2. The latter is supported by previous findings (Fabian et al 2006) and previous in 
vivo studies have shown that carvacrol as a feed additive is well tolerated and does not show 
signs of great cytotoxicity (Michiels et al 2010, Windisch et al 2008). Another challenge is 
to simultaneously find the optimal iron preparation and dose for effective improvement 
of host iron status, with minimal effect on the gut microbiota. Although we did not test 
the effect of iron carrying substances other than ferric citrate on bacterial virulence, we 
213
Iron induced virulence of Salmonella Typhimurium at the intestinal epithelial interface can be suppressed by carvacrol
6
believe that most soluble iron sources will enhance the virulence of intestinal pathogens as 
we previously showed for ferric citrate (Kortman et al 2012). Taken together, carvacrol is 
a known natural dietary additive, with the potential to prevent gastrointestinal side effects 
during oral iron therapy in infection endemic regions. Nevertheless, it goes without saying 
that future in vivo studies are required to further evaluate the real therapeutic utility of 
carvacrol as anti-infective agent in combination with dietary iron supplements.
Supplementary Figures and legends
Supplementary Figure 1. Effect of iron and subinhibitory concentrations of carvacrol on growth 
of S. Typhimurium.
Effect of carvacrol on S. Typhimurium growth (mean ± range) in medium with 1 µmol/L (grey circles), 10 
µmol/L (squares), 50 µmol/L (triangles), or 100 µmol/L ferric citrate (black circles), n = 2. (A) control conditions 
without addition of carvacrol. (B) With addition of 0.4 mmol/L carvacrol. (C) With addition of 0.6 mmol/L 
carvacrol. 
Supplementary Figure 2. Effect of carvacrol on 
iron induced adhesion of S. Typhimurium to an 
epithelial monolayer.
Adhesion (mean + SD) of S. Typhimurium to a 
monolayer of Caco-2 cells is given as percentage of 
the inoculum and is not normalized for the adhesion 
at the conditions without iron during pre-incubation. 
Data consists of 3 separate experiments in which 
adherent colony forming units were determined 
on different days with duplicate wells, n = 6. 
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Iron is a highly abundant metal on earth and is vital for virtually all organisms, including 
most bacterial species. Nonetheless, iron deficiency is the most prevalent human nutrition 
disorder worldwide and is generally treated by oral iron administration. In particular infants 
and young children in tropical underdeveloped countries with high infection pressure 
are vulnerable to iron deficiency. Ironically, iron supplementation has been associated 
with an increased burden of infectious diseases and accumulating evidence suggests that 
unabsorbed iron can stimulate growth and virulence of bacterial pathogens in the intestinal 
environment. Simultaneously, host iron status influences the intestinal defense against 
pathogens. 
The human gut is the natural habitat for a unique large and dynamic bacterial community. 
Major functions include important trophic effects on intestinal epithelia, on immune 
structure and function, and protection of the colonized host against invasion by pathogenic 
microbes via the production of trophic metabolites and immunostimulatory molecules. 
The healthy gut microbiota is a balanced community that is shaped by host immunity and 
metabolism and environmental factors. Perturbations of the balanced gut microbiota have 
been associated with gastrointestinal disorders such as diarrhea, gastroenteritis and chronic 
inflammatory bowel disease. Importantly, oral iron administration has been associated with 
a potentially more pathogenic gut microbiota profile and an increase in diarrhea and gut 
inflammation. This thesis covers the multifaceted aspects of nutritional iron with respect 
to growth, composition, metabolism and pathogenicity of the gut microbiota in relation to 
human health.
Clinical outcomes of oral iron fortification and the effects on the gut microbiome 
in Kenyan infants
Chapter 2 describes the clinical outcomes of oral iron fortification and the effects on the gut 
microbiome in a clinically very relevant target population; Kenyan infants living in a rural 
area where infections are endemic. One group of infants received a micronutrient powder 
(MNP) containing 2.5 mg iron and another group received a different MNP containing 12.5 
mg iron, the control groups received a MNP without iron. Remarkably, after 4 months the 
iron-fortified groups showed a lower relative abundance of beneficial Bifidobacteriaceae 
and a higher relative abundance of potentially pathogenic Enterobacteriaceae, while 
also the ratio of Enterobacteriaceae to Lactobacillaceae was increased. Importantly, iron 
fortification increased the abundance of pathogenic E. coli strains and caused elevated fecal 
calprotectin levels, indicating increased intestinal inflammation. In this setting, provision 
of iron-containing MNPs to weaning infants thus adversely affects the gut microbiome and 
appears to promote gut inflammation. This study underscores the importance of further 
basic research on the effects of iron on the gut microbiota for which both in vitro as animal 
models were exploited as outlined below.
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Iron-induced changes at the host-microbial interface in experimental models: gut 
microbiota composition, metabolism and host responses
Chapter 3 extensively describes the effects of supplementary iron in different formulations 
and doses on the human gut microbiota. This was studied in the well suited and highly 
controlled TNO’s Intestinal Model for the human large intestine (TIM-2). Microbiome 
analysis showed clear iron-induced changes and prominent shifts included a relative 
decrease of beneficial Bifidobacteriaceae and Lactobacillaceae under iron-rich conditions. 
Metagenomic analyses showed a general enrichment of bacterial motility-chemotaxis 
systems under iron-rich conditions. Metabolome profiling showed that gut microbial 
activity markedly shifted from a saccharolytic to a proteolytic profile in response to iron, in 
particular with ferrous sulfate. Importantly, cell viability tests showed increased cytotoxicity 
of metabolite-containing effluent from iron-rich conditions. These data indicate that iron 
preparations induce a more hostile intestinal environment characterized by i) reduction 
of beneficial microbes, ii) increased levels of bacterial metabolites that can impair the 
barrier function of the gut wall, and iii) increase of virulence-associated pathways of enteric 
pathogens. 
Both the in vivo Kenyan field study (Chapter 2) as well as the experiments with the in vitro 
model for the large intestine (Chapter 3) show that supplementary iron can change the gut 
microbiota composition towards a potentially more pathogenic profile. In combination with 
an increased toxicity in vitro (Chapter 3) and increased gut inflammation in vivo (Chapter 
2) this may be a bad recipe for the human host. Intestinal inflammation is highly associated 
with dysbiosis of the gut microbiota and we hypothesized that oral iron administration 
exaggerates intestinal inflammation caused by bacterial infection, via promoting pathogenic 
growth and virulence or via effects on the host inflammatory response. These hypotheses 
were tested in a mouse model as well as in a simple nematode model for intestinal infection, 
and are described in Chapter 4. Dietary intervention (iron-deficient, normal-iron, or high-
iron diet) significantly altered tissue iron stores in uninfected mice and in mice infected 
with Citrobacter rodentium. Microbiome analysis, like in the human and in vitro studies, 
revealed a lower relative abundance of Bifidobacteriaceae and Lactobacillaceae in iron-
supplemented mice compared to mice on a iron-deficient diet. Fecal levels of the innate 
defensive molecules and markers of inflammation lipocalin-2 and calprotectin were lower 
in iron-deprived infected mice. These mice also tended to have a lower grade of colon 
pathology and to gain more weight. Surprisingly, similar to animals on the iron-deficient 
diet, mice on the high-iron diet also showed decreased intestinal inflammatory responses 
compared to the normal-iron diet. Notably, iron-deprivation was associated with prolonged 
survival of the nematode Caenorhabditis elegans after infection with Salmonella enterica 
serovar Typhimurium, while supplementary iron increased the pathogenicity of this 
pathogen (see also Chapter 5; described below). Together, these experiments support the 
notion that low iron intake is beneficial in case of intestinal infection and inflammation, but 
also suggest that the clinical outcomes of oral iron administration may highly depend on 
the iron status, immune status and the gut microbiota composition of children that receive 
oral iron treatment. 
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Iron-induced virulence of intestinal pathogens at the intestinal epithelial interface 
in vitro
In Chapter 5 we investigated the effect of iron on bacterial growth, bacterial attachment to 
intestinal epithelial cells, and the ability of bacteria to break through an intestinal epithelial 
cell layer in vitro. Our results clearly show that supplementary iron can promote growth 
and adhesion of intestinal pathogens, which potentially plays an important role during the 
initial and succeeding stages of gut-borne infections in the human body. These data fit with 
the consensus that oral iron administration in underdeveloped tropical countries is not 
without risk as iron could, in addition to inducing pathogenic overgrowth, also increase the 
virulence of prevalent enteric pathogens. 
The outcomes of these experiments raised the question which bacterial mechanisms are 
responsible for the increased ability to adhere to intestinal epithelial cells. This motivated 
us to explore which iron-induced bacterial factors were involved as understanding of 
iron-induced adhesion mechanisms may provide leads for preventive interventions. 
Explorations at the surface of the model organism S. Typhimurium suggested that iron-
induced adhesion is rather due to a change in surface LPS expression and composition 
than to a change in the expression of surface adhesion proteins (data not shown and ongoing 
investigations).
In Chapter 6 we explored the potential of carvacrol, a natural compound with antimicrobial 
activity against various intestinal bacterial pathogens, in preventing iron-induced 
pathogenicity of S. Typhimurium. This study investigated a presumed interaction between 
carvacrol, bacterial adhesion and iron handling, and the ability of carvacrol to interfere 
with LPS structure at the surface of S. Typhimurium. Carvacrol retarded growth of S. 
Typhimurium at any iron concentration. Furthermore, iron-induced epithelial adhesion 
was effectively reduced by carvacrol at high iron concentrations. With our experiments we 
could not show that carvacrol altered LPS abundance or structure at the bacterial surface, 
but carvacrol was able to weaken iron-ligand interactions by which it may possibly interfere 
with bacterial virulence. In conclusion, our in vitro data suggest that carvacrol has the 
potential to serve as a novel dietary supplement to prevent pathogenic overgrowth and 
colonization in the large intestine during oral iron therapy, but for which further in vivo 
research is warranted.
Conclusion
Together, this thesis exemplifies that oral administration can increase the abundance 
of intestinal pathogens and may increase their pathogenicity, while it may decrease the 
host intestinal defense (i.e. via: iron-induced oxidative damage to the gut wall, increased 
production of toxic microbial metabolites affecting the gut wall, or a decreased host innate 
defense) at the same time. This undesired combination may provide intestinal pathogens 
with increased opportunities to evade the host defense during oral iron therapy. This 
strengthens the idea that oral iron administration programs in developing countries with 
high infection pressure need to be set up with the highest amount of care, and should 
be accompanied with close health monitoring until the remaining questions about the 
actual effect of iron at the intestinal host-microbiota interface have been unraveled. 
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Future research should also be directed at finding iron formulations that minimize the 
negative impact on the gut microbiome. This thesis exposes health problems and potential 
threats with regarding to oral iron administration and it increases the understanding of 
iron-driven alterations of host-pathogen interactions, which is indispensible in the design 





This thesis provides a comprehensive view on the effects of oral iron treatment on the gut 
microbiota. As described in the summary, it documents novel findings that show profound 
effects of iron supplements on microbiota composition, metabolism and virulence. A 
burning question that remains to be answered is however whether these generally adverse 
effects are indeed a threat for human health. 
Adverse effects of oral iron administration on the gut microbiota and clinical 
relevance
Iron deficiency is widespread among the world, even in industrialized countries, and 
treatment with orally administrated iron is commonly associated with gastrointestinal 
complaints, such as diarrhea, constipation and nausea (Schumann et al 2007). Notably, iron 
deficiency is much more prevalent in developing countries with a high burden of infectious 
diseases and, importantly, in these areas oral iron administration has been associated with 
an increased morbidity and a tendency towards increased mortality among African children 
(Sazawal et al 2006). Especially iron-replete children that received extra iron appeared to 
suffer from this treatment, suggesting that iron treatment should be targeted at iron-deficient 
individuals only. In this study most adverse events appeared to be due to malaria, but also 
other infections, possibly in part derived from invading intestinal pathogens, were among the 
adverse events (Sazawal et al 2006). 
As a large part of orally administrated iron is not taken up by the upper intestine, most 
iron ends up in the colon were it, at least partly, becomes available to the large and diverse 
community of gut microbes. In the past few years multiple studies (including studies in this 
thesis) have shown that iron indeed can alter the gut microbiota composition, can influence 
gut microbial metabolism, and can enhance the virulence of intestinal pathogens in vitro 
(Chapters 1-5). In the aforementioned study of Sazawal et al., iron supplementation was not 
associated with an increased incidence of diarrhea, but it has been systematically reviewed 
in 2002 that oral iron administration causes a slight increase in the risk for diarrhea (Gera 
and Sachdev 2002), which was corroborated by additional recent studies (Soofi et al 2013, 
Zlotkin et al 2013) (Chapter 2). The effect of oral iron administration on diarrhea outcome is a 
major concern as diarrhea is a common symptom of intestinal infection, and is an important 
cause of death among African children (WHO and UNICEF 2009, WHO 2013). One study 
among Pakistani children showed that Aeromonas spp. were increasingly detected in diarrhea 
samples from children on micronutrient fortification (including iron) compared to children 
on placebo treatment (Soofi et al 2013). Aeromonas spp. are a known cause of diarrhea in 
Asia (Kotloff et al 2014) and this is so far the first intestinal pathogen that has been shown to 
be associated with micronutrient-induced diarrhea. It should be noted that micronutrients 
other than iron might have contributed to the effect in the Pakistan study. Two recent 
studies among African children and infants showed clear iron-induced adverse effects on 
the microbiome composition (Zimmermann et al 2010) (Chapter 2) and showed a higher 
level of gut inflammation (as reflected by fecal calprotectin levels) in the groups treated with 
iron. In the first study performed in Ivory Coast, gut inflammation was correlated with an 
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increase in Enterobacteriaceae (Zimmermann et al 2010). However, an iron fortification study 
performed in Kenya did not yield gut microbiome related associations for the increased level 
of gut inflammation (Chapter 2). Overall, these latter two studies did not report any study 
related serious adverse effects. The number of individuals in these studies might have been 
too small to detect a significant increase in morbidity, but it should be noted that the Kenyan 
infants in the subgroup with a dose of 12.5 mg iron per day tended to require treatment for 
diarrhea more often compared to infants in the control group. Together, these African field 
studies clearly show an undesirable shift of the gut microbiome towards one with an increased 
pathogenic potential, which goes together with a higher level of gut inflammation. The clinical 
implications of this shift and potential effects on the long term are nevertheless not yet clear 
and require further investigations. 
As described in Chapter 1, various studies have described differential outcomes of the effects 
of iron fortification/supplementation on the gut microbiota composition. We note that, 
among other influences, the dose of iron and the length of treatment will have contributed to 
the differential findings so far. This is underscored by findings in Chapter 2. In this chapter, 
the low and medium iron doses had only a slightly different effect on the gut microbiota 
composition of (mainly breast-fed) Kenyan infants. However, the ratio of Enterobacteriaceae 
to Lactobacillaceae or Bifidobacteriaceae was only higher in the iron groups after 4 months 
of fortification, while this was not the case after 3 weeks. Even the opposite was found 
for the Enterobacteriaceae to Lactobacillaceae ratio at 3 weeks, pointing at a temporary 
potentially beneficial effect. It should however be noted that rapid fluctuations in the gut 
microbiome at 3 weeks, caused by the recent introduction of complementary feeding, may 
have contributed to this effect. This indicates it is important to allow the gut microbiome 
time to adapt to changes in diet when evaluating an intervention and comparing different 
trials. Overall, fortification/supplementation studies nevertheless support the notion of 
the studies in Africa that Lactobacillaceae and Bifidobacteriaceae decrease, while members 
of the Enterobacteriaceae tend to increase upon supplementary iron (Chapter 1). It is yet 
unknown if, and to what extent this effect can persist after discontinuation of iron treatment.
It is not only the effect of iron on the gut microbiota composition that raises concerns 
with regard to safety, also the combination with other (potential) effects of supplementary 
iron on the gut microbiota and the host intestine indicate that prudency is needed when 
supplementing iron in regions with high infection pressure and low hygiene standards. First 
of all, as outlined in Chapter 1, iron may elicit direct harm to the gut by the generation of 
oxidative stress, thereby increasing the permeability of the gut wall. Secondly, this effect 
may be enhanced by the increased production of toxic metabolic products associated with 
proteolytic activity of the gut microbiota (Chapter 3). It should be noted that this effect 
has so far only be demonstrated in vitro, and which thus requires further investigations. 
In the third place, this thesis also shows that iron can induce the virulence of intestinal 
pathogens in vitro (Chapter 5) and in a simple in vivo intestinal infection model (Chapter 4). 
Furthermore, it can increase the relative abundance of virulence associated pathways 
within the gut microbiota in an in vitro model for the human large intestine (Chapter 3). 
The effects of oral iron treatment on the virulence of intestinal pathogens and its 
implications have however not yet been investigated in human individuals. Finally, host 
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iron status and the gut microbiota composition influence the host immune response. Vice 
versa, host iron status and immune responses influence the gut microbiota composition. 
It is therefore difficult to predict what the effects of oral iron administration are on the 
inflammatory response of iron deficient and iron replete individuals. This thesis shows 
that oral iron administration appears to attenuate the intestinal inflammatory response in 
mice (Chapter 4), which is in particular undesired in combination with the aforementioned 
adverse effects of iron on gut microbiota composition, metabolism and virulence. Also this 
issue needs further investigation to unravel the underlying mechanisms of this attenuated 
inflammatory response and to find out how this is related to the increase in gut inflammation 
and infectious disease that has been observed in the field studies in Africa. More insight in 
this complex interplay may help us to prevent potential attenuating effects of supplementary 
iron on the host immune system.
Taken together, a tempting question is whether the adverse effects of oral iron administration 
on the gut microbiota and intestinal defense can contribute to an increased incidence of 
infectious diseases which has previously been shown in the larger clinical trials and meta-
analyses (Gera and Sachdev 2002, Iannotti et al 2006, Oppenheimer 2001, Sazawal et al 2006, 
Zlotkin et al 2013). This question is difficult to answer due to lack of direct evidence, but it 
is conceivable that part of the iron-induced reported infections may have originated from 
the gut. Although this question remains to be answered, the reported increase in diarrhea 
and gut inflammation upon oral iron treatment is nonetheless worrisome and clinically 
very important. The current data points at a role of the gut microbiota in this matter and 
implicates that the negative impact of oral iron administration on the gut microbiota needs 
to be minimized.
Future perspectives
Future studies should aim at gaining mechanistic insights in the effects of oral iron 
administration on the gut microbiota and host responses, which will aid in the development 
of safe iron administration programmes. Simultaneously, future research should already 
be directed at finding ways of iron administration that prevent adverse effects on the gut 
microbiota. Both types of research should be done in experimental models that reflect 
better the clinically relevant human situation. Until safe approaches have been found, iron 
administration programmes in infection endemic regions should be executed according to 
the recommendations of the World Health Organization (WHO) as described below. 
 
Development of experimental models that better reflect the clinically relevant 
human situation
As indicated above, the effects of iron on gut microbial virulence and metabolism need to 
be investigated in more relevant in vivo situations. In vivo studies should in particular reveal 
whether oral iron administration can indeed enhance the virulence of intestinal pathogens, 
whether it indeed stimulates gut microbial proteolytic activity in the human intestine, and 
which clinical consequences this might have. Past studies can help us in finding the most 
optimal design of future studies, as they revealed the limitations of study models and gaps 
in knowledge of how iron behaves in the colon. The most clinically relevant setting for 
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this research is in developing countries where iron deficiency and infections are highly 
prevalent. This setting is difficult to simulate in vitro and in vivo models, but an advantage 
is that these models can be better controlled. Studies in industrialized countries so far not 
only involved in vitro and in vivo models, but were also performed with infants from these 
countries. Although similar studies can still be very useful in finding oral iron preparations 
with less impact on the gut microbiota, we should realize that they do not totally reflect 
the clinically most relevant situation. Other past studies involved rats and mice with a 
very different gut microbiota profile and dietary intake compared to humans, or in vitro 
fermentation models with a microbiota from healthy ‘Western’ individuals. Notably, iron 
concentrations and availability in vitro do not necessarily reflect the in vivo situation and 
animal iron depletion-repletion models may not accurately represent the relevant human 
situation (Chapter 1). Several measures could however bring these models closer to the 
clinical relevant setting, which will be discussed below.
Animal models can possibly be improved by establishing a humanized gut microbiota 
first, which so far has been done for one iron-related study (Dostal et al 2014). To get 
even more close to the most relevant situation this humanized microbiota should ideally be 
derived from (anemic) infant/child stools from a rural setting with high infection pressure. 
Most relevant for studying both iron bioavailability to the host and the effects on the gut 
microbiota are iron-deficient animals. Notably, past studies did establish iron deficiency 
by feeding the animals an iron-deficient diet, but other ways such as iron chelation or 
phlebotomy might have been better alternatives as an iron-deficient diet not only lowers 
host iron status, it also directly alters gut microbiota composition and activity. Hence, 
the gut microbiota had already changed before an iron preparation was administrated, 
which makes it difficult to distinguish the effects of initial iron depletion from the effects 
of consequent iron supplementation on the gut microbiota. Even though iron deficient 
individuals have a low iron status, their diet usually is not that much depleted from iron 
(though it is likely to be lowly bioavailable). This is underscored by iron measurements in 
feces of iron deficient weaning infants fed with complementary solid food, which show that 
their total fecal iron content is comparable to that of adults consuming western type diets 
(Chapter 1). This also appeared from our preliminary iron measurements in feces of Kenyan 
infants (data not shown). 
The relevance of in vitro gut models, which are in particular useful to study gut microbial 
metabolic activity, can also be improved. Also in this case fecal samples which more 
closely resemble the gut microbiota of infants/children from rural areas with high 
infection pressure may be used. In combination with mammalian cell models these 
gut models can be very valuable tools to study the effects of iron on both the gut microbiota 
and the host. Also here the iron concentrations applied are important and should 
closely resemble the fecal iron concentration of infants/children. By determining 
iron speciation in vitro gut models and comparison with the in vivo situation, better 
insight in the relevance of these in vitro models can be obtained. By simulation of the 
digestive tract from the mouth onwards an iron speciation profile more similar to 
the in vivo situation can possibly be attained. Achieving this can however in particular 
be very challenging in cell culture models as iron added to culture media will have a 
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completely different availability and speciation profile compared to iron in feces, or iron in 
fermentation media (used in in vitro gut models) that more closely resemble feces. 
Gaining mechanistic insights in the utilization of iron by gut microbiota members
As described above, iron measurements in feces can help to find the most relevant fecal 
iron concentration to simulate in the experimental models. It is pivotal to also look into 
the speciation of iron and the ability of gut microbes to utilize this iron, as total fecal 
iron concentration cannot predict the availability to the gut microbiota. This is not only 
relevant for experimental models, but also in the human situation as increased insights 
in the iron speciation and availability can help us in the design of oral iron administration 
approaches that do not increase the availability of iron to the gut microbiota. Notably, 
when the speciation of supplementary iron in the colon has been analyzed, it will still 
be difficult to evaluate the bioavailability of the various iron species. A good alternative 
indicator for iron availability to the gut microbiota is potentially siderophore production. If 
iron bioavailability to the microbes in the colon lumen is high, siderophore production will 
likely be low and vice versa. Levels of bacterial siderophores in the colon lumen or feces may 
therefore predict iron availability to the gut microbiota. In case an oral iron preparation 
results in lower siderophore levels, this indicates that the iron becomes available to the gut 
microbiota. However, practical assays to measure siderophores in human and animal feces 
need to be developed.
A methodology to actually pinpoint the bacteria that take up the supplemented iron can 
be the Halogen In Situ Hybridization-Secondary Ion Mass Spectroscopy (HISH-SIMS). 
With this technique stable iron isotopes can be quantified within bacterial cells, and 
by staining the same cells with specific probes (on the genus or family level) it can be 
deduced which bacteria take up the extra iron. Next, by applying metabolomic, 
metatranscriptomic and metaproteomics analyses a much better view on the actual 
metabolic and pathogenic activity of the gut microbiota in response to iron can be obtained. 
These approaches will gain mechanistic insights that aid in the design of more safe oral iron 
administration programmes.
Prevention of iron-induced adverse effects on the gut microbiota
To minimize the impact of oral iron administration on the gut microbiota, while maintaining 
or increasing bioavailability to humans, strategies to prevent undesired effects of iron on the 
gut microbiota need to be developed. Although this is most important in developing countries 
where infections are highly endemic, it is conceivable that such strategies also increase the 
tolerance of the gastrointestinal tract for oral iron in western society. Chapter 1 describes 
various approaches to achieve this, but most have not yet been tested for their effects on the 
gut microbiome. Successful strategies of universal administration with a minimal impact 
on the gut microbiota depend on the combination of successful improvement of host iron 
status of the person in need with i) the prevention of gut microbiota iron uptake, or ii) the 
simultaneous suppression of intestinal pathogens, or iii) the stimulation of beneficial gut 
microbiota members such as Bifidobacteriaceae and Lactobacillaceae, hereby restraining 
pathogenic growth and/or improving gut health. 
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One approach that has been tested in this thesis is the provision of iron in a low dose, 
but highly bioavailable preparation, to prevent large amounts of iron entering the colon. 
However, as outlined in Chapter 2, in Kenyan infants this approach was not successful as 
their gut microbiota still shifted towards a more pathogenic profile, similar to children that 
received a 5 times higher dose. Importantly, the low dose approach did not yield a better 
iron status, while the higher dose approach did successfully improve infant iron levels. This 
also questions the approach of universal iron fortification programmes without screening 
individuals for actual iron deficiency, while screening was already recommended by the 
WHO (WHO 2007). If adverse effects on the gut microbiota in iron deficient individuals 
are accompanied by an improved body iron status, the possible adverse effects may be 
acceptable as long as health is closely monitored. In contrast, adverse effects on the gut 
microbiome are surely not acceptable in iron replete infants, because they do not benefit 
from the iron fortificant. Screening of individuals for their iron status in underdeveloped, 
rural and infection endemic regions is however highly challenging and costly, while proper 
biomarkers to this purpose have not yet been found. The peptide hormone hepcidin, 
that regulates body iron homeostasis, has been proposed as a promising biomarker to 
this purpose (Prentice et al 2012). Hepcidin levels usually decrease when the iron requirement 
of the body is high, and increase upon infection. Notably, in severely anemic individuals, 
hepcidin levels can be low despite infection, which limits its value as a biomarker to guide 
safe iron administration (Jaeggi et al 2013, Jonker et al 2014, Jonker et al 2013) (Chapter 1). 
Notably, iron treatment to combat iron deficiency is needed because iron deficiency has 
major health consequences such as impaired physical and cognitive development of children 
(McCann and Ames 2007, WHO and UNICEF 2004). The benefits are thus substantial and 
not treating iron deficiency to prevent adverse effects is therefore not under consideration, 
but sufficient health care to combat adverse effects and to monitor health during oral iron 
treatment should be available (WHO 2007). 
In this thesis, next to the provision of a highly bioavailable low dose iron preparation, one 
other approach of preventing an increase in pathogenic gut microbiota members during 
oral iron administration was explored. This is the provision of the antimicrobial compound 
carvacrol, as described in Chapter 6. It is interesting to note that carvacrol may not only 
prevent iron-induced virulence of intestinal pathogens, but also inhibit the microbial 
production of (proteolytic activity related) isobutyrate, isovalerate and valerate. It has 
previously been shown that carvacrol can reduce the production of these compounds in 
swine waste, while lactate accumulated when carvacrol was added (Michiels 2009). Next to 
its inhibiting effects on growth and virulence of pathogens as described above, carvacrol 
may thus have the potential to prevent the iron-induced undesired metabolic changes that 
were described in Chapter 3, but this issue is subject to further investigations. In addition, 




To further investigate the clinical relevance, future studies should be directed to: 
I.  further assess the potential involvement of iron-induced changes in the gut microbiota 
(composition, metabolism, virulence) in the development of:
 a. diarrhea,
 b. intestinal inflammation, 
 c. and invasive disease;
To increase the understanding of iron-host-microbiota interactions and thereby aid in 
the design of more safe oral iron preparations, future studies should be performed in 
experimental models that closely mimic the human in vivo situation and should aim at 
elucidating:
II. iron speciation and availability in the colon;
III. the effect of oral iron administration on gut microbial siderophore production;
IV. which members of the gut microbiota:
 a. utilize the orally administrated iron, 
 b. are responsible for the undesired metabolic shift in response to iron,
 c. get more virulent in response to iron;
V.  the complex interplay between host iron status, host immunity and gut microbiota;
Furthermore, future research should be directed at:
VI.  developing a point of care test that easily discriminates between iron-deficient and 
iron-replete individuals. This would allow to selectively target the iron to those in need, 
until safe formulations for universal use have been developed.
Concluding remarks
This thesis provides multiple novel insights in the effects of iron on the gut microbiota 
and its pathogenic members; it becomes clear that iron has profound effects on the gut 
microbiota composition, metabolism, and virulence of intestinal pathogens. Together, this 
points at unbeneficial effects from the host’ perspective. Although these unwanted side-
effects need to be examined in closer detail, it is anyhow desired to reduce the risk for 
dysbiosis, intestinal infection and diarrhea. More knowledge on the responses of gut bacteria 
to supplementary iron will aid in the design of novel iron supplementation strategies that 
improve host iron status while minimizing the negative impact on the gut microbiota and 
gut health.
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IJzer is één van de meest voorkomende metalen op aarde en is essentieel voor 
nagenoeg alle levende wezens, waaronder de meeste soorten bacteriën. Ondanks de 
grote hoeveelheid ijzer op onze aardbol is ijzertekort bij mensen wereldwijd de meest 
voorkomende voedingsgerelateerde stoornis. Vooral baby’s en jonge kinderen in tropische 
ontwikkelingslanden waar veel infecties voorkomen, zijn vatbaar en hebben vaak ijzertekort. 
IJzertekort wordt meestal behandeld door ijzersupplementatie in de vorm van tabletten of 
verrijking van voedsel met ijzer, maar uit onderzoek blijkt dat dat ervoor kan zorgen dat 
kinderen in die landen meer infecties krijgen. 
Niet al het ijzer uit supplementen of voeding wordt opgenomen in het eerste deel van de darm, 
en komt in de dikke darm terecht. De menselijke dikke darm is de natuurlijke leefomgeving 
van een unieke, grote en dynamische darmflora (darmmicrobiota, ofwel alle bacteriën en 
andere micro-organismen in de darm samen). Het heeft een belangrijke positieve invloed 
op ons immuunsysteem en de gezonde darmmicrobiota beschermt onze darm tegen invasie 
van pathogene (ziekteverwekkende) bacteriën. De gezonde darmmicrobiota is in balans en 
wordt gevormd door ons immuunsysteem, onze stofwisseling en omgevingsfactoren zoals 
voeding. Onder andere de ijzerstatus (de hoeveelheid ijzer in het menselijk lichaam) is van 
belang voor een goede werking van de afweer in de darm. De gebalanceerde microbiota 
kan verstoord raken en dit komt voor bij darmziekten zoals diarree, darminfectie en 
chronische inflammatoire darmziekten. De afgelopen jaren is steeds meer bewijs gevonden 
dat ijzersupplementatie en ijzerverrijking de groei en pathogeniciteit (het vermogen van 
bacteriën om infecties te veroorzaken) van bacteriën in de dikke darm kan stimuleren. 
Daarnaast is het geassocieerd met een toename van diarree en ontsteking van de darm. 
Dit proefschrift beschrijft verscheidene aspecten van ijzertoediening in relatie tot de groei, 
samenstelling, metabolisme en pathogeniciteit van de darmmicrobiota en de effecten op 
menselijke gezondheid.
Klinische resultaten van ijzerverrijking en effecten op de darmmicrobiota in 
Keniaanse baby’s
In Hoofdstuk 2 beschrijven we de uitkomsten van ijzerverrijking en de effecten op de 
darmmicrobiota in een klinisch relevante doelpopulatie; Keniaanse baby’s die opgroeien in 
een plattelandsgebied waar infecties veel voorkomen. Eén groep baby’s in deze studie gaven 
we dagelijks een micronutriëntenpoeder (MNP) dat 2,5 mg ijzer bevatte en een andere groep 
kreeg een ander MNP met 12,5 mg ijzer. De controlegroepen kregen een identiek MNP, maar 
zonder ijzer. Na 4 maanden was er in de groep die ijzerverrijking kreeg een lagere relatieve 
hoeveelheid van gezonde Bifidobacteriaceae te zien, terwijl de relatieve hoeveelheid van 
potentieel pathogene Enterobacteriaceae hoger was dan in de controlegroep. Ook was de 
verhouding tussen Enterobacteriaceae en gezonde Lactobacillaceae significant toegenomen. 
Daarnaast zorgde ijzerverrijking voor een toename van pathogene E. coli soorten en een 
verhoging van de ontstekingsmarker calprotectine, wat een toename in darmontsteking 
aangeeft. In deze studie zorgt de toediening van ijzerbevattende MNPs aan baby’s dus 
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voor een negatief effect op de darmmicrobiota en bevordert het darmontsteking. Dit 
onderstreept het belang van het doen van meer onderzoek naar de effecten van ijzer op 
de darmmicrobiota, waarvoor in dit proefschrift zowel in vitro modellen als diermodellen 
werden toegepast en zoals hieronder beschreven wordt. 
Veranderingen veroorzaakt door ijzer op het grensvlak van gastheer en bacterie: 
samenstelling van de darmmicrobiota, metabolisme en reacties van de gastheer 
Hoofdstuk 3 beschrijft uitgebreid de effecten van verschillende ijzerpreparaten en 
hoeveelheden op de darmmicrobiota van de mens. We hebben dit bestudeerd in een sterk 
gereguleerd en computergestuurd model voor de humane dikke darm; TNO’s Intestinal 
Model (TIM-2). Analyse van de samenstelling van de darmmicrobiota liet zien dat er 
duidelijke veranderingen waren in de testcondities waarbij ijzer aan de darminhoud 
was toegevoegd, met onder andere een afname van de gunstige Bifidobacteriaceae en 
Lactobacillaceae. Analyse van het microbiële metagenoom (genetische eigenschappen 
van de darmmicrobiota) liet een verrijking van mobiliteit- en chemotaxissystemen 
zien in ijzerrijke condities, wat mogelijk het veroorzaken van infecties stimuleert. Het 
metabolisme van de darmmicrobiota verschoof duidelijk van een saccharolytisch (afbreken 
van koolhydraten) naar een proteolytisch (afbreken van eiwitten) profiel, vooral in de 
aanwezigheid van ijzersulfaat. Dat bleek bovendien meer toxische producten te geven die 
schadelijk waren voor gekweekte darmcellen. Samengenomen wijzen deze data erop dat 
ijzerpreparaten een nadelige omgeving in de darm veroorzaken die gekenmerkt wordt door 
i) een afname van gunstige darmbacteriën, ii) een toename van microbiële metabolieten die 
de barrièrefunctie van de darmwand aantasten, en iii) een toename van pathogeniciteits-
geassocieerde eigenschappen van de darmmicrobiota. 
 Zowel de in vivo veldstudie in Kenia (Hoofdstuk 2) als de experimenten met het in vitro 
darmmodel (Hoofdstuk 3) laten zien dat door toediening van ijzer de samenstelling van 
de darmmicrobiota potentieel meer pathogeen wordt. In combinatie met een toegenomen 
toxiciteit (in vitro; Hoofdstuk 3) en een toename van darmontsteking (in vivo; Hoofdstuk 2) 
zou dit een slechte mix kunnen zijn voor de menselijke gastheer. Darmontsteking is sterk 
geassocieerd met een disbalans van de darmmicrobiota en onze hypothese in Hoofdstuk 4 
was dat orale ijzertoediening bacteriële darmontsteking verergert, door het stimuleren van 
de groei en pathogeniciteit van pathogene bacteriën, of door effecten op de immuunrespons 
van de gastheer. Dit werd getest in een muismodel en in een eenvoudig wormmodel voor 
darminfectie. Interventie met ijzer via de voeding (laag-ijzer, normaal-ijzer, of hoog-ijzer) 
zorgde voor een verandering in de hoeveelheid ijzer die opgeslagen is in de lever en de 
milt van niet-geïnfecteerde muizen en muizen die geïnfecteerd waren met de knaagdier- en 
darmpathogeen Citrobacter rodentium. Analyse van de samenstelling van de darmmicrobiota 
liet, net als in de humane en in vitro studies, zien dat er een lagere relatieve hoeveelheid 
van gunstige Bifidobacteriaceae en Lactobacillaceae was in de muizen met ijzer in de 
voeding ten opzichte van muizen op een dieet met een laag ijzergehalte. Daarnaast waren 
de waarden van de afweermoleculen en markers van ontsteking lipocalin-2 en calprotectine 
in de ontlasting verlaagd in ijzerarme en geïnfecteerde muizen. Deze muizen hadden tevens 
een iets lagere graad van darmschade/infectie, zoals bekeken met microscopie, en hun 
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lichaamsgewicht leek minder te lijden te hebben onder de darminfectie. Verrassend genoeg 
hadden de muizen op een hoog-ijzerdieet, net als de muizen op een laag-ijzerdieet, een 
verlaagde ontstekingsreactie vergeleken met muizen op het normaal-ijzerdieet. Een andere 
belangrijke bevinding was dat het weghouden van ijzer bij de darmpathogeen Salmonella 
enterica serovar Typhimurium ervoor zorgt dat de overleving van Caenorhabditis elegans 
wormen, die geïnfecteerd zijn met S. Typhimurium, verlengd wordt. Tegelijkertijd maakte 
dit duidelijk dat ijzer de pathogeniciteit van deze bacterie verhoogt (zie ook Hoofdstuk 5; 
hieronder beschreven). Samen doen deze resultaten vermoeden dat een lage ijzerinname 
gunstig is tijdens darminfectie en ontsteking, maar ze suggereren ook dat de klinische 
uitkomsten van ijzersupplementatie sterk afhankelijk zijn van de ijzerstatus, immuunstatus 
en samenstelling van de darmmicrobiota van individuen die behandeld worden.
IJzergeïnduceerde pathogeniciteit van pathogene darmbacteriën bij het 
darmepitheel in vitro
 In Hoofdstuk 5 hebben we het effect van ijzer op de bacteriegroei, het vermogen van 
bacteriën om aan darmcellen te hechten en het vermogen van bacteriën om door het 
darmepitheel heen te breken, onderzocht. De resultaten maken duidelijk dat extra ijzer 
de groei en hechting van pathogene darmbacteriën aan darmcellen stimuleert. Dit speelt 
mogelijk een belangrijke rol tijdens het vroege stadium van infecties die ontstaan in de 
darm. Deze bevindingen passen bij de algemene gedachte dat ijzersupplementatie in 
ontwikkelingslanden niet zonder risico is, omdat ijzer niet alleen overgroei van pathogene 
darmbacteriën, maar ook de pathogeniciteit van veel voorkomende pathogene darmbacteriën 
zou kunnen stimuleren. 
De bevindingen van deze experimenten roepen de vraag op welke bacteriële mechanismen 
betrokken zijn bij de toename in hechting aan darmcellen. Daarom hebben we gezocht 
naar ijzergeïnduceerde bacteriële factoren die hierbij betrokken zijn, wat mogelijk 
aanknopingspunten biedt voor het nemen van preventieve maatregelen tijdens 
ijzersupplementatie. Onderzoek naar het oppervlak van de pathogene darmbacterie 
S. Typhimurium suggereerde dat ijzergeïnduceerde hechting aan darmcellen mogelijk 
komt door een verandering in de hoeveelheid en samenstelling van het lipopolysaccharide 
(LPS; suikerstructuren met vetketens die in de bacteriemembraan zitten), terwijl een 
verandering in de hoeveelheid van hechtingseiwitten aan het bacterieoppervlak minder 
waarschijnlijk is (deze data staan niet in dit proefschrift).
In Hoofdstuk 6 hebben we onderzocht of carvacrol, een natuurlijke stof met antimicrobiële 
werking tegen verscheidene pathogene darmbacteriën, ijzergeïnduceerde hechting 
van S. Typhimurium aan darmcellen kan voorkomen. Deze studie toetste hiermee een 
veronderstelde interactie tussen carvacrol, bacteriële ijzerhuishouding en hechting aan 
darmcellen, en het vermogen van carvacrol om de structuur van LPS op het bacteriële 
oppervlak te beïnvloeden. Carvacrol vertraagde de groei van S. Typhimurium bij elke 
ijzerconcentratie en het was effectief in het verminderen van ijzergeïnduceerde hechting 
bij hoge ijzerconcentraties. Met onze experimenten hebben we niet kunnen aantonen 
dat dit komt doordat carvacrol de LPS op het bacterieoppervlak beïnvloedt. Wel vonden 
we dat carvacrol de binding van ijzer aan een ijzerbindende stof kan verzwakken, een 
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mechanisme waarmee het mogelijk de pathogeniciteit van bacteriën kan beïnvloeden. We 
concluderen dat deze in vitro data erop wijst dat carvacrol de potentie heeft om als een 
nieuw voedingssupplement te dienen om overgroei en kolonisatie van pathogene bacteriën 
in de dikke darm tijdens ijzersupplementatie te voorkomen. Meer onderzoek hiernaar, met 
name in vivo, is echter vereist om te testen of toediening van carvacrol dat inderdaad kan 
bereiken. 
Conclusie
Samenvattend demonstreert dit proefschrift dat ijzersupplementatie de groei en 
pathogeniciteit van pathogene darmbacteriën kan stimuleren, terwijl het tegelijkertijd 
mogelijk ook de barrièrefunctie en immunologische afweer van de darm kan verzwakken. 
Dat is een ongewenste combinatie die pathogene darmbacteriën mogelijk in staat stelt om 
de afweer van de gastheer tijdens ijzersupplementatie beter te ontwijken. Dit versterkt de 
gedachte dat ijzersupplementatieprogramma’s in tropische ontwikkelingslanden opgezet 
moeten worden met de hoogst mogelijke hoeveelheid zorg. IJzersupplementatie zou 
dus vergezeld moeten gaan met het goed in de gaten houden van de gezondheid totdat 
de opengebleven vragen over het effect van ijzer op de darmmicrobiota en de darm zijn 
beantwoord. Verder onderzoek moet dit uitwijzen en zou ook gericht moeten zijn op het 
ontwikkelen van ijzerpreparaten die weinig of geen negatieve effecten op de darmmicrobiota 
hebben. Dit proefschrift laat zien welke gezondheidsproblemen en potentiële gevaren er 
zijn met betrekking tot ijzersupplementatie. Daarnaast draagt het bij aan de kennis over 
ijzergeïnduceerde veranderingen in de interactie tussen gastheer en pathogene bacteriën, 




Het is pas af als je ermee ophoudt. Met het schrijven van dit laatste, maar belangrijke, 
onderdeel kan ik er bijna mee ophouden en vormt mijn proefschrift een geheel. Dit 
proefschrift is het resultaat van ruim 4 jaar werk, maar was niet geworden tot wat het nu 
is zonder de hulp van vele anderen en waardevolle samenwerkingen. In dit dankwoord wil 
ik daarom graag iedereen bedanken die op de een of andere manier heeft bijgedragen en 
waarbij ik een aantal mensen in het bijzonder wil noemen.
Als eerste wil ik graag mijn promotor Dorine Swinkels bedanken voor het faciliteren en 
begeleiden van mijn promotietraject. Beste Dorine, wat een tekort of een overschot aan ijzer 
met het menselijke lichaam kan doen was jou aan het begin van mijn onderzoek natuurlijk 
al als geen ander al bekend, maar hoe reageren darmbacteriën daar eigenlijk op? Ik vond het 
erg leuk en boeiend dat twee onderzoeksonderwerpen binnen de onderzoeksgroep, ‘ijzer’ en 
‘darmbacteriën’, bij elkaar kwamen in mijn project. Binnen dit project was je enthousiasme 
stimulerend, hebben je ‘so-what vragen’ me aan het denken gezet en hadden we waardevolle 
overlegmomenten waarin we het totaalplaatje duidelijk kregen. “De aanhouder wint”, dat 
komt ook bij me op en dit is inderdaad meerdere keren gebleken. Je advies en steun bij het 
uitstippelen van mijn vervolgcarrière is erg fijn. Bedankt voor dit alles! 
Beste Harold, als copromotor was je het nauwst betrokken bij mijn hele promotietraject. 
Je dagelijkse begeleiding, waarbij je altijd tijd had voor een vraag of discussie, was 
onmisbaar. Meestal leidde dat een pragmatische oplossing waarmee we verder konden en 
wat me het vertrouwen gaf dat ik goed bezig was. Op het gebied van het schrijven van 
een wetenschappelijk artikel, en het gepubliceerd krijgen daarvan, heb ik ook veel van 
je geleerd. Je goede verbeteringen en mooie zinnen hebben een grote bijdrage geleverd 
aan de inhoud van dit proefschrift. We hebben meerdere onderzoekslijntjes uitgezet en 
samenwerkingen gezocht, waarvan de meeste goed zijn uitgepakt en erg leerzaam waren. 
Ter ontspanning waren de gezamenlijke lunchwandelingen erg prettig en zo ook de talrijke 
woordgrapjes. Die woordgrapjes of andere droge humor zorgden ook voor de nodige lach 
als het onderzoek even, of langer, tegenzat. Ongeveer anderhalf jaar geleden is het alweer 
dat je aankondigde het lab te gaan verlaten om een moeder-kind huis te beginnen samen 
met je vrouw, een bijzonder en mooi plan. Je zei meteen dat je de begeleiding van mijn 
promotie zeker af zou maken en dat was voor mij natuurlijk erg fijn. Veel succes met jullie 
onderneming en bedankt voor alles! 
Het spreekt voor zich dat ik nu uitkom bij mijn andere directe collega’s binnen de IJzergroep. 
Annemarie, je hebt me vooral in het begin goed op weg geholpen door me wegwijs te maken 
op de verschillende labs en bij het opzetten van experimenten. Ik vond het ook erg leuk om 
met je samen te werken en het was fijn om promotieperikelen te delen. Rian, wij hebben 
veel experimenten samen gedaan, vooral in de zoektocht naar een antwoord op de vraag hoe 
het komt dat bacteriën beter aan darmcellen hechten als we ze extra ijzer geven. Het kostte 
veel herhalen van experimenten, het doen van vele blotjes en kleuringen, en zelfs een flinke 
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krachtinspanning bij het filter-steriliseren van groeimedia met Salmonella. Uiteindelijk 
hebben de blotjes het net niet gered tot in dit proefschrift, maar ik ga ervan uit dat we ze nog 
gaan publiceren. Wel zien we de LPS-kleuringen, ijzermetingen en calprotectinemetingen 
terug. Erwin, wij hebben vooral op het darmmicrobioomgebied samengewerkt. Je hebt veel 
PCR’s gedaan om darmmicrobiomen voor de verschillende projecten in kaart te kunnen 
brengen. Het duurde soms wat lang door ongrijpbare technische euvels, maar zodra 
deze uit de lucht waren, was het ook zo gedaan. Coby, het eerste wat ik me herinner is zo 
ongeveer het gooien van sneeuwballen bij een vrolijke lunchwandeling… en het volgende 
je hulp en kritische blik bij de ‘iron removal from transferrin assay’. Zo waren er nog wat 
meer pilotexperimentjes en natuurlijk de hepcidinemetingen bij de muizen uit Boston, die 
terug te vinden zijn in dit proefschrift. Siem, jij stond ook steeds paraat, bij het vinden 
van ruimte in de vriezer en het last-minute printen van etiketten. Ook al is het (nog) geen 
begrip geworden op het lab, de betekenis van het woord ‘strube’ (stront-in-een-tube) zal 
ik niet snel vergeten. ’IJzercollega’s’ of ‘IJzerstudenten’ Joyce, Rieneke, Carla, Charlotte, 
Jos, Susanne, Lucas, Louise, Tessel, Nienke, Rachel, Sanne en Rens, we hebben niet veel 
samengewerkt, maar zoals voor de hele IJzergroep geldt: allemaal erg bedankt voor en/
of al het werk, de goede samenwerking en de gezelligheid op het lab, bij congressen en bij 
uitstapjes!
Veel dank ook aan de enthousiaste studenten die ik heb mogen begeleiden. Anne-Claire, 
je hebt veel cellen en bacteriën gekweekt om te onderzoeken of de lipocalin-2 productie 
door darmcellen beïnvloed wordt door ijzer en bacteriën. Jouw werk was de basis en 
inspiratie voor een volgend project waarin we dit verder hebben uitgezocht. Je schreef ook 
een indrukwekkende scriptie en inmiddels ben je zelf met een promotieonderzoek bezig, 
veel succes daarmee! Michelle en Thijs, jullie maakten deel uit van dat volgende project. 
Een stoomcursus labvaardigheden, een stage in Boston en het eraan vastplakken van 
jullie wetenschappelijke stage op ons lab hebben uiteindelijk geleid tot hoofdstuk 4 in dit 
proefschrift en straks een mooie publicatie. Veel succes nog met jullie studie geneeskunde 
en wie weet welk nieuw onderzoek van jullie we nog gaan zien!
Vervolgens wil ik graag alle coauteurs bedanken, allereerst in het Engels. Next, I would like 
to thank all coauthors from abroad. Michael Zimmermann, Diego Moretti and especially 
Tanja Jaeggi from ETH Zürich, it was very nice working with you on the Kenyan infant gut 
microbiome project in which I learned a lot, and which lead to a very nice publication in 
‘Gut’ and to chapter 2 in my thesis. Many thanks and I’m looking forward to work on the next 
gut microbiome project together! Bobby Cherayil from the Massachusetts General Hospital 
in Boston, thank you for all experiments performed in your lab and supervising Thijs and 
Michelle during their fruitful internships. The results of their projects make up a large part 
of chapter 4 in this thesis and that will hopefully be published soon. Albert Bolhuis from 
the University of Bath, of course you can also read Dutch, but the results of the ‘bugs and 
worms’ experiments also made a really nice contribution to the work in chapter 4, thank 
you. Manuela Raffatellu from the University of California at Irvine, thank you very much for 
your contribution to our literature review, which now has been published and which makes 
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up the introduction of this thesis. Nu terug naar het Nederlands. Annet Maathuis en Koen 
Venema van (destijds) TNO in Zeist, de experimenten met het indrukwekkende TIM-2 model 
waren erg waardevol en hebben veel resultaten en nieuwe inzichten opgeleverd die we terug 
zien in hoofdstuk 3 van dit proefschrift. Dank voor al het werk en de goede samenwerking, 
wellicht kunnen we in toekomst nog eens samen nieuwe TIM-2 experimenten doen! Udo 
Engelke en Leo Kluijtmans, jullie 1H-NMR-spectroscopie dan wel organisch zuren analyses 
waren erg waardevol bij het in kaart brengen van het bacteriële metaboloom in TIM-2, 
dat vinden we uitgebreid terug in hoofdstuk 3. Bas Dutilh, je metagenoomanalyses zijn 
een hele mooie toevoeging aan datzelfde hoofdstuk, bedankt voor het inzichtelijk maken 
van deze ingewikkelde data en je kritische blik op het manuscript. Harro Timmerman en 
Jos Boekhorst van NIZO Food Research BV in Ede, bedankt voor jullie erg nuttige input 
en bioinformatische analyses van het darmmicrobioom die belangrijk waren voor maar 
liefst de hoofdstukken 2 t/m 4. De pyrosequencingprojecten hebben veel inzicht gegeven 
in de effecten van ijzer op de samenstelling van het darmmicrobioom. Nu is het volgende 
interessante project alweer aanstaande. Sara Burt van de Universiteit Utrecht, onze posters 
hingen naast elkaar op de Gut day in Gent en hadden na jouw idee geleidelijk aan het ene 
na het andere experimentje tot gevolg. Zo ontstond hoofdstuk 6 en een leuke publicatie, 
bedankt voor deze samenwerking. 
Door de promotiejaren heen heb ik op verschillende laboratoria en gastlaboratoria binnen 
het Radboudumc gewerkt. Die gastvrijheid en samenwerking waren onmisbaar voor dit 
proefschrift. Wilbert Peters en analisten Hennie en Rene van het Laboratorium Maag, 
Darm en Leverziekten, bedankt voor de mogelijkheid om bij jullie te celkweken en de 
ultracentrifuge te gebruiken. Peter Hermans en Marien de Jonge van lab Kindergeneeskunde 
en infectieziekten (LKI), bedankt voor de vele uren die ik bij jullie op het ML-II lab 
mocht werken. Daarnaast waren de tips, interacties en discussies op het lab en tijdens de 
werkbesprekingen erg nuttig en een meerwaarde voor dit proefschrift. Eigenlijk wil ik jullie 
allen bij naam noemen, maar dat zou een lange lijst worden. Daarom veel dank aan alle 
LKI-collega’s en ook dank aan de collega’s van het lab Kindergeneeskunde en oncologie 
(LKO)! Het eerste jaar van mijn promotietraject waren we onderdeel van het Laboratorium 
Klinische Chemie (LKC), een dank aan de collega’s waarmee we toen het lab deelden. 
Daarna werd het Laboratorium Genetische Endocriene en Metabole ziekten mijn thuislab. 
Ook hier ontstonden waardevolle samenwerkingen en kwam er hulp vanuit de verschillende 
onderzoeksgroepen en diagnostiekgroepen op verscheidene vlakken, die allen bijdroegen 
aan dit proefschrift. Daarnaast, vooral de collega’s aan de Q-kant, ook bedankt voor de 
gezelligheid op het lab, tijdens de pauzes en bij uitjes. In het bijzonder noem ik daarin 
mijn collega’s van de Neurochemie Research, de verschillende activiteiten, o.a. de Efteling, 
pubquizzes, barbecue en diner rouler waren gezellig. En wat was het een eer om de hoofdrol 
te spelen in de speelfilm ‘Toren Q’… Marcel, nu heeft de palindroom ‘Nelli plaatst op ene 
parterretrap ene pot staalpillen’ het toch nog tot in mijn proefschrift geschopt. 
Het was vaak hard werken, maar er was gelukkig ook een fijn privéleven en ruimte voor vrije 
tijd. Als ik terugdenk aan mijn eerste tijd in Nijmegen, denk ik meteen aan QHarmony. Dit 
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leuke studentenorkest maakte mede dat ik me snel thuis voelde in Nijmegen en zorgde voor 
fijne vriendschappen tot op heden en voor in de toekomst. Beste vrienden, bedankt daarvoor 
en voor de ontspanning bij het fijne muziek maken samen, en daarbuiten bij bijvoorbeeld 
feestjes, uitstapjes en spelletjes spelen. Ik kan me eigenlijk geen leven zonder muziek maken 
voorstellen. In de afgelopen jaren was het ook een belangrijke vorm van ontspanning en vaak 
een goede reden om het werk even te laten liggen. Daarom een bedankt alle muziekvrienden 
en bekenden van QHarmony, het Symfonisch Blaasorkest Nijmegen, Philharmonie Gelre, 
de Sint Plechelmusharmonie en De Luttermuzikanten. Ode aan de muziek! 
Tot slot, maar heel belangrijk, nog even terug naar mijn roots in De Lutte. Mijn broers 
Roel en Stef, ook heel erg bedankt. Sinds ik in Nijmegen woon zien we elkaar minder vaak 
dan vroeger, maar als we bij elkaar zijn is het zeker gezellig, met vaak de nodige ongein. 
Leuk en bedankt dat jullie nu mijn paranimfen willen zijn! Lieve Pap en Mam, wat zou een 
dankwoord zijn zonder jullie te noemen. Jullie hebben mede gemaakt dat ik hier sta en het is 
erg fijn dat ik altijd bij jullie terecht kan. Ontzettend bedankt voor jullie steun, vertrouwen, 
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